DATE ADDED TO CATALOG	PUBMEDID	FIRST AUTHOR	DATE	JOURNAL	LINK	STUDY	DISEASE/TRAIT	INITIAL SAMPLE SIZE	REPLICATION SAMPLE SIZE	REGION	CHR_ID	CHR_POS	REPORTED GENE(S)	MAPPED_GENE	UPSTREAM_GENE_ID	DOWNSTREAM_GENE_ID	SNP_GENE_IDS	UPSTREAM_GENE_DISTANCE	DOWNSTREAM_GENE_DISTANCE	STRONGEST SNP-RISK ALLELE	SNPS	MERGED	SNP_ID_CURRENT	CONTEXT	INTERGENIC	RISK ALLELE FREQUENCY	P-VALUE	PVALUE_MLOG	P-VALUE (TEXT)	OR or BETA	95% CI (TEXT)	PLATFORM [SNPS PASSING QC]	CNV
2010-05-05	20383146	Kottgen A	2010-04-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20383146	New loci associated with kidney function and chronic kidney disease.	Chronic kidney disease	Up to 67,093 European ancestry individuals	Up to 22,982 European ancestry individuals	10p15.3	10	1110225	WDR37	WDR37			ENSG00000047056	NA	NA	rs10794720-T	rs10794720	0	10794720	intron_variant	0	0.08	1E-8	8	(eGFRcrea)	0.01	[0.010-0.018] unit decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-05-05	20383146	Kottgen A	2010-04-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20383146	New loci associated with kidney function and chronic kidney disease.	Chronic kidney disease	Up to 67,093 European ancestry individuals	Up to 22,982 European ancestry individuals	15q21.3	15	53654396	WDR72	WDR72			ENSG00000166415	NA	NA	rs491567-C	rs491567	0	491567	intron_variant	0	0.22	3E-13	12.5228787452803	(eGFRcrea)	0.01	[0.005-0.013] unit increase	Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-05-05	20383146	Kottgen A	2010-04-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20383146	New loci associated with kidney function and chronic kidney disease.	Chronic kidney disease	Up to 67,093 European ancestry individuals	Up to 22,982 European ancestry individuals	9q21.11	9	68819791	PIP5K1B, FAM122A	PIP5K1B			ENSG00000107242	NA	NA	rs4744712-A	rs4744712	0	4744712	intron_variant	0	0.39	8E-14	13.0969100130081	(eGFRcrea)	0.01	[0.008-0.016] unit decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-05-05	20383146	Kottgen A	2010-04-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20383146	New loci associated with kidney function and chronic kidney disease.	Chronic kidney disease	Up to 67,093 European ancestry individuals	Up to 22,982 European ancestry individuals	1p13.3	1	109457216	AMIGO1, SORT1, ATXN7L2, SYPL2, CYB561D1, PSMA5	PSMA5 - SYPL2	ENSG00000143106	ENSG00000143028		30768	9330	rs1933182-A	rs1933182	0	1933182	intergenic_variant	1	0.3	1E-7	7	(eGFRcrea)	0.01	[0.006-0.010] unit decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-05-05	20383146	Kottgen A	2010-04-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20383146	New loci associated with kidney function and chronic kidney disease.	Chronic kidney disease	Up to 67,093 European ancestry individuals	Up to 22,982 European ancestry individuals	13q21.33	13	71773564	DACH1	DACH1			ENSG00000276644	NA	NA	rs626277-C	rs626277	0	626277	intron_variant	0	0.4	3E-11	10.5228787452803	(eGFRcrea)	0.01	[0.007-0.011] unit increase	Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-05-05	20383146	Kottgen A	2010-04-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20383146	New loci associated with kidney function and chronic kidney disease.	Chronic kidney disease	Up to 67,093 European ancestry individuals	Up to 22,982 European ancestry individuals	15q24.2	15	75866642	UBE2Q2, FBX022	UBE2Q2			ENSG00000140367	NA	NA	rs1394125-A	rs1394125	0	1394125	intron_variant	0	0.35	3E-17	16.5228787452803	(eGFRcrea)	0.01	[0.007-0.011] unit decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-05-05	20383146	Kottgen A	2010-04-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20383146	New loci associated with kidney function and chronic kidney disease.	Chronic kidney disease	Up to 67,093 European ancestry individuals	Up to 22,982 European ancestry individuals	17q23.2	17	61379228	BCAS3, TBX2, C17orf82	BCAS3, AC005746.2			ENSG00000141376, ENSG00000267131	NA	NA	rs9895661-C	rs9895661	0	9895661	non_coding_transcript_exon_variant	0	0.19	1E-15	15	(eGFRcrea)	0.01	[0.007-0.015] unit decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-05-05	20383146	Kottgen A	2010-04-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20383146	New loci associated with kidney function and chronic kidney disease.	Chronic kidney disease	Up to 67,093 European ancestry individuals	Up to 22,982 European ancestry individuals	2p25.2	2	5767748	SOX11	AC010729.1 - LINC01810	ENSG00000236106	ENSG00000237266		37393	42893	rs16864170-C	rs16864170	0	16864170	intergenic_variant	1	0.05	2E-7	6.69897000433602	(CKD)	1.3	[1.18-1.43]	Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-05-05	20383146	Kottgen A	2010-04-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20383146	New loci associated with kidney function and chronic kidney disease.	Chronic kidney disease	Up to 67,093 European ancestry individuals	Up to 22,982 European ancestry individuals	3q23	3	142088295	TFDP2	TFDP2			ENSG00000114126	NA	NA	rs347685-C	rs347685	0	347685	intron_variant	0	0.28	3E-11	10.5228787452803	(eGFRcrea)	1.09	[0.007-0.011] unit increase	Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-05-05	20383146	Kottgen A	2010-04-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20383146	New loci associated with kidney function and chronic kidney disease.	Chronic kidney disease	Up to 67,093 European ancestry individuals	Up to 22,982 European ancestry individuals	1q21.3	1	150979001	SETDB1, LASS2, ANXA9, PRUNE, FAM63A, BNIPL	AL590133.1 - ANXA9	ENSG00000231073	ENSG00000143412		3467	3248	rs267734-C	rs267734	0	267734	regulatory_region_variant	1	0.2	1E-12	12	(eGFRcrea)	0.01	[0.004-0.016] unit increase	Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-05-05	20383146	Kottgen A	2010-04-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20383146	New loci associated with kidney function and chronic kidney disease.	Chronic kidney disease	Up to 67,093 European ancestry individuals	Up to 22,982 European ancestry individuals	19q13.11	19	32865985	CCDC123, ECAT8, SLC7A9	SLC7A9			ENSG00000021488	NA	NA	rs12460876-C	rs12460876	0	12460876	intron_variant	0	0.39	3E-15	14.5228787452803	(eGFRcrea)	0.01	[0.006-0.01] unit increase	Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-05-05	20383146	Kottgen A	2010-04-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20383146	New loci associated with kidney function and chronic kidney disease.	Chronic kidney disease	Up to 67,093 European ancestry individuals	Up to 22,982 European ancestry individuals	6q25.3	6	160247357	SLC22A2	SLC22A2			ENSG00000112499	NA	NA	rs2279463-G	rs2279463	0	2279463	intron_variant	0	0.12	6E-12	11.2218487496164	(eGFRcrea)	0.01	[0.009-0.017] unit decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-05-05	20383146	Kottgen A	2010-04-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20383146	New loci associated with kidney function and chronic kidney disease.	Chronic kidney disease	Up to 67,093 European ancestry individuals	Up to 22,982 European ancestry individuals	12p13.33	12	240132	SLC6A13, JARID1A, SLC6A12	SLC6A13			ENSG00000010379	NA	NA	rs10774021-C	rs10774021	0	10774021	intron_variant	0	0.36	1E-9	9	(eGFRcrea)	1.05	[0.006-0.010] unit increase	Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-05-05	20383146	Kottgen A	2010-04-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20383146	New loci associated with kidney function and chronic kidney disease.	Chronic kidney disease	Up to 67,093 European ancestry individuals	Up to 22,982 European ancestry individuals	6p21.1	6	43838872	VEGFA	AL157371.2			ENSG00000283573	NA	NA	rs881858-G	rs881858	0	881858	intron_variant	0	0.28	9E-14	13.0457574905607	(eGFRcrea)	1.08	[0.007-0.015] unit increase	Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-05-05	20383146	Kottgen A	2010-04-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20383146	New loci associated with kidney function and chronic kidney disease.	Chronic kidney disease	Up to 67,093 European ancestry individuals	Up to 22,982 European ancestry individuals	7q36.1	7	151710715	PRKAG2	PRKAG2			ENSG00000106617	NA	NA	rs7805747-A	rs7805747	0	7805747	intron_variant	0	0.24	4E-12	11.397940008672	(CKD)	1.18	[1.12-1.25]	Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-05-05	20383146	Kottgen A	2010-04-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20383146	New loci associated with kidney function and chronic kidney disease.	Chronic kidney disease	Up to 67,093 European ancestry individuals	Up to 22,982 European ancestry individuals	11q13.1	11	65739351	RNASEH2C, KAT5, OVOL1	KRT8P26 - AP001266.2	ENSG00000214659	ENSG00000255557		11137	6378	rs4014195-G	rs4014195	0	4014195	intergenic_variant	1	0.35	1E-7	7	(eGFRcrea)	0.01	[0.006-0.010] unit decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-05-05	20383146	Kottgen A	2010-04-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20383146	New loci associated with kidney function and chronic kidney disease.	Chronic kidney disease	Up to 67,093 European ancestry individuals	Up to 22,982 European ancestry individuals	2p13.1	2	73641201	NAT8, NAT8B, ALMS1	ALMS1P1, NAT8			ENSG00000163016, ENSG00000144035	NA	NA	rs13538-G	rs13538	0	13538	missense_variant	0	0.23	5E-14	13.301029995664	(eGFRcrea)	0.01	[0.005-0.013] unit increase	Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-05-05	20383146	Kottgen A	2010-04-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20383146	New loci associated with kidney function and chronic kidney disease.	Chronic kidney disease	Up to 67,093 European ancestry individuals	Up to 22,982 European ancestry individuals	7q11.23	7	77787122	PHTF2, RSBN1L, TMEM60	RSBN1L - TMEM60	ENSG00000187257	ENSG00000135211		4100	6606	rs6465825-C	rs6465825	0	6465825	intergenic_variant	1	0.39	2E-9	8.69897000433602	(eGFRcrea)	0.01	[0.006-0.01] unit decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-05-05	20383146	Kottgen A	2010-04-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20383146	New loci associated with kidney function and chronic kidney disease.	Chronic kidney disease	Up to 67,093 European ancestry individuals	Up to 22,982 European ancestry individuals	4q21.1	4	76447694	CCDC158, SHROOM3	SHROOM3			ENSG00000138771	NA	NA	rs17319721-A	rs17319721	0	17319721	intron_variant	0	0.43	1E-19	19	(eGFRcrea)	NA		Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-05-05	20383146	Kottgen A	2010-04-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20383146	New loci associated with kidney function and chronic kidney disease.	Chronic kidney disease	Up to 67,093 European ancestry individuals	Up to 22,982 European ancestry individuals	15q21.1	15	45349027	SPATA5L1, GATM	AC051619.2 - RNU6-953P	ENSG00000259433	ENSG00000238941		16393	5752	rs2453533-?	rs2453533	0	2453533	intergenic_variant	1	0.38	5E-22	21.301029995664	(eGFRcrea)	NA		Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-05-05	20383146	Kottgen A	2010-04-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20383146	New loci associated with kidney function and chronic kidney disease.	Chronic kidney disease	Up to 67,093 European ancestry individuals	Up to 22,982 European ancestry individuals	16p12.3	16	20356368	UMOD, ACSM5, GP2, PDILT	UMOD - PDILT	ENSG00000169344	ENSG00000169340		67	2807	rs12917707-T	rs12917707	0	12917707	intergenic_variant	1	0.18	1E-20	20	(eGFRcrea)	NA		Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-05-05	20383146	Kottgen A	2010-04-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20383146	New loci associated with kidney function and chronic kidney disease.	Chronic kidney disease	Up to 67,093 European ancestry individuals	Up to 22,982 European ancestry individuals	8p21.2	8	23893638	STC1	STC1 - RNU1-148P	ENSG00000159167	ENSG00000207201		38832	183359	rs10109414-T	rs10109414	0	10109414	regulatory_region_variant	1	0.42	1E-8	8	(eGFRcrea)	NA		Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-05-05	20383146	Kottgen A	2010-04-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20383146	New loci associated with kidney function and chronic kidney disease.	Chronic kidney disease	Up to 67,093 European ancestry individuals	Up to 22,982 European ancestry individuals	20p11.21	20	23632100	CST9, CST3, CST4	CST3, AL121894.2			ENSG00000101439, ENSG00000270001	NA	NA	rs911119-?	rs911119	0	911119	non_coding_transcript_exon_variant	0	0.21	2E-138	137.698970004336	(eGFRcys)	NA		Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-05-05	20383146	Kottgen A	2010-04-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20383146	New loci associated with kidney function and chronic kidney disease.	Chronic kidney disease	Up to 67,093 European ancestry individuals	Up to 22,982 European ancestry individuals	2p23.3	2	27508073	FNDC4, IFT172, GCKR	GCKR			ENSG00000084734	NA	NA	rs1260326-T	rs1260326	0	1260326	missense_variant	0	0.41	3E-14	13.5228787452803	(eGFRcrea)	0.01	[0.007-0.011] unit increase	Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-05-05	20383146	Kottgen A	2010-04-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20383146	New loci associated with kidney function and chronic kidney disease.	Chronic kidney disease	Up to 67,093 European ancestry individuals	Up to 22,982 European ancestry individuals	5p13.1	5	39397030	DAB2, C9	DAB2, C9			ENSG00000153071, ENSG00000113600	NA	NA	rs11959928-A	rs11959928	0	11959928	intron_variant	0	0.44	1E-7	7	(eGFRcrea)	0.01	[0.007-0.011] unit decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-05-05	20383146	Kottgen A	2010-04-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20383146	New loci associated with kidney function and chronic kidney disease.	Chronic kidney disease	Up to 67,093 European ancestry individuals	Up to 22,982 European ancestry individuals	5q35.3	5	177390635	RGS14, PRR7, PFN3, GRK6, SLC34A1, F12, LMAN2	SLC34A1			ENSG00000131183	NA	NA	rs6420094-G	rs6420094	0	6420094	intron_variant	0	0.34	1E-14	14	(eGFRcrea)	0.01	[0.007-0.015] unit decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-05-05	20383146	Kottgen A	2010-04-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20383146	New loci associated with kidney function and chronic kidney disease.	Chronic kidney disease	Up to 67,093 European ancestry individuals	Up to 22,982 European ancestry individuals	12q24.12	12	111569952	ATXN2	ATXN2			ENSG00000204842	NA	NA	rs653178-T	rs653178	0	653178	intron_variant	0	0.5	4E-11	10.397940008672	(eGFRcys)	0.01	[0.009-0.017] unit increase	Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-05-05	20383146	Kottgen A	2010-04-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20383146	New loci associated with kidney function and chronic kidney disease.	Chronic kidney disease	Up to 67,093 European ancestry individuals	Up to 22,982 European ancestry individuals	2q34	2	210675783	CPS1	CPS1			ENSG00000021826	NA	NA	rs7422339-A	rs7422339	1	1047891	missense_variant	0	0.32	1E-15	15	(eGFRcrea)	0.01	[0.005-0.013] unit decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N
2012-05-24	22479191	Pattaro C	2012-03-29	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/22479191	Genome-wide association and functional follow-up reveals new loci for kidney function.	Chronic kidney disease	74,354  European ancestry individuals	56,246 European ancestry individuals	11p14.1	11	30738788	MPPED2	MPPED2-AS1 - AL122014.1	ENSG00000254489	ENSG00000287373		106205	35125	rs3925584-?	rs3925584	0	3925584	intergenic_variant	1	NR	8E-18	17.0969100130081		0.0075	[0.0057-0.0093] ml/min/1.73m^2 decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N
2012-05-24	22479191	Pattaro C	2012-03-29	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/22479191	Genome-wide association and functional follow-up reveals new loci for kidney function.	Chronic kidney disease	74,354  European ancestry individuals	56,246 European ancestry individuals	2p24.3	2	15722878	DDX1	LINC01804			ENSG00000231031	NA	NA	rs6431731-?	rs6431731	0	6431731	intron_variant	0	NR	4E-8	7.39794000867204		0.0127	[0.0082-0.0172] ml/min/1.73m^2 decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-09-11	20686651	Gudbjartsson DF	2010-07-29	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/20686651	Association of variants at UMOD with chronic kidney disease and kidney stones-role of age and comorbid diseases.	Chronic kidney disease and serum creatinine levels	1,689 European ancestry cases, 37,076 European ancestry controls	1,972 European ancestry cases, 6,125 European ancestry controls	16p12.3	16	20353266	UMOD	UMOD			ENSG00000169344	NA	NA	rs4293393-T	rs4293393	0	4293393	intron_variant	0	0.798	4E-10	9.39794000867204	(CKD)	1.25	[1.17-1.35]	Illumina [~ 2500000] (imputed)	N
2010-09-11	20686651	Gudbjartsson DF	2010-07-29	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/20686651	Association of variants at UMOD with chronic kidney disease and kidney stones-role of age and comorbid diseases.	Chronic kidney disease and serum creatinine levels	1,689 European ancestry cases, 37,076 European ancestry controls	1,972 European ancestry cases, 6,125 European ancestry controls	5p12	5	45197677	NR	AC114954.1 - AC116350.1	ENSG00000248148	ENSG00000287540		99030	28609	rs10941694-A	rs10941694	0	10941694	intergenic_variant	1	0.06	9E-6	5.04575749056067	(CKD)	1.35	[1.19-1.56]	Illumina [~ 2500000] (imputed)	N
2010-09-11	20686651	Gudbjartsson DF	2010-07-29	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/20686651	Association of variants at UMOD with chronic kidney disease and kidney stones-role of age and comorbid diseases.	Chronic kidney disease and serum creatinine levels	1,689 European ancestry cases, 37,076 European ancestry controls	1,972 European ancestry cases, 6,125 European ancestry controls	3p24.3	3	23052083	NR	SALL4P5 - RPL24P7	ENSG00000231915	ENSG00000215016		60501	82289	rs9310709-C	rs9310709	0	9310709	regulatory_region_variant	1	0.41	2E-6	5.69897000433602	(CKD)	1.15	[1.09-1.22]	Illumina [~ 2500000] (imputed)	N
2010-09-11	20686651	Gudbjartsson DF	2010-07-29	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/20686651	Association of variants at UMOD with chronic kidney disease and kidney stones-role of age and comorbid diseases.	Chronic kidney disease and serum creatinine levels	1,689 European ancestry cases, 37,076 European ancestry controls	1,972 European ancestry cases, 6,125 European ancestry controls	3q12.1	3	99547493	NR	AC107029.1 - AC107029.2	ENSG00000243089	ENSG00000244464		17508	50571	rs13070584-T	rs13070584	0	13070584	intergenic_variant	1	0.05	2E-6	5.69897000433602	(CKD)	1.42	[1.23-1.65]	Illumina [~ 2500000] (imputed)	N
2009-05-27	19430482	Kottgen A	2009-05-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19430482	Multiple loci associated with indices of renal function and chronic kidney disease.	Renal function and chronic kidney disease	2,388 European ancestry cases, 17,489 European ancestry controls	1,932 cases, 19,534 controls	16p12.3	16	20356368	UMOD	UMOD - PDILT	ENSG00000169344	ENSG00000169340		67	2807	rs12917707-T	rs12917707	0	12917707	intergenic_variant	1	0.18	5E-16	15.301029995664	(eGFRcrea)	0.02	[0.014-0.022] ml/min/1.73m2 increase	Affymetrix, Illumina [~ 2500000] (imputed)	N
2009-05-27	19430482	Kottgen A	2009-05-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19430482	Multiple loci associated with indices of renal function and chronic kidney disease.	Renal function and chronic kidney disease	2,388 European ancestry cases, 17,489 European ancestry controls	1,932 cases, 19,534 controls	15q21.1	15	45406595	SPATA5L1, GATM	SPATA5L1			ENSG00000171763	NA	NA	rs2467853-G	rs2467853	0	2467853	intron_variant	0	0.38	6E-14	13.2218487496164	(eGFRcrea)	0.01	[0.009-0.017] ml/min/1.73m2 decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N
2009-05-27	19430482	Kottgen A	2009-05-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19430482	Multiple loci associated with indices of renal function and chronic kidney disease.	Renal function and chronic kidney disease	2,388 European ancestry cases, 17,489 European ancestry controls	1,932 cases, 19,534 controls	16p12.3	16	20356368	UMOD	UMOD - PDILT	ENSG00000169344	ENSG00000169340		67	2807	rs12917707-G	rs12917707	0	12917707	intergenic_variant	1	0.82	2E-12	11.698970004336	(CKD)	1.25	[1.18-1.33]	Affymetrix, Illumina [~ 2500000] (imputed)	N
2009-05-27	19430482	Kottgen A	2009-05-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19430482	Multiple loci associated with indices of renal function and chronic kidney disease.	Renal function and chronic kidney disease	2,388 European ancestry cases, 17,489 European ancestry controls	1,932 cases, 19,534 controls	4q21.1	4	76447694	SHROOM3	SHROOM3			ENSG00000138771	NA	NA	rs17319721-A	rs17319721	0	17319721	intron_variant	0	0.44	1E-12	12	(eGFRcrea)	0.01	[0.008-0.016] ml/min/1.73m2 decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N
2014-08-05	24351856	Nanayakkara S	2013-12-18	J Occup Health	www.ncbi.nlm.nih.gov/pubmed/24351856	An integrative study of the genetic, social and environmental determinants of chronic kidney disease characterized by tubulointerstitial damages in the North Central Region of Sri Lanka.	Chronic kidney disease	301 Sri Lankan Sinhalese ancestry cases, 276 Sri Lankan Sinhalese ancestry controls	NA	20q13.12	20	46659814	SLC13A3	SLC13A3			ENSG00000158296	NA	NA	rs6066043-G	rs6066043	0	6066043	intron_variant	0	0.62	2E-9	8.69897000433602		2.13	[NR]	Illumina [543848]	N
2016-11-25	26831199	Pattaro C	2016-01-21	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26831199	Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function.	Chronic kidney disease	12,385 European ancestry cases, 104,780 European ancestry controls	33,972 European ancestry individuals	2q24.3	2	163327819	FIGN	RNU6-627P - FIGN	ENSG00000200902	ENSG00000182263		38723	265577	rs1032843-T	rs1032843	0	1032843	intergenic_variant	1	0.07	6E-6	5.22184874961636		0.1174	[0.067-0.168] unit increase	Affymetrix, Illumina [~ 2500000] (imputed)	N
2016-11-25	26831199	Pattaro C	2016-01-21	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26831199	Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function.	Chronic kidney disease	12,385 European ancestry cases, 104,780 European ancestry controls	33,972 European ancestry individuals	11p11.2	11	47325172	MADD	MADD			ENSG00000110514	NA	NA	rs11039182-T	rs11039182	0	11039182	intron_variant	0	0.7	3E-6	5.52287874528034		0.0678	[0.040-0.096] unit decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N
2016-11-25	26831199	Pattaro C	2016-01-21	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26831199	Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function.	Chronic kidney disease	12,385 European ancestry cases, 104,780 European ancestry controls	33,972 European ancestry individuals	2q34	2	210675783	CPS1	CPS1			ENSG00000021826	NA	NA	rs7422339-A	rs7422339	1	1047891	missense_variant	0	0.32	8E-9	8.09691001300806		1.11	[1.07-1.15]	Affymetrix, Illumina [~ 2500000] (imputed)	N
2016-11-25	26831199	Pattaro C	2016-01-21	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26831199	Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function.	Chronic kidney disease	12,385 European ancestry cases, 104,780 European ancestry controls	33,972 European ancestry individuals	4q21.1	4	76447694	SHROOM3	SHROOM3			ENSG00000138771	NA	NA	rs17319721-A	rs17319721	0	17319721	intron_variant	0	0.43	8E-6	5.09691001300806		1.07	[1.04-1.10]	Affymetrix, Illumina [~ 2500000] (imputed)	N
2016-11-25	26831199	Pattaro C	2016-01-21	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26831199	Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function.	Chronic kidney disease	12,385 European ancestry cases, 104,780 European ancestry controls	33,972 European ancestry individuals	5q35.3	5	177390635	SLC34A1	SLC34A1			ENSG00000131183	NA	NA	rs6420094-G	rs6420094	0	6420094	intron_variant	0	0.34	4E-9	8.39794000867204		1.098901	[1.06-1.14]	Affymetrix, Illumina [~ 2500000] (imputed)	N
2016-11-25	26831199	Pattaro C	2016-01-21	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26831199	Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function.	Chronic kidney disease	12,385 European ancestry cases, 104,780 European ancestry controls	33,972 European ancestry individuals	7q36.1	7	151710715	PRKAG2	PRKAG2			ENSG00000106617	NA	NA	rs7805747-A	rs7805747	0	7805747	intron_variant	0	0.25	2E-14	13.698970004336		1.16	[1.11-1.20]	Affymetrix, Illumina [~ 2500000] (imputed)	N
2016-11-25	26831199	Pattaro C	2016-01-21	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26831199	Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function.	Chronic kidney disease	12,385 European ancestry cases, 104,780 European ancestry controls	33,972 European ancestry individuals	10p15.3	10	1019770	WDR37	GTPBP4, IDI2			ENSG00000107937, ENSG00000148377	NA	NA	rs1044261-T	rs1044261	0	1044261	stop_gained	0	0.08	4E-7	6.39794000867204		1.15	[1.09-1.22]	Affymetrix, Illumina [~ 2500000] (imputed)	N
2016-11-25	26831199	Pattaro C	2016-01-21	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26831199	Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function.	Chronic kidney disease	12,385 European ancestry cases, 104,780 European ancestry controls	33,972 European ancestry individuals	11p14.1	11	30727543	MPPED2	MPPED2-AS1 - AL122014.1	ENSG00000254489	ENSG00000287373		94960	46370	rs963837-T	rs963837	0	963837	intergenic_variant	1	0.54	9E-8	7.04575749056067		1.09	[1.05-1.12]	Affymetrix, Illumina [~ 2500000] (imputed)	N
2016-11-25	26831199	Pattaro C	2016-01-21	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26831199	Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function.	Chronic kidney disease	12,385 European ancestry cases, 104,780 European ancestry controls	33,972 European ancestry individuals	15q21.1	15	45406595	GATM	SPATA5L1			ENSG00000171763	NA	NA	rs2467853-G	rs2467853	0	2467853	intron_variant	0	0.38	2E-11	10.698970004336		1.1111112	[1.08-1.15]	Affymetrix, Illumina [~ 2500000] (imputed)	N
2016-11-25	26831199	Pattaro C	2016-01-21	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26831199	Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function.	Chronic kidney disease	12,385 European ancestry cases, 104,780 European ancestry controls	33,972 European ancestry individuals	16p12.3	16	20355185	UMOD	UMOD			ENSG00000169344	NA	NA	rs13329952-T	rs13329952	0	13329952	intron_variant	0	0.81	2E-25	24.698970004336		1.24	[1.19-1.29]	Affymetrix, Illumina [~ 2500000] (imputed)	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	950 African American cases, 50 African American diabetic controls, 1,887 African American non-diabetic controls, 471 American Indian ancestry cases, 340 American Indian ancestry diabetic controls, 486 American Indian ancestry non-diabetic controls, 582 European ancestry ancestry cases, 205 European ancestry diabetic controls, 2,568 European ancestry non-diabetic controls	11q21	11	94990459	KDM4D	KDM4D			ENSG00000186280	NA	NA	rs12285658-?	rs12285658	0	12285658	intron_variant	0	0.9	4E-6	5.39794000867204	(AA, dominant )	1.4285715		Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	950 African American cases, 50 African American diabetic controls, 1,887 African American non-diabetic controls, 471 American Indian ancestry cases, 340 American Indian ancestry diabetic controls, 486 American Indian ancestry non-diabetic controls, 582 European ancestry ancestry cases, 205 European ancestry diabetic controls, 2,568 European ancestry non-diabetic controls	11p15.1	11	18717171	IGSF22	IGSF22, AC103974.1			ENSG00000179057, ENSG00000254966	NA	NA	rs10766496-?	rs10766496	0	10766496	intron_variant	0	0.79	5E-6	5.30102999566398	(AA, dominant )	1.3333333		Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	950 African American cases, 50 African American diabetic controls, 1,887 African American non-diabetic controls, 471 American Indian ancestry cases, 340 American Indian ancestry diabetic controls, 486 American Indian ancestry non-diabetic controls, 582 European ancestry ancestry cases, 205 European ancestry diabetic controls, 2,568 European ancestry non-diabetic controls	6q25.2	6	154633286	SCAF8, CNKSR3	AL591419.1 - AL591499.1	ENSG00000231316	ENSG00000205625		27332	73357	rs12523822-?	rs12523822	0	12523822	intergenic_variant	1	0.74	6E-9	8.22184874961636	(American Indian, dominant )	1.754386		Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	950 African American cases, 50 African American diabetic controls, 1,887 African American non-diabetic controls, 471 American Indian ancestry cases, 340 American Indian ancestry diabetic controls, 486 American Indian ancestry non-diabetic controls, 582 European ancestry ancestry cases, 205 European ancestry diabetic controls, 2,568 European ancestry non-diabetic controls	8q24.13	8	123077286	WDR67	TBC1D31			ENSG00000156787	NA	NA	rs13254600-?	rs13254600	0	13254600	intron_variant	0	0.77	6E-8	7.22184874961636	(American Indian, dominant )	1.724138		Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	950 African American cases, 50 African American diabetic controls, 1,887 African American non-diabetic controls, 471 American Indian ancestry cases, 340 American Indian ancestry diabetic controls, 486 American Indian ancestry non-diabetic controls, 582 European ancestry ancestry cases, 205 European ancestry diabetic controls, 2,568 European ancestry non-diabetic controls	7q36.1	7	152565713	XRCC2	LINC01003 - AC104843.2	ENSG00000261455	ENSG00000231139		100164	24928	rs10952362-C	rs10952362	0	10952362	regulatory_region_variant	1	0.5	2E-7	6.69897000433602	(American Indian, additive )	1.42	[1.24-1.63]	Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	950 African American cases, 50 African American diabetic controls, 1,887 African American non-diabetic controls, 471 American Indian ancestry cases, 340 American Indian ancestry diabetic controls, 486 American Indian ancestry non-diabetic controls, 582 European ancestry ancestry cases, 205 European ancestry diabetic controls, 2,568 European ancestry non-diabetic controls	4q32.1	4	155712034	GUCY1A3	GUCY1A1			ENSG00000164116	NA	NA	rs10019835-?	rs10019835	0	10019835	intron_variant	0	0.63	5E-7	6.30102999566398	(American Indian, additive )	1.4285715		Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	950 African American cases, 50 African American diabetic controls, 1,887 African American non-diabetic controls, 471 American Indian ancestry cases, 340 American Indian ancestry diabetic controls, 486 American Indian ancestry non-diabetic controls, 582 European ancestry ancestry cases, 205 European ancestry diabetic controls, 2,568 European ancestry non-diabetic controls	2q24.2	2	162832637	KCNH7	KCNH7			ENSG00000184611	NA	NA	rs4667466-T	rs4667466	0	4667466	intron_variant	0	0.39	1E-6	6	(American Indian, additive )	1.39	[1.21-1.58]	Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	950 African American cases, 50 African American diabetic controls, 1,887 African American non-diabetic controls, 471 American Indian ancestry cases, 340 American Indian ancestry diabetic controls, 486 American Indian ancestry non-diabetic controls, 582 European ancestry ancestry cases, 205 European ancestry diabetic controls, 2,568 European ancestry non-diabetic controls	3p14.1	3	67407074	SUCLG2	SUCLG2			ENSG00000172340	NA	NA	rs4453858-?	rs4453858	0	4453858	intron_variant	0	0.41	2E-6	5.69897000433602	(American Indian, additive )	1.4084507		Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	950 African American cases, 50 African American diabetic controls, 1,887 African American non-diabetic controls, 471 American Indian ancestry cases, 340 American Indian ancestry diabetic controls, 486 American Indian ancestry non-diabetic controls, 582 European ancestry ancestry cases, 205 European ancestry diabetic controls, 2,568 European ancestry non-diabetic controls	12q23.3	12	107407624	BTBD11	BTBD11			ENSG00000151136	NA	NA	rs10778560-C	rs10778560	0	10778560	intron_variant	0	0.07	2E-6	5.69897000433602	(American Indian, dominant )	2.11	[1.56-2.86]	Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	950 African American cases, 50 African American diabetic controls, 1,887 African American non-diabetic controls, 471 American Indian ancestry cases, 340 American Indian ancestry diabetic controls, 486 American Indian ancestry non-diabetic controls, 582 European ancestry ancestry cases, 205 European ancestry diabetic controls, 2,568 European ancestry non-diabetic controls	2q31.1	2	172453843	ITGA6	ITGA6			ENSG00000091409	NA	NA	rs13421350-?	rs13421350	0	13421350	intron_variant	0	0.85	3E-6	5.52287874528034	(American Indian, additive )	1.5873016		Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	950 African American cases, 50 African American diabetic controls, 1,887 African American non-diabetic controls, 471 American Indian ancestry cases, 340 American Indian ancestry diabetic controls, 486 American Indian ancestry non-diabetic controls, 582 European ancestry ancestry cases, 205 European ancestry diabetic controls, 2,568 European ancestry non-diabetic controls	3q13.31	3	117045163	NR	LSAMP			ENSG00000185565	NA	NA	rs12497655-?	rs12497655	0	12497655	intron_variant	0	0.73	3E-6	5.52287874528034	(American Indian, additive )	1.4285715		Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	950 African American cases, 50 African American diabetic controls, 1,887 African American non-diabetic controls, 471 American Indian ancestry cases, 340 American Indian ancestry diabetic controls, 486 American Indian ancestry non-diabetic controls, 582 European ancestry ancestry cases, 205 European ancestry diabetic controls, 2,568 European ancestry non-diabetic controls	8p23.2	8	6124750	NR	AC009435.1			ENSG00000253880	NA	NA	rs2077212-G	rs2077212	0	2077212	intron_variant	0	0.48	4E-6	5.39794000867204	(American Indian, additive )	1.36	[1.20-1.55]	Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	950 African American cases, 50 African American diabetic controls, 1,887 African American non-diabetic controls, 471 American Indian ancestry cases, 340 American Indian ancestry diabetic controls, 486 American Indian ancestry non-diabetic controls, 582 European ancestry ancestry cases, 205 European ancestry diabetic controls, 2,568 European ancestry non-diabetic controls	12q24.21	12	115716849	MED13L	AC009803.1 - RN7SL865P	ENSG00000257407	ENSG00000240205		77115	876	rs7975752-G	rs7975752	0	7975752	intergenic_variant	1	0.25	2E-6	5.69897000433602	(Mexican, dominant )	1.76	[1.39-2.21]	Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	950 African American cases, 50 African American diabetic controls, 1,887 African American non-diabetic controls, 471 American Indian ancestry cases, 340 American Indian ancestry diabetic controls, 486 American Indian ancestry non-diabetic controls, 582 European ancestry ancestry cases, 205 European ancestry diabetic controls, 2,568 European ancestry non-diabetic controls	7q35	7	147709170	CNTNAP2	CNTNAP2			ENSG00000174469	NA	NA	rs731565-T	rs731565	0	731565	intron_variant	0	0.2	4E-6	5.39794000867204	(Mexican, additive )	1.58	[1.30-1.92]	Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	950 African American cases, 50 African American diabetic controls, 1,887 African American non-diabetic controls, 471 American Indian ancestry cases, 340 American Indian ancestry diabetic controls, 486 American Indian ancestry non-diabetic controls, 582 European ancestry ancestry cases, 205 European ancestry diabetic controls, 2,568 European ancestry non-diabetic controls	16q12.2	16	55180181	NR	AC109136.1 - AC109462.1	ENSG00000285775	ENSG00000259283		130863	79788	rs728571-?	rs728571	0	728571	regulatory_region_variant	1	0.61	6E-6	5.22184874961636	(Mexican, additive )	1.4925373		Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	950 African American cases, 50 African American diabetic controls, 1,887 African American non-diabetic controls, 471 American Indian ancestry cases, 340 American Indian ancestry diabetic controls, 486 American Indian ancestry non-diabetic controls, 582 European ancestry ancestry cases, 205 European ancestry diabetic controls, 2,568 European ancestry non-diabetic controls	2p25.2	2	4561337	SOX11	NPM1P48 - LINC01249	ENSG00000231821	ENSG00000231532		46281	66879	rs4849965-C	rs4849965	0	4849965	regulatory_region_variant	1	0.28	6E-6	5.22184874961636	(Mexican, additive )	1.5	[1.26-1.79]	Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	950 African American cases, 50 African American diabetic controls, 1,887 African American non-diabetic controls, 471 American Indian ancestry cases, 340 American Indian ancestry diabetic controls, 486 American Indian ancestry non-diabetic controls, 582 European ancestry ancestry cases, 205 European ancestry diabetic controls, 2,568 European ancestry non-diabetic controls	4p13	4	42855556	NR	AC096734.1 - RN7SKP82	ENSG00000251517	ENSG00000252595		148221	36840	rs10004231-?	rs10004231	0	10004231	intergenic_variant	1	0.78	8E-6	5.09691001300806	(Mexican, recessive )	5.882353		Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	950 African American cases, 50 African American diabetic controls, 1,887 African American non-diabetic controls, 471 American Indian ancestry cases, 340 American Indian ancestry diabetic controls, 486 American Indian ancestry non-diabetic controls, 582 European ancestry ancestry cases, 205 European ancestry diabetic controls, 2,568 European ancestry non-diabetic controls	6p24.2	6	11101685	SMIM13	SMIM13			ENSG00000224531	NA	NA	rs6910061-A	rs6910061	0	6910061	intron_variant	0	0.11	9E-6	5.04575749056067	(Mexican, additive )	1.74	[1.36-2.22]	Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	950 African American cases, 50 African American diabetic controls, 1,887 African American non-diabetic controls, 471 American Indian ancestry cases, 340 American Indian ancestry diabetic controls, 486 American Indian ancestry non-diabetic controls, 582 European ancestry ancestry cases, 205 European ancestry diabetic controls, 2,568 European ancestry non-diabetic controls	17p13.1	17	9484136	NR	STX8			ENSG00000170310	NA	NA	rs2168858-?	rs2168858	0	2168858	intron_variant	0	0.58	5E-6	5.30102999566398	(Mexican, additive )	1.4705882	[1.25-1.72]	Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	950 African American cases, 50 African American diabetic controls, 1,887 African American non-diabetic controls, 471 American Indian ancestry cases, 340 American Indian ancestry diabetic controls, 486 American Indian ancestry non-diabetic controls, 582 European ancestry ancestry cases, 205 European ancestry diabetic controls, 2,568 European ancestry non-diabetic controls	12q24.21	12	115725627	NR	RN7SL865P - AC009387.1	ENSG00000240205	ENSG00000257781		7614	29635	rs1424609-G	rs1424609	0	1424609	intergenic_variant	1	0.21	5E-6	5.30102999566398	(Mexican, dominant )	1.72	[1.36-2.18]	Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	950 African American cases, 50 African American diabetic controls, 1,887 African American non-diabetic controls, 471 American Indian ancestry cases, 340 American Indian ancestry diabetic controls, 486 American Indian ancestry non-diabetic controls, 582 European ancestry ancestry cases, 205 European ancestry diabetic controls, 2,568 European ancestry non-diabetic controls	6q25.2	6	154626274	intergenic	AL591419.1 - AL591499.1	ENSG00000231316	ENSG00000205625		20320	80369	rs955333-?	rs955333	0	955333	intergenic_variant	1	NR	1E-8	8	(additive )	1.369863		Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	950 African American cases, 50 African American diabetic controls, 1,887 African American non-diabetic controls, 471 American Indian ancestry cases, 340 American Indian ancestry diabetic controls, 486 American Indian ancestry non-diabetic controls, 582 European ancestry ancestry cases, 205 European ancestry diabetic controls, 2,568 European ancestry non-diabetic controls	22q12.3	22	36312438	MYH9	MYH9			ENSG00000100345	NA	NA	rs5750250-G	rs5750250	0	5750250	intron_variant	0	NR	8E-8	7.09691001300806	(additive )	1.27	[1.16-1.38]	Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	950 African American cases, 50 African American diabetic controls, 1,887 African American non-diabetic controls, 471 American Indian ancestry cases, 340 American Indian ancestry diabetic controls, 486 American Indian ancestry non-diabetic controls, 582 European ancestry ancestry cases, 205 European ancestry diabetic controls, 2,568 European ancestry non-diabetic controls	22q12.3	22	36261386	APOL1	APOL1			ENSG00000100342	NA	NA	rs136161-G	rs136161	0	136161	intron_variant	0	NR	2E-6	5.69897000433602	(recessive )	1.27	[1.10-1.46]	Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	950 African American cases, 50 African American diabetic controls, 1,887 African American non-diabetic controls, 471 American Indian ancestry cases, 340 American Indian ancestry diabetic controls, 486 American Indian ancestry non-diabetic controls, 582 European ancestry ancestry cases, 205 European ancestry diabetic controls, 2,568 European ancestry non-diabetic controls	12q21.2	12	77971000	NAV3	NAV3			ENSG00000067798	NA	NA	rs11107616-C	rs11107616	0	11107616	intron_variant	0	NR	1E-6	6	(additive )	1.38	[1.21-1.57]	Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	950 African American cases, 50 African American diabetic controls, 1,887 African American non-diabetic controls, 471 American Indian ancestry cases, 340 American Indian ancestry diabetic controls, 486 American Indian ancestry non-diabetic controls, 582 European ancestry ancestry cases, 205 European ancestry diabetic controls, 2,568 European ancestry non-diabetic controls	11q21	11	94990459	KDM4D	KDM4D			ENSG00000186280	NA	NA	rs12285658-?	rs12285658	0	12285658	intron_variant	0	NR	2E-6	5.69897000433602	(dominant )	1.6129031		Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	950 African American cases, 50 African American diabetic controls, 1,887 African American non-diabetic controls, 471 American Indian ancestry cases, 340 American Indian ancestry diabetic controls, 486 American Indian ancestry non-diabetic controls, 582 European ancestry ancestry cases, 205 European ancestry diabetic controls, 2,568 European ancestry non-diabetic controls	9p13.3	9	33205410	intergenic	B4GALT1-AS1 - SPINK4	ENSG00000233554	ENSG00000122711		22545	12955	rs4879670-G	rs4879670	0	4879670	intergenic_variant	1	NR	2E-6	5.69897000433602	(additive )	1.15	[1.09-1.22]	Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	950 African American cases, 50 African American diabetic controls, 1,887 African American non-diabetic controls, 471 American Indian ancestry cases, 340 American Indian ancestry diabetic controls, 486 American Indian ancestry non-diabetic controls, 582 European ancestry ancestry cases, 205 European ancestry diabetic controls, 2,568 European ancestry non-diabetic controls	1p31.1	1	82754973	intergenic	AL157944.1			ENSG00000233290	NA	NA	rs11582609-?	rs11582609	0	11582609	intron_variant	0	NR	3E-6	5.52287874528034	(dominant )	1.2345679		Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	950 African American cases, 50 African American diabetic controls, 1,887 African American non-diabetic controls, 471 American Indian ancestry cases, 340 American Indian ancestry diabetic controls, 486 American Indian ancestry non-diabetic controls, 582 European ancestry ancestry cases, 205 European ancestry diabetic controls, 2,568 European ancestry non-diabetic controls	10q25.1	10	105003805	SORCS3	SORCS3			ENSG00000156395	NA	NA	rs1997066-?	rs1997066	0	1997066	intron_variant	0	NR	4E-6	5.39794000867204	(dominant )	1.4705882		Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	950 African American cases, 50 African American diabetic controls, 1,887 African American non-diabetic controls, 471 American Indian ancestry cases, 340 American Indian ancestry diabetic controls, 486 American Indian ancestry non-diabetic controls, 582 European ancestry ancestry cases, 205 European ancestry diabetic controls, 2,568 European ancestry non-diabetic controls	8q23.3	8	112103668	intergenic	LINC02237 - RNU4-37P	ENSG00000253434	ENSG00000222146		345958	45074	rs13259109-G	rs13259109	0	13259109	intergenic_variant	1	NR	5E-6	5.30102999566398	(additive )	1.19	[1.11-1.27]	Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	950 African American cases, 50 African American diabetic controls, 1,887 African American non-diabetic controls, 471 American Indian ancestry cases, 340 American Indian ancestry diabetic controls, 486 American Indian ancestry non-diabetic controls, 582 European ancestry ancestry cases, 205 European ancestry diabetic controls, 2,568 European ancestry non-diabetic controls	2q24.3	2	165898043	TTC21B	TTC21B			ENSG00000123607	NA	NA	rs6432852-?	rs6432852	0	6432852	intron_variant	0	NR	5E-6	5.30102999566398	(additive )	1.1764705		Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	950 African American cases, 50 African American diabetic controls, 1,887 African American non-diabetic controls, 471 American Indian ancestry cases, 340 American Indian ancestry diabetic controls, 486 American Indian ancestry non-diabetic controls, 582 European ancestry ancestry cases, 205 European ancestry diabetic controls, 2,568 European ancestry non-diabetic controls	22q12.3	22	36312438	MYH9	MYH9			ENSG00000100345	NA	NA	rs5750250-G	rs5750250	0	5750250	intron_variant	0	0.52	8E-8	7.09691001300806	(AA, additive )	1.27	[1.16-1.38]	Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	950 African American cases, 50 African American diabetic controls, 1,887 African American non-diabetic controls, 471 American Indian ancestry cases, 340 American Indian ancestry diabetic controls, 486 American Indian ancestry non-diabetic controls, 582 European ancestry ancestry cases, 205 European ancestry diabetic controls, 2,568 European ancestry non-diabetic controls	22q12.3	22	36261386	APOL1	APOL1			ENSG00000100342	NA	NA	rs136161-G	rs136161	0	136161	intron_variant	0	0.74	5E-7	6.30102999566398	(AA, recessive )	1.36	[1.21-1.54]	Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	950 African American cases, 50 African American diabetic controls, 1,887 African American non-diabetic controls, 471 American Indian ancestry cases, 340 American Indian ancestry diabetic controls, 486 American Indian ancestry non-diabetic controls, 582 European ancestry ancestry cases, 205 European ancestry diabetic controls, 2,568 European ancestry non-diabetic controls	10q22.3	10	80253378	MAT1A, ANXA11	AL359195.2			ENSG00000279359	NA	NA	rs1298908-G	rs1298908	0	1298908	non_coding_transcript_exon_variant	0	0.22	9E-7	6.04575749056067	(AA, dominant )	1.36	[1.21-1.54]	Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	950 African American cases, 50 African American diabetic controls, 1,887 African American non-diabetic controls, 471 American Indian ancestry cases, 340 American Indian ancestry diabetic controls, 486 American Indian ancestry non-diabetic controls, 582 European ancestry ancestry cases, 205 European ancestry diabetic controls, 2,568 European ancestry non-diabetic controls	3p26.1	3	4504140	ITPR1	ITPR1			ENSG00000150995	NA	NA	rs304029-G	rs304029	0	304029	intron_variant	0	0.28	1E-6	6	(AA, additive )	1.26	[1.15-1.38]	Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	950 African American cases, 50 African American diabetic controls, 1,887 African American non-diabetic controls, 471 American Indian ancestry cases, 340 American Indian ancestry diabetic controls, 486 American Indian ancestry non-diabetic controls, 582 European ancestry ancestry cases, 205 European ancestry diabetic controls, 2,568 European ancestry non-diabetic controls	6q26	6	160957160	NR	AL139393.1			ENSG00000231863	NA	NA	rs590884-?	rs590884	0	590884	intron_variant	0	0.66	2E-6	5.69897000433602	(AA, additive )	1.25		Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	950 African American cases, 50 African American diabetic controls, 1,887 African American non-diabetic controls, 471 American Indian ancestry cases, 340 American Indian ancestry diabetic controls, 486 American Indian ancestry non-diabetic controls, 582 European ancestry ancestry cases, 205 European ancestry diabetic controls, 2,568 European ancestry non-diabetic controls	17p11.2	17	16913342	NR	AL353996.1 - TBC1D27P	ENSG00000265853	ENSG00000128438		19913	9573	rs8067287-?	rs8067287	0	8067287	intergenic_variant	1	0.78	2E-6	5.69897000433602	(AA, recessive )	2.0833335		Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	950 African American cases, 50 African American diabetic controls, 1,887 African American non-diabetic controls, 471 American Indian ancestry cases, 340 American Indian ancestry diabetic controls, 486 American Indian ancestry non-diabetic controls, 582 European ancestry ancestry cases, 205 European ancestry diabetic controls, 2,568 European ancestry non-diabetic controls	7p15.3	7	22375027	NR	RAPGEF5 - STEAP1B	ENSG00000136237	ENSG00000105889		17873	44417	rs6943931-?	rs6943931	0	6943931	intergenic_variant	1	0.72	2E-6	5.69897000433602	(AA, dominant )	1.3333333		Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	950 African American cases, 50 African American diabetic controls, 1,887 African American non-diabetic controls, 471 American Indian ancestry cases, 340 American Indian ancestry diabetic controls, 486 American Indian ancestry non-diabetic controls, 582 European ancestry ancestry cases, 205 European ancestry diabetic controls, 2,568 European ancestry non-diabetic controls	13q12.12	13	23641873	TNFRSF19	TNFRSF19			ENSG00000127863	NA	NA	rs9510795-A	rs9510795	0	9510795	intron_variant	0	0.61	4E-6	5.39794000867204	(AA, additive )	1.23	[1.13-1.34]	Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	up to 1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	NA	1p31.3	1	64863417	NR	JAK1			ENSG00000162434	NA	NA	rs2780902-?	rs2780902	0	2780902	intron_variant	0	0.41	3E-7	6.52287874528034	(African American, dominant)	1.923077	[1.52-2.5]	Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	up to 1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	NA	3q13.2	3	112672327	NR	CCDC80 - AC048334.1	ENSG00000091986	ENSG00000242308		22797	24581	rs1249910-?	rs1249910	0	1249910	intergenic_variant	1	0.35	1E-6	6	(African American, dominant)	2.0408163	[1.54-2.78]	Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	up to 1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	NA	11q14.1	11	80707921	NR	ARL6IP1P3 - LINC02720	ENSG00000255014	ENSG00000255178		53933	43279	rs1945380-?	rs1945380	0	1945380	intergenic_variant	1	0.5	2E-6	5.69897000433602	(African American, additive)	1.3888888	[1.22-1.59]	Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	up to 1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	NA	1p21.3	1	95559990	NR	LINC02607			ENSG00000228971	NA	NA	rs1396626-?	rs1396626	0	1396626	intron_variant	0	0.51	3E-6	5.52287874528034	(African American, recessive)	1.724138	[1.37-2.17]	Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	up to 1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	NA	6q16.1	6	96082223	NR	FUT9			ENSG00000172461	NA	NA	rs4598084-?	rs4598084	0	4598084	intron_variant	0	0.64	3E-6	5.52287874528034	(African American, recessive)	1.6666665	[1.33-2.04]	Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	up to 1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	NA	7q34	7	139971318	NR	TBXAS1			ENSG00000059377	NA	NA	rs6962291-?	rs6962291	0	6962291	intron_variant	0	0.6	5E-6	5.30102999566398	(African American, additive)	1.3888888	[1.2-1.61]	Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	up to 1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	NA	15q14	15	33428525	NR	RYR3			ENSG00000198838	NA	NA	rs2596230-G	rs2596230	0	2596230	intron_variant	0	0.14	9E-6	5.04575749056067	(African American, additive)	1.56	1.28-1.89	Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	up to 1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	NA	14q32.2	14	97067025	NR	AL049833.4 - AL049833.2	ENSG00000288034	ENSG00000259026		59401	43391	rs8020941-?	rs8020941	0	8020941	intergenic_variant	1	0.78	9E-6	5.04575749056067	(African American, dominant)	1.5625	[1.28-1.92]	Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	up to 1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	NA	12q21.2	12	77944156	NR	NAV3			ENSG00000067798	NA	NA	rs1677894-G	rs1677894	0	1677894	intron_variant	0	NR	9E-6	5.04575749056067	(additive)	1.44	1.22-1.70	Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	up to 1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	NA	12q21.33	12	91053746	NR	KERA			ENSG00000139330	NA	NA	rs11105956-?	rs11105956	0	11105956	intron_variant	0	NR	6E-6	5.22184874961636	(additive)	1.3513513	[1.18-1.54]	Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	up to 1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	NA	13q13.1	13	32990725	NR	TOMM22P3 - KL	ENSG00000227604	ENSG00000133116		36324	25698	rs490049-?	rs490049	0	490049	intergenic_variant	1	NR	2E-6	5.69897000433602	(dominant)	2	[1.37-2.94]	Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	up to 1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	NA	15q26.3	15	101457786	NR	PCSK6			ENSG00000140479	NA	NA	rs903552-?	rs903552	0	903552	intron_variant	0	NR	2E-6	5.69897000433602	(dominant)	1.3513513	[1.18-1.54]	Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	up to 1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	NA	1q25.3	1	182996532	NR	RNU6-41P - LAMC1	ENSG00000207472	ENSG00000135862		14214	26888	rs10911184-?	rs10911184	0	10911184	intergenic_variant	1	NR	5E-6	5.30102999566398	(additive)	1.2345679	[1.11-1.35]	Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	up to 1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	NA	3q13.2	3	112672327	NR	CCDC80 - AC048334.1	ENSG00000091986	ENSG00000242308		22797	24581	rs1249910-?	rs1249910	0	1249910	intergenic_variant	1	NR	8E-6	5.09691001300806	(dominant)	1.3888888	[1.19-1.61]	Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	up to 1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	NA	4q22.3	4	96021887	NR	RNU6-1059P - RNU6-34P	ENSG00000200622	ENSG00000201744		153123	130410	rs13120432-?	rs13120432	0	13120432	intergenic_variant	1	NR	4E-6	5.39794000867204	(dominant)	1.5384616	[1.25-1.92]	Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	up to 1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	NA	6p21.1	6	42944851	NR	AL035587.1			ENSG00000231113	NA	NA	rs6927188-?	rs6927188	0	6927188	intron_variant	0	NR	6E-6	5.22184874961636	(additive)	1.3513513	[1.18-1.54]	Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	up to 1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	NA	6p25.1	6	6552761	NR	LY86-AS1			ENSG00000216863	NA	NA	rs594074-?	rs594074	0	594074	intron_variant	0	NR	5E-6	5.30102999566398	(dominant)	1.4084507	[1.22-1.64]	Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	up to 1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	NA	7p21.2	7	15200269	NR	AC006458.1 - AGMO	ENSG00000227489	ENSG00000187546		131618	48	rs12531478-A	rs12531478	0	12531478	intergenic_variant	1	NR	4E-6	5.39794000867204	(additive)	2.24	1.59-3.15	Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	up to 1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	NA	7q11.21	7	66134209	NR	CRCP, AC068533.4, AC068533.3			ENSG00000241258, ENSG00000249319, ENSG00000234185	NA	NA	rs2243480-?	rs2243480	0	2243480	intron_variant	0	NR	8E-6	5.09691001300806	(additive)	1.4084507	[1.2-1.64]	Affymetrix [NR]	N
2016-08-16	26305897	Iyengar SK	2015-08-25	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/26305897	Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).	Diabetic kidney disease	up to 1,564 African American cases, 369  African American diabetic controls, 1,288 African American non-diabetic controls, 538 American Indian ancestry cases, 319 American Indian ancestry diabetic controls, 342 European ancestry cases, 404 European ancestry diabetic controls, 779 Mexican ancestry cases, 594 Mexican ancestry diabetic controls	NA	8q21.13	8	75313281	NR	CASC9			ENSG00000249395	NA	NA	rs17373728-C	rs17373728	0	17373728	intron_variant	0	NR	2E-6	5.69897000433602	(additive)	1.34	1.19-1.52	Affymetrix [NR]	N
2016-09-12	26420894	Wuttke M	2015-09-28	Nephrol Dial Transplant	www.ncbi.nlm.nih.gov/pubmed/26420894	Genetic loci associated with renal function measures and chronic kidney disease in children: the Pediatric Investigation for Genetic Factors Linked with Renal Progression Consortium.	Glomerular filtration rate in chronic kidney disease	up to 744 Central European ancestry child cases, up to 397 Turkish ancestry child cases	NA	14q24.1	14	67497454	TMEM229B	TMEM229B			ENSG00000198133	NA	NA	rs12898179-C	rs12898179	0	12898179	intron_variant	0	0.79	9E-6	5.04575749056067		0.08	[0.041-0.119] unit decrease	Illumina [~ 8300000] (imputed)	N
2016-09-12	26420894	Wuttke M	2015-09-28	Nephrol Dial Transplant	www.ncbi.nlm.nih.gov/pubmed/26420894	Genetic loci associated with renal function measures and chronic kidney disease in children: the Pediatric Investigation for Genetic Factors Linked with Renal Progression Consortium.	Glomerular filtration rate in chronic kidney disease	up to 744 Central European ancestry child cases, up to 397 Turkish ancestry child cases	NA	16p13.3	16	1923515	HS3ST6, MSRB1	HS3ST6 - MSRB1	ENSG00000162040	ENSG00000198736		5100	14695	rs344364-A	rs344364	0	344364	regulatory_region_variant	1	0.22	5E-6	5.30102999566398		0.08	[0.041-0.119] unit increase	Illumina [~ 8300000] (imputed)	N
2016-09-12	26420894	Wuttke M	2015-09-28	Nephrol Dial Transplant	www.ncbi.nlm.nih.gov/pubmed/26420894	Genetic loci associated with renal function measures and chronic kidney disease in children: the Pediatric Investigation for Genetic Factors Linked with Renal Progression Consortium.	Glomerular filtration rate in chronic kidney disease	up to 744 Central European ancestry child cases, up to 397 Turkish ancestry child cases	NA	20p13	20	2510563	ZNF343, TMC2	ZNF343			ENSG00000088876	NA	NA	rs6036759-A	rs6036759	0	6036759	intron_variant	0	0.41	2E-6	5.69897000433602		0.07	[0.05-0.09] unit increase	Illumina [~ 8300000] (imputed)	N
2016-09-12	26420894	Wuttke M	2015-09-28	Nephrol Dial Transplant	www.ncbi.nlm.nih.gov/pubmed/26420894	Genetic loci associated with renal function measures and chronic kidney disease in children: the Pediatric Investigation for Genetic Factors Linked with Renal Progression Consortium.	Glomerular filtration rate in chronic kidney disease	up to 744 Central European ancestry child cases, up to 397 Turkish ancestry child cases	NA	2q24.3	2	164629468	GRB14, COBLL1	GRB14 - COBLL1	ENSG00000115290	ENSG00000082438		7986	24156	rs4487103-C	rs4487103	0	4487103	intergenic_variant	1	0.6	2E-6	5.69897000433602	(EA)	0.08	[0.041-0.119] unit decrease	Illumina [~ 8300000] (imputed)	N
2016-09-12	26420894	Wuttke M	2015-09-28	Nephrol Dial Transplant	www.ncbi.nlm.nih.gov/pubmed/26420894	Genetic loci associated with renal function measures and chronic kidney disease in children: the Pediatric Investigation for Genetic Factors Linked with Renal Progression Consortium.	Glomerular filtration rate in chronic kidney disease	up to 744 Central European ancestry child cases, up to 397 Turkish ancestry child cases	NA	4p15.32	4	16118049	PROM1, TAPT1	AC108063.2 - TAPT1	ENSG00000286280	ENSG00000169762		570	42456	rs894638-C	rs894638	0	894638	intergenic_variant	1	0.19	8E-6	5.09691001300806	(EA)	0.1	[0.061-0.139] unit decrease	Illumina [~ 8300000] (imputed)	N
2016-09-12	26420894	Wuttke M	2015-09-28	Nephrol Dial Transplant	www.ncbi.nlm.nih.gov/pubmed/26420894	Genetic loci associated with renal function measures and chronic kidney disease in children: the Pediatric Investigation for Genetic Factors Linked with Renal Progression Consortium.	Glomerular filtration rate in chronic kidney disease	up to 744 Central European ancestry child cases, up to 397 Turkish ancestry child cases	NA	4q32.3	4	165929313	TLL1	TLL1			ENSG00000038295	NA	NA	rs7674118-T	rs7674118	0	7674118	intron_variant	0	0.1	1E-6	6	(EA)	0.15	[0.091-0.209] unit decrease	Illumina [~ 8300000] (imputed)	N
2016-09-12	26420894	Wuttke M	2015-09-28	Nephrol Dial Transplant	www.ncbi.nlm.nih.gov/pubmed/26420894	Genetic loci associated with renal function measures and chronic kidney disease in children: the Pediatric Investigation for Genetic Factors Linked with Renal Progression Consortium.	Glomerular filtration rate in chronic kidney disease	up to 744 Central European ancestry child cases, up to 397 Turkish ancestry child cases	NA	5q14.3	5	89309812	MEF2C	MEF2C-AS1			ENSG00000248309	NA	NA	rs10054413-G	rs10054413	0	10054413	intron_variant	0	0.14	5E-6	5.30102999566398	(EA)	0.12	[0.061-0.179] unit decrease	Illumina [~ 8300000] (imputed)	N
2016-09-12	26420894	Wuttke M	2015-09-28	Nephrol Dial Transplant	www.ncbi.nlm.nih.gov/pubmed/26420894	Genetic loci associated with renal function measures and chronic kidney disease in children: the Pediatric Investigation for Genetic Factors Linked with Renal Progression Consortium.	Glomerular filtration rate in chronic kidney disease	up to 744 Central European ancestry child cases, up to 397 Turkish ancestry child cases	NA	6q23.2	6	134503073	LOC154092	CT69, LINC01010			ENSG00000231971, ENSG00000236700	NA	NA	rs10872424-T	rs10872424	0	10872424	non_coding_transcript_exon_variant	0	0.14	4E-6	5.39794000867204	(EA)	0.12	[0.061-0.179] unit decrease	Illumina [~ 8300000] (imputed)	N
2016-09-12	26420894	Wuttke M	2015-09-28	Nephrol Dial Transplant	www.ncbi.nlm.nih.gov/pubmed/26420894	Genetic loci associated with renal function measures and chronic kidney disease in children: the Pediatric Investigation for Genetic Factors Linked with Renal Progression Consortium.	Glomerular filtration rate in chronic kidney disease	up to 744 Central European ancestry child cases, up to 397 Turkish ancestry child cases	NA	2p22.3	2	33948334	MYADML	LINC01320			ENSG00000228262	NA	NA	rs11677592-T	rs11677592	0	11677592	intron_variant	0	0.37	6E-6	5.22184874961636	(Turkish ancestry)	0.13	[0.071-0.189] unit decrease	Illumina [~ 8300000] (imputed)	N
2016-09-12	26420894	Wuttke M	2015-09-28	Nephrol Dial Transplant	www.ncbi.nlm.nih.gov/pubmed/26420894	Genetic loci associated with renal function measures and chronic kidney disease in children: the Pediatric Investigation for Genetic Factors Linked with Renal Progression Consortium.	Glomerular filtration rate in chronic kidney disease	up to 744 Central European ancestry child cases, up to 397 Turkish ancestry child cases	NA	2p11.2	2	86441699	KDM3A	KDM3A			ENSG00000115548	NA	NA	rs111226991-A	rs111226991	0	111226991	intron_variant	0	0.14	6E-6	5.22184874961636	(Turkish ancestry)	0.18	[0.1-0.26] unit increase	Illumina [~ 8300000] (imputed)	N
2016-09-12	26420894	Wuttke M	2015-09-28	Nephrol Dial Transplant	www.ncbi.nlm.nih.gov/pubmed/26420894	Genetic loci associated with renal function measures and chronic kidney disease in children: the Pediatric Investigation for Genetic Factors Linked with Renal Progression Consortium.	Glomerular filtration rate in chronic kidney disease	up to 744 Central European ancestry child cases, up to 397 Turkish ancestry child cases	NA	2p11.2	2	86549112	CHMP3, RNF103-CHMP3	RNF103-CHMP3, CHMP3			ENSG00000249884, ENSG00000115561	NA	NA	rs181394970-T	rs181394970	0	181394970	intron_variant	0	0.14	4E-6	5.39794000867204	(Turkish ancestry)	0.19	[0.11-0.27] unit increase	Illumina [~ 8300000] (imputed)	N
2016-09-12	26420894	Wuttke M	2015-09-28	Nephrol Dial Transplant	www.ncbi.nlm.nih.gov/pubmed/26420894	Genetic loci associated with renal function measures and chronic kidney disease in children: the Pediatric Investigation for Genetic Factors Linked with Renal Progression Consortium.	Glomerular filtration rate in chronic kidney disease	up to 744 Central European ancestry child cases, up to 397 Turkish ancestry child cases	NA	5p13.3	5	29489684	LSP1P3	LINC02064 - AC027345.1	ENSG00000248391	ENSG00000276098		93589	26321	rs13180077-G	rs13180077	0	13180077	intergenic_variant	1	0.65	6E-6	5.22184874961636	(Turkish ancestry)	0.14	[0.081-0.199] unit increase	Illumina [~ 8300000] (imputed)	N
2016-09-12	26420894	Wuttke M	2015-09-28	Nephrol Dial Transplant	www.ncbi.nlm.nih.gov/pubmed/26420894	Genetic loci associated with renal function measures and chronic kidney disease in children: the Pediatric Investigation for Genetic Factors Linked with Renal Progression Consortium.	Glomerular filtration rate in chronic kidney disease	up to 744 Central European ancestry child cases, up to 397 Turkish ancestry child cases	NA	9q22.32	9	96167968	LOC158434, HSD17B3	EIF4BP3 - HSD17B3	ENSG00000224546	ENSG00000130948		20112	67338	rs9785234-G	rs9785234	0	9785234	intergenic_variant	1	0.28	9E-6	5.04575749056067	(Turkish ancestry)	0.13	[0.071-0.189] unit increase	Illumina [~ 8300000] (imputed)	N
2016-09-12	26420894	Wuttke M	2015-09-28	Nephrol Dial Transplant	www.ncbi.nlm.nih.gov/pubmed/26420894	Genetic loci associated with renal function measures and chronic kidney disease in children: the Pediatric Investigation for Genetic Factors Linked with Renal Progression Consortium.	Glomerular filtration rate in chronic kidney disease	up to 744 Central European ancestry child cases, up to 397 Turkish ancestry child cases	NA	9q33.2	9	122458945	OR1J1, PTGS1	AL359636.2			ENSG00000234156	NA	NA	rs1771792-C	rs1771792	0	1771792	intron_variant	0	0.9	4E-6	5.39794000867204	(Turkish ancestry)	0.21	[0.11-0.31] unit decrease	Illumina [~ 8300000] (imputed)	N
2016-09-12	26420894	Wuttke M	2015-09-28	Nephrol Dial Transplant	www.ncbi.nlm.nih.gov/pubmed/26420894	Genetic loci associated with renal function measures and chronic kidney disease in children: the Pediatric Investigation for Genetic Factors Linked with Renal Progression Consortium.	Glomerular filtration rate in chronic kidney disease	up to 744 Central European ancestry child cases, up to 397 Turkish ancestry child cases	NA	3p12.2	3	80386640	ROBO1	HNRNPA3P8 - AC108740.1	ENSG00000239699	ENSG00000242586		169406	55441	rs12635820-T	rs12635820	0	12635820	intergenic_variant	1	0.33	2E-6	5.69897000433602	(Turkish ancestry)	0.14	[0.081-0.199] unit increase	Illumina [~ 8300000] (imputed)	N
2016-05-17	26083657	Stafford-Smith M	2015-06-17	Kidney Int	www.ncbi.nlm.nih.gov/pubmed/26083657	Genome-wide association study of acute kidney injury after coronary bypass graft surgery identifies susceptibility loci.	Acute kidney injury in coronary artery bypass surgery (creatinine rise)	873 European ancestry cases	380 European ancestry cases	1p31.1	1	78354261	MGC27382	PTGFR, AC096531.2			ENSG00000122420, ENSG00000237413	NA	NA	rs2352039-A	rs2352039	0	2352039	intron_variant	0	0.156	2E-6	5.69897000433602		8.9	[5.2-12.6] unit increase	Illumina [530716] (imputed)	N
2016-05-17	26083657	Stafford-Smith M	2015-06-17	Kidney Int	www.ncbi.nlm.nih.gov/pubmed/26083657	Genome-wide association study of acute kidney injury after coronary bypass graft surgery identifies susceptibility loci.	Acute kidney injury in coronary artery bypass surgery (creatinine rise)	873 European ancestry cases	380 European ancestry cases	3p25.3	3	8100265	GRM7, LMCD1-AS1	AC018832.1, LMCD1-AS1			ENSG00000228351, ENSG00000227110	NA	NA	rs13317787-A	rs13317787	0	13317787	intron_variant	0	0.028	5E-7	6.30102999566398		21.66	[13.19-30.13] unit increase	Illumina [530716] (imputed)	N
2016-05-17	26083657	Stafford-Smith M	2015-06-17	Kidney Int	www.ncbi.nlm.nih.gov/pubmed/26083657	Genome-wide association study of acute kidney injury after coronary bypass graft surgery identifies susceptibility loci.	Acute kidney injury in coronary artery bypass surgery (creatinine rise)	873 European ancestry cases	380 European ancestry cases	7p14.3	7	33510429	BBS9	BBS9			ENSG00000122507	NA	NA	rs10262995-A	rs10262995	0	10262995	intron_variant	0	0.087	2E-7	6.69897000433602		12.84	[7.98-17.7] unit increase	Illumina [530716] (imputed)	N
2016-09-12	26420894	Wuttke M	2015-09-28	Nephrol Dial Transplant	www.ncbi.nlm.nih.gov/pubmed/26420894	Genetic loci associated with renal function measures and chronic kidney disease in children: the Pediatric Investigation for Genetic Factors Linked with Renal Progression Consortium.	Proteinuria in chronic kidney disease	up to 744 European ancestry child cases, up to 397 Turkish ancestry child cases	NA	6q23.1	6	130194349	SAMD3	SAMD3			ENSG00000164483	NA	NA	rs61201007-T	rs61201007	0	61201007	intron_variant	0	0.37	9E-6	5.04575749056067		1.54	[1.271.87]	Illumina [~ 8300000] (imputed)	N
2016-09-12	26420894	Wuttke M	2015-09-28	Nephrol Dial Transplant	www.ncbi.nlm.nih.gov/pubmed/26420894	Genetic loci associated with renal function measures and chronic kidney disease in children: the Pediatric Investigation for Genetic Factors Linked with Renal Progression Consortium.	Proteinuria in chronic kidney disease	up to 744 European ancestry child cases, up to 397 Turkish ancestry child cases	NA	11q24.1	11	123318295	MIR4493, CLMP	LINC02727 - PHBP17	ENSG00000254823	ENSG00000254407		2955	21879	rs55847827-G	rs55847827	0	55847827	intergenic_variant	1	0.18	7E-6	5.15490195998574		1.8	[1.392.32]	Illumina [~ 8300000] (imputed)	N
2016-09-12	26420894	Wuttke M	2015-09-28	Nephrol Dial Transplant	www.ncbi.nlm.nih.gov/pubmed/26420894	Genetic loci associated with renal function measures and chronic kidney disease in children: the Pediatric Investigation for Genetic Factors Linked with Renal Progression Consortium.	Proteinuria in chronic kidney disease	up to 744 European ancestry child cases, up to 397 Turkish ancestry child cases	NA	15q21.3	15	55016808	RSL24D1, UNC13C	UNC13C - AC025272.1	ENSG00000137766	ENSG00000260937		383394	39915	rs76158983-?	rs76158983	0	76158983	intergenic_variant	1	0.95	5E-6	5.30102999566398		2.86	[1.82-4.55]	Illumina [~ 8300000] (imputed)	N
2016-09-12	26420894	Wuttke M	2015-09-28	Nephrol Dial Transplant	www.ncbi.nlm.nih.gov/pubmed/26420894	Genetic loci associated with renal function measures and chronic kidney disease in children: the Pediatric Investigation for Genetic Factors Linked with Renal Progression Consortium.	Proteinuria in chronic kidney disease	up to 744 European ancestry child cases, up to 397 Turkish ancestry child cases	NA	5q14.1	5	80538468	FAM151B	FAM151B			ENSG00000152380	NA	NA	rs145768835-?	rs145768835	0	145768835	intron_variant	0	0.82	7E-6	5.15490195998574		1.82	[1.41-2.38]	Illumina [~ 8300000] (imputed)	N
2016-09-12	26420894	Wuttke M	2015-09-28	Nephrol Dial Transplant	www.ncbi.nlm.nih.gov/pubmed/26420894	Genetic loci associated with renal function measures and chronic kidney disease in children: the Pediatric Investigation for Genetic Factors Linked with Renal Progression Consortium.	Chronic kidney disease	658 European ancestry child cases, 1,347 European ancestry child controls	NA	11q23.2	11	113948030	HTR3B, HTR3A	HTR3B			ENSG00000149305	NA	NA	rs7129190-?	rs7129190	0	7129190	3_prime_UTR_variant	0	0.47	5E-6	5.30102999566398		1.41	[1.20-1.61]	Illumina [~ 8300000] (imputed)	N
2016-09-12	26420894	Wuttke M	2015-09-28	Nephrol Dial Transplant	www.ncbi.nlm.nih.gov/pubmed/26420894	Genetic loci associated with renal function measures and chronic kidney disease in children: the Pediatric Investigation for Genetic Factors Linked with Renal Progression Consortium.	Chronic kidney disease	658 European ancestry child cases, 1,347 European ancestry child controls	NA	16p13.2	16	9735991	GRIN2A	AC007218.1 - GRIN2A	ENSG00000260362	ENSG00000183454		59148	17413	rs6497441-T	rs6497441	0	6497441	intergenic_variant	1	0.29	5E-6	5.30102999566398		1.44	[1.231.69]	Illumina [~ 8300000] (imputed)	N
2016-09-12	26420894	Wuttke M	2015-09-28	Nephrol Dial Transplant	www.ncbi.nlm.nih.gov/pubmed/26420894	Genetic loci associated with renal function measures and chronic kidney disease in children: the Pediatric Investigation for Genetic Factors Linked with Renal Progression Consortium.	Chronic kidney disease	658 European ancestry child cases, 1,347 European ancestry child controls	NA	20p12.3	20	8109993	PLCB1, TMX4	PLCB1			ENSG00000182621	NA	NA	rs8117834-T	rs8117834	0	8117834	intron_variant	0	0.14	6E-6	5.22184874961636		1.68	[1.342.10]	Illumina [~ 8300000] (imputed)	N
2016-09-12	26420894	Wuttke M	2015-09-28	Nephrol Dial Transplant	www.ncbi.nlm.nih.gov/pubmed/26420894	Genetic loci associated with renal function measures and chronic kidney disease in children: the Pediatric Investigation for Genetic Factors Linked with Renal Progression Consortium.	Chronic kidney disease	658 European ancestry child cases, 1,347 European ancestry child controls	NA	3q21.1	3	123459285	ADCY5, PTPLB	ADCY5 - HACD2	ENSG00000173175	ENSG00000206527		9527	31535	rs13072153-?	rs13072153	0	13072153	intergenic_variant	1	0.62	3E-6	5.52287874528034		1.43	[1.23-1.67]	Illumina [~ 8300000] (imputed)	N
2016-09-12	26420894	Wuttke M	2015-09-28	Nephrol Dial Transplant	www.ncbi.nlm.nih.gov/pubmed/26420894	Genetic loci associated with renal function measures and chronic kidney disease in children: the Pediatric Investigation for Genetic Factors Linked with Renal Progression Consortium.	Chronic kidney disease	658 European ancestry child cases, 1,347 European ancestry child controls	NA	13q14.2	13	48349672	RB1	RB1			ENSG00000139687	NA	NA	rs9535020-G	rs9535020	0	9535020	intron_variant	0	0.13	4E-6	5.39794000867204		1.69	[1.352.10]	Illumina [~ 8300000] (imputed)	N
2016-09-12	26420894	Wuttke M	2015-09-28	Nephrol Dial Transplant	www.ncbi.nlm.nih.gov/pubmed/26420894	Genetic loci associated with renal function measures and chronic kidney disease in children: the Pediatric Investigation for Genetic Factors Linked with Renal Progression Consortium.	Proteinuria and chronic kidney disease	294 European ancestry child cases, 1,347 European ancestry child controls	NA	2p25.2	2	5378545	SOX11	AC073143.1 - AC107057.1	ENSG00000228585	ENSG00000232835		64411	171235	rs792064-T	rs792064	0	792064	intergenic_variant	1	0.42	2E-6	5.69897000433602		1.64	[1.332.01]	Illumina [~ 10500000] (imputed)	N
2016-09-12	26420894	Wuttke M	2015-09-28	Nephrol Dial Transplant	www.ncbi.nlm.nih.gov/pubmed/26420894	Genetic loci associated with renal function measures and chronic kidney disease in children: the Pediatric Investigation for Genetic Factors Linked with Renal Progression Consortium.	Proteinuria and chronic kidney disease	294 European ancestry child cases, 1,347 European ancestry child controls	NA	3p24.3	3	20899351	VENTXP7	SGO1-AS1			ENSG00000231304	NA	NA	rs11720887-A	rs11720887	0	11720887	intron_variant	0	0.13	4E-6	5.39794000867204		1.87	[1.442.43]	Illumina [~ 10500000] (imputed)	N
2016-09-12	26420894	Wuttke M	2015-09-28	Nephrol Dial Transplant	www.ncbi.nlm.nih.gov/pubmed/26420894	Genetic loci associated with renal function measures and chronic kidney disease in children: the Pediatric Investigation for Genetic Factors Linked with Renal Progression Consortium.	Proteinuria and chronic kidney disease	294 European ancestry child cases, 1,347 European ancestry child controls	NA	10p12.31	10	19875064	PLXDC2	PLXDC2			ENSG00000120594	NA	NA	rs11011653-?	rs11011653	0	11011653	intron_variant	0	0.66	1E-6	6		1.69	[1.35-2.13]	Illumina [~ 10500000] (imputed)	N
2016-09-12	26420894	Wuttke M	2015-09-28	Nephrol Dial Transplant	www.ncbi.nlm.nih.gov/pubmed/26420894	Genetic loci associated with renal function measures and chronic kidney disease in children: the Pediatric Investigation for Genetic Factors Linked with Renal Progression Consortium.	Proteinuria and chronic kidney disease	294 European ancestry child cases, 1,347 European ancestry child controls	NA	11p15.5	11	762791	TALDO1	TALDO1			ENSG00000177156	NA	NA	rs4963124-C	rs4963124	0	4963124	intron_variant	0	0.71	9E-6	5.04575749056067		1.71	[1.342.18]	Illumina [~ 10500000] (imputed)	N
2016-09-12	26420894	Wuttke M	2015-09-28	Nephrol Dial Transplant	www.ncbi.nlm.nih.gov/pubmed/26420894	Genetic loci associated with renal function measures and chronic kidney disease in children: the Pediatric Investigation for Genetic Factors Linked with Renal Progression Consortium.	Proteinuria and chronic kidney disease	294 European ancestry child cases, 1,347 European ancestry child controls	NA	17p13.1	17	10174519	GAS7	GAS7			ENSG00000007237	NA	NA	rs35219335-?	rs35219335	0	35219335	intron_variant	0	0.86	4E-6	5.39794000867204		2.04	[1.49-2.86]	Illumina [~ 10500000] (imputed)	N
2016-09-12	26420894	Wuttke M	2015-09-28	Nephrol Dial Transplant	www.ncbi.nlm.nih.gov/pubmed/26420894	Genetic loci associated with renal function measures and chronic kidney disease in children: the Pediatric Investigation for Genetic Factors Linked with Renal Progression Consortium.	Proteinuria and chronic kidney disease	294 European ancestry child cases, 1,347 European ancestry child controls	NA	17p13.2	17	4615844	SMTNL2, ALOX15	LINC01996			ENSG00000261863	NA	NA	rs9895232-C	rs9895232	0	9895232	intron_variant	0	0.35	3E-6	5.52287874528034		1.62	[1.321.99]	Illumina [~ 10500000] (imputed)	N
2016-09-12	26420894	Wuttke M	2015-09-28	Nephrol Dial Transplant	www.ncbi.nlm.nih.gov/pubmed/26420894	Genetic loci associated with renal function measures and chronic kidney disease in children: the Pediatric Investigation for Genetic Factors Linked with Renal Progression Consortium.	Proteinuria and chronic kidney disease	294 European ancestry child cases, 1,347 European ancestry child controls	NA	17q25.3	17	82221271	CCDC57, SLC16A3	AC132872.2 - SLC16A3	ENSG00000264548	ENSG00000141526		3919	7126	rs12601558-?	rs12601558	0	12601558	intergenic_variant	1	0.78	6E-6	5.22184874961636		1.79	[1.37-2.33]	Illumina [~ 10500000] (imputed)	N
2016-09-12	26420894	Wuttke M	2015-09-28	Nephrol Dial Transplant	www.ncbi.nlm.nih.gov/pubmed/26420894	Genetic loci associated with renal function measures and chronic kidney disease in children: the Pediatric Investigation for Genetic Factors Linked with Renal Progression Consortium.	Proteinuria and chronic kidney disease	294 European ancestry child cases, 1,347 European ancestry child controls	NA	19p13.13	19	13322126	CACNA1A	CACNA1A			ENSG00000141837	NA	NA	rs56052703-?	rs56052703	0	56052703	intron_variant	0	0.66	3E-6	5.52287874528034		1.67	[1.33-2.08]	Illumina [~ 10500000] (imputed)	N
2016-09-12	26420894	Wuttke M	2015-09-28	Nephrol Dial Transplant	www.ncbi.nlm.nih.gov/pubmed/26420894	Genetic loci associated with renal function measures and chronic kidney disease in children: the Pediatric Investigation for Genetic Factors Linked with Renal Progression Consortium.	Proteinuria and chronic kidney disease	294 European ancestry child cases, 1,347 European ancestry child controls	NA	15q25.2	15	83481232	SH3GL3	SH3GL3			ENSG00000140600	NA	NA	rs78057470-C	rs78057470	1	1844860	intron_variant	0	0.32	7E-6	5.15490195998574		1.61	[1.311.98]	Illumina [~ 10500000] (imputed)	N
2016-09-12	26420894	Wuttke M	2015-09-28	Nephrol Dial Transplant	www.ncbi.nlm.nih.gov/pubmed/26420894	Genetic loci associated with renal function measures and chronic kidney disease in children: the Pediatric Investigation for Genetic Factors Linked with Renal Progression Consortium.	Glomerular filtration rate in chronic kidney disease	up to 744 Central European ancestry child cases, up to 397 Turkish ancestry child cases	NA	1p34.3	1	34876381	DLGAP3	DLGAP3			ENSG00000116544	NA	NA	rs7541937-G	rs7541937	0	7541937	intron_variant	0	0.47	4E-6	5.39794000867204		0.07	[0.05-0.09] unit decrease	Illumina [~ 8300000] (imputed)	N
2016-09-12	26420894	Wuttke M	2015-09-28	Nephrol Dial Transplant	www.ncbi.nlm.nih.gov/pubmed/26420894	Genetic loci associated with renal function measures and chronic kidney disease in children: the Pediatric Investigation for Genetic Factors Linked with Renal Progression Consortium.	Glomerular filtration rate in chronic kidney disease	up to 744 Central European ancestry child cases, up to 397 Turkish ancestry child cases	NA	2q22.1	2	139075570	NXPH2	AC023468.1 - AC013265.1	ENSG00000287147	ENSG00000286778		100564	248351	rs71413769-G	rs71413769	0	71413769	intergenic_variant	1	0.1	5E-6	5.30102999566398		0.11	[0.071-0.149] unit increase	Illumina [~ 8300000] (imputed)	N
2016-09-12	26420894	Wuttke M	2015-09-28	Nephrol Dial Transplant	www.ncbi.nlm.nih.gov/pubmed/26420894	Genetic loci associated with renal function measures and chronic kidney disease in children: the Pediatric Investigation for Genetic Factors Linked with Renal Progression Consortium.	Glomerular filtration rate in chronic kidney disease	up to 744 Central European ancestry child cases, up to 397 Turkish ancestry child cases	NA	2q22.2	2	142497154	LRP1B, KYNU	AC078882.1 - UBE2V1P14	ENSG00000244125	ENSG00000228134		359324	46264	rs10928150-A	rs10928150	0	10928150	intergenic_variant	1	0.46	7E-6	5.15490195998574		0.07	[0.05-0.09] unit decrease	Illumina [~ 8300000] (imputed)	N
2016-09-12	26420894	Wuttke M	2015-09-28	Nephrol Dial Transplant	www.ncbi.nlm.nih.gov/pubmed/26420894	Genetic loci associated with renal function measures and chronic kidney disease in children: the Pediatric Investigation for Genetic Factors Linked with Renal Progression Consortium.	Glomerular filtration rate in chronic kidney disease	up to 744 Central European ancestry child cases, up to 397 Turkish ancestry child cases	NA	3q13.11	3	105455358	ALCAM	ALCAM			ENSG00000170017	NA	NA	rs138904061-C	rs138904061	0	138904061	intron_variant	0	0.16	6E-6	5.22184874961636		0.09	[0.051-0.129] unit decrease	Illumina [~ 8300000] (imputed)	N
2016-09-12	26420894	Wuttke M	2015-09-28	Nephrol Dial Transplant	www.ncbi.nlm.nih.gov/pubmed/26420894	Genetic loci associated with renal function measures and chronic kidney disease in children: the Pediatric Investigation for Genetic Factors Linked with Renal Progression Consortium.	Glomerular filtration rate in chronic kidney disease	up to 744 Central European ancestry child cases, up to 397 Turkish ancestry child cases	NA	5q14.3	5	89309812	MEF2C	MEF2C-AS1			ENSG00000248309	NA	NA	rs10054413-G	rs10054413	0	10054413	intron_variant	0	0.14	7E-6	5.15490195998574		0.1	[0.061-0.139] unit decrease	Illumina [~ 8300000] (imputed)	N
2016-09-12	26420894	Wuttke M	2015-09-28	Nephrol Dial Transplant	www.ncbi.nlm.nih.gov/pubmed/26420894	Genetic loci associated with renal function measures and chronic kidney disease in children: the Pediatric Investigation for Genetic Factors Linked with Renal Progression Consortium.	Glomerular filtration rate in chronic kidney disease	up to 744 Central European ancestry child cases, up to 397 Turkish ancestry child cases	NA	7p22.1	7	5493688	FBXL18	FBXL18			ENSG00000155034	NA	NA	rs62441014-C	rs62441014	0	62441014	intron_variant	0	0.41	4E-6	5.39794000867204		0.07	[0.031-0.109] unit increase	Illumina [~ 8300000] (imputed)	N
2016-09-12	26420894	Wuttke M	2015-09-28	Nephrol Dial Transplant	www.ncbi.nlm.nih.gov/pubmed/26420894	Genetic loci associated with renal function measures and chronic kidney disease in children: the Pediatric Investigation for Genetic Factors Linked with Renal Progression Consortium.	Glomerular filtration rate in chronic kidney disease	up to 744 Central European ancestry child cases, up to 397 Turkish ancestry child cases	NA	12q24.13	12	113685597	RBM19, LHX5	LINC01234			ENSG00000249550	NA	NA	rs11066679-C	rs11066679	0	11066679	intron_variant	0	0.23	3E-6	5.52287874528034		0.08	[0.041-0.119] unit decrease	Illumina [~ 8300000] (imputed)	N
2017-03-31	27647854	Sandholm N	2016-09-19	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/27647854	The Genetic Landscape of Renal Complications in Type 1 Diabetes.	Chronic kidney disease (severe chronic kidney disease vs normal kidney function) in type 1 diabetes	907 European ancestry cases, 210 cases, 1,661 European ancestry controls, 357 controls	1,266 cases, 2,655 controls	20q13.33	20	60318758	NR	MIR646HG			ENSG00000228340	NA	NA	rs6027504-T	rs6027504	0	6027504	intron_variant	0	0.60	3E-6	5.52287874528034		1.21	[1.12-1.30]	Illumina [NR] (imputed)	N
2017-03-31	27647854	Sandholm N	2016-09-19	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/27647854	The Genetic Landscape of Renal Complications in Type 1 Diabetes.	Chronic kidney disease (severe chronic kidney disease vs normal kidney function) in type 1 diabetes	907 European ancestry cases, 210 cases, 1,661 European ancestry controls, 357 controls	1,266 cases, 2,655 controls	7q36.1	7	148443990	CNTNAP2	RN7SL72P - AC083849.2	ENSG00000243374	ENSG00000274133		5413	1796	rs1989248-C	rs1989248	0	1989248	intron_variant	1	0.29	6E-7	6.22184874961636		1.26	[1.15-1.38]	Illumina [NR] (imputed)	N
2017-03-31	27647854	Sandholm N	2016-09-19	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/27647854	The Genetic Landscape of Renal Complications in Type 1 Diabetes.	Chronic kidney disease (chronic kidney disease vs normal or mildly reduced eGFR) in type 1 diabetes	1,142 European ancestry cases, 113 cases, 2,442 European ancestry controls, 467 controls	2,046 cases, 4,549 controls	6p24.3	6	8226764	NR	AL355499.2, AL355499.1			ENSG00000285216, ENSG00000232234	NA	NA	rs13217044-A	rs13217044	0	13217044	intron_variant	0	0.71	4E-6	5.39794000867204		1.15	[1.07-1.23]	Illumina [NR] (imputed)	N
2018-01-15	29160300	Oetting WS	2017-11-21	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/29160300	Genome-wide association study identifies the common variants in CYP3A4 and CYP3A5 responsible for variation in tacrolimus trough concentration in Caucasian kidney transplant recipients.	Tacrolimus trough concentration in kidney transplant patients	1,345 European ancestry individuals (homozygous for LoF CYPA3A5)	NA	7q22.1	7	99768693	CYP3A43, CYP3A4, ZKSCAN5, CPSF4, ATP5J2, PTCD1, ZNF789, GSI-259H13.2, TRIM4	CYP3A4			ENSG00000160868	NA	NA	rs35599367-A	rs35599367	0	35599367	intron_variant	0	0.054	2E-17	16.698970004336		0.3	[0.23-0.37] unit increase	Affymetrix [1221308] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite concentrations in chronic kidney disease	1,143 European ancestry cases	NA	6q21	6	110454809	SLC22A16	SLC22A16			ENSG00000004809	NA	NA	rs12194000-G	rs12194000	0	12194000	intron_variant	0	NR	3E-11	10.5228787452803	(Octadecadienoylcarnitine)	0.306187	[0.22-0.4] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite concentrations in chronic kidney disease	1,143 European ancestry cases	NA	6q25.3	6	160100853	IGF2R	IGF2R			ENSG00000197081	NA	NA	rs146203232-T	rs146203232	0	146203232	intron_variant	0	NR	2E-18	17.698970004336	(Butyrylcarnitine, Isobutyrylcarnitine)	0.541769	[0.42-0.66] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite concentrations in chronic kidney disease	1,143 European ancestry cases	NA	7q36.1	7	150824966	TMEM176A, AOC1	AOC1			ENSG00000002726	NA	NA	rs4725366-G	rs4725366	0	4725366	splice_region_variant	0	NR	2E-12	11.698970004336	(Putrescine)	0.356606	[0.26-0.46] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite concentrations in chronic kidney disease	1,143 European ancestry cases	NA	7q36.3	7	157757146	PTPRN2	PTPRN2			ENSG00000155093	NA	NA	rs1242780-G	rs1242780	0	1242780	intron_variant	0	NR	2E-8	7.69897000433602	(Lysophosphatidylcholine with acyl residue C18:1)	0.294109	[0.19-0.4] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite concentrations in chronic kidney disease	1,143 European ancestry cases	NA	9q21.33	9	84611173	SLC28A3, NTRK2	AL157886.1			ENSG00000285987	NA	NA	rs1020120-T	rs1020120	0	1020120	intron_variant	0	NR	3E-9	8.52287874528034	(Histidine)	0.242898	[0.16-0.32] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite concentrations in chronic kidney disease	1,143 European ancestry cases	NA	9q32	9	113967563	ZNF618	ZNF618			ENSG00000157657	NA	NA	rs814698-T	rs814698	0	814698	intron_variant	0	NR	2E-8	7.69897000433602	(Phosphatidylcholine with acyl-alkyl residue sum C44:4)	0.26961	[0.18-0.36] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite concentrations in chronic kidney disease	1,143 European ancestry cases	NA	10q21.2	10	59708831	SLC16A9	SLC16A9			ENSG00000165449	NA	NA	rs1171616-T	rs1171616	0	1171616	intron_variant	0	NR	3E-15	14.5228787452803	(Carnitine (free))	0.377038	[0.28-0.47] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite concentrations in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61774535	MYRF	TMEM258, MYRF			ENSG00000134825, ENSG00000124920	NA	NA	rs11320420-G	rs11320420	0	11320420	intron_variant	0	NR	2E-10	9.69897000433602	(Phosphatidylcholine with acyl-alkyl residue sum C38:4)	0.281823	[0.2-0.37] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite concentrations in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61774535	MYRF	TMEM258, MYRF			ENSG00000134825, ENSG00000124920	NA	NA	rs11320420-G	rs11320420	0	11320420	intron_variant	0	NR	3E-13	12.5228787452803	(Phosphatidylcholine with acyl-alkyl residue sum C38:5)	0.3281	[0.24-0.42] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite concentrations in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61774535	MYRF	TMEM258, MYRF			ENSG00000134825, ENSG00000124920	NA	NA	rs11320420-G	rs11320420	0	11320420	intron_variant	0	NR	1E-14	14	(Phosphatidylcholine with acyl-alkyl residue sum C36:5)	0.343113	[0.26-0.43] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite concentrations in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61785208	MYRF	TMEM258, MYRF			ENSG00000134825, ENSG00000124920	NA	NA	rs174537-T	rs174537	0	174537	non_coding_transcript_exon_variant	0	NR	5E-10	9.30102999566398	(Phosphatidylcholine with acyl-alkyl residue sum C38:4)	0.272908	[0.19-0.36] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite concentrations in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61785208	MYRF	TMEM258, MYRF			ENSG00000134825, ENSG00000124920	NA	NA	rs174537-T	rs174537	0	174537	non_coding_transcript_exon_variant	0	NR	9E-13	12.0457574905607	(Phosphatidylcholine with acyl-alkyl residue sum C38:5)	0.317125	[0.23-0.4] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite concentrations in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61785208	MYRF	TMEM258, MYRF			ENSG00000134825, ENSG00000124920	NA	NA	rs174537-T	rs174537	0	174537	non_coding_transcript_exon_variant	0	NR	2E-14	13.698970004336	(Phosphatidylcholine with acyl-alkyl residue sum C36:5)	0.336305	[0.25-0.42] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite concentrations in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61785208	MYRF	TMEM258, MYRF			ENSG00000134825, ENSG00000124920	NA	NA	rs174537-T	rs174537	0	174537	non_coding_transcript_exon_variant	0	NR	1E-16	16	(Phosphatidylcholine with diacyl residue sum C38:5)	0.357607	[0.27-0.44] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite concentrations in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61790331	TMEM258	TMEM258			ENSG00000134825	NA	NA	rs102275-C	rs102275	0	102275	non_coding_transcript_exon_variant	0	NR	1E-20	20	(Phosphatidylcholine with diacyl residue sum C38:4)	0.399628	[0.32-0.48] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Urinary metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	1q21.3	1	151967388	THEM4, S100A10	AL450992.4 - S100A10	ENSG00000286581	ENSG00000197747		13403	15527	rs6657658-C	rs6657658	0	6657658	regulatory_region_variant	1	NR	1E-12	12	(Decadienoylcarnitine/Glutarylcarnitine)	0.304258	[0.22-0.39] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Urinary metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	2p13.1	2	73643197	NAT8	ALMS1P1			ENSG00000163016	NA	NA	rs375811360-G	rs375811360	1	2860716	intron_variant	0	NR	2E-12	11.698970004336	(Carnitine (free)/Propionylcarnitine)	0.349493	[0.25-0.45] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Urinary metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	2p13.1	2	73628380	ALMS1, NAT8	ALMS1 - NAT8	ENSG00000116127	ENSG00000144035		3214	12343	rs10178409-T	rs10178409	0	10178409	regulatory_region_variant	1	NR	6E-18	17.2218487496164	(Tryptophan/Acetylornithine)	0.44248	[0.34-0.54] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Urinary metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	2p13.1	2	73628380	ALMS1, NAT8	ALMS1 - NAT8	ENSG00000116127	ENSG00000144035		3214	12343	rs10178409-T	rs10178409	0	10178409	regulatory_region_variant	1	NR	7E-18	17.1549019599857	(Acetylornithine/Propionylcarnitine)	0.448751	[0.35-0.55] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Urinary metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	2p13.1	2	73628380	ALMS1, NAT8	ALMS1 - NAT8	ENSG00000116127	ENSG00000144035		3214	12343	rs10178409-T	rs10178409	0	10178409	regulatory_region_variant	1	NR	2E-16	15.698970004336	(Tyrosine/Acetylornithine)	0.422951	[0.32-0.52] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Urinary metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	19q13.11	19	32865985	SLC7A9	SLC7A9			ENSG00000021488	NA	NA	rs12460876-C	rs12460876	0	12460876	intron_variant	0	NR	2E-23	22.698970004336	(Lysine/Glutamine)	0.415753	[0.34-0.5] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Urinary metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	19q13.11	19	32865985	SLC7A9	SLC7A9			ENSG00000021488	NA	NA	rs12460876-C	rs12460876	0	12460876	intron_variant	0	NR	3E-22	21.5228787452803	(Lysine/Tyrosine)	0.406924	[0.33-0.49] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Urinary metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	19q13.11	19	32869463	SLC7A9	SLC7A9			ENSG00000021488	NA	NA	rs7252778-C	rs7252778	0	7252778	intron_variant	0	NR	6E-22	21.2218487496164	(Lysine/Threonine)	0.402279	[0.32-0.48] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Urinary metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	19q13.11	19	32865985	SLC7A9	SLC7A9			ENSG00000021488	NA	NA	rs12460876-C	rs12460876	0	12460876	intron_variant	0	NR	2E-19	18.698970004336	(Lysine/Alanine)	0.378875	[0.3-0.46] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Urinary metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	19q13.11	19	32865985	SLC7A9	SLC7A9			ENSG00000021488	NA	NA	rs12460876-C	rs12460876	0	12460876	intron_variant	0	NR	5E-19	18.301029995664	(Lysine/Glycine)	0.36788	[0.29-0.45] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61830500	FADS2	FADS2			ENSG00000134824	NA	NA	rs1535-G	rs1535	0	1535	intron_variant	0	NR	2E-16	15.698970004336	(Phosphatidylcholine with diacyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C44:6)	0.359791	[0.28-0.44] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61830500	FADS2	FADS2			ENSG00000134824	NA	NA	rs1535-G	rs1535	0	1535	intron_variant	0	NR	1E-16	16	(Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C44:5)	0.359305	[0.28-0.44] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61827449	FADS2	FADS2, FADS1			ENSG00000134824, ENSG00000149485	NA	NA	rs3834458-C	rs3834458	0	3834458	intron_variant	0	NR	6E-21	20.2218487496164	(Phosphatidylcholine with diacyl residue sum C36:5/Lysophosphatidylcholine with acyl residue C20:3)	0.400902	[0.32-0.48] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61828851	FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs5792235-C	rs5792235	0	5792235	intron_variant	0	NR	2E-25	24.698970004336	(Phosphatidylcholine with diacyl residue sum C36:5/Phosphatidylcholine with diacyl residue sum C38:3)	0.454654	[0.37-0.54] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61827449	FADS2	FADS2, FADS1			ENSG00000134824, ENSG00000149485	NA	NA	rs3834458-C	rs3834458	0	3834458	intron_variant	0	NR	3E-26	25.5228787452803	(Phosphatidylcholine with diacyl residue sum C38:3/Phosphatidylcholine with acyl-alkyl residue sum C36:5)	0.464179	[0.38-0.55] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61828092	FADS2	FADS2, FADS1			ENSG00000134824, ENSG00000149485	NA	NA	rs968567-T	rs968567	0	968567	intron_variant	0	NR	5E-14	13.301029995664	(Phosphatidylcholine with diacyl residue sum C42:0/Phosphatidylcholine with acyl-alkyl residue sum C44:6)	0.395747	[0.29-0.5] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61832870	FADS2	FADS2			ENSG00000134824	NA	NA	rs174574-C	rs174574	0	174574	intron_variant	0	NR	2E-17	16.698970004336	(Phosphatidylcholine with diacyl residue sum C42:4/Phosphatidylcholine with acyl-alkyl residue sum C38:2)	0.366461	[0.28-0.45] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61839211	FADS2	FADS2			ENSG00000134824	NA	NA	rs174581-A	rs174581	0	174581	intron_variant	0	NR	1E-15	15	(Phosphatidylcholine with acyl-alkyl residue sum C34:0/Phosphatidylcholine with acyl-alkyl residue sum C36:2)	0.341664	[0.26-0.42] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61830500	FADS2	FADS2			ENSG00000134824	NA	NA	rs1535-G	rs1535	0	1535	intron_variant	0	NR	1E-13	13	(Phosphatidylcholine with acyl-alkyl residue sum C34:2/Phosphatidylcholine with acyl-alkyl residue sum C44:6)	0.321785	[0.24-0.41] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61830500	FADS2	FADS2			ENSG00000134824	NA	NA	rs1535-G	rs1535	0	1535	intron_variant	0	NR	2E-18	17.698970004336	(Phosphatidylcholine with acyl-alkyl residue sum C36:1/Phosphatidylcholine with acyl-alkyl residue sum C40:5)	0.371389	[0.29-0.45] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61839211	FADS2	FADS2			ENSG00000134824	NA	NA	rs174581-A	rs174581	0	174581	intron_variant	0	NR	3E-18	17.5228787452803	(Phosphatidylcholine with acyl-alkyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C36:4)	0.360322	[0.28-0.44] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61839211	FADS2	FADS2			ENSG00000134824	NA	NA	rs174581-A	rs174581	0	174581	intron_variant	0	NR	4E-25	24.397940008672	(Phosphatidylcholine with acyl-alkyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C38:5)	0.42572	[0.35-0.5] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61852357	FADS2	FADS2			ENSG00000134824	NA	NA	rs174594-A	rs174594	0	174594	intron_variant	0	NR	5E-13	12.301029995664	(Phosphatidylcholine with acyl-alkyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C42:5)	0.301599	[0.22-0.38] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61830500	FADS2	FADS2			ENSG00000134824	NA	NA	rs1535-G	rs1535	0	1535	intron_variant	0	NR	3E-19	18.5228787452803	(Phosphatidylcholine with acyl-alkyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C44:6)	0.385795	[0.3-0.47] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61830500	FADS2	FADS2			ENSG00000134824	NA	NA	rs1535-G	rs1535	0	1535	intron_variant	0	NR	2E-17	16.698970004336	(Phosphatidylcholine with acyl-alkyl residue sum C36:2/Hydroxysphingomyelin with acyl residue sum C22:2)	0.372567	[0.29-0.46] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61832870	FADS2	FADS2			ENSG00000134824	NA	NA	rs174574-C	rs174574	0	174574	intron_variant	0	NR	1E-13	13	(Phosphatidylcholine with acyl-alkyl residue sum C36:2/Sphingomyelin with acyl residue sum C16:1)	0.328301	[0.24-0.41] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61830500	FADS2	FADS2			ENSG00000134824	NA	NA	rs1535-G	rs1535	0	1535	intron_variant	0	NR	3E-14	13.5228787452803	(Phosphatidylcholine with acyl-alkyl residue sum C36:3/Hydroxysphingomyelin with acyl residue sum C22:2)	0.326039	[0.24-0.41] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61839170	FADS2	FADS2			ENSG00000134824	NA	NA	rs174580-G	rs174580	0	174580	intron_variant	0	NR	5E-12	11.301029995664	(Phosphatidylcholine with acyl-alkyl residue sum C36:4/Sphingomyelin with acyl residue sum C24:0)	0.30041	[0.22-0.38] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61851136	FADS2	FADS2			ENSG00000134824	NA	NA	rs174592-G	rs174592	0	174592	intron_variant	0	NR	3E-13	12.5228787452803	(Phosphatidylcholine with acyl-alkyl residue sum C38:4/Sphingomyelin with acyl residue sum C16:0)	0.311966	[0.23-0.39] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61839170	FADS2	FADS2			ENSG00000134824	NA	NA	rs174580-G	rs174580	0	174580	intron_variant	0	NR	1E-17	17	(Phosphatidylcholine with acyl-alkyl residue sum C38:5/Sphingomyelin with acyl residue sum C24:0)	0.372766	[0.29-0.46] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61842278	FADS2	FADS2			ENSG00000134824	NA	NA	rs174583-T	rs174583	0	174583	intron_variant	0	NR	7E-18	17.1549019599857	(Phosphatidylcholine with acyl-alkyl residue sum C38:5/Sphingomyelin with acyl residue sum C16:0)	0.361779	[0.28-0.44] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61828851	FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs5792235-C	rs5792235	0	5792235	intron_variant	0	NR	6E-19	18.2218487496164	(Phosphatidylcholine with diacyl residue sum C32:0/Phosphatidylcholine with diacyl residue sum C36:2)	0.395416	[0.31-0.48] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61828851	FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs5792235-C	rs5792235	0	5792235	intron_variant	0	NR	9E-15	14.0457574905607	(Phosphatidylcholine with diacyl residue sum C32:0/Phosphatidylcholine with diacyl residue sum C38:3)	0.343531	[0.26-0.43] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61839211	FADS2	FADS2			ENSG00000134824	NA	NA	rs174581-A	rs174581	0	174581	intron_variant	0	NR	7E-15	14.1549019599857	(Phosphatidylcholine with diacyl residue sum C32:0/Phosphatidylcholine with acyl-alkyl residue sum C36:2)	0.330756	[0.25-0.41] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61827449	FADS2	FADS2, FADS1			ENSG00000134824, ENSG00000149485	NA	NA	rs3834458-C	rs3834458	0	3834458	intron_variant	0	NR	5E-14	13.301029995664	(Phosphatidylcholine with acyl-alkyl residue sum C40:5/Phosphatidylcholine with acyl-alkyl residue sum C44:3)	0.335787	[0.25-0.42] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61832870	FADS2	FADS2			ENSG00000134824	NA	NA	rs174574-C	rs174574	0	174574	intron_variant	0	NR	3E-14	13.5228787452803	(Phosphatidylcholine with acyl-alkyl residue sum C42:3/Phosphatidylcholine with acyl-alkyl residue sum C44:6)	0.323843	[0.24-0.41] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	19p13.2	19	8208084	FBN3, CERS4	CERS4			ENSG00000090661	NA	NA	rs201631095-CA	rs201631095	0	201631095	intron_variant	0	NR	3E-13	12.5228787452803	(Sphingomyelin with acyl residue sum C18:0/Sphingomyelin with acyl residue sum C24:1)	0.29578	[0.22-0.37] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61798436	FEN1, FADS1	FADS2			ENSG00000134824	NA	NA	rs174541-C	rs174541	0	174541	intron_variant	0	NR	3E-12	11.5228787452803	(Phosphatidylcholine with diacyl residue sum C36:2/Phosphatidylcholine with diacyl residue sum C42:4)	0.302653	[0.22-0.39] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61798436	FEN1, FADS1	FADS2			ENSG00000134824	NA	NA	rs174541-C	rs174541	0	174541	intron_variant	0	NR	1E-15	15	(Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C40:4)	0.349222	[0.26-0.43] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61798436	FEN1, FADS1	FADS2			ENSG00000134824	NA	NA	rs174541-C	rs174541	0	174541	intron_variant	0	NR	9E-16	15.0457574905607	(Phosphatidylcholine with acyl-alkyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C40:5)	0.348321	[0.26-0.43] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61798436	FEN1, FADS1	FADS2			ENSG00000134824	NA	NA	rs174541-C	rs174541	0	174541	intron_variant	0	NR	3E-13	12.5228787452803	(Phosphatidylcholine with acyl-alkyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C40:4)	0.3193	[0.23-0.4] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61798436	FEN1, FADS1	FADS2			ENSG00000134824	NA	NA	rs174541-C	rs174541	0	174541	intron_variant	0	NR	2E-18	17.698970004336	(Phosphatidylcholine with acyl-alkyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C40:5)	0.380947	[0.3-0.46] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61798436	FEN1, FADS1	FADS2			ENSG00000134824	NA	NA	rs174541-C	rs174541	0	174541	intron_variant	0	NR	6E-17	16.2218487496164	(Phosphatidylcholine with acyl-alkyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C42:5)	0.365348	[0.28-0.45] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61815236	MIR1908	FADS1, MIR1908, FADS2			ENSG00000149485, ENSG00000284416, ENSG00000134824	NA	NA	rs174561-C	rs174561	0	174561	5_prime_UTR_variant	0	NR	3E-17	16.5228787452803	(Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with diacyl residue sum C42:1)	0.384602	[0.3-0.47] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61815236	MIR1908	FADS1, MIR1908, FADS2			ENSG00000149485, ENSG00000284416, ENSG00000134824	NA	NA	rs174561-C	rs174561	0	174561	5_prime_UTR_variant	0	NR	2E-19	18.698970004336	(Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C44:6)	0.404607	[0.32-0.49] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61815236	MIR1908	FADS1, MIR1908, FADS2			ENSG00000149485, ENSG00000284416, ENSG00000134824	NA	NA	rs174561-C	rs174561	0	174561	5_prime_UTR_variant	0	NR	1E-18	18	(Phosphatidylcholine with diacyl residue sum C42:1/Phosphatidylcholine with acyl-alkyl residue sum C36:3)	0.400157	[0.31-0.49] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61815236	MIR1908	FADS1, MIR1908, FADS2			ENSG00000149485, ENSG00000284416, ENSG00000134824	NA	NA	rs174561-C	rs174561	0	174561	5_prime_UTR_variant	0	NR	3E-16	15.5228787452803	(Phosphatidylcholine with acyl-alkyl residue sum C32:1/Phosphatidylcholine with acyl-alkyl residue sum C36:3)	0.371213	[0.28-0.46] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61815236	MIR1908	FADS1, MIR1908, FADS2			ENSG00000149485, ENSG00000284416, ENSG00000134824	NA	NA	rs174561-C	rs174561	0	174561	5_prime_UTR_variant	0	NR	5E-34	33.301029995664	(Phosphatidylcholine with diacyl residue sum C32:0/Phosphatidylcholine with diacyl residue sum C36:3)	0.545071	[0.46-0.63] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61774535	MYRF	TMEM258, MYRF			ENSG00000134825, ENSG00000124920	NA	NA	rs11320420-G	rs11320420	0	11320420	intron_variant	0	NR	8E-36	35.0969100130081	(Lysophosphatidylcholine with acyl residue C16:1/Lysophosphatidylcholine with acyl residue C20:4)	0.526048	[0.45-0.61] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61776027	MYRF	TMEM258, MYRF			ENSG00000134825, ENSG00000124920	NA	NA	rs174528-C	rs174528	0	174528	intron_variant	0	NR	9E-14	13.0457574905607	(Phosphatidylcholine with diacyl residue sum C34:1/Phosphatidylcholine with diacyl residue sum C40:5)	0.323791	[0.24-0.41] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61776027	MYRF	TMEM258, MYRF			ENSG00000134825, ENSG00000124920	NA	NA	rs174528-C	rs174528	0	174528	intron_variant	0	NR	8E-15	14.0969100130081	(Phosphatidylcholine with diacyl residue sum C34:3/Phosphatidylcholine with diacyl residue sum C40:5)	0.329919	[0.25-0.41] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61774535	MYRF	TMEM258, MYRF			ENSG00000134825, ENSG00000124920	NA	NA	rs11320420-G	rs11320420	0	11320420	intron_variant	0	NR	5E-13	12.301029995664	(Phosphatidylcholine with diacyl residue sum C34:3/Phosphatidylcholine with acyl-alkyl residue sum C36:4)	0.310827	[0.23-0.39] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61774535	MYRF	TMEM258, MYRF			ENSG00000134825, ENSG00000124920	NA	NA	rs11320420-G	rs11320420	0	11320420	intron_variant	0	NR	9E-22	21.0457574905607	(Phosphatidylcholine with diacyl residue sum C34:3/Phosphatidylcholine with acyl-alkyl residue sum C36:5)	0.414984	[0.33-0.5] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61774535	MYRF	TMEM258, MYRF			ENSG00000134825, ENSG00000124920	NA	NA	rs11320420-G	rs11320420	0	11320420	intron_variant	0	NR	7E-15	14.1549019599857	(Phosphatidylcholine with diacyl residue sum C34:3/Phosphatidylcholine with acyl-alkyl residue sum C38:4)	0.342667	[0.26-0.43] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61774535	MYRF	TMEM258, MYRF			ENSG00000134825, ENSG00000124920	NA	NA	rs11320420-G	rs11320420	0	11320420	intron_variant	0	NR	2E-17	16.698970004336	(Phosphatidylcholine with diacyl residue sum C34:3/Phosphatidylcholine with acyl-alkyl residue sum C40:1)	0.372488	[0.29-0.46] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61774535	MYRF	TMEM258, MYRF			ENSG00000134825, ENSG00000124920	NA	NA	rs11320420-G	rs11320420	0	11320420	intron_variant	0	NR	5E-12	11.301029995664	(Phosphatidylcholine with diacyl residue sum C34:3/Phosphatidylcholine with acyl-alkyl residue sum C40:5)	0.304972	[0.22-0.39] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61774535	MYRF	TMEM258, MYRF			ENSG00000134825, ENSG00000124920	NA	NA	rs11320420-G	rs11320420	0	11320420	intron_variant	0	NR	7E-24	23.1549019599857	(Phosphatidylcholine with diacyl residue sum C38:5/Phosphatidylcholine with acyl-alkyl residue sum C34:1)	0.440607	[0.36-0.52] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61776027	MYRF	TMEM258, MYRF			ENSG00000134825, ENSG00000124920	NA	NA	rs174528-C	rs174528	0	174528	intron_variant	0	NR	4E-13	12.397940008672	(Phosphatidylcholine with diacyl residue sum C40:5/Phosphatidylcholine with acyl-alkyl residue sum C36:2)	0.314088	[0.23-0.4] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61774535	MYRF	TMEM258, MYRF			ENSG00000134825, ENSG00000124920	NA	NA	rs11320420-G	rs11320420	0	11320420	intron_variant	0	NR	1E-20	20	(Phosphatidylcholine with acyl-alkyl residue sum C34:1/Phosphatidylcholine with acyl-alkyl residue sum C36:5)	0.402542	[0.32-0.49] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61774535	MYRF	TMEM258, MYRF			ENSG00000134825, ENSG00000124920	NA	NA	rs11320420-G	rs11320420	0	11320420	intron_variant	0	NR	2E-19	18.698970004336	(Phosphatidylcholine with acyl-alkyl residue sum C34:1/Phosphatidylcholine with acyl-alkyl residue sum C38:4)	0.392775	[0.31-0.48] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite concentrations in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61790331	TMEM258	TMEM258			ENSG00000134825	NA	NA	rs102275-C	rs102275	0	102275	non_coding_transcript_exon_variant	0	NR	3E-32	31.5228787452803	(Lysophosphatidylcholine with acyl residue C20:4)	0.502958	[0.42-0.58] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite concentrations in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61790354	TMEM258	TMEM258			ENSG00000134825	NA	NA	rs102274-C	rs102274	0	102274	non_coding_transcript_exon_variant	0	NR	8E-21	20.0969100130081	(Phosphatidylcholine with diacyl residue sum C36:4)	0.407955	[0.32-0.49] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite concentrations in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61813978	FADS1	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs7394579-G	rs7394579	0	7394579	intron_variant	0	NR	2E-8	7.69897000433602	(Phosphatidylcholine with acyl-alkyl residue sum C44:6)	0.264318	[0.17-0.36] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite concentrations in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61814292	FADS1	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs174560-C	rs174560	0	174560	non_coding_transcript_exon_variant	0	NR	3E-10	9.52287874528034	(Phosphatidylcholine with diacyl residue sum C36:3)	0.278836	[0.19-0.36] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite concentrations in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61824524	FADS1, FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs57668028-G	rs57668028	0	57668028	intron_variant	0	NR	1E-8	8	(Phosphatidylcholine with acyl-alkyl residue sum C44:6)	0.261806	[0.17-0.35] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite concentrations in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61824890	FADS1, FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs174566-G	rs174566	0	174566	intron_variant	0	NR	5E-14	13.301029995664	(Phosphatidylcholine with diacyl residue sum C36:5)	0.320688	[0.24-0.4] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite concentrations in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61826344	FADS1, FADS2	FADS2, FADS1			ENSG00000134824, ENSG00000149485	NA	NA	rs174568-T	rs174568	0	174568	missense_variant	0	NR	3E-8	7.52287874528034	(Phosphatidylcholine with diacyl residue sum C34:4)	0.237543	[0.15-0.32] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite concentrations in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61828851	FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs5792235-C	rs5792235	0	5792235	intron_variant	0	NR	2E-8	7.69897000433602	(Phosphatidylcholine with diacyl residue sum C34:4)	0.239467	[0.16-0.32] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite concentrations in chronic kidney disease	1,143 European ancestry cases	NA	12q24.31	12	120737721	ACADS	ACADS			ENSG00000122971	NA	NA	rs2014355-C	rs2014355	0	2014355	non_coding_transcript_exon_variant	0	NR	4E-27	26.397940008672	(Butyrylcarnitine / Isobutyrylcarnitine)	0.417057	[0.34-0.49] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite concentrations in chronic kidney disease	1,143 European ancestry cases	NA	14q23.2	14	63765502	SGPP1, SYNE2	SYNE2			ENSG00000054654	NA	NA	rs7160525-A	rs7160525	0	7160525	intron_variant	0	NR	7E-15	14.1549019599857	(Phosphatidylcholine with diacyl residue sum C28:1)	0.415635	[0.31-0.52] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite concentrations in chronic kidney disease	1,143 European ancestry cases	NA	14q23.2	14	63773160	SGPP1, SYNE2	SYNE2			ENSG00000054654	NA	NA	rs112329286-TTTTA	rs112329286	0	112329286	intron_variant	0	NR	5E-12	11.301029995664	(Hydroxysphingomyelin with acyl residue sum C14:1)	0.363114	[0.26-0.47] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite concentrations in chronic kidney disease	1,143 European ancestry cases	NA	14q24.1	14	67509105	TMEM229B	TMEM229B			ENSG00000198133	NA	NA	rs1077989-C	rs1077989	0	1077989	intron_variant	0	NR	2E-12	11.698970004336	(Phosphatidylcholine with acyl-alkyl residue sum C32:1)	0.278589	[0.2-0.36] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite concentrations in chronic kidney disease	1,143 European ancestry cases	NA	14q24.1	14	67509105	TMEM229B	TMEM229B			ENSG00000198133	NA	NA	rs1077989-C	rs1077989	0	1077989	intron_variant	0	NR	2E-8	7.69897000433602	(Phosphatidylcholine with acyl-alkyl residue sum C32:2)	0.212349	[0.14-0.29] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite concentrations in chronic kidney disease	1,143 European ancestry cases	NA	14q32.33	14	104105483	ASPG	ASPG			ENSG00000166183	NA	NA	rs2282377-G	rs2282377	0	2282377	intron_variant	0	NR	1E-11	11	(Asparagine)	0.426586	[0.3-0.55] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite concentrations in chronic kidney disease	1,143 European ancestry cases	NA	15q11.2	15	23679185	MAGEL2, NDN	MAGEL2 - NDN	ENSG00000254585	ENSG00000182636		31318	6215	rs850799-G	rs850799	0	850799	intergenic_variant	1	NR	5E-8	7.30102999566398	(Phosphatidylcholine with acyl-alkyl residue sum C42:3)	0.285624	[0.18-0.39] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite concentrations in chronic kidney disease	1,143 European ancestry cases	NA	17q25.3	17	78447415	DNAH17	DNAH17			ENSG00000187775	NA	NA	rs55888180-C	rs55888180	0	55888180	intron_variant	0	NR	4E-8	7.39794000867204	(Phosphatidylcholine with acyl-alkyl residue sum C36:3)	0.400252	[0.26-0.54] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite concentrations in chronic kidney disease	1,143 European ancestry cases	NA	22q11.21	22	18923820	PRODH	AC007326.4, PRODH			ENSG00000283809, ENSG00000100033	NA	NA	rs117935223-A	rs117935223	0	117935223	non_coding_transcript_exon_variant	0	NR	2E-17	16.698970004336	(Proline)	0.619758	[0.48-0.76] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite concentrations in chronic kidney disease	1,143 European ancestry cases	NA	1p31.1	1	75671921	ACADM, SLC44A5	AL137803.1			ENSG00000230863	NA	NA	rs12134854-C	rs12134854	0	12134854	intron_variant	0	NR	1E-12	12	(Decanoylcarnitine)	0.297101	[0.22-0.38] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite concentrations in chronic kidney disease	1,143 European ancestry cases	NA	1q21.3	1	151907285	THEM4	THEM4			ENSG00000159445	NA	NA	rs28415528-A	rs28415528	0	28415528	intron_variant	0	NR	4E-9	8.39794000867204	(Nonanoylcarnitine)	0.224275	[0.15-0.3] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite concentrations in chronic kidney disease	1,143 European ancestry cases	NA	2p13.1	2	73643197	NAT8	ALMS1P1			ENSG00000163016	NA	NA	rs375811360-G	rs375811360	1	2860716	intron_variant	0	NR	1E-62	62	(Acetylornithine)	0.839768	[0.75-0.93] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite concentrations in chronic kidney disease	1,143 European ancestry cases	NA	2q34	2	210210185	ACADL	ACADL, AC006994.1			ENSG00000115361, ENSG00000279317	NA	NA	rs3764913-C	rs3764913	0	3764913	non_coding_transcript_exon_variant	0	NR	1E-35	35	(Nonanoylcarnitine)	0.457998	[0.39-0.53] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite concentrations in chronic kidney disease	1,143 European ancestry cases	NA	2q34	2	210675783	CPS1	CPS1			ENSG00000021826	NA	NA	rs1047891-A	rs1047891	0	1047891	missense_variant	0	NR	2E-20	19.698970004336	(Glycine)	0.394115	[0.31-0.48] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite concentrations in chronic kidney disease	1,143 European ancestry cases	NA	3q28	3	191708066	PYDC2, FGF12	AC072023.1 - AC026320.2	ENSG00000201860	ENSG00000237653		66829	244283	rs1066621-T	rs1066621	0	1066621	regulatory_region_variant	1	NR	3E-8	7.52287874528034	(Phosphatidylcholine with diacyl residue sum C36:0)	0.245354	[0.16-0.33] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite concentrations in chronic kidney disease	1,143 European ancestry cases	NA	4p15.31	4	20645949	SLIT2, PACRGL	SLIT2 - PACRGL	ENSG00000145147	ENSG00000163138		25388	50333	rs57802047-T	rs57802047	0	57802047	intergenic_variant	1	NR	9E-10	9.04575749056067	(Phosphatidylcholine with acyl-alkyl residue sum C38:0)	0.490673	[0.34-0.65] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite concentrations in chronic kidney disease	1,143 European ancestry cases	NA	5p14.3	5	21172184	CDH18, GUSBP1	AC140168.1 - AC140172.1	ENSG00000286751	ENSG00000248286		139339	24536	rs17253658-T	rs17253658	0	17253658	intergenic_variant	1	NR	1E-8	8	(Serine)	0.475572	[0.31-0.64] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Urinary metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	19q13.11	19	32866527	SLC7A9	SLC7A9			ENSG00000021488	NA	NA	rs35975406-C	rs35975406	0	35975406	intron_variant	0	NR	1E-18	18	(Lysine/Serine)	0.373312	[0.29-0.45] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Urinary metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	19q13.11	19	32865985	SLC7A9	SLC7A9			ENSG00000021488	NA	NA	rs12460876-C	rs12460876	0	12460876	intron_variant	0	NR	3E-17	16.5228787452803	(Lysine/Asparagine)	0.356427	[0.28-0.44] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Urinary metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	19q13.11	19	32865985	SLC7A9	SLC7A9			ENSG00000021488	NA	NA	rs12460876-C	rs12460876	0	12460876	intron_variant	0	NR	8E-17	16.0969100130081	(Lysine/Phenylalanine)	0.351713	[0.27-0.43] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Urinary metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	19q13.11	19	32865985	SLC7A9	SLC7A9			ENSG00000021488	NA	NA	rs12460876-C	rs12460876	0	12460876	intron_variant	0	NR	9E-17	16.0457574905607	(Lysine/Tryptophan)	0.350727	[0.27-0.43] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	12q24.31	12	120738280	ACADS	ACADS			ENSG00000122971	NA	NA	rs1799958-A	rs1799958	0	1799958	missense_variant	0	NR	2E-33	32.698970004336	(Carnitine (free)/Butyrylcarnitine / Isobutyrylcarnitine)	0.484864	[0.41-0.56] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	12q24.31	12	120738280	ACADS	ACADS			ENSG00000122971	NA	NA	rs1799958-A	rs1799958	0	1799958	missense_variant	0	NR	6E-37	36.2218487496164	(Butyrylcarnitine / Isobutyrylcarnitine/Isovalerylcarnitine / 2-Methylbutyrylcarnitine / Valerylcarnitine)	0.541971	[0.46-0.62] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	12q24.31	12	120742216	ACADS, SPPL3	AC069234.1			ENSG00000255946	NA	NA	rs34708625-C	rs34708625	0	34708625	intron_variant	0	NR	3E-40	39.5228787452803	(Propionylcarnitine/Butyrylcarnitine / Isobutyrylcarnitine)	0.54364	[0.47-0.62] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	20p12.1	20	12992873	BTBD3, SPTLC3	LINC01723			ENSG00000234265	NA	NA	rs686548-T	rs686548	0	686548	intron_variant	0	NR	4E-16	15.397940008672	(Phosphatidylcholine with acyl-alkyl residue sum C36:0/Phosphatidylcholine with acyl-alkyl residue sum C40:2)	0.326566	[0.25-0.4] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	20p12.1	20	12992873	BTBD3, SPTLC3	LINC01723			ENSG00000234265	NA	NA	rs686548-T	rs686548	0	686548	intron_variant	0	NR	2E-12	11.698970004336	(Phosphatidylcholine with acyl-alkyl residue sum C40:2/Phosphatidylcholine with acyl-alkyl residue sum C40:5)	0.28471	[0.21-0.36] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	20p12.1	20	12992873	BTBD3, SPTLC3	LINC01723			ENSG00000234265	NA	NA	rs686548-T	rs686548	0	686548	intron_variant	0	NR	2E-15	14.698970004336	(Phosphatidylcholine with acyl-alkyl residue sum C40:2/Phosphatidylcholine with acyl-alkyl residue sum C42:2)	0.321292	[0.24-0.4] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	20p12.1	20	12992873	BTBD3, SPTLC3	LINC01723			ENSG00000234265	NA	NA	rs686548-T	rs686548	0	686548	intron_variant	0	NR	6E-14	13.2218487496164	(Phosphatidylcholine with acyl-alkyl residue sum C40:2/Phosphatidylcholine with acyl-alkyl residue sum C42:3)	0.302724	[0.22-0.38] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	20p12.1	20	12992873	BTBD3, SPTLC3	LINC01723			ENSG00000234265	NA	NA	rs686548-T	rs686548	0	686548	intron_variant	0	NR	6E-15	14.2218487496164	(Sphingomyelin with acyl residue sum C24:1/Sphingomyelin with acyl residue sum C26:1)	0.317197	[0.24-0.4] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	20p12.1	20	12992873	BTBD3, SPTLC3	LINC01723			ENSG00000234265	NA	NA	rs686548-T	rs686548	0	686548	intron_variant	0	NR	5E-14	13.301029995664	(Hydroxysphingomyelin with acyl residue sum C16:1/Sphingomyelin with acyl residue sum C16:1)	0.311299	[0.23-0.39] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	20p12.1	20	12992873	BTBD3, SPTLC3	LINC01723			ENSG00000234265	NA	NA	rs686548-T	rs686548	0	686548	intron_variant	0	NR	5E-16	15.301029995664	(Hydroxysphingomyelin with acyl residue sum C24:1/Sphingomyelin with acyl residue sum C24:0)	0.333831	[0.25-0.41] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	19p13.2	19	8222034	CERS4	CERS4			ENSG00000090661	NA	NA	rs7253584-C	rs7253584	0	7253584	intron_variant	0	NR	2E-14	13.698970004336	(Hydroxysphingomyelin with acyl residue sum C22:1/Sphingomyelin with acyl residue sum C18:0)	0.39057	[0.29-0.49] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	19p13.2	19	8222034	CERS4	CERS4			ENSG00000090661	NA	NA	rs7253584-C	rs7253584	0	7253584	intron_variant	0	NR	4E-12	11.397940008672	(Hydroxysphingomyelin with acyl residue sum C22:2/Sphingomyelin with acyl residue sum C18:1)	0.353524	[0.25-0.45] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	19p13.2	19	8222034	CERS4	CERS4			ENSG00000090661	NA	NA	rs7253584-C	rs7253584	0	7253584	intron_variant	0	NR	1E-12	12	(Sphingomyelin with acyl residue sum C16:0/Sphingomyelin with acyl residue sum C18:0)	0.359092	[0.26-0.46] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	19p13.2	19	8223873	CERS4	AC022146.2, CERS4			ENSG00000271717, ENSG00000090661	NA	NA	rs9749262-T	rs9749262	0	9749262	intron_variant	0	NR	5E-12	11.301029995664	(Sphingomyelin with acyl residue sum C18:0/Sphingomyelin with acyl residue sum C24:0)	0.34754	[0.25-0.44] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	19p13.2	19	8226788	CERS4	CERS4, AC022146.2			ENSG00000090661, ENSG00000271717	NA	NA	rs7259572-G	rs7259572	0	7259572	intron_variant	0	NR	8E-14	13.0969100130081	(Sphingomyelin with acyl residue sum C16:1/Sphingomyelin with acyl residue sum C18:0)	0.382112	[0.28-0.48] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	19p13.2	19	8226788	CERS4	CERS4, AC022146.2			ENSG00000090661, ENSG00000271717	NA	NA	rs7259572-G	rs7259572	0	7259572	intron_variant	0	NR	6E-19	18.2218487496164	(Sphingomyelin with acyl residue sum C16:1/Sphingomyelin with acyl residue sum C18:1)	0.44741	[0.35-0.54] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	6p24.2	6	11028421	ELOVL2	ELOVL2			ENSG00000197977	NA	NA	rs2208338-A	rs2208338	0	2208338	intron_variant	0	NR	2E-13	12.698970004336	(Phosphatidylcholine with diacyl residue sum C38:5/Phosphatidylcholine with diacyl residue sum C42:5)	0.351992	[0.26-0.44] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61814292	FADS1	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs174560-C	rs174560	0	174560	non_coding_transcript_exon_variant	0	NR	5E-13	12.301029995664	(Phosphatidylcholine with diacyl residue sum C34:2/Phosphatidylcholine with diacyl residue sum C42:1)	0.324237	[0.24-0.41] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61817672	FADS1	FADS2, FADS1			ENSG00000134824, ENSG00000149485	NA	NA	rs174562-G	rs174562	0	174562	intron_variant	0	NR	3E-21	20.5228787452803	(Phosphatidylcholine with diacyl residue sum C34:2/Phosphatidylcholine with acyl-alkyl residue sum C40:1)	0.418017	[0.33-0.5] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61817672	FADS1	FADS2, FADS1			ENSG00000134824, ENSG00000149485	NA	NA	rs174562-G	rs174562	0	174562	intron_variant	0	NR	6E-16	15.2218487496164	(Phosphatidylcholine with diacyl residue sum C34:2/Phosphatidylcholine with acyl-alkyl residue sum C40:5)	0.355629	[0.27-0.44] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61814292	FADS1	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs174560-C	rs174560	0	174560	non_coding_transcript_exon_variant	0	NR	1E-12	12	(Phosphatidylcholine with diacyl residue sum C36:1/Phosphatidylcholine with diacyl residue sum C40:4)	0.315009	[0.23-0.4] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61803876	FADS1	FADS2, FADS1			ENSG00000134824, ENSG00000149485	NA	NA	rs174548-G	rs174548	0	174548	5_prime_UTR_variant	0	NR	3E-14	13.5228787452803	(Phosphatidylcholine with diacyl residue sum C36:3/Lysophosphatidylcholine with acyl residue C16:0)	0.32381	[0.24-0.41] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61803876	FADS1	FADS2, FADS1			ENSG00000134824, ENSG00000149485	NA	NA	rs174548-G	rs174548	0	174548	5_prime_UTR_variant	0	NR	3E-33	32.5228787452803	(Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with diacyl residue sum C40:4)	0.523084	[0.44-0.61] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61803910	FADS1	FADS2, FADS1			ENSG00000134824, ENSG00000149485	NA	NA	rs174549-A	rs174549	0	174549	5_prime_UTR_variant	0	NR	2E-18	17.698970004336	(Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with diacyl residue sum C42:4)	0.385272	[0.3-0.47] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61814292	FADS1	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs174560-C	rs174560	0	174560	non_coding_transcript_exon_variant	0	NR	7E-18	17.1549019599857	(Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with diacyl residue sum C42:5)	0.38643	[0.3-0.47] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61817672	FADS1	FADS2, FADS1			ENSG00000134824, ENSG00000149485	NA	NA	rs174562-G	rs174562	0	174562	intron_variant	0	NR	7E-30	29.1549019599857	(Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C40:1)	0.496589	[0.41-0.58] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61817672	FADS1	FADS2, FADS1			ENSG00000134824, ENSG00000149485	NA	NA	rs174562-G	rs174562	0	174562	intron_variant	0	NR	3E-22	21.5228787452803	(Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C40:5)	0.424191	[0.34-0.51] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61813896	FADS1	FADS2, FADS1			ENSG00000134824, ENSG00000149485	NA	NA	rs174557-G	rs174557	0	174557	intron_variant	0	NR	4E-29	28.397940008672	(Phosphatidylcholine with diacyl residue sum C36:4/Lysophosphatidylcholine with acyl residue C20:3)	0.49858	[0.41-0.58] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61803876	FADS1	FADS2, FADS1			ENSG00000134824, ENSG00000149485	NA	NA	rs174548-G	rs174548	0	174548	5_prime_UTR_variant	0	NR	1E-39	39	(Phosphatidylcholine with diacyl residue sum C38:3/Phosphatidylcholine with diacyl residue sum C40:4)	0.561158	[0.48-0.64] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61803910	FADS1	FADS2, FADS1			ENSG00000134824, ENSG00000149485	NA	NA	rs174549-A	rs174549	0	174549	5_prime_UTR_variant	0	NR	4E-12	11.397940008672	(Phosphatidylcholine with diacyl residue sum C38:3/Phosphatidylcholine with diacyl residue sum C42:4)	0.30512	[0.22-0.39] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61811991	FADS1	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs174554-G	rs174554	0	174554	intron_variant	0	NR	3E-17	16.5228787452803	(Phosphatidylcholine with diacyl residue sum C38:3/Phosphatidylcholine with acyl-alkyl residue sum C40:1)	0.370484	[0.29-0.46] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61814292	FADS1	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs174560-C	rs174560	0	174560	non_coding_transcript_exon_variant	0	NR	4E-28	27.397940008672	(Phosphatidylcholine with diacyl residue sum C38:4/Lysophosphatidylcholine with acyl residue C20:3)	0.481575	[0.4-0.57] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61803876	FADS1	FADS2, FADS1			ENSG00000134824, ENSG00000149485	NA	NA	rs174548-G	rs174548	0	174548	5_prime_UTR_variant	0	NR	8E-14	13.0969100130081	(Phosphatidylcholine with diacyl residue sum C40:4/Phosphatidylcholine with acyl-alkyl residue sum C36:3)	0.332072	[0.25-0.42] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61814292	FADS1	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs174560-C	rs174560	0	174560	non_coding_transcript_exon_variant	0	NR	4E-15	14.397940008672	(Phosphatidylcholine with diacyl residue sum C40:5/Lysophosphatidylcholine with acyl residue C20:3)	0.348537	[0.26-0.43] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61803876	FADS1	FADS2, FADS1			ENSG00000134824, ENSG00000149485	NA	NA	rs174548-G	rs174548	0	174548	5_prime_UTR_variant	0	NR	1E-15	15	(Phosphatidylcholine with diacyl residue sum C40:5/Phosphatidylcholine with acyl-alkyl residue sum C36:3)	0.354703	[0.27-0.44] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61814292	FADS1	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs174560-C	rs174560	0	174560	non_coding_transcript_exon_variant	0	NR	4E-12	11.397940008672	(Phosphatidylcholine with diacyl residue sum C42:1/Phosphatidylcholine with acyl-alkyl residue sum C42:3)	0.310284	[0.22-0.4] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61814292	FADS1	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs174560-C	rs174560	0	174560	non_coding_transcript_exon_variant	0	NR	5E-20	19.301029995664	(Phosphatidylcholine with diacyl residue sum C42:4/Phosphatidylcholine with acyl-alkyl residue sum C38:3)	0.397827	[0.31-0.48] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61814292	FADS1	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs174560-C	rs174560	0	174560	non_coding_transcript_exon_variant	0	NR	3E-17	16.5228787452803	(Phosphatidylcholine with acyl-alkyl residue sum C32:2/Phosphatidylcholine with acyl-alkyl residue sum C36:3)	0.369914	[0.29-0.45] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61817672	FADS1	FADS2, FADS1			ENSG00000134824, ENSG00000149485	NA	NA	rs174562-G	rs174562	0	174562	intron_variant	0	NR	1E-19	19	(Phosphatidylcholine with acyl-alkyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C40:1)	0.396611	[0.31-0.48] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61801834	FADS1	FADS2, FADS1			ENSG00000134824, ENSG00000149485	NA	NA	rs174545-G	rs174545	0	174545	3_prime_UTR_variant	0	NR	7E-21	20.1549019599857	(Phosphatidylcholine with acyl-alkyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C40:1)	0.407966	[0.32-0.49] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61803876	FADS1	FADS2, FADS1			ENSG00000134824, ENSG00000149485	NA	NA	rs174548-G	rs174548	0	174548	5_prime_UTR_variant	0	NR	5E-12	11.301029995664	(Phosphatidylcholine with acyl-alkyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C42:2)	0.307499	[0.22-0.39] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61814292	FADS1	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs174560-C	rs174560	0	174560	non_coding_transcript_exon_variant	0	NR	5E-24	23.301029995664	(Phosphatidylcholine with acyl-alkyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C44:6)	0.444499	[0.36-0.53] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61803876	FADS1	FADS2, FADS1			ENSG00000134824, ENSG00000149485	NA	NA	rs174548-G	rs174548	0	174548	5_prime_UTR_variant	0	NR	6E-14	13.2218487496164	(Phosphatidylcholine with acyl-alkyl residue sum C36:3/Sphingomyelin with acyl residue sum C16:0)	0.335386	[0.25-0.42] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61814292	FADS1	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs174560-C	rs174560	0	174560	non_coding_transcript_exon_variant	0	NR	1E-17	17	(Phosphatidylcholine with acyl-alkyl residue sum C36:3/Sphingomyelin with acyl residue sum C16:1)	0.383918	[0.3-0.47] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61814292	FADS1	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs174560-C	rs174560	0	174560	non_coding_transcript_exon_variant	0	NR	3E-13	12.5228787452803	(Phosphatidylcholine with acyl-alkyl residue sum C36:3/Sphingomyelin with acyl residue sum C18:1)	0.325269	[0.24-0.41] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61803910	FADS1	FADS2, FADS1			ENSG00000134824, ENSG00000149485	NA	NA	rs174549-A	rs174549	0	174549	5_prime_UTR_variant	0	NR	1E-20	20	(Phosphatidylcholine with acyl-alkyl residue sum C42:5/Phosphatidylcholine with acyl-alkyl residue sum C44:4)	0.416489	[0.33-0.5] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61820833	FADS1, FADS2	FADS2, FADS1			ENSG00000134824, ENSG00000149485	NA	NA	rs174564-G	rs174564	0	174564	intron_variant	0	NR	1E-35	35	(Phosphatidylcholine with diacyl residue sum C36:2/Phosphatidylcholine with diacyl residue sum C38:5)	0.537812	[0.46-0.62] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61820833	FADS1, FADS2	FADS2, FADS1			ENSG00000134824, ENSG00000149485	NA	NA	rs174564-G	rs174564	0	174564	intron_variant	0	NR	3E-19	18.5228787452803	(Phosphatidylcholine with diacyl residue sum C36:2/Phosphatidylcholine with diacyl residue sum C40:5)	0.391509	[0.31-0.48] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61820833	FADS1, FADS2	FADS2, FADS1			ENSG00000134824, ENSG00000149485	NA	NA	rs174564-G	rs174564	0	174564	intron_variant	0	NR	5E-27	26.301029995664	(Phosphatidylcholine with diacyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C38:4)	0.465781	[0.38-0.55] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61820833	FADS1, FADS2	FADS2, FADS1			ENSG00000134824, ENSG00000149485	NA	NA	rs174564-G	rs174564	0	174564	intron_variant	0	NR	1E-29	29	(Phosphatidylcholine with diacyl residue sum C36:4/Phosphatidylcholine with acyl-alkyl residue sum C36:2)	0.477627	[0.4-0.56] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61820833	FADS1, FADS2	FADS2, FADS1			ENSG00000134824, ENSG00000149485	NA	NA	rs174564-G	rs174564	0	174564	intron_variant	0	NR	6E-25	24.2218487496164	(Phosphatidylcholine with diacyl residue sum C38:4/Phosphatidylcholine with acyl-alkyl residue sum C36:2)	0.441026	[0.36-0.52] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61820833	FADS1, FADS2	FADS2, FADS1			ENSG00000134824, ENSG00000149485	NA	NA	rs174564-G	rs174564	0	174564	intron_variant	0	NR	2E-28	27.698970004336	(Phosphatidylcholine with diacyl residue sum C38:5/Phosphatidylcholine with acyl-alkyl residue sum C36:2)	0.474674	[0.39-0.56] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61820833	FADS1, FADS2	FADS2, FADS1			ENSG00000134824, ENSG00000149485	NA	NA	rs174564-G	rs174564	0	174564	intron_variant	0	NR	3E-16	15.5228787452803	(Phosphatidylcholine with diacyl residue sum C30:0/Phosphatidylcholine with diacyl residue sum C32:2)	0.351995	[0.27-0.44] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61820833	FADS1, FADS2	FADS2, FADS1			ENSG00000134824, ENSG00000149485	NA	NA	rs174564-G	rs174564	0	174564	intron_variant	0	NR	2E-13	12.698970004336	(Phosphatidylcholine with acyl-alkyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C44:5)	0.312607	[0.23-0.39] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61820833	FADS1, FADS2	FADS2, FADS1			ENSG00000134824, ENSG00000149485	NA	NA	rs174564-G	rs174564	0	174564	intron_variant	0	NR	4E-25	24.397940008672	(Phosphatidylcholine with diacyl residue sum C32:0/Phosphatidylcholine with diacyl residue sum C34:2)	0.450238	[0.37-0.53] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61820833	FADS1, FADS2	FADS2, FADS1			ENSG00000134824, ENSG00000149485	NA	NA	rs174564-G	rs174564	0	174564	intron_variant	0	NR	2E-38	37.698970004336	(Phosphatidylcholine with diacyl residue sum C32:2/Phosphatidylcholine with diacyl residue sum C34:4)	0.553333	[0.47-0.63] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61822009	FADS1, FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs28456-G	rs28456	0	28456	intron_variant	0	NR	3E-15	14.5228787452803	(Phosphatidylcholine with diacyl residue sum C42:1/Phosphatidylcholine with acyl-alkyl residue sum C36:2)	0.350198	[0.26-0.44] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61822009	FADS1, FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs28456-G	rs28456	0	28456	intron_variant	0	NR	1E-18	18	(Phosphatidylcholine with acyl-alkyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C44:5)	0.385672	[0.3-0.47] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61822009	FADS1, FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs28456-G	rs28456	0	28456	intron_variant	0	NR	6E-19	18.2218487496164	(Phosphatidylcholine with diacyl residue sum C32:0/Phosphatidylcholine with acyl-alkyl residue sum C36:3)	0.39209	[0.31-0.48] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61824524	FADS1, FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs57668028-G	rs57668028	0	57668028	intron_variant	0	NR	6E-15	14.2218487496164	(Phosphatidylcholine with diacyl residue sum C34:2/Sphingomyelin with acyl residue sum C16:1)	0.35035	[0.26-0.44] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61824524	FADS1, FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs57668028-G	rs57668028	0	57668028	intron_variant	0	NR	6E-15	14.2218487496164	(Phosphatidylcholine with diacyl residue sum C36:2/Sphingomyelin with acyl residue sum C16:1)	0.355135	[0.27-0.44] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61824524	FADS1, FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs57668028-G	rs57668028	0	57668028	intron_variant	0	NR	1E-19	19	(Phosphatidylcholine with diacyl residue sum C36:3/Sphingomyelin with acyl residue sum C16:1)	0.414122	[0.33-0.5] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61824524	FADS1, FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs57668028-G	rs57668028	0	57668028	intron_variant	0	NR	8E-14	13.0969100130081	(Phosphatidylcholine with diacyl residue sum C38:3/Phosphatidylcholine with acyl-alkyl residue sum C44:6)	0.339838	[0.25-0.43] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61824890	FADS1, FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs174566-G	rs174566	0	174566	intron_variant	0	NR	3E-44	43.5228787452803	(Lysophosphatidylcholine with acyl residue C18:1/Lysophosphatidylcholine with acyl residue C20:4)	0.587293	[0.51-0.67] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61824890	FADS1, FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs174566-G	rs174566	0	174566	intron_variant	0	NR	1E-22	22	(Phosphatidylcholine with diacyl residue sum C34:1/Phosphatidylcholine with diacyl residue sum C36:5)	0.418673	[0.34-0.5] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61824890	FADS1, FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs174566-G	rs174566	0	174566	intron_variant	0	NR	6E-18	17.2218487496164	(Phosphatidylcholine with diacyl residue sum C34:2/Phosphatidylcholine with diacyl residue sum C34:4)	0.366984	[0.29-0.45] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61824890	FADS1, FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs174566-G	rs174566	0	174566	intron_variant	0	NR	3E-23	22.5228787452803	(Phosphatidylcholine with diacyl residue sum C34:2/Phosphatidylcholine with diacyl residue sum C36:5)	0.42408	[0.34-0.51] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61824890	FADS1, FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs174566-G	rs174566	0	174566	intron_variant	0	NR	2E-17	16.698970004336	(Phosphatidylcholine with diacyl residue sum C34:2/Phosphatidylcholine with acyl-alkyl residue sum C38:6)	0.37028	[0.29-0.45] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61824890	FADS1, FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs174566-G	rs174566	0	174566	intron_variant	0	NR	6E-32	31.2218487496164	(Phosphatidylcholine with diacyl residue sum C34:3/Phosphatidylcholine with diacyl residue sum C34:4)	0.504805	[0.42-0.59] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61824890	FADS1, FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs174566-G	rs174566	0	174566	intron_variant	0	NR	2E-33	32.698970004336	(Phosphatidylcholine with diacyl residue sum C34:3/Phosphatidylcholine with diacyl residue sum C36:5)	0.511064	[0.43-0.59] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61824890	FADS1, FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs174566-G	rs174566	0	174566	intron_variant	0	NR	1E-19	19	(Phosphatidylcholine with diacyl residue sum C34:4/Phosphatidylcholine with acyl-alkyl residue sum C36:3)	0.390098	[0.31-0.47] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61814292	FADS1	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs174560-C	rs174560	0	174560	non_coding_transcript_exon_variant	0	NR	2E-14	13.698970004336	(Phosphatidylcholine with acyl-alkyl residue sum C44:3/Phosphatidylcholine with acyl-alkyl residue sum C44:6)	0.336433	[0.25-0.42] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61814292	FADS1	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs174560-C	rs174560	0	174560	non_coding_transcript_exon_variant	0	NR	2E-32	31.698970004336	(Phosphatidylcholine with acyl-alkyl residue sum C44:4/Phosphatidylcholine with acyl-alkyl residue sum C44:5)	0.518862	[0.44-0.6] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61814292	FADS1	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs174560-C	rs174560	0	174560	non_coding_transcript_exon_variant	0	NR	1E-30	30	(Phosphatidylcholine with acyl-alkyl residue sum C44:4/Phosphatidylcholine with acyl-alkyl residue sum C44:6)	0.510583	[0.43-0.59] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61818857	FADS1, FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs35473591-CT	rs35473591	0	35473591	intron_variant	0	NR	8E-15	14.0969100130081	(Phosphatidylcholine with diacyl residue sum C36:1/Phosphatidylcholine with acyl-alkyl residue sum C40:1)	0.343554	[0.26-0.43] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61818857	FADS1, FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs35473591-CT	rs35473591	0	35473591	intron_variant	0	NR	3E-22	21.5228787452803	(Phosphatidylcholine with diacyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C40:1)	0.42944	[0.34-0.51] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61818857	FADS1, FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs35473591-CT	rs35473591	0	35473591	intron_variant	0	NR	8E-17	16.0969100130081	(Phosphatidylcholine with diacyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C40:5)	0.365477	[0.28-0.45] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61818857	FADS1, FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs35473591-CT	rs35473591	0	35473591	intron_variant	0	NR	3E-13	12.5228787452803	(Phosphatidylcholine with diacyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C42:5)	0.320303	[0.24-0.41] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61818857	FADS1, FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs35473591-CT	rs35473591	0	35473591	intron_variant	0	NR	1E-17	17	(Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C42:5)	0.375213	[0.29-0.46] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61818857	FADS1, FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs35473591-CT	rs35473591	0	35473591	intron_variant	0	NR	2E-48	47.698970004336	(Phosphatidylcholine with diacyl residue sum C36:4/Phosphatidylcholine with diacyl residue sum C38:3)	0.624654	[0.54-0.7] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61818857	FADS1, FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs35473591-CT	rs35473591	0	35473591	intron_variant	0	NR	7E-41	40.1549019599857	(Phosphatidylcholine with diacyl residue sum C38:3/Lysophosphatidylcholine with acyl residue C20:4)	0.551355	[0.47-0.63] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61818857	FADS1, FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs35473591-CT	rs35473591	0	35473591	intron_variant	0	NR	3E-44	43.5228787452803	(Phosphatidylcholine with diacyl residue sum C38:3/Phosphatidylcholine with diacyl residue sum C38:5)	0.601789	[0.52-0.68] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61818857	FADS1, FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs35473591-CT	rs35473591	0	35473591	intron_variant	0	NR	2E-18	17.698970004336	(Phosphatidylcholine with diacyl residue sum C38:3/Phosphatidylcholine with acyl-alkyl residue sum C36:4)	0.381911	[0.3-0.47] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61818857	FADS1, FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs35473591-CT	rs35473591	0	35473591	intron_variant	0	NR	1E-23	23	(Phosphatidylcholine with diacyl residue sum C38:3/Phosphatidylcholine with acyl-alkyl residue sum C38:4)	0.438861	[0.35-0.52] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61818857	FADS1, FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs35473591-CT	rs35473591	0	35473591	intron_variant	0	NR	2E-23	22.698970004336	(Phosphatidylcholine with diacyl residue sum C38:3/Phosphatidylcholine with acyl-alkyl residue sum C38:5)	0.430615	[0.35-0.51] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61818857	FADS1, FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs35473591-CT	rs35473591	0	35473591	intron_variant	0	NR	6E-14	13.2218487496164	(Phosphatidylcholine with diacyl residue sum C38:3/Phosphatidylcholine with acyl-alkyl residue sum C40:5)	0.328617	[0.24-0.41] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61820833	FADS1, FADS2	FADS2, FADS1			ENSG00000134824, ENSG00000149485	NA	NA	rs174564-G	rs174564	0	174564	intron_variant	0	NR	2E-42	41.698970004336	(Lysophosphatidylcholine with acyl residue C16:0/Lysophosphatidylcholine with acyl residue C20:4)	0.575391	[0.5-0.65] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61820833	FADS1, FADS2	FADS2, FADS1			ENSG00000134824, ENSG00000149485	NA	NA	rs174564-G	rs174564	0	174564	intron_variant	0	NR	3E-36	35.5228787452803	(Phosphatidylcholine with diacyl residue sum C34:2/Lysophosphatidylcholine with acyl residue C20:4)	0.524786	[0.45-0.6] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61820833	FADS1, FADS2	FADS2, FADS1			ENSG00000134824, ENSG00000149485	NA	NA	rs174564-G	rs174564	0	174564	intron_variant	0	NR	1E-52	52	(Phosphatidylcholine with diacyl residue sum C34:2/Phosphatidylcholine with diacyl residue sum C36:4)	0.645129	[0.57-0.72] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61820833	FADS1, FADS2	FADS2, FADS1			ENSG00000134824, ENSG00000149485	NA	NA	rs174564-G	rs174564	0	174564	intron_variant	0	NR	2E-35	34.698970004336	(Phosphatidylcholine with diacyl residue sum C34:2/Phosphatidylcholine with diacyl residue sum C38:4)	0.533243	[0.45-0.61] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61820833	FADS1, FADS2	FADS2, FADS1			ENSG00000134824, ENSG00000149485	NA	NA	rs174564-G	rs174564	0	174564	intron_variant	0	NR	3E-34	33.5228787452803	(Phosphatidylcholine with diacyl residue sum C34:2/Phosphatidylcholine with diacyl residue sum C38:5)	0.524021	[0.44-0.61] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61820833	FADS1, FADS2	FADS2, FADS1			ENSG00000134824, ENSG00000149485	NA	NA	rs174564-G	rs174564	0	174564	intron_variant	0	NR	4E-32	31.397940008672	(Phosphatidylcholine with diacyl residue sum C34:2/Phosphatidylcholine with acyl-alkyl residue sum C36:5)	0.507788	[0.43-0.59] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61820833	FADS1, FADS2	FADS2, FADS1			ENSG00000134824, ENSG00000149485	NA	NA	rs174564-G	rs174564	0	174564	intron_variant	0	NR	2E-26	25.698970004336	(Phosphatidylcholine with diacyl residue sum C34:2/Phosphatidylcholine with acyl-alkyl residue sum C38:4)	0.458945	[0.38-0.54] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61820833	FADS1, FADS2	FADS2, FADS1			ENSG00000134824, ENSG00000149485	NA	NA	rs174564-G	rs174564	0	174564	intron_variant	0	NR	3E-36	35.5228787452803	(Phosphatidylcholine with diacyl residue sum C36:2/Lysophosphatidylcholine with acyl residue C20:4)	0.521575	[0.44-0.6] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61820833	FADS1, FADS2	FADS2, FADS1			ENSG00000134824, ENSG00000149485	NA	NA	rs174564-G	rs174564	0	174564	intron_variant	0	NR	3E-43	42.5228787452803	(Phosphatidylcholine with diacyl residue sum C36:2/Phosphatidylcholine with diacyl residue sum C36:4)	0.588171	[0.51-0.67] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61820833	FADS1, FADS2	FADS2, FADS1			ENSG00000134824, ENSG00000149485	NA	NA	rs174564-G	rs174564	0	174564	intron_variant	0	NR	2E-42	41.698970004336	(Phosphatidylcholine with diacyl residue sum C36:2/Phosphatidylcholine with diacyl residue sum C38:4)	0.582478	[0.5-0.66] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61774535	MYRF	TMEM258, MYRF			ENSG00000134825, ENSG00000124920	NA	NA	rs11320420-G	rs11320420	0	11320420	intron_variant	0	NR	1E-18	18	(Phosphatidylcholine with acyl-alkyl residue sum C34:1/Phosphatidylcholine with acyl-alkyl residue sum C38:5)	0.371764	[0.29-0.45] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61779596	MYRF	TMEM258, MYRF			ENSG00000134825, ENSG00000124920	NA	NA	rs7943728-A	rs7943728	0	7943728	intron_variant	0	NR	4E-19	18.397940008672	(Phosphatidylcholine with acyl-alkyl residue sum C34:2/Phosphatidylcholine with acyl-alkyl residue sum C36:3)	0.484582	[0.38-0.59] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61781553	MYRF	TMEM258, MYRF			ENSG00000134825, ENSG00000124920	NA	NA	rs174533-A	rs174533	0	174533	intron_variant	0	NR	5E-17	16.301029995664	(Phosphatidylcholine with acyl-alkyl residue sum C34:2/Phosphatidylcholine with acyl-alkyl residue sum C38:6)	0.365851	[0.28-0.45] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61785208	MYRF	TMEM258, MYRF			ENSG00000134825, ENSG00000124920	NA	NA	rs174537-T	rs174537	0	174537	non_coding_transcript_exon_variant	0	NR	2E-19	18.698970004336	(Phosphatidylcholine with acyl-alkyl residue sum C36:5/Sphingomyelin with acyl residue sum C16:0)	0.389852	[0.31-0.47] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61785208	MYRF	TMEM258, MYRF			ENSG00000134825, ENSG00000124920	NA	NA	rs174537-T	rs174537	0	174537	non_coding_transcript_exon_variant	0	NR	7E-14	13.1549019599857	(Phosphatidylcholine with acyl-alkyl residue sum C40:5/Phosphatidylcholine with acyl-alkyl residue sum C44:4)	0.32504	[0.24-0.41] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61774535	MYRF	TMEM258, MYRF			ENSG00000134825, ENSG00000124920	NA	NA	rs11320420-G	rs11320420	0	11320420	intron_variant	0	NR	5E-20	19.301029995664	(Phosphatidylcholine with diacyl residue sum C32:1/Phosphatidylcholine with diacyl residue sum C36:5)	0.406939	[0.32-0.49] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61774535	MYRF	TMEM258, MYRF			ENSG00000134825, ENSG00000124920	NA	NA	rs11320420-G	rs11320420	0	11320420	intron_variant	0	NR	5E-24	23.301029995664	(Phosphatidylcholine with diacyl residue sum C32:2/Phosphatidylcholine with diacyl residue sum C36:5)	0.440476	[0.36-0.52] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61774535	MYRF	TMEM258, MYRF			ENSG00000134825, ENSG00000124920	NA	NA	rs11320420-G	rs11320420	0	11320420	intron_variant	0	NR	7E-15	14.1549019599857	(Phosphatidylcholine with diacyl residue sum C32:2/Phosphatidylcholine with diacyl residue sum C36:6)	0.347264	[0.26-0.43] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61779120	MYRF	MYRF, TMEM258			ENSG00000124920, ENSG00000134825	NA	NA	rs174530-G	rs174530	0	174530	non_coding_transcript_exon_variant	0	NR	2E-12	11.698970004336	(Phosphatidylcholine with diacyl residue sum C32:3/Phosphatidylcholine with diacyl residue sum C34:4)	0.303616	[0.22-0.39] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61776027	MYRF	TMEM258, MYRF			ENSG00000134825, ENSG00000124920	NA	NA	rs174528-C	rs174528	0	174528	intron_variant	0	NR	5E-18	17.301029995664	(Phosphatidylcholine with diacyl residue sum C32:3/Phosphatidylcholine with diacyl residue sum C36:5)	0.363709	[0.28-0.44] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	16p13.11	16	15052204	NTAN1	NTAN1, NTAN1, PDXDC1, PDXDC1			ENSG00000275779, ENSG00000157045, ENSG00000179889, ENSG00000275498	NA	NA	rs35574015-C	rs35574015	0	35574015	intron_variant	0	NR	3E-13	12.5228787452803	(Lysophosphatidylcholine with acyl residue C18:1/Lysophosphatidylcholine with acyl residue C20:3)	0.31705	[0.23-0.4] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	10q24.31	10	100315722	PKD2L1	PKD2L1			ENSG00000107593	NA	NA	rs603424-A	rs603424	0	603424	intron_variant	0	NR	3E-13	12.5228787452803	(Lysophosphatidylcholine with acyl residue C16:0/Lysophosphatidylcholine with acyl residue C16:1)	0.35231	[0.26-0.45] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	14q23.2	14	63767002	SGPP1, SYNE2	SYNE2			ENSG00000054654	NA	NA	rs8008070-T	rs8008070	0	8008070	intron_variant	0	NR	5E-22	21.301029995664	(Hydroxysphingomyelin with acyl residue sum C14:1/Hydroxysphingomyelin with acyl residue sum C16:1)	0.535136	[0.43-0.64] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	10q21.2	10	59709780	SLC16A9	SLC16A9			ENSG00000165449	NA	NA	rs1171614-C	rs1171614	0	1171614	5_prime_UTR_variant	0	NR	3E-12	11.5228787452803	(Valine/Propionylcarnitine)	0.328612	[0.24-0.42] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	1p31.1	1	75671921	SLC44A5, ACADM	AL137803.1			ENSG00000230863	NA	NA	rs12134854-C	rs12134854	0	12134854	intron_variant	0	NR	2E-18	17.698970004336	(Decanoylcarnitine/Tetradecenoylcarnitine)	0.368137	[0.29-0.45] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	1p31.1	1	75702239	SLC44A5, ACADM	AL137803.1			ENSG00000230863	NA	NA	rs76963882-C	rs76963882	0	76963882	intron_variant	0	NR	4E-30	29.397940008672	(Decanoylcarnitine/Dodecanoylcarnitine)	0.504574	[0.42-0.59] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	14q24.1	14	67502391	TMEM229B	TMEM229B			ENSG00000198133	NA	NA	rs72719193-A	rs72719193	0	72719193	intron_variant	0	NR	3E-16	15.5228787452803	(Phosphatidylcholine with acyl-alkyl residue sum C32:2/Phosphatidylcholine with acyl-alkyl residue sum C34:1)	0.330504	[0.25-0.41] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	14q24.1	14	67502391	TMEM229B	TMEM229B			ENSG00000198133	NA	NA	rs72719193-A	rs72719193	0	72719193	intron_variant	0	NR	4E-21	20.397940008672	(Phosphatidylcholine with acyl-alkyl residue sum C36:5/Phosphatidylcholine with acyl-alkyl residue sum C38:5)	0.376328	[0.3-0.45] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	14q24.1	14	67509105	TMEM229B	TMEM229B			ENSG00000198133	NA	NA	rs1077989-C	rs1077989	0	1077989	intron_variant	0	NR	3E-14	13.5228787452803	(Phosphatidylcholine with acyl-alkyl residue sum C32:2/Hydroxysphingomyelin with acyl residue sum C22:2)	0.308987	[0.23-0.39] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	14q24.1	14	67509105	TMEM229B	TMEM229B			ENSG00000198133	NA	NA	rs1077989-C	rs1077989	0	1077989	intron_variant	0	NR	6E-16	15.2218487496164	(Phosphatidylcholine with acyl-alkyl residue sum C32:2/Sphingomyelin with acyl residue sum C16:1)	0.328811	[0.25-0.41] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	14q24.1	14	67509105	TMEM229B	TMEM229B			ENSG00000198133	NA	NA	rs1077989-C	rs1077989	0	1077989	intron_variant	0	NR	2E-20	19.698970004336	(Phosphatidylcholine with acyl-alkyl residue sum C36:4/Phosphatidylcholine with acyl-alkyl residue sum C36:5)	0.368982	[0.29-0.45] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	14q24.1	14	67509608	TMEM229B	TMEM229B			ENSG00000198133	NA	NA	rs1885041-T	rs1885041	0	1885041	intron_variant	0	NR	5E-30	29.301029995664	(Phosphatidylcholine with acyl-alkyl residue sum C32:1/Phosphatidylcholine with acyl-alkyl residue sum C34:1)	0.452313	[0.38-0.53] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	14q24.1	14	67509608	TMEM229B	TMEM229B			ENSG00000198133	NA	NA	rs1885041-T	rs1885041	0	1885041	intron_variant	0	NR	5E-22	21.301029995664	(Phosphatidylcholine with diacyl residue sum C32:0/Phosphatidylcholine with acyl-alkyl residue sum C32:1)	0.384229	[0.31-0.46] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61790331	TMEM258	TMEM258			ENSG00000134825	NA	NA	rs102275-C	rs102275	0	102275	non_coding_transcript_exon_variant	0	NR	2E-75	74.698970004336	(Lysophosphatidylcholine with acyl residue C20:3/Lysophosphatidylcholine with acyl residue C20:4)	0.753679	[0.68-0.83] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61790331	TMEM258	TMEM258			ENSG00000134825	NA	NA	rs102275-C	rs102275	0	102275	non_coding_transcript_exon_variant	0	NR	3E-40	39.5228787452803	(Phosphatidylcholine with diacyl residue sum C34:1/Phosphatidylcholine with diacyl residue sum C36:4)	0.565899	[0.49-0.65] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61790331	TMEM258	TMEM258			ENSG00000134825	NA	NA	rs102275-C	rs102275	0	102275	non_coding_transcript_exon_variant	0	NR	7E-27	26.1549019599857	(Phosphatidylcholine with diacyl residue sum C34:1/Phosphatidylcholine with diacyl residue sum C38:4)	0.462963	[0.38-0.55] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61790331	TMEM258	TMEM258			ENSG00000134825	NA	NA	rs102275-C	rs102275	0	102275	non_coding_transcript_exon_variant	0	NR	2E-32	31.698970004336	(Phosphatidylcholine with diacyl residue sum C34:1/Phosphatidylcholine with diacyl residue sum C38:5)	0.505096	[0.42-0.59] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61790331	TMEM258	TMEM258			ENSG00000134825	NA	NA	rs102275-C	rs102275	0	102275	non_coding_transcript_exon_variant	0	NR	2E-15	14.698970004336	(Phosphatidylcholine with diacyl residue sum C34:2/Phosphatidylcholine with diacyl residue sum C40:5)	0.348733	[0.26-0.43] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61790331	TMEM258	TMEM258			ENSG00000134825	NA	NA	rs102275-C	rs102275	0	102275	non_coding_transcript_exon_variant	0	NR	5E-32	31.301029995664	(Phosphatidylcholine with diacyl residue sum C34:3/Phosphatidylcholine with diacyl residue sum C36:4)	0.490688	[0.41-0.57] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61790331	TMEM258	TMEM258			ENSG00000134825	NA	NA	rs102275-C	rs102275	0	102275	non_coding_transcript_exon_variant	0	NR	3E-31	30.5228787452803	(Phosphatidylcholine with diacyl residue sum C34:3/Phosphatidylcholine with diacyl residue sum C38:5)	0.490477	[0.41-0.57] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61790331	TMEM258	TMEM258			ENSG00000134825	NA	NA	rs102275-C	rs102275	0	102275	non_coding_transcript_exon_variant	0	NR	2E-30	29.698970004336	(Phosphatidylcholine with diacyl residue sum C36:1/Phosphatidylcholine with diacyl residue sum C38:4)	0.49379	[0.41-0.58] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61790331	TMEM258	TMEM258			ENSG00000134825	NA	NA	rs102275-C	rs102275	0	102275	non_coding_transcript_exon_variant	0	NR	6E-15	14.2218487496164	(Phosphatidylcholine with diacyl residue sum C36:1/Phosphatidylcholine with acyl-alkyl residue sum C38:4)	0.340896	[0.26-0.43] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61790331	TMEM258	TMEM258			ENSG00000134825	NA	NA	rs102275-C	rs102275	0	102275	non_coding_transcript_exon_variant	0	NR	5E-49	48.301029995664	(Phosphatidylcholine with diacyl residue sum C36:3/Lysophosphatidylcholine with acyl residue C20:4)	0.597844	[0.52-0.67] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61790331	TMEM258	TMEM258			ENSG00000134825	NA	NA	rs102275-C	rs102275	0	102275	non_coding_transcript_exon_variant	0	NR	2E-82	81.698970004336	(Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with diacyl residue sum C36:4)	0.786835	[0.71-0.86] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61790331	TMEM258	TMEM258			ENSG00000134825	NA	NA	rs102275-C	rs102275	0	102275	non_coding_transcript_exon_variant	0	NR	3E-26	25.5228787452803	(Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C36:4)	0.454031	[0.37-0.54] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61790331	TMEM258	TMEM258			ENSG00000134825	NA	NA	rs102275-C	rs102275	0	102275	non_coding_transcript_exon_variant	0	NR	3E-38	37.5228787452803	(Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C38:4)	0.555338	[0.47-0.64] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61790331	TMEM258	TMEM258			ENSG00000134825	NA	NA	rs102275-C	rs102275	0	102275	non_coding_transcript_exon_variant	0	NR	3E-35	34.5228787452803	(Phosphatidylcholine with diacyl residue sum C36:4/Phosphatidylcholine with acyl-alkyl residue sum C36:3)	0.523961	[0.44-0.6] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61790331	TMEM258	TMEM258			ENSG00000134825	NA	NA	rs102275-C	rs102275	0	102275	non_coding_transcript_exon_variant	0	NR	4E-26	25.397940008672	(Phosphatidylcholine with diacyl residue sum C36:4/Sphingomyelin with acyl residue sum C24:0)	0.460145	[0.38-0.54] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61790331	TMEM258	TMEM258			ENSG00000134825	NA	NA	rs102275-C	rs102275	0	102275	non_coding_transcript_exon_variant	0	NR	5E-18	17.301029995664	(Phosphatidylcholine with diacyl residue sum C36:5/Phosphatidylcholine with diacyl residue sum C36:6)	0.36532	[0.28-0.45] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61790331	TMEM258	TMEM258			ENSG00000134825	NA	NA	rs102275-C	rs102275	0	102275	non_coding_transcript_exon_variant	0	NR	1E-73	73	(Phosphatidylcholine with diacyl residue sum C38:3/Phosphatidylcholine with diacyl residue sum C38:4)	0.747911	[0.67-0.82] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61790331	TMEM258	TMEM258			ENSG00000134825	NA	NA	rs102275-C	rs102275	0	102275	non_coding_transcript_exon_variant	0	NR	1E-42	42	(Phosphatidylcholine with diacyl residue sum C38:3/Phosphatidylcholine with diacyl residue sum C40:5)	0.578435	[0.5-0.66] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61790331	TMEM258	TMEM258			ENSG00000134825	NA	NA	rs102275-C	rs102275	0	102275	non_coding_transcript_exon_variant	0	NR	4E-30	29.397940008672	(Phosphatidylcholine with diacyl residue sum C38:4/Phosphatidylcholine with acyl-alkyl residue sum C36:3)	0.487475	[0.41-0.57] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61790331	TMEM258	TMEM258			ENSG00000134825	NA	NA	rs102275-C	rs102275	0	102275	non_coding_transcript_exon_variant	0	NR	6E-26	25.2218487496164	(Phosphatidylcholine with diacyl residue sum C38:4/Sphingomyelin with acyl residue sum C24:0)	0.457665	[0.37-0.54] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61790331	TMEM258	TMEM258			ENSG00000134825	NA	NA	rs102275-C	rs102275	0	102275	non_coding_transcript_exon_variant	0	NR	2E-30	29.698970004336	(Phosphatidylcholine with diacyl residue sum C38:5/Phosphatidylcholine with acyl-alkyl residue sum C36:3)	0.491381	[0.41-0.57] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61790331	TMEM258	TMEM258			ENSG00000134825	NA	NA	rs102275-C	rs102275	0	102275	non_coding_transcript_exon_variant	0	NR	1E-20	20	(Phosphatidylcholine with diacyl residue sum C38:5/Sphingomyelin with acyl residue sum C24:0)	0.407048	[0.32-0.49] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61790331	TMEM258	TMEM258			ENSG00000134825	NA	NA	rs102275-C	rs102275	0	102275	non_coding_transcript_exon_variant	0	NR	1E-20	20	(Phosphatidylcholine with acyl-alkyl residue sum C34:2/Phosphatidylcholine with acyl-alkyl residue sum C36:4)	0.384988	[0.31-0.46] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61790331	TMEM258	TMEM258			ENSG00000134825	NA	NA	rs102275-C	rs102275	0	102275	non_coding_transcript_exon_variant	0	NR	1E-30	30	(Phosphatidylcholine with acyl-alkyl residue sum C34:2/Phosphatidylcholine with acyl-alkyl residue sum C36:5)	0.478987	[0.4-0.56] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61790331	TMEM258	TMEM258			ENSG00000134825	NA	NA	rs102275-C	rs102275	0	102275	non_coding_transcript_exon_variant	0	NR	2E-17	16.698970004336	(Phosphatidylcholine with acyl-alkyl residue sum C34:2/Phosphatidylcholine with acyl-alkyl residue sum C38:4)	0.366763	[0.28-0.45] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61790331	TMEM258	TMEM258			ENSG00000134825	NA	NA	rs102275-C	rs102275	0	102275	non_coding_transcript_exon_variant	0	NR	1E-24	24	(Phosphatidylcholine with acyl-alkyl residue sum C34:2/Phosphatidylcholine with acyl-alkyl residue sum C38:5)	0.425111	[0.35-0.5] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61790331	TMEM258	TMEM258			ENSG00000134825	NA	NA	rs102275-C	rs102275	0	102275	non_coding_transcript_exon_variant	0	NR	3E-26	25.5228787452803	(Phosphatidylcholine with acyl-alkyl residue sum C34:3/Phosphatidylcholine with acyl-alkyl residue sum C36:5)	0.43919	[0.36-0.52] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61826344	FADS1, FADS2	FADS2, FADS1			ENSG00000134824, ENSG00000149485	NA	NA	rs174568-T	rs174568	0	174568	missense_variant	0	NR	4E-24	23.397940008672	(Phosphatidylcholine with diacyl residue sum C38:5/Lysophosphatidylcholine with acyl residue C20:3)	0.435294	[0.35-0.52] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61828851	FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs5792235-C	rs5792235	0	5792235	intron_variant	0	NR	6E-15	14.2218487496164	(Phosphatidylcholine with diacyl residue sum C34:1/Phosphatidylcholine with diacyl residue sum C34:4)	0.335276	[0.25-0.42] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61839211	FADS2	FADS2			ENSG00000134824	NA	NA	rs174581-A	rs174581	0	174581	intron_variant	0	NR	3E-12	11.5228787452803	(Phosphatidylcholine with diacyl residue sum C34:2/Phosphatidylcholine with diacyl residue sum C40:4)	0.303191	[0.22-0.39] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61839170	FADS2	FADS2			ENSG00000134824	NA	NA	rs174580-G	rs174580	0	174580	intron_variant	0	NR	4E-20	19.397940008672	(Phosphatidylcholine with diacyl residue sum C34:2/Phosphatidylcholine with acyl-alkyl residue sum C36:4)	0.391712	[0.31-0.47] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61839170	FADS2	FADS2			ENSG00000134824	NA	NA	rs174580-G	rs174580	0	174580	intron_variant	0	NR	2E-28	27.698970004336	(Phosphatidylcholine with diacyl residue sum C34:2/Phosphatidylcholine with acyl-alkyl residue sum C38:5)	0.469249	[0.39-0.55] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61856709	FADS2	FADS2			ENSG00000134824	NA	NA	rs97384-C	rs97384	0	97384	non_coding_transcript_exon_variant	0	NR	4E-13	12.397940008672	(Phosphatidylcholine with diacyl residue sum C34:2/Phosphatidylcholine with acyl-alkyl residue sum C42:5)	0.304614	[0.22-0.39] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61830500	FADS2	FADS2			ENSG00000134824	NA	NA	rs1535-G	rs1535	0	1535	intron_variant	0	NR	5E-16	15.301029995664	(Phosphatidylcholine with diacyl residue sum C34:2/Phosphatidylcholine with acyl-alkyl residue sum C44:6)	0.353448	[0.27-0.44] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61830500	FADS2	FADS2			ENSG00000134824	NA	NA	rs1535-G	rs1535	0	1535	intron_variant	0	NR	8E-16	15.0969100130081	(Phosphatidylcholine with diacyl residue sum C34:3/Phosphatidylcholine with diacyl residue sum C36:6)	0.353321	[0.27-0.44] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61828851	FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs5792235-C	rs5792235	0	5792235	intron_variant	0	NR	2E-16	15.698970004336	(Phosphatidylcholine with diacyl residue sum C34:4/Phosphatidylcholine with diacyl residue sum C36:1)	0.360572	[0.28-0.45] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61828851	FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs5792235-C	rs5792235	0	5792235	intron_variant	0	NR	3E-17	16.5228787452803	(Phosphatidylcholine with diacyl residue sum C34:4/Phosphatidylcholine with diacyl residue sum C36:2)	0.368846	[0.28-0.45] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61828851	FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs5792235-C	rs5792235	0	5792235	intron_variant	0	NR	3E-29	28.5228787452803	(Phosphatidylcholine with diacyl residue sum C34:4/Phosphatidylcholine with diacyl residue sum C36:3)	0.481829	[0.4-0.56] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61828851	FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs5792235-C	rs5792235	0	5792235	intron_variant	0	NR	2E-22	21.698970004336	(Phosphatidylcholine with diacyl residue sum C34:4/Phosphatidylcholine with diacyl residue sum C38:3)	0.426484	[0.34-0.51] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61829161	FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs99780-T	rs99780	0	99780	intron_variant	0	NR	2E-16	15.698970004336	(Phosphatidylcholine with diacyl residue sum C34:4/Phosphatidylcholine with acyl-alkyl residue sum C36:2)	0.356899	[0.27-0.44] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61836038	FADS2	FADS2			ENSG00000134824	NA	NA	rs174576-A	rs174576	0	174576	intron_variant	0	NR	1E-30	30	(Phosphatidylcholine with diacyl residue sum C36:1/Phosphatidylcholine with diacyl residue sum C36:4)	0.493266	[0.41-0.57] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61828851	FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs5792235-C	rs5792235	0	5792235	intron_variant	0	NR	2E-24	23.698970004336	(Phosphatidylcholine with diacyl residue sum C36:1/Phosphatidylcholine with diacyl residue sum C36:5)	0.443353	[0.36-0.53] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61828851	FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs5792235-C	rs5792235	0	5792235	intron_variant	0	NR	3E-34	33.5228787452803	(Phosphatidylcholine with diacyl residue sum C36:1/Phosphatidylcholine with diacyl residue sum C38:5)	0.531533	[0.45-0.61] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61827449	FADS2	FADS2, FADS1			ENSG00000134824, ENSG00000149485	NA	NA	rs3834458-C	rs3834458	0	3834458	intron_variant	0	NR	1E-21	21	(Phosphatidylcholine with diacyl residue sum C36:1/Phosphatidylcholine with acyl-alkyl residue sum C36:5)	0.421445	[0.34-0.51] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61838027	FADS2	FADS2			ENSG00000134824	NA	NA	rs174578-A	rs174578	0	174578	intron_variant	0	NR	9E-18	17.0457574905607	(Phosphatidylcholine with diacyl residue sum C36:1/Phosphatidylcholine with acyl-alkyl residue sum C38:5)	0.368288	[0.29-0.45] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61839211	FADS2	FADS2			ENSG00000134824	NA	NA	rs174581-A	rs174581	0	174581	intron_variant	0	NR	4E-15	14.397940008672	(Phosphatidylcholine with diacyl residue sum C36:2/Phosphatidylcholine with diacyl residue sum C40:4)	0.337981	[0.25-0.42] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61830500	FADS2	FADS2			ENSG00000134824	NA	NA	rs1535-G	rs1535	0	1535	intron_variant	0	NR	1E-13	13	(Phosphatidylcholine with diacyl residue sum C36:2/Phosphatidylcholine with diacyl residue sum C42:1)	0.329548	[0.24-0.42] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61839170	FADS2	FADS2			ENSG00000134824	NA	NA	rs174580-G	rs174580	0	174580	intron_variant	0	NR	6E-21	20.2218487496164	(Phosphatidylcholine with diacyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C36:4)	0.399068	[0.32-0.48] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61827449	FADS2	FADS2, FADS1			ENSG00000134824, ENSG00000149485	NA	NA	rs3834458-C	rs3834458	0	3834458	intron_variant	0	NR	4E-32	31.397940008672	(Phosphatidylcholine with diacyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C36:5)	0.514307	[0.43-0.6] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61839170	FADS2	FADS2			ENSG00000134824	NA	NA	rs174580-G	rs174580	0	174580	intron_variant	0	NR	9E-31	30.0457574905607	(Phosphatidylcholine with diacyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C38:5)	0.486578	[0.41-0.57] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61830500	FADS2	FADS2			ENSG00000134824	NA	NA	rs1535-G	rs1535	0	1535	intron_variant	0	NR	3E-18	17.5228787452803	(Phosphatidylcholine with diacyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C38:6)	0.386446	[0.3-0.47] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61830500	FADS2	FADS2			ENSG00000134824	NA	NA	rs1535-G	rs1535	0	1535	intron_variant	0	NR	3E-12	11.5228787452803	(Phosphatidylcholine with diacyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C44:5)	0.304566	[0.22-0.39] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61824890	FADS1, FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs174566-G	rs174566	0	174566	intron_variant	0	NR	4E-19	18.397940008672	(Phosphatidylcholine with diacyl residue sum C36:1/Phosphatidylcholine with diacyl residue sum C40:5)	0.388595	[0.3-0.47] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61824890	FADS1, FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs174566-G	rs174566	0	174566	intron_variant	0	NR	1E-22	22	(Phosphatidylcholine with diacyl residue sum C36:2/Phosphatidylcholine with diacyl residue sum C36:5)	0.420283	[0.34-0.5] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61824890	FADS1, FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs174566-G	rs174566	0	174566	intron_variant	0	NR	1E-31	31	(Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with diacyl residue sum C36:5)	0.495456	[0.41-0.58] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61824890	FADS1, FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs174566-G	rs174566	0	174566	intron_variant	0	NR	1E-60	60	(Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with diacyl residue sum C38:4)	0.69013	[0.61-0.77] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61824890	FADS1, FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs174566-G	rs174566	0	174566	intron_variant	0	NR	4E-61	60.397940008672	(Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with diacyl residue sum C38:5)	0.690358	[0.61-0.77] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61824890	FADS1, FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs174566-G	rs174566	0	174566	intron_variant	0	NR	2E-32	31.698970004336	(Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with diacyl residue sum C40:5)	0.510299	[0.43-0.59] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61824890	FADS1, FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs174566-G	rs174566	0	174566	intron_variant	0	NR	3E-37	36.5228787452803	(Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C36:5)	0.54754	[0.47-0.63] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61824890	FADS1, FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs174566-G	rs174566	0	174566	intron_variant	0	NR	4E-35	34.397940008672	(Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C38:5)	0.526618	[0.45-0.61] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61824890	FADS1, FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs174566-G	rs174566	0	174566	intron_variant	0	NR	2E-20	19.698970004336	(Phosphatidylcholine with diacyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C38:6)	0.404913	[0.32-0.49] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61824890	FADS1, FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs174566-G	rs174566	0	174566	intron_variant	0	NR	2E-19	18.698970004336	(Phosphatidylcholine with diacyl residue sum C36:5/Phosphatidylcholine with acyl-alkyl residue sum C34:1)	0.385622	[0.3-0.47] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61824890	FADS1, FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs174566-G	rs174566	0	174566	intron_variant	0	NR	2E-22	21.698970004336	(Phosphatidylcholine with diacyl residue sum C36:5/Phosphatidylcholine with acyl-alkyl residue sum C36:2)	0.419622	[0.34-0.5] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61824890	FADS1, FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs174566-G	rs174566	0	174566	intron_variant	0	NR	8E-24	23.0969100130081	(Phosphatidylcholine with diacyl residue sum C36:5/Phosphatidylcholine with acyl-alkyl residue sum C36:3)	0.427452	[0.35-0.51] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61824890	FADS1, FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs174566-G	rs174566	0	174566	intron_variant	0	NR	5E-21	20.301029995664	(Phosphatidylcholine with diacyl residue sum C36:5/Phosphatidylcholine with acyl-alkyl residue sum C38:0)	0.405654	[0.32-0.49] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61824890	FADS1, FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs174566-G	rs174566	0	174566	intron_variant	0	NR	1E-20	20	(Phosphatidylcholine with diacyl residue sum C38:5/Phosphatidylcholine with acyl-alkyl residue sum C38:3)	0.400939	[0.32-0.48] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61824890	FADS1, FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs174566-G	rs174566	0	174566	intron_variant	0	NR	2E-15	14.698970004336	(Phosphatidylcholine with diacyl residue sum C30:0/Phosphatidylcholine with diacyl residue sum C34:3)	0.350305	[0.27-0.44] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61824890	FADS1, FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs174566-G	rs174566	0	174566	intron_variant	0	NR	6E-28	27.2218487496164	(Phosphatidylcholine with acyl-alkyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C36:5)	0.460557	[0.38-0.54] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61824890	FADS1, FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs174566-G	rs174566	0	174566	intron_variant	0	NR	1E-18	18	(Phosphatidylcholine with acyl-alkyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C38:6)	0.381532	[0.3-0.46] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61824890	FADS1, FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs174566-G	rs174566	0	174566	intron_variant	0	NR	2E-16	15.698970004336	(Phosphatidylcholine with acyl-alkyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C40:6)	0.358584	[0.27-0.44] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61824890	FADS1, FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs174566-G	rs174566	0	174566	intron_variant	0	NR	1E-31	31	(Phosphatidylcholine with acyl-alkyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C38:6)	0.501424	[0.42-0.58] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61824890	FADS1, FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs174566-G	rs174566	0	174566	intron_variant	0	NR	1E-18	18	(Phosphatidylcholine with acyl-alkyl residue sum C38:2/Phosphatidylcholine with acyl-alkyl residue sum C40:4)	0.378422	[0.3-0.46] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61824890	FADS1, FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs174566-G	rs174566	0	174566	intron_variant	0	NR	4E-20	19.397940008672	(Phosphatidylcholine with acyl-alkyl residue sum C38:2/Phosphatidylcholine with acyl-alkyl residue sum C40:5)	0.392683	[0.31-0.47] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61824890	FADS1, FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs174566-G	rs174566	0	174566	intron_variant	0	NR	1E-22	22	(Phosphatidylcholine with acyl-alkyl residue sum C38:3/Phosphatidylcholine with acyl-alkyl residue sum C40:5)	0.411168	[0.33-0.49] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61824890	FADS1, FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs174566-G	rs174566	0	174566	intron_variant	0	NR	1E-15	15	(Phosphatidylcholine with acyl-alkyl residue sum C40:3/Phosphatidylcholine with acyl-alkyl residue sum C40:5)	0.337478	[0.26-0.42] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61825533	FADS1, FADS2	FADS1, FADS2			ENSG00000149485, ENSG00000134824	NA	NA	rs174567-G	rs174567	0	174567	intron_variant	0	NR	2E-13	12.698970004336	(Phosphatidylcholine with acyl-alkyl residue sum C42:5/Phosphatidylcholine with acyl-alkyl residue sum C44:3)	0.31854	[0.23-0.4] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61826344	FADS1, FADS2	FADS2, FADS1			ENSG00000134824, ENSG00000149485	NA	NA	rs174568-T	rs174568	0	174568	missense_variant	0	NR	3E-14	13.5228787452803	(Phosphatidylcholine with diacyl residue sum C38:0/Phosphatidylcholine with acyl-alkyl residue sum C38:6)	0.339	[0.25-0.43] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61790331	TMEM258	TMEM258			ENSG00000134825	NA	NA	rs102275-C	rs102275	0	102275	non_coding_transcript_exon_variant	0	NR	2E-30	29.698970004336	(Phosphatidylcholine with acyl-alkyl residue sum C36:2/Phosphatidylcholine with acyl-alkyl residue sum C38:4)	0.48109	[0.4-0.56] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61790331	TMEM258	TMEM258			ENSG00000134825	NA	NA	rs102275-C	rs102275	0	102275	non_coding_transcript_exon_variant	0	NR	2E-47	46.698970004336	(Phosphatidylcholine with acyl-alkyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C36:4)	0.586854	[0.51-0.66] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61790331	TMEM258	TMEM258			ENSG00000134825	NA	NA	rs102275-C	rs102275	0	102275	non_coding_transcript_exon_variant	0	NR	1E-56	56	(Phosphatidylcholine with acyl-alkyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C36:5)	0.649031	[0.57-0.72] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61790331	TMEM258	TMEM258			ENSG00000134825	NA	NA	rs102275-C	rs102275	0	102275	non_coding_transcript_exon_variant	0	NR	2E-39	38.698970004336	(Phosphatidylcholine with acyl-alkyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C38:4)	0.557815	[0.48-0.64] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61790331	TMEM258	TMEM258			ENSG00000134825	NA	NA	rs102275-C	rs102275	0	102275	non_coding_transcript_exon_variant	0	NR	2E-56	55.698970004336	(Phosphatidylcholine with acyl-alkyl residue sum C36:3/Phosphatidylcholine with acyl-alkyl residue sum C38:5)	0.639075	[0.56-0.71] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61790331	TMEM258	TMEM258			ENSG00000134825	NA	NA	rs102275-C	rs102275	0	102275	non_coding_transcript_exon_variant	0	NR	2E-23	22.698970004336	(Phosphatidylcholine with acyl-alkyl residue sum C36:5/Sphingomyelin with acyl residue sum C24:0)	0.434116	[0.35-0.52] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61790331	TMEM258	TMEM258			ENSG00000134825	NA	NA	rs102275-C	rs102275	0	102275	non_coding_transcript_exon_variant	0	NR	5E-20	19.301029995664	(Phosphatidylcholine with acyl-alkyl residue sum C36:5/Sphingomyelin with acyl residue sum C24:1)	0.394712	[0.31-0.48] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61790331	TMEM258	TMEM258			ENSG00000134825	NA	NA	rs102275-C	rs102275	0	102275	non_coding_transcript_exon_variant	0	NR	1E-21	21	(Phosphatidylcholine with acyl-alkyl residue sum C38:3/Phosphatidylcholine with acyl-alkyl residue sum C38:4)	0.406293	[0.32-0.49] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61790331	TMEM258	TMEM258			ENSG00000134825	NA	NA	rs102275-C	rs102275	0	102275	non_coding_transcript_exon_variant	0	NR	2E-23	22.698970004336	(Phosphatidylcholine with acyl-alkyl residue sum C38:3/Phosphatidylcholine with acyl-alkyl residue sum C40:4)	0.417262	[0.34-0.5] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61790331	TMEM258	TMEM258			ENSG00000134825	NA	NA	rs102275-C	rs102275	0	102275	non_coding_transcript_exon_variant	0	NR	3E-17	16.5228787452803	(Phosphatidylcholine with acyl-alkyl residue sum C38:4/Phosphatidylcholine with acyl-alkyl residue sum C44:4)	0.365504	[0.28-0.45] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61790331	TMEM258	TMEM258			ENSG00000134825	NA	NA	rs102275-C	rs102275	0	102275	non_coding_transcript_exon_variant	0	NR	2E-14	13.698970004336	(Phosphatidylcholine with acyl-alkyl residue sum C38:4/Sphingomyelin with acyl residue sum C24:0)	0.339909	[0.25-0.43] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61790331	TMEM258	TMEM258			ENSG00000134825	NA	NA	rs102275-C	rs102275	0	102275	non_coding_transcript_exon_variant	0	NR	8E-17	16.0969100130081	(Phosphatidylcholine with acyl-alkyl residue sum C38:5/Phosphatidylcholine with acyl-alkyl residue sum C44:4)	0.357382	[0.27-0.44] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Serum metabolite ratios in chronic kidney disease	1,143 European ancestry cases	NA	11q12.2	11	61790331	TMEM258	TMEM258			ENSG00000134825	NA	NA	rs102275-C	rs102275	0	102275	non_coding_transcript_exon_variant	0	NR	1E-15	15	(Phosphatidylcholine with diacyl residue sum C32:0/Phosphatidylcholine with diacyl residue sum C34:3)	0.337497	[0.26-0.42] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Urinary metabolite levels in chronic kidney disease	1,143 European ancestry cases	NA	1q21.3	1	151982754	S100A10	AL450992.4 - S100A10	ENSG00000286581	ENSG00000197747		28769	161	rs6587640-T	rs6587640	0	6587640	regulatory_region_variant	1	NR	9E-9	8.04575749056067	(Decadienoylcarnitine)	0.248976	[0.16-0.33] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Urinary metabolite levels in chronic kidney disease	1,143 European ancestry cases	NA	2p13.1	2	73628380	ALMS1, NAT8	ALMS1 - NAT8	ENSG00000116127	ENSG00000144035		3214	12343	rs10178409-T	rs10178409	0	10178409	regulatory_region_variant	1	NR	1E-11	11	(Acetylornithine)	0.342181	[0.24-0.44] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Urinary metabolite levels in chronic kidney disease	1,143 European ancestry cases	NA	2q23.3	2	151100757	RND3, RBM43	AC023469.1 - AC018731.1	ENSG00000222031	ENSG00000236885		51983	14054	rs142864856-TACAC	rs142864856	0	142864856	intergenic_variant	1	NR	4E-8	7.39794000867204	(Glutamine)	0.493745	[0.32-0.67] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Urinary metabolite levels in chronic kidney disease	1,143 European ancestry cases	NA	3p14.2	3	59603270	C3orf67, FHIT	AC126121.3			ENSG00000243295	NA	NA	rs12634709-T	rs12634709	0	12634709	intron_variant	0	NR	4E-8	7.39794000867204	(Decanoylcarnitine)	0.297105	[0.19-0.4] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Urinary metabolite levels in chronic kidney disease	1,143 European ancestry cases	NA	6q25.3	6	160130454	SLC22A1	SLC22A1			ENSG00000175003	NA	NA	rs112201728-T	rs112201728	0	112201728	intron_variant	0	NR	5E-8	7.30102999566398	(Butyrylcarnitine, Isobutyrylcarnitine)	0.389716	[0.25-0.53] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Urinary metabolite levels in chronic kidney disease	1,143 European ancestry cases	NA	11q22.2	11	102617342	MMP20	MMP20, AP000851.1			ENSG00000137674, ENSG00000256916	NA	NA	rs1317947-A	rs1317947	0	1317947	intron_variant	0	NR	5E-8	7.30102999566398	(Alanine)	0.232435	[0.15-0.32] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Urinary metabolite levels in chronic kidney disease	1,143 European ancestry cases	NA	19q13.11	19	32865985	SLC7A9	SLC7A9			ENSG00000021488	NA	NA	rs12460876-C	rs12460876	0	12460876	intron_variant	0	NR	5E-12	11.301029995664	(Lysine)	0.290828	[0.21-0.37] unit increase	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Urinary metabolite levels in chronic kidney disease	1,143 European ancestry cases	NA	19q13.12	19	35856498	KIRREL2	KIRREL2, NPHS1			ENSG00000126259, ENSG00000161270	NA	NA	rs447707-G	rs447707	0	447707	intron_variant	0	NR	5E-8	7.30102999566398	(Octanoylcarnitine)	0.513646	[0.33-0.7] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-05-30	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Urinary metabolite levels in chronic kidney disease	1,143 European ancestry cases	NA	20q13.2	20	52676385	ZFP64, TSHZ2	AL031674.1			ENSG00000232294	NA	NA	rs6022039-T	rs6022039	0	6022039	intron_variant	0	NR	3E-8	7.52287874528034	(Serotonin)	0.549885	[0.36-0.74] unit increase	Illumina [up to 9281895] (imputed)	N
2018-06-04	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Fractional excretion of metabolites in chronic kidney disease	1,143 European ancestry cases	NA	18q22.1	18	65592400	LOC284294, CDH7	LINC01916 - AC090358.1	ENSG00000264232	ENSG00000265217		144233	13679	rs11662622-G	rs11662622	0	11662622	intergenic_variant	1	NR	3E-8	7.52287874528034	(Lysine)	0.258826	[0.17-0.35] unit decrease	Illumina [up to 9281895] (imputed)	N
2018-06-04	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Fractional excretion of metabolites in chronic kidney disease	1,143 European ancestry cases	NA	19q13.11	19	32865985	SLC7A9	SLC7A9			ENSG00000021488	NA	NA	rs12460876-C	rs12460876	0	12460876	intron_variant	0	NR	2E-9	8.69897000433602	(Lysine)	0.253759	[0.17-0.34] unit increase	Illumina [up to 9281895] (imputed)	N
2018-06-04	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Fractional excretion of metabolites in chronic kidney disease	1,143 European ancestry cases	NA	6q12	6	67286779	SLC25A51P1, BAI3	AL591004.1 - AL365503.1	ENSG00000212229	ENSG00000271111		76299	169567	rs72881923-C	rs72881923	0	72881923	intergenic_variant	1	NR	4E-8	7.39794000867204	(Dodecanoylcarnitine)	0.264461	[0.17-0.36] unit increase	Illumina [up to 9281895] (imputed)	N
2018-06-04	29545352	Li Y	2018-03-15	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/29545352	Genome-Wide Association Studies of Metabolites in Patients with CKD Identify Multiple Loci and Illuminate Tubular Transport Mechanisms.	Fractional excretion of metabolites in chronic kidney disease	1,143 European ancestry cases	NA	12q24.31	12	120702516	MLEC	MLEC - AC069234.5	ENSG00000110917	ENSG00000277423		657	1351	rs2393778-T	rs2393778	0	2393778	intergenic_variant	1	NR	3E-14	13.5228787452803	(Butyrylcarnitine, Isobutyrylcarnitine)	0.344447	[0.26-0.43] unit decrease	Illumina [up to 9281895] (imputed)	N
2017-09-28	28679651	Meziane I	2017-07-04	Haematologica	www.ncbi.nlm.nih.gov/pubmed/28679651	Genome-wide association study of clinical parameters in immunoglobulin light chain amyloidosis in three patient cohorts.	Immunoglobulin light chain (AL) amyloidosis (heart and kidney involvement)	426 cases, controls	NA	2p25.2	2	6303084	LINC01247, ACO17053.1	AC017053.1			ENSG00000234275	NA	NA	rs6752376-T	rs6752376	0	6752376	intron_variant	0	NR	3E-8	7.52287874528034		1.54	[1.32-1.79]	NR [NR]	N
2017-09-28	28679651	Meziane I	2017-07-04	Haematologica	www.ncbi.nlm.nih.gov/pubmed/28679651	Genome-wide association study of clinical parameters in immunoglobulin light chain amyloidosis in three patient cohorts.	Immunoglobulin light chain (AL) amyloidosis (kidney involvement)	844 cases, controls	NA	11q13.3	11	69648142	NR	CCND1			ENSG00000110092	NA	NA	rs9344-G	rs9344	0	9344	splice_region_variant	0	NR	7E-8	7.15490195998574		1.34	[1.20-1.48]	NR [NR]	N
2019-07-05	31152163	Wuttke M	2019-05-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31152163	A catalog of genetic loci associated with kidney function from analyses of a million individuals.	Chronic kidney disease	64,164 European and unknown ancestry cases, 561,055 European and unknown ancestry controls	NA	16p12.3	16	20381010	PDILT	PDILT			ENSG00000169340	NA	NA	rs77924615-G	rs77924615	0	77924615	intron_variant	0	0.8	7E-86	85.1549019599858		1.2318305	[1.21-1.26]	Affymetrix, Illumina [9585923] (imputed)	N
2019-07-05	31152163	Wuttke M	2019-05-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31152163	A catalog of genetic loci associated with kidney function from analyses of a million individuals.	Chronic kidney disease	64,164 European and unknown ancestry cases, 561,055 European and unknown ancestry controls	NA	2q31.1	2	176128855	HOXD8	HOXD-AS2			ENSG00000237380	NA	NA	rs187355703-G	rs187355703	0	187355703	intron_variant	0	0.03	3E-10	9.52287874528034		1.2155099	[1.14-1.29]	Affymetrix, Illumina [9585923] (imputed)	N
2019-07-05	31152163	Wuttke M	2019-05-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31152163	A catalog of genetic loci associated with kidney function from analyses of a million individuals.	Chronic kidney disease	64,164 European and unknown ancestry cases, 561,055 European and unknown ancestry controls	NA	10p15.3	10	853131	LARP4B	LARP4B			ENSG00000107929	NA	NA	rs80282103-T	rs80282103	0	80282103	intron_variant	0	0.09	1E-10	10		1.0967317	[1.07-1.13]	Affymetrix, Illumina [9585923] (imputed)	N
2019-07-05	31152163	Wuttke M	2019-05-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31152163	A catalog of genetic loci associated with kidney function from analyses of a million individuals.	Chronic kidney disease	64,164 European and unknown ancestry cases, 561,055 European and unknown ancestry controls	NA	15q21.3	15	53615751	WDR72	WDR72			ENSG00000166415	NA	NA	rs17730281-G	rs17730281	0	17730281	missense_variant	0	0.71	1E-18	18		1.0816658	[1.06-1.1]	Affymetrix, Illumina [9585923] (imputed)	N
2019-07-05	31152163	Wuttke M	2019-05-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31152163	A catalog of genetic loci associated with kidney function from analyses of a million individuals.	Chronic kidney disease	64,164 European and unknown ancestry cases, 561,055 European and unknown ancestry controls	NA	18q23	18	79396537	NFATC1	NFATC1			ENSG00000131196	NA	NA	rs8096658-G	rs8096658	0	8096658	intron_variant	0	0.41	2E-12	11.698970004336		1.066098	[1.05-1.09]	Affymetrix, Illumina [9585923] (imputed)	N
2019-07-05	31152163	Wuttke M	2019-05-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31152163	A catalog of genetic loci associated with kidney function from analyses of a million individuals.	Chronic kidney disease	64,164 European and unknown ancestry cases, 561,055 European and unknown ancestry controls	NA	1p13.2	1	112715671	PPM1J	PPM1J - AL603832.2	ENSG00000155367	ENSG00000261595		194	1	rs12736457-G	rs12736457	0	12736457	TF_binding_site_variant	1	0.13	2E-6	5.69897000433602		1.0655301	[1.04-1.09]	Affymetrix, Illumina [9585923] (imputed)	N
2019-07-05	31152163	Wuttke M	2019-05-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31152163	A catalog of genetic loci associated with kidney function from analyses of a million individuals.	Chronic kidney disease	64,164 European and unknown ancestry cases, 561,055 European and unknown ancestry controls	NA	2p13.1	2	73668638	ALMS1P1	ALMS1P1			ENSG00000163016	NA	NA	rs6546869-G	rs6546869	0	6546869	intron_variant	0	0.77	7E-8	7.15490195998574		1.0588734	[1.04-1.08]	Affymetrix, Illumina [9585923] (imputed)	N
2019-07-05	31152163	Wuttke M	2019-05-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31152163	A catalog of genetic loci associated with kidney function from analyses of a million individuals.	Chronic kidney disease	64,164 European and unknown ancestry cases, 561,055 European and unknown ancestry controls	NA	2q34	2	210675783	CPS1	CPS1			ENSG00000021826	NA	NA	rs1047891-A	rs1047891	0	1047891	missense_variant	0	0.29	3E-8	7.52287874528034		1.0532	[1.034-1.0728]	Affymetrix, Illumina [9585923] (imputed)	N
2019-07-05	31152163	Wuttke M	2019-05-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31152163	A catalog of genetic loci associated with kidney function from analyses of a million individuals.	Chronic kidney disease	64,164 European and unknown ancestry cases, 561,055 European and unknown ancestry controls	NA	11p11.12	11	49036051	TRIM49B	TRIM49B			ENSG00000182053	NA	NA	rs2727040-T	rs2727040	0	2727040	intron_variant	0	0.24	8E-7	6.09691001300806		1.055	[1.0329-1.0776]	Affymetrix, Illumina [9585923] (imputed)	N
2019-07-05	31152163	Wuttke M	2019-05-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31152163	A catalog of genetic loci associated with kidney function from analyses of a million individuals.	Chronic kidney disease	64,164 European and unknown ancestry cases, 561,055 European and unknown ancestry controls	NA	5p13.1	5	39378013	DAB2	DAB2, C9			ENSG00000153071, ENSG00000113600	NA	NA	rs1362800-T	rs1362800	0	1362800	intron_variant	0	0.38	5E-11	10.301029995664		1.0571	[1.0399-1.0747]	Affymetrix, Illumina [9585923] (imputed)	N
2019-07-05	31152163	Wuttke M	2019-05-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31152163	A catalog of genetic loci associated with kidney function from analyses of a million individuals.	Chronic kidney disease	64,164 European and unknown ancestry cases, 561,055 European and unknown ancestry controls	NA	11q13.1	11	65756781	AP5B1	AP001266.2			ENSG00000255557	NA	NA	rs7123489-A	rs7123489	0	7123489	intron_variant	0	0.31	2E-11	10.698970004336		1.0592	[1.0417-1.077]	Affymetrix, Illumina [9585923] (imputed)	N
2019-07-05	31152163	Wuttke M	2019-05-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31152163	A catalog of genetic loci associated with kidney function from analyses of a million individuals.	Chronic kidney disease	64,164 European and unknown ancestry cases, 561,055 European and unknown ancestry controls	NA	7p22.3	7	1246608	UNCX	UNCX - AC073094.1	ENSG00000164853	ENSG00000233082		9282	20745	rs13230625-A	rs13230625	0	13230625	regulatory_region_variant	1	0.53	9E-13	12.0457574905607		1.0681	[1.049-1.0875]	Affymetrix, Illumina [9585923] (imputed)	N
2019-07-05	31152163	Wuttke M	2019-05-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31152163	A catalog of genetic loci associated with kidney function from analyses of a million individuals.	Chronic kidney disease	64,164 European and unknown ancestry cases, 561,055 European and unknown ancestry controls	NA	5q35.3	5	177386403	SLC34A1	SLC34A1			ENSG00000131183	NA	NA	rs3812036-T	rs3812036	0	3812036	intron_variant	0	0.26	1E-12	12		1.0684	[1.0491-1.088]	Affymetrix, Illumina [9585923] (imputed)	N
2019-07-05	31152163	Wuttke M	2019-05-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31152163	A catalog of genetic loci associated with kidney function from analyses of a million individuals.	Chronic kidney disease	64,164 European and unknown ancestry cases, 561,055 European and unknown ancestry controls	NA	4q21.1	4	76480299	SHROOM3	SHROOM3			ENSG00000138771	NA	NA	rs28817415-T	rs28817415	0	28817415	intron_variant	0	0.40	2E-16	15.698970004336		1.069	[1.0522-1.0861]	Affymetrix, Illumina [9585923] (imputed)	N
2019-07-05	31152163	Wuttke M	2019-05-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31152163	A catalog of genetic loci associated with kidney function from analyses of a million individuals.	Chronic kidney disease	64,164 European and unknown ancestry cases, 561,055 European and unknown ancestry controls	NA	4q21.21	4	80261400	FGF5	PRDM8 - FGF5	ENSG00000152784	ENSG00000138675		57071	5199	rs12509595-T	rs12509595	0	12509595	intergenic_variant	1	0.70	5E-14	13.301029995664		1.0692	[1.0508-1.0881]	Affymetrix, Illumina [9585923] (imputed)	N
2019-07-05	31152163	Wuttke M	2019-05-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31152163	A catalog of genetic loci associated with kidney function from analyses of a million individuals.	Chronic kidney disease	64,164 European and unknown ancestry cases, 561,055 European and unknown ancestry controls	NA	1q43	1	243306367	SDCCAG8	SDCCAG8, SDCCAG8			ENSG00000054282, ENSG00000276111	NA	NA	rs2490391-A	rs2490391	0	2490391	3_prime_UTR_variant	0	0.41	4E-17	16.397940008672		1.0698	[1.0531-1.0867]	Affymetrix, Illumina [9585923] (imputed)	N
2019-07-05	31152163	Wuttke M	2019-05-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31152163	A catalog of genetic loci associated with kidney function from analyses of a million individuals.	Chronic kidney disease	64,164 European and unknown ancestry cases, 561,055 European and unknown ancestry controls	NA	15q21.1	15	45391597	GATM	GATM			ENSG00000171766	NA	NA	rs1145077-T	rs1145077	0	1145077	intron_variant	0	0.42	2E-16	15.698970004336		1.0746	[1.0562-1.0933]	Affymetrix, Illumina [9585923] (imputed)	N
2019-07-05	31152163	Wuttke M	2019-05-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31152163	A catalog of genetic loci associated with kidney function from analyses of a million individuals.	Chronic kidney disease	64,164 European and unknown ancestry cases, 561,055 European and unknown ancestry controls	NA	18q11.2	18	26813249	AQP4	AQP4-AS1			ENSG00000260372	NA	NA	rs16942751-A	rs16942751	0	16942751	intron_variant	0	0.18	2E-10	9.69897000433602		1.076	[1.052-1.1005]	Affymetrix, Illumina [9585923] (imputed)	N
2019-07-05	31152163	Wuttke M	2019-05-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31152163	A catalog of genetic loci associated with kidney function from analyses of a million individuals.	Chronic kidney disease	64,164 European and unknown ancestry cases, 561,055 European and unknown ancestry controls	NA	11p14.1	11	30727543	DCDC1	MPPED2-AS1 - AL122014.1	ENSG00000254489	ENSG00000287373		94960	46370	rs963837-T	rs963837	0	963837	intergenic_variant	1	0.57	2E-21	20.698970004336		1.0838	[1.0661-1.1018]	Affymetrix, Illumina [9585923] (imputed)	N
2019-07-05	31152163	Wuttke M	2019-05-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31152163	A catalog of genetic loci associated with kidney function from analyses of a million individuals.	Chronic kidney disease	64,164 European and unknown ancestry cases, 561,055 European and unknown ancestry controls	NA	6q25.3	6	160212075	SLC22A2	SLC22A2			ENSG00000112499	NA	NA	rs12207180-A	rs12207180	0	12207180	intron_variant	0	0.11	1E-10	10		1.0877	[1.0603-1.1158]	Affymetrix, Illumina [9585923] (imputed)	N
2019-07-05	31152163	Wuttke M	2019-05-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31152163	A catalog of genetic loci associated with kidney function from analyses of a million individuals.	Chronic kidney disease	64,164 European and unknown ancestry cases, 561,055 European and unknown ancestry controls	NA	7q36.1	7	151714408	PRKAG2	PRKAG2			ENSG00000106617	NA	NA	rs73728279-T	rs73728279	0	73728279	intron_variant	0	0.27	7E-24	23.1549019599857		1.1124	[1.0896-1.1358]	Affymetrix, Illumina [9585923] (imputed)	N
2019-07-05	31152163	Wuttke M	2019-05-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31152163	A catalog of genetic loci associated with kidney function from analyses of a million individuals.	Chronic kidney disease	64,164 European and unknown ancestry cases, 561,055 European and unknown ancestry controls	NA	2q31.1	2	176232294	MTX2	AC016739.1 - RPSAP25	ENSG00000218175	ENSG00000230384		31042	9817	rs72929920-T	rs72929920	0	72929920	intergenic_variant	1	0.03	8E-7	6.09691001300806		1.1395	[1.082-1.2]	Affymetrix, Illumina [9585923] (imputed)	N
2019-07-05	31152163	Wuttke M	2019-05-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31152163	A catalog of genetic loci associated with kidney function from analyses of a million individuals.	Chronic kidney disease	64,164 European and unknown ancestry cases, 561,055 European and unknown ancestry controls	NA	2q14.1	2	113209498	PSD4	PSD4 - PAX8-AS1	ENSG00000125637	ENSG00000189223		102	1923	rs11123169-C	rs11123169	0	11123169	intergenic_variant	1	0.32	2E-10	9.69897000433602		1.0544075	[1.04-1.07]	Affymetrix, Illumina [9585923] (imputed)	N
2019-07-05	31152163	Wuttke M	2019-05-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31152163	A catalog of genetic loci associated with kidney function from analyses of a million individuals.	Chronic kidney disease	64,164 European and unknown ancestry cases, 561,055 European and unknown ancestry controls	NA	5q35.3	5	177361569	RGS14	RGS14			ENSG00000169220	NA	NA	rs4976646-C	rs4976646	0	4976646	intron_variant	0	0.35	2E-10	9.69897000433602		1.0535188	[1.04-1.07]	Affymetrix, Illumina [9585923] (imputed)	N
2019-07-05	31152163	Wuttke M	2019-05-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31152163	A catalog of genetic loci associated with kidney function from analyses of a million individuals.	Chronic kidney disease	64,164 European and unknown ancestry cases, 561,055 European and unknown ancestry controls	NA	17q23.2	17	61379228	BCAS3	BCAS3, AC005746.2			ENSG00000141376, ENSG00000267131	NA	NA	rs9895661-C	rs9895661	0	9895661	non_coding_transcript_exon_variant	0	0.35	5E-7	6.30102999566398		1.0505306	[1.03-1.07]	Affymetrix, Illumina [9585923] (imputed)	N
2019-07-05	31152163	Wuttke M	2019-05-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31152163	A catalog of genetic loci associated with kidney function from analyses of a million individuals.	Chronic kidney disease	64,164 European and unknown ancestry cases, 561,055 European and unknown ancestry controls	NA	6q23.1	6	130053316	L3MBTL3	L3MBTL3			ENSG00000198945	NA	NA	rs7740107-T	rs7740107	0	7740107	intron_variant	0	0.26	1E-6	6		1.0490978	[1.03-1.07]	Affymetrix, Illumina [9585923] (imputed)	N
2019-07-05	31152163	Wuttke M	2019-05-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31152163	A catalog of genetic loci associated with kidney function from analyses of a million individuals.	Chronic kidney disease	64,164 European and unknown ancestry cases, 561,055 European and unknown ancestry controls	NA	11p11.12	11	50509630	LOC646813	AC024405.1 - OR4C50P	ENSG00000214883	ENSG00000237610		87314	4081850	rs1813937-C	rs1813937	0	1813937	intergenic_variant	1	0.28	1E-7	7		1.0485477	[1.03-1.07]	Affymetrix, Illumina [9585923] (imputed)	N
2019-07-05	31152163	Wuttke M	2019-05-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31152163	A catalog of genetic loci associated with kidney function from analyses of a million individuals.	Chronic kidney disease	64,164 European and unknown ancestry cases, 561,055 European and unknown ancestry controls	NA	7q36.3	7	156460245	LINC01006	LINC01006			ENSG00000182648	NA	NA	rs868822-G	rs868822	0	868822	intron_variant	0	0.67	3E-8	7.52287874528034		1.0484378	[1.03-1.07]	Affymetrix, Illumina [9585923] (imputed)	N
2019-07-05	31152163	Wuttke M	2019-05-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31152163	A catalog of genetic loci associated with kidney function from analyses of a million individuals.	Chronic kidney disease	64,164 European and unknown ancestry cases, 561,055 European and unknown ancestry controls	NA	17p11.2	17	19525406	SLC47A1	SLC47A1			ENSG00000142494	NA	NA	rs2440165-C	rs2440165	0	2440165	intron_variant	0	0.36	3E-7	6.52287874528034		1.0479983	[1.03-1.07]	Affymetrix, Illumina [9585923] (imputed)	N
2019-07-05	31152163	Wuttke M	2019-05-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31152163	A catalog of genetic loci associated with kidney function from analyses of a million individuals.	Chronic kidney disease	64,164 European and unknown ancestry cases, 561,055 European and unknown ancestry controls	NA	11p11.2	11	48229123	OR4B1	OR4B2P - OR4X2	ENSG00000255514	ENSG00000172208		813	15933	rs7127946-C	rs7127946	0	7127946	intergenic_variant	1	0.36	6E-8	7.22184874961636		1.046682	[1.03-1.06]	Affymetrix, Illumina [9585923] (imputed)	N
2019-07-05	31152163	Wuttke M	2019-05-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31152163	A catalog of genetic loci associated with kidney function from analyses of a million individuals.	Chronic kidney disease	64,164 European and unknown ancestry cases, 561,055 European and unknown ancestry controls	NA	11p11.2	11	47406116	SLC39A13	AC090559.1			ENSG00000255197	NA	NA	rs61897431-C	rs61897431	0	61897431	intron_variant	0	0.35	3E-7	6.52287874528034		1.0465724	[1.03-1.07]	Affymetrix, Illumina [9585923] (imputed)	N
2019-07-05	31152163	Wuttke M	2019-05-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31152163	A catalog of genetic loci associated with kidney function from analyses of a million individuals.	Chronic kidney disease	64,164 European and unknown ancestry cases, 561,055 European and unknown ancestry controls	NA	9q21.11	9	68817258	PIP5K1B	PIP5K1B			ENSG00000107242	NA	NA	rs2039424-G	rs2039424	0	2039424	intron_variant	0	0.36	5E-8	7.30102999566398		1.0443864	[1.03-1.06]	Affymetrix, Illumina [9585923] (imputed)	N
2019-07-05	31152163	Wuttke M	2019-05-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31152163	A catalog of genetic loci associated with kidney function from analyses of a million individuals.	Chronic kidney disease	64,164 European and unknown ancestry cases, 561,055 European and unknown ancestry controls	NA	19q13.11	19	32911513	CEP89	CEP89			ENSG00000121289	NA	NA	rs8101667-C	rs8101667	0	8101667	intron_variant	0	0.61	2E-6	5.69897000433602		1.0397172	[1.02-1.06]	Affymetrix, Illumina [9585923] (imputed)	N
2019-07-05	31152163	Wuttke M	2019-05-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31152163	A catalog of genetic loci associated with kidney function from analyses of a million individuals.	Chronic kidney disease	64,164 European and unknown ancestry cases, 561,055 European and unknown ancestry controls	NA	2q35	2	216801065	TNP1	AC007563.2, AC007563.1			ENSG00000236886, ENSG00000229352	NA	NA	rs1548945-C	rs1548945	0	1548945	intron_variant	0	0.56	2E-6	5.69897000433602		1.0397172	[1.02-1.06]	Affymetrix, Illumina [9585923] (imputed)	N
2019-07-05	31152163	Wuttke M	2019-05-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31152163	A catalog of genetic loci associated with kidney function from analyses of a million individuals.	Chronic kidney disease	64,164 European and unknown ancestry cases, 561,055 European and unknown ancestry controls	NA	15q14	15	39013242	C15orf54	LINC02694, AC013652.1			ENSG00000175779, ENSG00000259345	NA	NA	rs12913015-C	rs12913015	0	12913015	intron_variant	0	0.59	3E-6	5.52287874528034		1.039393	[1.02-1.06]	Affymetrix, Illumina [9585923] (imputed)	N
2019-07-05	31152163	Wuttke M	2019-05-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31152163	A catalog of genetic loci associated with kidney function from analyses of a million individuals.	Chronic kidney disease	64,164 European and unknown ancestry cases, 561,055 European and unknown ancestry controls	NA	10q21.3	10	68205420	MYPN	MYPN			ENSG00000138347	NA	NA	rs7475348-C	rs7475348	0	7475348	intron_variant	0	0.54	7E-6	5.15490195998574		1.0379905	[1.02-1.05]	Affymetrix, Illumina [9585923] (imputed)	N
2019-07-05	31152163	Wuttke M	2019-05-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31152163	A catalog of genetic loci associated with kidney function from analyses of a million individuals.	Chronic kidney disease	64,164 European and unknown ancestry cases, 561,055 European and unknown ancestry controls	NA	18p11.31	18	5585159	EPB41L3	EPB41L3			ENSG00000082397	NA	NA	rs1719934-G	rs1719934	0	1719934	intron_variant	0	0.42	4E-6	5.39794000867204		1.0378827	[1.02-1.05]	Affymetrix, Illumina [9585923] (imputed)	N
2019-07-05	31152163	Wuttke M	2019-05-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31152163	A catalog of genetic loci associated with kidney function from analyses of a million individuals.	Chronic kidney disease	64,164 European and unknown ancestry cases, 561,055 European and unknown ancestry controls	NA	2p16.2	2	54658503	SPTBN1	SPTBN1			ENSG00000115306	NA	NA	rs2971880-A	rs2971880	0	2971880	intron_variant	0	0.37	5E-6	5.30102999566398		1.0372	[1.0211-1.0536]	Affymetrix, Illumina [9585923] (imputed)	N
2019-07-05	31152163	Wuttke M	2019-05-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31152163	A catalog of genetic loci associated with kidney function from analyses of a million individuals.	Chronic kidney disease	64,164 European and unknown ancestry cases, 561,055 European and unknown ancestry controls	NA	5p13.2	5	34504172	RAI14	AC138853.1 - AC025754.2	ENSG00000249380	ENSG00000271874		130322	147285	rs13157326-A	rs13157326	0	13157326	intergenic_variant	1	0.45	3E-6	5.52287874528034		1.0375	[1.0216-1.0537]	Affymetrix, Illumina [9585923] (imputed)	N
2019-07-05	31152163	Wuttke M	2019-05-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31152163	A catalog of genetic loci associated with kidney function from analyses of a million individuals.	Chronic kidney disease	64,164 European and unknown ancestry cases, 561,055 European and unknown ancestry controls	NA	2q14.2	2	121231348	TFCP2L1	TFCP2L1			ENSG00000115112	NA	NA	rs1078442-A	rs1078442	0	1078442	intron_variant	0	0.46	3E-6	5.52287874528034		1.038	[1.022-1.0542]	Affymetrix, Illumina [9585923] (imputed)	N
2019-07-05	31152163	Wuttke M	2019-05-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31152163	A catalog of genetic loci associated with kidney function from analyses of a million individuals.	Chronic kidney disease	64,164 European and unknown ancestry cases, 561,055 European and unknown ancestry controls	NA	20q13.33	20	64074752	RGS19	RGS19			ENSG00000171700	NA	NA	rs4408777-A	rs4408777	0	4408777	intron_variant	0	0.51	2E-6	5.69897000433602		1.0388	[1.0224-1.0554]	Affymetrix, Illumina [9585923] (imputed)	N
2019-07-05	31152163	Wuttke M	2019-05-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31152163	A catalog of genetic loci associated with kidney function from analyses of a million individuals.	Chronic kidney disease	64,164 European and unknown ancestry cases, 561,055 European and unknown ancestry controls	NA	1p36.12	1	23372847	ZNF436-AS1	ZNF436-AS1 - AL109936.3	ENSG00000283106	ENSG00000271420		1008	5533	rs2749153-A	rs2749153	0	2749153	intergenic_variant	1	0.69	5E-6	5.30102999566398		1.0394	[1.0222-1.0569]	Affymetrix, Illumina [9585923] (imputed)	N
2019-07-05	31152163	Wuttke M	2019-05-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31152163	A catalog of genetic loci associated with kidney function from analyses of a million individuals.	Chronic kidney disease	64,164 European and unknown ancestry cases, 561,055 European and unknown ancestry controls	NA	8p21.2	8	23890907	STC1	STC1 - RNU1-148P	ENSG00000159167	ENSG00000207201		36101	186090	rs34861762-T	rs34861762	0	34861762	regulatory_region_variant	1	0.39	1E-7	7		1.0443	[1.0277-1.0612]	Affymetrix, Illumina [9585923] (imputed)	N
2019-07-05	31152163	Wuttke M	2019-05-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31152163	A catalog of genetic loci associated with kidney function from analyses of a million individuals.	Chronic kidney disease	64,164 European and unknown ancestry cases, 561,055 European and unknown ancestry controls	NA	6q23.2	6	131560938	ARG1	ARG1			ENSG00000118520	NA	NA	rs9375818-A	rs9375818	0	9375818	intron_variant	0	0.25	2E-6	5.69897000433602		1.0446	[1.026-1.0636]	Affymetrix, Illumina [9585923] (imputed)	N
2019-07-05	31152163	Wuttke M	2019-05-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31152163	A catalog of genetic loci associated with kidney function from analyses of a million individuals.	Chronic kidney disease	64,164 European and unknown ancestry cases, 561,055 European and unknown ancestry controls	NA	12p12.3	12	15172097	RERG	RERG			ENSG00000134533	NA	NA	rs10846157-A	rs10846157	0	10846157	intron_variant	0	0.76	2E-6	5.69897000433602		1.0451	[1.0263-1.0644]	Affymetrix, Illumina [9585923] (imputed)	N
2019-07-05	31152163	Wuttke M	2019-05-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31152163	A catalog of genetic loci associated with kidney function from analyses of a million individuals.	Chronic kidney disease	64,164 European and unknown ancestry cases, 561,055 European and unknown ancestry controls	NA	17q12	17	36527167	MYO19	MYO19, MYO19			ENSG00000278372, ENSG00000278259	NA	NA	rs2411192-A	rs2411192	0	2411192	intron_variant	0	0.6	4E-9	8.39794000867204		1.0475	[1.0315-1.0639]	Affymetrix, Illumina [9585923] (imputed)	N
2019-07-05	31152163	Wuttke M	2019-05-31	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31152163	A catalog of genetic loci associated with kidney function from analyses of a million individuals.	Chronic kidney disease	64,164 European and unknown ancestry cases, 561,055 European and unknown ancestry controls	NA	21q21.1	21	15204463	NRIP1	AF222685.1			ENSG00000288555	NA	NA	rs2823139-A	rs2823139	0	2823139	intron_variant	0	0.33	1E-8	8		1.0485	[1.0316-1.0657]	Affymetrix, Illumina [9585923] (imputed)	N
2017-02-24	27576016	Zhao B	2016-08-30	Am J Respir Crit Care Med	www.ncbi.nlm.nih.gov/pubmed/27576016	A Genome-Wide Association Study to Identify Single-Nucleotide Polymorphisms for Acute Kidney Injury.	Acute kidney injury in critical illness	709 European ancestry cases, 619  European ancestry controls	206  European ancestry cases, 1,406  European ancestry controls	9p24.1	9	6226289	NR	IL33			ENSG00000137033	NA	NA	rs10815381-?	rs10815381	0	10815381	intron_variant	0	NR	8E-6	5.09691001300806		1.43	[1.22-1.67]	Illumina [9076120] (imputed)	N
2017-02-24	27576016	Zhao B	2016-08-30	Am J Respir Crit Care Med	www.ncbi.nlm.nih.gov/pubmed/27576016	A Genome-Wide Association Study to Identify Single-Nucleotide Polymorphisms for Acute Kidney Injury.	Acute kidney injury in critical illness	709 European ancestry cases, 619  European ancestry controls	206  European ancestry cases, 1,406  European ancestry controls	22q11.21	22	19623159	TBX1	LINC00895 - AC000077.1	ENSG00000281548	ENSG00000230485		56320	7591	rs10854554-?	rs10854554	0	10854554	regulatory_region_variant	1	NR	7E-7	6.15490195998574		1.49	[1.27-1.75]	Illumina [9076120] (imputed)	N
2017-02-24	27576016	Zhao B	2016-08-30	Am J Respir Crit Care Med	www.ncbi.nlm.nih.gov/pubmed/27576016	A Genome-Wide Association Study to Identify Single-Nucleotide Polymorphisms for Acute Kidney Injury.	Acute kidney injury in critical illness	709 European ancestry cases, 619  European ancestry controls	206  European ancestry cases, 1,406  European ancestry controls	4q35.1	4	184238281	IRF2	ENPP6 - AC079080.1	ENSG00000164303	ENSG00000240159		17051	16228	rs62341639-?	rs62341639	0	62341639	intergenic_variant	1	NR	2E-7	6.69897000433602		1.5625	[1.32-1.82]	Illumina [9076120] (imputed)	N
2019-08-08	31178898	Lin BM	2019-05-24	Front Genet	www.ncbi.nlm.nih.gov/pubmed/31178898	Genetics of Chronic Kidney Disease Stages Across Ancestries: The PAGE Study.	Mild to moderate chronic kidney disease	1,532 African American cases, 1,336 Hispanic cases, 575 East Asian cases, 608 Native Hawaiian cases, 42 American Indian cases, 57 cases, 13,761 African American controls, 19,317 Hispanic controls, 3,540 East Asian controls, 2,892 Native Hawaiian controls, 595 American Indian controls, 936 controls	NA	21q22.2	21	40295451	DSCAM	DSCAM			ENSG00000171587	NA	NA	rs2837554-G	rs2837554	0	2837554	intron_variant	0	0.701	3E-7	6.52287874528034		1.16	[1.10-1.24]	Illumina [1438399] (imputed)	N
2019-08-08	31178898	Lin BM	2019-05-24	Front Genet	www.ncbi.nlm.nih.gov/pubmed/31178898	Genetics of Chronic Kidney Disease Stages Across Ancestries: The PAGE Study.	Mild to moderate chronic kidney disease	1,532 African American cases, 1,336 Hispanic cases, 575 East Asian cases, 608 Native Hawaiian cases, 42 American Indian cases, 57 cases, 13,761 African American controls, 19,317 Hispanic controls, 3,540 East Asian controls, 2,892 Native Hawaiian controls, 595 American Indian controls, 936 controls	NA	21q22.3	21	41628325	LINC00111	PCSEAT - LINC00111	ENSG00000286027	ENSG00000227702		45438	50856	rs187652497-C	rs187652497	0	187652497	regulatory_region_variant	1	0.007	1E-7	7		2.23	[1.66-3.00]	Illumina [1438399] (imputed)	N
2019-08-08	31178898	Lin BM	2019-05-24	Front Genet	www.ncbi.nlm.nih.gov/pubmed/31178898	Genetics of Chronic Kidney Disease Stages Across Ancestries: The PAGE Study.	End-stage kidney disease	584 African American cases, 282 Hispanic cases, 112 East Asian cases, 96 Native Hawaiian cases, 1 American Indian cases, 30 cases, 8,429 African American controls, 15,852 Hispanic controls, 3,536 East Asian controls, 2,892 Native Hawaiian controls, 49 American Indian controls, 936 controls	NA	1p31.1	1	78168337	GIPC2	GIPC2 - RNFT1P2	ENSG00000137960	ENSG00000233333		29893	2144	rs77138376-A	rs77138376	0	77138376	regulatory_region_variant	1	0.009	2E-7	6.69897000433602		2.63	[1.83-3.78]	Illumina [1438399] (imputed)	N
2019-08-08	31178898	Lin BM	2019-05-24	Front Genet	www.ncbi.nlm.nih.gov/pubmed/31178898	Genetics of Chronic Kidney Disease Stages Across Ancestries: The PAGE Study.	End-stage kidney disease	584 African American cases, 282 Hispanic cases, 112 East Asian cases, 96 Native Hawaiian cases, 1 American Indian cases, 30 cases, 8,429 African American controls, 15,852 Hispanic controls, 3,536 East Asian controls, 2,892 Native Hawaiian controls, 49 American Indian controls, 936 controls	NA	1q21.1	1	147339048	LINC00624	LINC00624			ENSG00000278811	NA	NA	rs12032578-C	rs12032578	0	12032578	intron_variant	0	0.088	3E-7	6.52287874528034		1.44	[1.25-1.66]	Illumina [1438399] (imputed)	N
2019-08-08	31178898	Lin BM	2019-05-24	Front Genet	www.ncbi.nlm.nih.gov/pubmed/31178898	Genetics of Chronic Kidney Disease Stages Across Ancestries: The PAGE Study.	End-stage kidney disease	584 African American cases, 282 Hispanic cases, 112 East Asian cases, 96 Native Hawaiian cases, 1 American Indian cases, 30 cases, 8,429 African American controls, 15,852 Hispanic controls, 3,536 East Asian controls, 2,892 Native Hawaiian controls, 49 American Indian controls, 936 controls	NA	3p26.1	3	5505762	MIR4790	AC026202.1 - AC087857.1	ENSG00000230944	ENSG00000229642		249001	457080	rs112407915-A	rs112407915	0	112407915	intergenic_variant	1	0.02	9E-8	7.04575749056067		1.96	[1.53-2.51]	Illumina [1438399] (imputed)	N
2019-08-08	31178898	Lin BM	2019-05-24	Front Genet	www.ncbi.nlm.nih.gov/pubmed/31178898	Genetics of Chronic Kidney Disease Stages Across Ancestries: The PAGE Study.	End-stage kidney disease	584 African American cases, 282 Hispanic cases, 112 East Asian cases, 96 Native Hawaiian cases, 1 American Indian cases, 30 cases, 8,429 African American controls, 15,852 Hispanic controls, 3,536 East Asian controls, 2,892 Native Hawaiian controls, 49 American Indian controls, 936 controls	NA	4q26	4	117920116	NDST3	LINC02264 - NDST3	ENSG00000229565	ENSG00000164100		50156	113502	rs114425659-A	rs114425659	0	114425659	intergenic_variant	1	0.039	9E-7	6.04575749056067		1.87	[1.45-2.39]	Illumina [1438399] (imputed)	N
2019-08-08	31178898	Lin BM	2019-05-24	Front Genet	www.ncbi.nlm.nih.gov/pubmed/31178898	Genetics of Chronic Kidney Disease Stages Across Ancestries: The PAGE Study.	End-stage kidney disease	584 African American cases, 282 Hispanic cases, 112 East Asian cases, 96 Native Hawaiian cases, 1 American Indian cases, 30 cases, 8,429 African American controls, 15,852 Hispanic controls, 3,536 East Asian controls, 2,892 Native Hawaiian controls, 49 American Indian controls, 936 controls	NA	7p21.3	7	11578298	THSD7A	THSD7A			ENSG00000005108	NA	NA	rs74614630-C	rs74614630	0	74614630	intron_variant	0	0.012	9E-7	6.04575749056067		2.25	[1.63-3.11]	Illumina [1438399] (imputed)	N
2019-08-08	31178898	Lin BM	2019-05-24	Front Genet	www.ncbi.nlm.nih.gov/pubmed/31178898	Genetics of Chronic Kidney Disease Stages Across Ancestries: The PAGE Study.	End-stage kidney disease	584 African American cases, 282 Hispanic cases, 112 East Asian cases, 96 Native Hawaiian cases, 1 American Indian cases, 30 cases, 8,429 African American controls, 15,852 Hispanic controls, 3,536 East Asian controls, 2,892 Native Hawaiian controls, 49 American Indian controls, 936 controls	NA	9q21.2	9	76994030	FOXB2	AL353637.1 - FOXB2	ENSG00000229857	ENSG00000204612		922	25625	rs115747230-C	rs115747230	0	115747230	intergenic_variant	1	0.021	4E-7	6.39794000867204		1.88	[1.47-2.39]	Illumina [1438399] (imputed)	N
2019-08-08	31178898	Lin BM	2019-05-24	Front Genet	www.ncbi.nlm.nih.gov/pubmed/31178898	Genetics of Chronic Kidney Disease Stages Across Ancestries: The PAGE Study.	End-stage kidney disease	584 African American cases, 282 Hispanic cases, 112 East Asian cases, 96 Native Hawaiian cases, 1 American Indian cases, 30 cases, 8,429 African American controls, 15,852 Hispanic controls, 3,536 East Asian controls, 2,892 Native Hawaiian controls, 49 American Indian controls, 936 controls	NA	11p14.3	11	24209937	LUZP2	AC099842.1 - LINC02686	ENSG00000277803	ENSG00000254594		316380	25540	rs116510623-G	rs116510623	0	116510623	intergenic_variant	1	0.034	6E-7	6.22184874961636		1.65	[1.35-2.01]	Illumina [1438399] (imputed)	N
2019-08-08	31178898	Lin BM	2019-05-24	Front Genet	www.ncbi.nlm.nih.gov/pubmed/31178898	Genetics of Chronic Kidney Disease Stages Across Ancestries: The PAGE Study.	End-stage kidney disease	584 African American cases, 282 Hispanic cases, 112 East Asian cases, 96 Native Hawaiian cases, 1 American Indian cases, 30 cases, 8,429 African American controls, 15,852 Hispanic controls, 3,536 East Asian controls, 2,892 Native Hawaiian controls, 49 American Indian controls, 936 controls	NA	13q13.1	13	32309059	ZAR1L	ZAR1L			ENSG00000189167	NA	NA	rs60236946-T	rs60236946	0	60236946	intron_variant	0	0.021	9E-7	6.04575749056067		1.86	[1.45-2.38]	Illumina [1438399] (imputed)	N
2019-08-08	31178898	Lin BM	2019-05-24	Front Genet	www.ncbi.nlm.nih.gov/pubmed/31178898	Genetics of Chronic Kidney Disease Stages Across Ancestries: The PAGE Study.	End-stage kidney disease	584 African American cases, 282 Hispanic cases, 112 East Asian cases, 96 Native Hawaiian cases, 1 American Indian cases, 30 cases, 8,429 African American controls, 15,852 Hispanic controls, 3,536 East Asian controls, 2,892 Native Hawaiian controls, 49 American Indian controls, 936 controls	NA	14q22.3	14	56358353	PELI2	LINC02284			ENSG00000259719	NA	NA	rs115007604-A	rs115007604	0	115007604	intron_variant	0	0.008	9E-7	6.04575749056067		2.67	[1.81-3.95]	Illumina [1438399] (imputed)	N
2019-08-08	31178898	Lin BM	2019-05-24	Front Genet	www.ncbi.nlm.nih.gov/pubmed/31178898	Genetics of Chronic Kidney Disease Stages Across Ancestries: The PAGE Study.	End-stage kidney disease	584 African American cases, 282 Hispanic cases, 112 East Asian cases, 96 Native Hawaiian cases, 1 American Indian cases, 30 cases, 8,429 African American controls, 15,852 Hispanic controls, 3,536 East Asian controls, 2,892 Native Hawaiian controls, 49 American Indian controls, 936 controls	NA	16q12.2	16	53852312	FTO	FTO			ENSG00000140718	NA	NA	rs7189997-G	rs7189997	0	7189997	intron_variant	0	0.009	3E-7	6.52287874528034		2.44	[1.73-3.42]	Illumina [1438399] (imputed)	N
2019-08-08	31178898	Lin BM	2019-05-24	Front Genet	www.ncbi.nlm.nih.gov/pubmed/31178898	Genetics of Chronic Kidney Disease Stages Across Ancestries: The PAGE Study.	End-stage kidney disease	584 African American cases, 282 Hispanic cases, 112 East Asian cases, 96 Native Hawaiian cases, 1 American Indian cases, 30 cases, 8,429 African American controls, 15,852 Hispanic controls, 3,536 East Asian controls, 2,892 Native Hawaiian controls, 49 American Indian controls, 936 controls	NA	16q12.2	16	54379818	IRX3	AC018553.3 - AC007343.1	ENSG00000287885	ENSG00000286845		5090	110463	rs8050506-A	rs8050506	0	8050506	intergenic_variant	1	0.211	8E-7	6.09691001300806		1.29	[1.17-1.43]	Illumina [1438399] (imputed)	N
2019-08-08	31178898	Lin BM	2019-05-24	Front Genet	www.ncbi.nlm.nih.gov/pubmed/31178898	Genetics of Chronic Kidney Disease Stages Across Ancestries: The PAGE Study.	End-stage kidney disease	584 African American cases, 282 Hispanic cases, 112 East Asian cases, 96 Native Hawaiian cases, 1 American Indian cases, 30 cases, 8,429 African American controls, 15,852 Hispanic controls, 3,536 East Asian controls, 2,892 Native Hawaiian controls, 49 American Indian controls, 936 controls	NA	17p12	17	14286592	HS3ST3B1	CDRT15 - AC005224.1	ENSG00000223510	ENSG00000262786		49730	8920	rs191540116-A	rs191540116	0	191540116	intergenic_variant	1	0.011	9E-7	6.04575749056067		2.32	[1.66-3.25]	Illumina [1438399] (imputed)	N
2019-08-08	31178898	Lin BM	2019-05-24	Front Genet	www.ncbi.nlm.nih.gov/pubmed/31178898	Genetics of Chronic Kidney Disease Stages Across Ancestries: The PAGE Study.	End-stage kidney disease	584 African American cases, 282 Hispanic cases, 112 East Asian cases, 96 Native Hawaiian cases, 1 American Indian cases, 30 cases, 8,429 African American controls, 15,852 Hispanic controls, 3,536 East Asian controls, 2,892 Native Hawaiian controls, 49 American Indian controls, 936 controls	NA	18q21.31	18	57097183	LINC-ROR	LINC-ROR - AC100775.1	ENSG00000258609	ENSG00000267789		25064	39139	rs12963285-T	rs12963285	0	12963285	intergenic_variant	1	0.834	1E-6	6		1.3513513	[1.19-1.52]	Illumina [1438399] (imputed)	N
2019-08-08	31178898	Lin BM	2019-05-24	Front Genet	www.ncbi.nlm.nih.gov/pubmed/31178898	Genetics of Chronic Kidney Disease Stages Across Ancestries: The PAGE Study.	End-stage kidney disease	584 African American cases, 282 Hispanic cases, 112 East Asian cases, 96 Native Hawaiian cases, 1 American Indian cases, 30 cases, 8,429 African American controls, 15,852 Hispanic controls, 3,536 East Asian controls, 2,892 Native Hawaiian controls, 49 American Indian controls, 936 controls	NA	22q12.1	22	29065297	C22orf31	C22orf31 - KREMEN1	ENSG00000100249	ENSG00000183762		3453	7781	rs138572244-A	rs138572244	0	138572244	intergenic_variant	1	0.008	2E-7	6.69897000433602		2.9	[1.94-4.35]	Illumina [1438399] (imputed)	N
2019-08-08	31178898	Lin BM	2019-05-24	Front Genet	www.ncbi.nlm.nih.gov/pubmed/31178898	Genetics of Chronic Kidney Disease Stages Across Ancestries: The PAGE Study.	End-stage kidney disease	584 African American cases, 282 Hispanic cases, 112 East Asian cases, 96 Native Hawaiian cases, 1 American Indian cases, 30 cases, 8,429 African American controls, 15,852 Hispanic controls, 3,536 East Asian controls, 2,892 Native Hawaiian controls, 49 American Indian controls, 936 controls	NA	22q12.3	22	36265860	APOL1	APOL1			ENSG00000100342	NA	NA	rs73885319-G	rs73885319	0	73885319	missense_variant	0	0.077	2E-9	8.69897000433602		1.51	[1.32-1.72]	Illumina [1438399] (imputed)	N
2019-08-08	31178898	Lin BM	2019-05-24	Front Genet	www.ncbi.nlm.nih.gov/pubmed/31178898	Genetics of Chronic Kidney Disease Stages Across Ancestries: The PAGE Study.	Mild to moderate chronic kidney disease	1,532 African American cases, 1,336 Hispanic cases, 575 East Asian cases, 608 Native Hawaiian cases, 42 American Indian cases, 57 cases, 13,761 African American controls, 19,317 Hispanic controls, 3,540 East Asian controls, 2,892 Native Hawaiian controls, 595 American Indian controls, 936 controls	NA	1q42.12	1	226335330	PARP1	AL359742.1 - PARP1	ENSG00000275406	ENSG00000143799		1675	25361	rs76064236-G	rs76064236	0	76064236	intergenic_variant	1	0.005	1E-6	6		2.28	[1.69-3.16]	Illumina [1438399] (imputed)	N
2019-08-08	31178898	Lin BM	2019-05-24	Front Genet	www.ncbi.nlm.nih.gov/pubmed/31178898	Genetics of Chronic Kidney Disease Stages Across Ancestries: The PAGE Study.	Mild to moderate chronic kidney disease	1,532 African American cases, 1,336 Hispanic cases, 575 East Asian cases, 608 Native Hawaiian cases, 42 American Indian cases, 57 cases, 13,761 African American controls, 19,317 Hispanic controls, 3,540 East Asian controls, 2,892 Native Hawaiian controls, 595 American Indian controls, 936 controls	NA	3q21.3	3	128669172	RPN1	RPN1			ENSG00000163902	NA	NA	rs146639727-C	rs146639727	0	146639727	intron_variant	0	0.004	5E-8	7.30102999566398		3.05	[2.04-4.56]	Illumina [1438399] (imputed)	N
2019-08-08	31178898	Lin BM	2019-05-24	Front Genet	www.ncbi.nlm.nih.gov/pubmed/31178898	Genetics of Chronic Kidney Disease Stages Across Ancestries: The PAGE Study.	Mild to moderate chronic kidney disease	1,532 African American cases, 1,336 Hispanic cases, 575 East Asian cases, 608 Native Hawaiian cases, 42 American Indian cases, 57 cases, 13,761 African American controls, 19,317 Hispanic controls, 3,540 East Asian controls, 2,892 Native Hawaiian controls, 595 American Indian controls, 936 controls	NA	8q24.22	8	130951170	ADCY8	ADCY8			ENSG00000155897	NA	NA	rs138873021-T	rs138873021	1	34814893	intron_variant	0	0.629	2E-7	6.69897000433602		1.17	[1.11-1.25]	Illumina [1438399] (imputed)	N
2019-08-08	31178898	Lin BM	2019-05-24	Front Genet	www.ncbi.nlm.nih.gov/pubmed/31178898	Genetics of Chronic Kidney Disease Stages Across Ancestries: The PAGE Study.	Mild to moderate chronic kidney disease	1,532 African American cases, 1,336 Hispanic cases, 575 East Asian cases, 608 Native Hawaiian cases, 42 American Indian cases, 57 cases, 13,761 African American controls, 19,317 Hispanic controls, 3,540 East Asian controls, 2,892 Native Hawaiian controls, 595 American Indian controls, 936 controls	NA	9p23	9	12141349	TYRP1	AL589678.1			ENSG00000224935	NA	NA	rs186208070-A	rs186208070	0	186208070	intron_variant	0	0.009	7E-8	7.15490195998574		2.07	[1.59-2.70]	Illumina [1438399] (imputed)	N
2019-08-08	31178898	Lin BM	2019-05-24	Front Genet	www.ncbi.nlm.nih.gov/pubmed/31178898	Genetics of Chronic Kidney Disease Stages Across Ancestries: The PAGE Study.	Mild to moderate chronic kidney disease	1,532 African American cases, 1,336 Hispanic cases, 575 East Asian cases, 608 Native Hawaiian cases, 42 American Indian cases, 57 cases, 13,761 African American controls, 19,317 Hispanic controls, 3,540 East Asian controls, 2,892 Native Hawaiian controls, 595 American Indian controls, 936 controls	NA	10p13	10	15183055	NMT2	AL590365.1 - FAM171A1	ENSG00000228181	ENSG00000148468		11777	28588	rs10906850-C	rs10906850	0	10906850	regulatory_region_variant	1	0.225	4E-8	7.39794000867204		1.18	[1.11-1.25]	Illumina [1438399] (imputed)	N
2019-08-08	31178898	Lin BM	2019-05-24	Front Genet	www.ncbi.nlm.nih.gov/pubmed/31178898	Genetics of Chronic Kidney Disease Stages Across Ancestries: The PAGE Study.	Mild to moderate chronic kidney disease	1,532 African American cases, 1,336 Hispanic cases, 575 East Asian cases, 608 Native Hawaiian cases, 42 American Indian cases, 57 cases, 13,761 African American controls, 19,317 Hispanic controls, 3,540 East Asian controls, 2,892 Native Hawaiian controls, 595 American Indian controls, 936 controls	NA	11q24.2	11	125970250	CDON	CDON			ENSG00000064309	NA	NA	rs183951714-T	rs183951714	0	183951714	intron_variant	0	0.011	7E-7	6.15490195998574		1.66	[1.36-2.02]	Illumina [1438399] (imputed)	N
2019-08-08	31178898	Lin BM	2019-05-24	Front Genet	www.ncbi.nlm.nih.gov/pubmed/31178898	Genetics of Chronic Kidney Disease Stages Across Ancestries: The PAGE Study.	Mild to moderate chronic kidney disease	1,532 African American cases, 1,336 Hispanic cases, 575 East Asian cases, 608 Native Hawaiian cases, 42 American Indian cases, 57 cases, 13,761 African American controls, 19,317 Hispanic controls, 3,540 East Asian controls, 2,892 Native Hawaiian controls, 595 American Indian controls, 936 controls	NA	12q23.3	12	105391125	C12orf75	C12orf75			ENSG00000235162	NA	NA	rs117329947-C	rs117329947	0	117329947	intron_variant	0	0.014	9E-7	6.04575749056067		1.79	[1.42-2.25]	Illumina [1438399] (imputed)	N
2019-08-08	31178898	Lin BM	2019-05-24	Front Genet	www.ncbi.nlm.nih.gov/pubmed/31178898	Genetics of Chronic Kidney Disease Stages Across Ancestries: The PAGE Study.	Mild to moderate chronic kidney disease	1,532 African American cases, 1,336 Hispanic cases, 575 East Asian cases, 608 Native Hawaiian cases, 42 American Indian cases, 57 cases, 13,761 African American controls, 19,317 Hispanic controls, 3,540 East Asian controls, 2,892 Native Hawaiian controls, 595 American Indian controls, 936 controls	NA	16q21	16	62966386	CDH8	AC010546.1 - AC040174.1	ENSG00000260332	ENSG00000261502		157680	90400	rs11645800-G	rs11645800	0	11645800	intergenic_variant	1	0.184	1E-7	7		1.2	[1.12-1.28]	Illumina [1438399] (imputed)	N
2019-08-08	31178898	Lin BM	2019-05-24	Front Genet	www.ncbi.nlm.nih.gov/pubmed/31178898	Genetics of Chronic Kidney Disease Stages Across Ancestries: The PAGE Study.	Mild to moderate chronic kidney disease	1,532 African American cases, 1,336 Hispanic cases, 575 East Asian cases, 608 Native Hawaiian cases, 42 American Indian cases, 57 cases, 13,761 African American controls, 19,317 Hispanic controls, 3,540 East Asian controls, 2,892 Native Hawaiian controls, 595 American Indian controls, 936 controls	NA	16q24.1	16	86727784	FOXL1	LINC02188			ENSG00000261175	NA	NA	rs147084429-C	rs147084429	0	147084429	intron_variant	0	0.981	5E-7	6.30102999566398		1.5873016	[1.32-1.89]	Illumina [1438399] (imputed)	N
2019-08-08	31178898	Lin BM	2019-05-24	Front Genet	www.ncbi.nlm.nih.gov/pubmed/31178898	Genetics of Chronic Kidney Disease Stages Across Ancestries: The PAGE Study.	Mild to moderate chronic kidney disease	1,532 African American cases, 1,336 Hispanic cases, 575 East Asian cases, 608 Native Hawaiian cases, 42 American Indian cases, 57 cases, 13,761 African American controls, 19,317 Hispanic controls, 3,540 East Asian controls, 2,892 Native Hawaiian controls, 595 American Indian controls, 936 controls	NA	17q21.33	17	50748155	LUC7L3	LUC7L3			ENSG00000108848	NA	NA	rs144210385-A	rs144210385	0	144210385	intron_variant	0	0.006	8E-8	7.09691001300806		2.85	[1.94-4.17]	Illumina [1438399] (imputed)	N
2019-05-08	30955190	Yun S	2019-04-06	Clin Exp Nephrol	www.ncbi.nlm.nih.gov/pubmed/30955190	Genetic risk score raises the risk of incidence of chronic kidney disease in Korean general population-based cohort.	Incident chronic kidney disease	281 Korean ancestry cases, 3,336 Korean ancestry controls	NA	1p21.2	1	99937719	AGL, SLC35A3	AGL - AC118553.1	ENSG00000162688	ENSG00000228084		13696	30664	rs10783124-G	rs10783124	0	10783124	intergenic_variant	1	0.09	1E-6	6		2.23	[NR]	Affymetrix [up to 1590162] (imputed)	N
2019-05-08	30955190	Yun S	2019-04-06	Clin Exp Nephrol	www.ncbi.nlm.nih.gov/pubmed/30955190	Genetic risk score raises the risk of incidence of chronic kidney disease in Korean general population-based cohort.	Incident chronic kidney disease	281 Korean ancestry cases, 3,336 Korean ancestry controls	NA	13q22.2	13	76307915	LMO7DN, KCTD12	RN7SL571P - AL136441.1	ENSG00000243274	ENSG00000285572		172690	244892	rs1505141-C	rs1505141	0	1505141	intergenic_variant	1	0.675	6E-7	6.22184874961636		1.61	[NR]	Affymetrix [up to 1590162] (imputed)	N
2019-12-16	31537649	Salem RM	2019-09-19	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/31537649	Genome-Wide Association Study of Diabetic Kidney Disease Highlights Biology Involved in Glomerular Basement Membrane Collagen.	Chronic kidney disease (reduced eGFR or end stage renal disease) in type 1 diabetes	4,266 European ancestry cases, 14,838 European ancestry controls	NA	2p25.3	2	3697625	COLEC11, ALLC	ALLC			ENSG00000151360	NA	NA	rs12615970-A	rs12615970	0	12615970	intron_variant	0	0.867	9E-9	8.04575749056067		1.3157895	[NR]	Illumina [up to 49000000] (imputed)	N
2019-12-16	31537649	Salem RM	2019-09-19	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/31537649	Genome-Wide Association Study of Diabetic Kidney Disease Highlights Biology Involved in Glomerular Basement Membrane Collagen.	Chronic kidney disease (reduced eGFR or end stage renal disease) in type 1 diabetes	4,266 European ancestry cases, 14,838 European ancestry controls	NA	18p11.32	18	1811107	Intergenic	AP005262.1			ENSG00000266602	NA	NA	rs185299109-T	rs185299109	0	185299109	intron_variant	0	0.007	1E-8	8		20.75	[NR]	Illumina [up to 49000000] (imputed)	N
2019-12-16	31537649	Salem RM	2019-09-19	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/31537649	Genome-Wide Association Study of Diabetic Kidney Disease Highlights Biology Involved in Glomerular Basement Membrane Collagen.	Chronic kidney disease (end stage renal disease vs. normal eGFR) in type 1 diabetes	2,235 European ancestry cases, 14,993 European ancestry controls	NA	5q23.2	5	122438887	SNCAIP	AC022101.1, SNCAIP			ENSG00000250328, ENSG00000064692	NA	NA	rs149641852-T	rs149641852	0	149641852	intron_variant	0	0.012	1E-8	8		9.01	[NR]	Illumina [up to 49000000] (imputed)	N
2019-09-02	30801552	Oetting WS	2019-02-19	Transplantation	www.ncbi.nlm.nih.gov/pubmed/30801552	Genetic Variants Associated with Immunosuppressant Pharmacokinetics and Adverse Effects in the DeKAF Genomics Genome Wide Association Studies.	Tacrolimus trough concentration in kidney transplant patients	1,363 European ancestry individuals, 299 African American individuals	609 European ancestry individuals, 171 African American individuals	7q22.1	7	99672916	NR	CYP3A5			ENSG00000106258	NA	NA	rs776746-?	rs776746	0	776746	splice_acceptor_variant	0	NR	4E-97	96.397940008672	(EA)	0.6443	[0.58-0.70] unit increase	Affymetrix [~ 40000000] (imputed)	N
2019-09-02	30801552	Oetting WS	2019-02-19	Transplantation	www.ncbi.nlm.nih.gov/pubmed/30801552	Genetic Variants Associated with Immunosuppressant Pharmacokinetics and Adverse Effects in the DeKAF Genomics Genome Wide Association Studies.	Tacrolimus trough concentration in kidney transplant patients	1,363 European ancestry individuals, 299 African American individuals	609 European ancestry individuals, 171 African American individuals	7q22.1	7	99768693	NR	CYP3A4			ENSG00000160868	NA	NA	rs35599367-?	rs35599367	0	35599367	intron_variant	0	NR	6E-18	17.2218487496164	(EA)	0.2896	[0.22-0.36] unit increase	Affymetrix [~ 40000000] (imputed)	N
2019-09-02	30801552	Oetting WS	2019-02-19	Transplantation	www.ncbi.nlm.nih.gov/pubmed/30801552	Genetic Variants Associated with Immunosuppressant Pharmacokinetics and Adverse Effects in the DeKAF Genomics Genome Wide Association Studies.	Tacrolimus trough concentration in kidney transplant patients	1,363 European ancestry individuals, 299 African American individuals	609 European ancestry individuals, 171 African American individuals	7q22.1	7	99672916	NR	CYP3A5			ENSG00000106258	NA	NA	rs776746-?	rs776746	0	776746	splice_acceptor_variant	0	NR	5E-35	34.301029995664	(AA)	0.4488	[0.38-0.52] unit increase	Affymetrix [~ 40000000] (imputed)	N
2019-09-02	30801552	Oetting WS	2019-02-19	Transplantation	www.ncbi.nlm.nih.gov/pubmed/30801552	Genetic Variants Associated with Immunosuppressant Pharmacokinetics and Adverse Effects in the DeKAF Genomics Genome Wide Association Studies.	Tacrolimus trough concentration in kidney transplant patients	1,363 European ancestry individuals, 299 African American individuals	609 European ancestry individuals, 171 African American individuals	7q22.1	7	99652771	NR	CYP3A5			ENSG00000106258	NA	NA	rs41303343-?	rs41303343	0	41303343	frameshift_variant	0	NR	4E-27	26.397940008672	(AA)	0.5614	[0.46-0.66] unit increase	Affymetrix [~ 40000000] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	6q25.3	6	160122116	SLC22A1	SLC22A1			ENSG00000175003	NA	NA	rs12208357-T	rs12208357	0	12208357	missense_variant	0	0.1	8E-16	15.0969100130081	(nicotinamide riboside)	0.376	[0.28-0.47] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	10q24.2	10	98383436	PYROXD2	LOXL4 - PYROXD2	ENSG00000138131	ENSG00000119943		115242	129	rs7905265-G	rs7905265	0	7905265	TF_binding_site_variant	1	0.38	7E-81	80.1549019599858	(N-methylpipecolate)	1.064	[0.95-1.17] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	1p31.1	1	75724884	ACADM	ACADM			ENSG00000117054	NA	NA	rs1251075-G	rs1251075	0	1251075	intron_variant	0	0.32	2E-18	17.698970004336	(N-octanoylglutamine)	0.37	[0.29-0.45] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	6p22.2	6	25785763	SLC17A1, SLC17A3, SLC17A4	SLC17A1			ENSG00000124568	NA	NA	rs13197514-T	rs13197514	0	13197514	intron_variant	0	0.45	9E-18	17.0457574905607	(N-octanoylglutamine)	0.343	[0.26-0.42] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	14q24.3	14	73589444	ACOT4	AC005225.2			ENSG00000258603	NA	NA	rs7159760-T	rs7159760	0	7159760	intron_variant	0	0.22	2E-25	24.698970004336	(nonenedioate (C9:1-DC))	0.296	[0.24-0.35] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	17q25.1	17	75973754	ACOX1	ACOX1			ENSG00000161533	NA	NA	rs3744032-T	rs3744032	0	3744032	missense_variant	0	0.06	2E-28	27.698970004336	(nonenedioate (C9:1-DC))	0.586	[0.48-0.69] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	22q13.33	22	50625049	ARSA	ARSA			ENSG00000100299	NA	NA	rs6151429-C	rs6151429	0	6151429	3_prime_UTR_variant	0	0.08	9E-13	12.0457574905607	(O-sulfo-L-tyrosine)	0.184	[0.13-0.23] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	5p15.33	5	1188170	SLC6A19	AC114291.1 - SLC6A19	ENSG00000249201	ENSG00000174358		9565	13425	rs11133665-A	rs11133665	0	11133665	intergenic_variant	1	0.27	2E-15	14.698970004336	(phenylalanine)	0.167	[0.13-0.21] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	1p36.12	1	21577881	ALPL	ALPL			ENSG00000162551	NA	NA	rs1772719-C	rs1772719	0	1772719	3_prime_UTR_variant	0	0.18	7E-13	12.1549019599857	(phosphoethanolamine)	0.303	[0.22-0.39] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	16q24.3	16	89631662	DPEP1	DPEP1			ENSG00000015413	NA	NA	rs2250598-T	rs2250598	0	2250598	intron_variant	0	0.46	4E-20	19.397940008672	(picolinate)	0.226	[0.18-0.27] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	11q12.3	11	63035630	SLC22A10	AP001858.2 - AP001858.1	ENSG00000256041	ENSG00000253547		2527	11155	rs17713514-T	rs17713514	0	17713514	regulatory_region_variant	1	0.05	2E-11	10.698970004336	(pregnanediol-3-glucuronide)	0.635	[0.45-0.82] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	19q13.33	19	47890094	SULT2A1	SULT2A1 - BSPH1	ENSG00000105398	ENSG00000188334		3779	77952	rs62129970-T	rs62129970	0	62129970	intergenic_variant	1	0.16	5E-26	25.301029995664	(pregnenediol disulfate (C21H34O8S2))	0.691	[0.56-0.82] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	16q24.3	16	89632344	DPEP1	DPEP1			ENSG00000015413	NA	NA	rs420332-T	rs420332	0	420332	intron_variant	0	0.46	1E-99	99	(prolylglycine)	0.77	[0.7-0.84] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	6p25.2	6	2996087	NQO2	NQO2-AS1, NQO2			ENSG00000224846, ENSG00000124588	NA	NA	rs6913474-C	rs6913474	0	6913474	intron_variant	0	0.42	1E-29	29	(pterin)	0.391	[0.32-0.46] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	6p22.2	6	25818538	SLC17A1, SLC17A3, SLC17A4	SLC17A1			ENSG00000124568	NA	NA	rs1165152-A	rs1165152	0	1165152	intron_variant	0	0.47	4E-11	10.397940008672	(pyridoxal)	0.39	[0.27-0.51] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	18p11.32	18	673086	TYMS	TYMS, ENOSF1			ENSG00000176890, ENSG00000132199	NA	NA	rs2790-G	rs2790	0	2790	3_prime_UTR_variant	0	0.21	4E-15	14.397940008672	(ribonate)	0.141	[0.11-0.18] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	3p14.1	3	67375539	SUCLG2	SUCLG2			ENSG00000172340	NA	NA	rs115560420-T	rs115560420	0	115560420	3_prime_UTR_variant	0	0.13	7E-15	14.1549019599857	(succinylcarnitine (C4-DC))	0.176	[0.13-0.22] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	15q22.2	15	63124282	LACTB	LACTB			ENSG00000103642	NA	NA	rs11071733-A	rs11071733	0	11071733	intron_variant	0	0.4	3E-19	18.5228787452803	(succinylcarnitine (C4-DC))	0.14	[0.11-0.17] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	7q22.1	7	99533211	ZKSCAN5	ZKSCAN5			ENSG00000196652	NA	NA	rs34670419-T	rs34670419	0	34670419	3_prime_UTR_variant	0	0.03	6E-18	17.2218487496164	(tauro-beta-muricholate)	1.245	[0.96-1.53] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	12p12.1	12	21204777	SLCO1B1	SLCO1B1			ENSG00000134538	NA	NA	rs58310495-T	rs58310495	0	58310495	intron_variant	0	0.18	1E-15	15	(taurocholenate sulfate)	0.585	[0.44-0.73] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	2q34	2	210675783	CPS1	CPS1			ENSG00000021826	NA	NA	rs1047891-A	rs1047891	0	1047891	missense_variant	0	0.33	7E-17	16.1549019599857	(tigloylglycine)	0.223	[0.17-0.28] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	12q23.1	12	95986028	HAL	HAL			ENSG00000084110	NA	NA	rs3213737-G	rs3213737	0	3213737	intron_variant	0	0.48	2E-25	24.698970004336	(trans-urocanate)	0.227	[0.18-0.27] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	5p15.33	5	1188170	SLC6A19	AC114291.1 - SLC6A19	ENSG00000249201	ENSG00000174358		9565	13425	rs11133665-A	rs11133665	0	11133665	intergenic_variant	1	0.27	5E-23	22.301029995664	(tryptophan)	0.271	[0.22-0.33] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	5p15.33	5	1188170	SLC6A19	AC114291.1 - SLC6A19	ENSG00000249201	ENSG00000174358		9565	13425	rs11133665-A	rs11133665	0	11133665	intergenic_variant	1	0.27	1E-16	16	(tyrosine)	0.228	[0.17-0.28] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	1q32.1	1	201983470	RNPEP	RNPEP			ENSG00000176393	NA	NA	rs56768485-A	rs56768485	0	56768485	missense_variant	0	0.28	1E-56	56	(X - 10457)	0.355	[0.31-0.4] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	2p13.1	2	73622734	NAT8	ALMS1			ENSG00000116127	NA	NA	rs6546861-T	rs6546861	0	6546861	intron_variant	0	0.21	2E-123	122.698970004336	(X - 11357)	0.873	[0.8-0.95] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	19q13.33	19	47962055	CABP5	SULT2A1 - BSPH1	ENSG00000105398	ENSG00000188334		75740	5991	rs2972516-T	rs2972516	0	2972516	regulatory_region_variant	1	0.17	4E-31	30.397940008672	(X - 11440)	0.623	[0.52-0.73] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	2p13.1	2	73644538	NAT8	ALMS1P1			ENSG00000163016	NA	NA	rs13384756-T	rs13384756	0	13384756	intron_variant	0	0.21	1E-109	109	(X - 12093)	1.118	[1.02-1.22] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	10q24.2	10	98388419	PYROXD2	PYROXD2			ENSG00000119943	NA	NA	rs2147896-G	rs2147896	0	2147896	missense_variant	0	0.36	2E-309	308.698970004336	(X - 12093)	1.3	[1.23-1.37] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	5p13.2	5	35037010	AGXT2	AGXT2			ENSG00000113492	NA	NA	rs37369-T	rs37369	0	37369	missense_variant	0	0.08	6E-27	26.2218487496164	(X - 12096)	0.657	[0.54-0.78] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	1p22.3	1	85411415	DDAH1	AL078459.1, DDAH1			ENSG00000223653, ENSG00000153904	NA	NA	rs1554597-C	rs1554597	0	1554597	intron_variant	0	0.36	6E-16	15.2218487496164	(X - 12097)	0.335	[0.25-0.42] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	5p13.2	5	35037010	AGXT2	AGXT2			ENSG00000113492	NA	NA	rs37369-T	rs37369	0	37369	missense_variant	0	0.08	4E-48	47.397940008672	(X - 12097)	1.009	[0.87-1.14] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	10q24.2	10	98399379	PYROXD2	PYROXD2			ENSG00000119943	NA	NA	rs4488133-T	rs4488133	0	4488133	intron_variant	0	0.36	1E-234	234	(X - 12112)	1.461	[1.37-1.55] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	5p13.2	5	35037010	AGXT2	AGXT2			ENSG00000113492	NA	NA	rs37369-T	rs37369	0	37369	missense_variant	0	0.08	6E-50	49.2218487496164	(X - 12117)	0.627	[0.54-0.71] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	2p13.1	2	73623693	NAT8	ALMS1			ENSG00000116127	NA	NA	rs6711001-G	rs6711001	0	6711001	intron_variant	0	0.21	2E-257	256.698970004336	(X - 12124)	0.709	[0.67-0.75] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	2p13.1	2	73631838	NAT8	ALMS1 - NAT8	ENSG00000116127	ENSG00000144035		6672	8885	rs10201159-C	rs10201159	0	10201159	intergenic_variant	1	0.21	2E-570	569.698970004336	(X - 12125)	1.657	[1.59-1.72] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	2p13.1	2	73641201	NAT8	ALMS1P1, NAT8			ENSG00000163016, ENSG00000144035	NA	NA	rs13538-G	rs13538	0	13538	missense_variant	0	0.21	9E-15	14.0457574905607	(X - 12379)	0.241	[0.18-0.3] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	8p22	8	18414928	NAT2	NAT2 - PSD3	ENSG00000156006	ENSG00000156011		13710	112375	rs4921914-C	rs4921914	0	4921914	intergenic_variant	1	0.22	5E-18	17.301029995664	(X - 12410)	0.377	[0.29-0.46] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	1p31.1	1	75677758	ACADM	AL137803.1			ENSG00000230863	NA	NA	rs7513363-G	rs7513363	0	7513363	intron_variant	0	0.32	5E-18	17.301029995664	(X - 12636)	0.336	[0.26-0.41] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	22q11.21	22	19963748	COMT	COMT			ENSG00000093010	NA	NA	rs4680-G	rs4680	0	4680	missense_variant	0	0.5	2E-11	10.698970004336	(X - 12707)	0.163	[0.12-0.21] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	22q11.21	22	19963748	COMT	COMT			ENSG00000093010	NA	NA	rs4680-G	rs4680	0	4680	missense_variant	0	0.5	2E-28	27.698970004336	(X - 12708)	0.228	[0.19-0.27] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	16p11.2	16	28530851	NUPR1	IL27 - NUPR1	ENSG00000197272	ENSG00000176046		18800	1857	rs231977-T	rs231977	0	231977	intergenic_variant	1	0.45	1E-12	12	(X - 12714)	0.213	[0.15-0.27] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	6p22.2	6	25818538	SLC17A1, SLC17A3, SLC17A4	SLC17A1			ENSG00000124568	NA	NA	rs1165152-A	rs1165152	0	1165152	intron_variant	0	0.47	5E-46	45.301029995664	(X - 12822)	0.299	[0.26-0.34] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	6p22.2	6	25768764	SLC17A1, SLC17A3, SLC17A4	SLC17A4			ENSG00000146039	NA	NA	rs1892249-G	rs1892249	0	1892249	intron_variant	0	0.45	1E-22	22	(X - 12839)	0.392	[0.31-0.47] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	2q34	2	210195326	ACADL	ACADL, AC006994.1			ENSG00000115361, ENSG00000279317	NA	NA	rs2286963-G	rs2286963	0	2286963	missense_variant	0	0.36	4E-75	74.397940008672	(X - 13431)	0.637	[0.57-0.71] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	4q13.2	4	68666410	UGT2B15	UGT2B15			ENSG00000277132	NA	NA	rs1531022-A	rs1531022	0	1531022	intron_variant	0	0.46	1E-13	13	(X - 13688)	0.187	[0.14-0.24] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	2p13.1	2	73631838	NAT8	ALMS1 - NAT8	ENSG00000116127	ENSG00000144035		6672	8885	rs10201159-C	rs10201159	0	10201159	intergenic_variant	1	0.21	4E-280	279.397940008672	(X - 13698)	0.81	[0.76-0.86] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	4p15.2	4	22821957	GBA3	GBA3 - AC097512.1	ENSG00000249948	ENSG00000248837		2382	167190	rs358228-C	rs358228	0	358228	intergenic_variant	1	0.16	1E-30	30	(X - 13847)	0.861	[0.71-1.01] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	6p22.2	6	25821388	SLC17A1, SLC17A3, SLC17A4	SLC17A1			ENSG00000124568	NA	NA	rs1165151-T	rs1165151	0	1165151	intron_variant	0	0.49	2E-14	13.698970004336	(X - 13866)	0.594	[0.44-0.75] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	12p12.1	12	21207827	SLCO1B1	SLCO1B1			ENSG00000134538	NA	NA	rs77289848-A	rs77289848	0	77289848	intron_variant	0	0.13	2E-11	10.698970004336	(X - 14662)	0.579	[0.41-0.75] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	16p12.3	16	20466152	ACSM2A	ACSM2A			ENSG00000183747	NA	NA	rs6497490-G	rs6497490	0	6497490	intron_variant	0	0.13	1E-30	30	(indoleacetylglutamine)	0.64	[0.53-0.75] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	6p22.2	6	25851301	SLC17A1, SLC17A3, SLC17A4	SLC17A3			ENSG00000124564	NA	NA	rs1747551-G	rs1747551	0	1747551	intron_variant	0	0.25	7E-24	23.1549019599857	(indolelactate)	0.361	[0.29-0.43] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	15q21.1	15	45223854	SLC28A2	H3P39 - AC051619.4	ENSG00000259338	ENSG00000259520		7911	12076	rs11854689-A	rs11854689	0	11854689	intergenic_variant	1	0.32	1E-26	26	(inosine)	0.402	[0.33-0.48] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	6q25.3	6	160143444	SLC22A1	SLC22A1			ENSG00000175003	NA	NA	rs662138-G	rs662138	0	662138	intron_variant	0	0.16	3E-13	12.5228787452803	(isobutyrylcarnitine (C4))	0.328	[0.24-0.42] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	2q34	2	210675783	CPS1	CPS1			ENSG00000021826	NA	NA	rs1047891-A	rs1047891	0	1047891	missense_variant	0	0.33	7E-18	17.1549019599857	(isobutyrylglycine)	0.273	[0.21-0.34] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	1p31.1	1	75677758	ACADM	AL137803.1			ENSG00000230863	NA	NA	rs7513363-G	rs7513363	0	7513363	intron_variant	0	0.32	3E-24	23.5228787452803	(isocaproylglutamine)	0.327	[0.26-0.39] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	6p22.2	6	25762418	SLC17A1, SLC17A3, SLC17A4	SLC17A4			ENSG00000146039	NA	NA	rs3799340-T	rs3799340	0	3799340	intron_variant	0	0.45	8E-32	31.0969100130081	(isocaproylglutamine)	0.353	[0.29-0.41] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	1p31.1	1	75677758	ACADM	AL137803.1			ENSG00000230863	NA	NA	rs7513363-G	rs7513363	0	7513363	intron_variant	0	0.32	6E-25	24.2218487496164	(isocaproylglycine)	0.335	[0.27-0.4] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	2q34	2	210675783	CPS1	CPS1			ENSG00000021826	NA	NA	rs1047891-A	rs1047891	0	1047891	missense_variant	0	0.33	1E-25	25	(isocaproylglycine)	0.351	[0.28-0.42] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	2q34	2	210675783	CPS1	CPS1			ENSG00000021826	NA	NA	rs1047891-A	rs1047891	0	1047891	missense_variant	0	0.33	4E-12	11.397940008672	(isovalerylglycine)	0.216	[0.16-0.28] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	6p25.2	6	2996087	NQO2	NQO2-AS1, NQO2			ENSG00000224846, ENSG00000124588	NA	NA	rs6913474-C	rs6913474	0	6913474	intron_variant	0	0.42	3E-88	87.5228787452803	(isoxanthopterin)	0.825	[0.74-0.91] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	1q43	1	241550102	KMO	KMO			ENSG00000117009	NA	NA	rs61825638-T	rs61825638	0	61825638	intron_variant	0	0.23	7E-18	17.1549019599857	(kynurenate)	0.17	[0.13-0.21] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	5p15.33	5	1188170	SLC6A19	AC114291.1 - SLC6A19	ENSG00000249201	ENSG00000174358		9565	13425	rs11133665-A	rs11133665	0	11133665	intergenic_variant	1	0.27	9E-16	15.0457574905607	(kynurenine)	0.365	[0.28-0.45] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	2q21.3	2	135623778	LCT	R3HDM1			ENSG00000048991	NA	NA	rs12465802-A	rs12465802	0	12465802	intron_variant	0	0.46	9E-18	17.0457574905607	(lactose)	0.274	[0.21-0.34] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	19q13.11	19	32692906	SLC7A9	NUDT19			ENSG00000213965	NA	NA	rs4805801-T	rs4805801	0	4805801	intron_variant	0	0.17	4E-21	20.397940008672	(lysine)	0.377	[0.3-0.46] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	1p33	1	48409997	SLC5A9	SPATA6			ENSG00000132122	NA	NA	rs140254647-C	rs140254647	0	140254647	intron_variant	0	0.22	4E-24	23.397940008672	(mannose)	0.803	[0.65-0.96] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	2q32.2	2	190323393	HIBCH	HIBCH			ENSG00000198130	NA	NA	rs291468-A	rs291468	0	291468	intron_variant	0	0.4	2E-14	13.698970004336	(methylmalonate (MMA))	0.38	[0.28-0.48] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	12q24.31	12	120739469	ACADS	ACADS			ENSG00000122971	NA	NA	rs3916-C	rs3916	0	3916	3_prime_UTR_variant	0	0.26	3E-11	10.5228787452803	(methylsuccinate)	0.161	[0.11-0.21] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	1p32.3	1	53191923	LRP8	AL606760.4 - CPT2	ENSG00000277397	ENSG00000157184		5023	4869	rs12410239-A	rs12410239	0	12410239	intergenic_variant	1	0.38	4E-18	17.397940008672	(methylsuccinoylcarnitine)	0.235	[0.18-0.29] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	16p12.1	16	24914993	SLC5A11	SLC5A11 - ARHGAP17	ENSG00000158865	ENSG00000140750		3365	4396	rs72770483-G	rs72770483	0	72770483	intergenic_variant	1	0.08	7E-30	29.1549019599857	(myo-inositol)	1.153	[0.95-1.35] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	10q26.3	10	133383915	PAOX	AL360181.3, PAOX			ENSG00000254536, ENSG00000148832	NA	NA	rs4240520-G	rs4240520	0	4240520	intron_variant	0	0.14	7E-12	11.1549019599857	(N1,N12-diacetylspermine)	0.469	[0.34-0.6] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	2p13.1	2	73641201	NAT8	ALMS1P1, NAT8			ENSG00000163016, ENSG00000144035	NA	NA	rs13538-G	rs13538	0	13538	missense_variant	0	0.21	1E-149	149	(N2,N6-diacetyllysine)	0.735	[0.68-0.79] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	2p13.1	2	73650092	NAT8	ALMS1P1			ENSG00000163016	NA	NA	rs10168931-A	rs10168931	0	10168931	intron_variant	0	0.21	8E-357	356.096910013008	(N2-acetyllysine)	0.888	[0.84-0.93] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	2p13.1	2	73644562	NAT8	ALMS1P1			ENSG00000163016	NA	NA	rs13410232-T	rs13410232	0	13410232	intron_variant	0	0.21	5E-19	18.301029995664	(N6-carboxyethyllysine)	0.185	[0.14-0.23] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	2p13.1	2	73622734	NAT8	ALMS1			ENSG00000116127	NA	NA	rs6546861-T	rs6546861	0	6546861	intron_variant	0	0.21	1E-111	111	(N-acetyl-1-methylhistidine)	0.731	[0.67-0.8] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	2p13.1	2	73627267	NAT8	ALMS1 - NAT8	ENSG00000116127	ENSG00000144035		2101	13456	rs111540621-G	rs111540621	0	111540621	regulatory_region_variant	1	0.21	3E-43	42.5228787452803	(N-acetyl-3-methylhistidine)	0.873	[0.75-1] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	2p13.1	2	73622734	NAT8	ALMS1			ENSG00000116127	NA	NA	rs6546861-T	rs6546861	0	6546861	intron_variant	0	0.21	6E-163	162.221848749616	(N-acetylarginine)	0.537	[0.5-0.58] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	2p13.1	2	73640735	NAT8	NAT8			ENSG00000144035	NA	NA	rs4547554-C	rs4547554	0	4547554	3_prime_UTR_variant	0	0.21	7E-159	158.154901959986	(N-acetylasparagine)	0.784	[0.73-0.84] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	11p11.12	11	49156256	FOLH1	FOLH1			ENSG00000086205	NA	NA	rs55728336-C	rs55728336	0	55728336	intron_variant	0	0.05	3E-96	95.5228787452803	(N-acetyl-aspartyl-glutamate (NAAG))	0.676	[0.61-0.74] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	11q11	11	55064850	TRIM48	OR4A6P - TRIM48	ENSG00000255078	ENSG00000150244		339034	197305	rs61898064-T	rs61898064	0	61898064	intergenic_variant	1	0.05	1E-73	73	(N-acetyl-aspartyl-glutamate (NAAG))	0.625	[0.56-0.69] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	2p13.1	2	73622734	NAT8	ALMS1			ENSG00000116127	NA	NA	rs6546861-T	rs6546861	0	6546861	intron_variant	0	0.21	3E-249	248.52287874528	(N-acetylcitrulline)	0.918	[0.87-0.97] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	5p13.2	5	35979443	UGT3A1	UGT3A1			ENSG00000145626	NA	NA	rs113590482-T	rs113590482	0	113590482	intron_variant	0	0.14	5E-37	36.301029995664	(N-acetylglucosamine conjugate of C24H40O4 bile acid)	1.079	[0.91-1.25] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	4q28.2	4	129118729	C4orf33	C4orf33 - AC093826.1	ENSG00000151470	ENSG00000251345		2089	14377	rs530686-A	rs530686	0	530686	intergenic_variant	1	0.39	6E-18	17.2218487496164	(N-acetylglucosamine/N-acetylgalactosamine)	0.095	[0.073-0.117] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	6q27	6	167295745	UNC93A	UNC93A			ENSG00000112494	NA	NA	rs66559683-G	rs66559683	0	66559683	intron_variant	0	0.12	7E-33	32.1549019599857	(N-acetylglucosamine/N-acetylgalactosamine)	0.197	[0.16-0.23] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	6q27	6	167295745	UNC93A	UNC93A			ENSG00000112494	NA	NA	rs66559683-G	rs66559683	0	66559683	intron_variant	0	0.12	2E-46	45.698970004336	(N-acetylglucosaminylasparagine)	0.271	[0.23-0.31] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	2p13.1	2	73640735	NAT8	NAT8			ENSG00000144035	NA	NA	rs4547554-C	rs4547554	0	4547554	3_prime_UTR_variant	0	0.21	4E-113	112.397940008672	(N-acetylglutamine)	0.8	[0.73-0.87] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	2p13.1	2	73485902	NAT8	ALMS1			ENSG00000116127	NA	NA	rs10195357-G	rs10195357	0	10195357	intron_variant	0	0.22	9E-30	29.0457574905607	(N-acetylhistidine)	0.218	[0.18-0.26] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	2p13.1	2	73503047	NAT8	ALMS1			ENSG00000116127	NA	NA	rs7607014-G	rs7607014	0	7607014	intron_variant	0	0.22	4E-24	23.397940008672	(N-acetylkynurenine (2))	0.737	[0.59-0.88] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	2p13.1	2	73640735	NAT8	NAT8			ENSG00000144035	NA	NA	rs4547554-C	rs4547554	0	4547554	3_prime_UTR_variant	0	0.21	3E-35	34.5228787452803	(N-acetylleucine)	0.437	[0.37-0.51] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	1q24.3	1	171379727	FMO4	SRP14P4 - GM2AP2	ENSG00000268062	ENSG00000239428		34420	12502	rs7547112-A	rs7547112	0	7547112	intergenic_variant	1	0.47	2E-16	15.698970004336	(N-acetylmethionine sulfoxide)	0.233	[0.18-0.29] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	2p13.1	2	73640735	NAT8	NAT8			ENSG00000144035	NA	NA	rs4547554-C	rs4547554	0	4547554	3_prime_UTR_variant	0	0.21	2E-84	83.698970004336	(N-acetylmethionine sulfoxide)	0.614	[0.55-0.68] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	2p13.1	2	73485902	NAT8	ALMS1			ENSG00000116127	NA	NA	rs10195357-G	rs10195357	0	10195357	intron_variant	0	0.22	1E-47	47	(N-acetylphenylalanine)	0.499	[0.43-0.57] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	11q13.2	11	67643949	ACY3	ACY3			ENSG00000132744	NA	NA	rs2514032-T	rs2514032	0	2514032	intron_variant	0	0.17	1E-11	11	(N-acetylphenylalanine)	0.266	[0.19-0.34] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	8p22	8	18415025	NAT2	NAT2 - PSD3	ENSG00000156006	ENSG00000156011		13807	112278	rs35246381-C	rs35246381	0	35246381	regulatory_region_variant	1	0.22	3E-35	34.5228787452803	(N-acetylputrescine)	0.229	[0.19-0.27] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	2p13.1	2	73641201	NAT8	ALMS1P1, NAT8			ENSG00000163016, ENSG00000144035	NA	NA	rs13538-G	rs13538	0	13538	missense_variant	0	0.21	3E-84	83.5228787452803	(N-acetylpyrraline)	0.747	[0.67-0.82] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	2p13.1	2	73650092	NAT8	ALMS1P1			ENSG00000163016	NA	NA	rs10168931-A	rs10168931	0	10168931	intron_variant	0	0.21	9E-66	65.0457574905607	(N-acetyltyrosine)	0.654	[0.58-0.73] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	11q13.2	11	67643949	ACY3	ACY3			ENSG00000132744	NA	NA	rs2514032-T	rs2514032	0	2514032	intron_variant	0	0.17	8E-13	12.0969100130081	(N-acetyltyrosine)	0.311	[0.23-0.4] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	2p13.1	2	73627267	NAT8	ALMS1 - NAT8	ENSG00000116127	ENSG00000144035		2101	13456	rs111540621-G	rs111540621	0	111540621	regulatory_region_variant	1	0.21	2E-46	45.698970004336	(N-alpha-acetylornithine)	0.35	[0.3-0.4] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	2p13.1	2	73648914	NAT8	ALMS1P1			ENSG00000163016	NA	NA	rs13431529-C	rs13431529	0	13431529	intron_variant	0	0.21	2E-109	108.698970004336	(N-delta-acetylornithine)	1.057	[0.96-1.15] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	17q25.3	17	78202506	AFMID	AFMID			ENSG00000183077	NA	NA	rs72897838-G	rs72897838	0	72897838	synonymous_variant	0	0.1	1E-27	27	(N-formylanthranilic acid)	0.505	[0.41-0.6] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	8p22	8	18415025	NAT2	NAT2 - PSD3	ENSG00000156006	ENSG00000156011		13807	112278	rs35246381-C	rs35246381	0	35246381	regulatory_region_variant	1	0.23	1E-72	72	(5-acetylamino-6-formylamino-3-methyluracil)	1.141	[1.02-1.26] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	5p13.2	5	35037010	AGXT2	AGXT2			ENSG00000113492	NA	NA	rs37369-T	rs37369	0	37369	missense_variant	0	0.08	1E-14	14	(5-aminovalerate)	0.632	[0.47-0.79] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	19q13.11	19	32865985	SLC7A9	SLC7A9			ENSG00000021488	NA	NA	rs12460876-C	rs12460876	0	12460876	intron_variant	0	0.38	2E-23	22.698970004336	(5-hydroxylysine)	0.65	[0.52-0.78] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	15q21.1	15	45184814	SLC28A2	SHF, AC051619.3			ENSG00000138606, ENSG00000259519	NA	NA	rs1706821-A	rs1706821	0	1706821	intron_variant	0	0.35	8E-25	24.0969100130081	(adenosine)	0.289	[0.23-0.34] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	6p22.2	6	25851141	SLC17A1, SLC17A3, SLC17A4	SLC17A3			ENSG00000124564	NA	NA	rs1165187-C	rs1165187	0	1165187	intron_variant	0	0.25	1E-39	39	(adenosine 3',5'-cyclic monophosphate (cAMP))	0.219	[0.19-0.25] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	19p13.12	19	15868125	CYP4F2	CLEC4O - CYP4F36P	ENSG00000267453	ENSG00000273330		3221	3542	rs12611275-A	rs12611275	0	12611275	intergenic_variant	1	0.27	2E-18	17.698970004336	(alpha-CEHC glucuronide)	0.397	[0.31-0.49] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	19p13.12	19	15871011	CYP4F2	CLEC4O - CYP4F36P	ENSG00000267453	ENSG00000273330		6107	656	rs55744319-A	rs55744319	0	55744319	intergenic_variant	1	0.27	2E-15	14.698970004336	(alpha-CEHC sulfate)	0.422	[0.32-0.53] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	22q13.2	22	42128945	CYP2D6	CYP2D6, CYP2D6, NDUFA6-DT, NDUFA6-DT, NDUFA6-DT			ENSG00000275211, ENSG00000100197, ENSG00000237037, ENSG00000280811, ENSG00000273616	NA	NA	rs3892097-T	rs3892097	0	3892097	splice_acceptor_variant	0	0.18	6E-16	15.2218487496164	(alpha-hydroxymetoprolol)	1.698	[1.29-2.11] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	7q22.1	7	99533211	ZKSCAN5	ZKSCAN5			ENSG00000196652	NA	NA	rs34670419-T	rs34670419	0	34670419	3_prime_UTR_variant	0	0.03	2E-12	11.698970004336	(andro steroid monosulfate C19H28O6S (1))	1.162	[0.84-1.49] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	19q13.33	19	47962055	CABP5	SULT2A1 - BSPH1	ENSG00000105398	ENSG00000188334		75740	5991	rs2972516-T	rs2972516	0	2972516	regulatory_region_variant	1	0.17	4E-20	19.397940008672	(androstenediol (3beta,17beta))	0.8	[0.63-0.97] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	11q14.3	11	90107954	NAALAD2	AP000648.2 - AP000648.9	ENSG00000254436	ENSG00000286665		9137	2684	rs7108196-A	rs7108196	0	7108196	intergenic_variant	1	0.15	3E-25	24.5228787452803	(beta-citrylglutamate)	0.272	[0.22-0.32] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	1p36.21	1	15587837	CASP9	DNAJC16, AL121992.1			ENSG00000116138, ENSG00000237301	NA	NA	rs6666886-G	rs6666886	0	6666886	non_coding_transcript_exon_variant	0	0.36	6E-31	30.2218487496164	(beta-guanidinopropanoate)	1.013	[0.84-1.19] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	1q24.3	1	171358944	FMO4	SRP14P4 - GM2AP2	ENSG00000268062	ENSG00000239428		13637	33285	rs6425194-C	rs6425194	0	6425194	intergenic_variant	1	0.33	2E-15	14.698970004336	(cysteinylglycine)	0.3	[0.23-0.37] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	16q24.3	16	89632344	DPEP1	DPEP1			ENSG00000015413	NA	NA	rs420332-T	rs420332	0	420332	intron_variant	0	0.46	9E-25	24.0457574905607	(cysteinylglycine disulfide)	0.194	[0.16-0.23] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	1p36.12	1	20589745	CDA	CDA			ENSG00000158825	NA	NA	rs66731853-A	rs66731853	0	66731853	intron_variant	0	0.33	2E-17	16.698970004336	(cytidine)	0.296	[0.23-0.36] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	10q26.3	10	133379745	PAOX	PAOX			ENSG00000148832	NA	NA	rs4617507-G	rs4617507	0	4617507	non_coding_transcript_exon_variant	0	0.23	1E-14	14	(diacetylspermidine)	0.257	[0.19-0.32] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	22q13.33	22	50246903	HDAC10	HDAC10, MAPK12			ENSG00000100429, ENSG00000188130	NA	NA	rs61748567-A	rs61748567	0	61748567	missense_variant	0	0.02	1E-24	24	(diacetylspermidine)	0.894	[0.72-1.06] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	10q23.33	10	95227255	ACSM6	ACSM6			ENSG00000173124	NA	NA	rs685607-A	rs685607	0	685607	intron_variant	0	0.45	1E-12	12	(dimethylmalonic acid)	0.139	[0.1-0.178] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	11q13.2	11	67634642	TBX10	TBX10			ENSG00000167800	NA	NA	rs2514022-C	rs2514022	0	2514022	intron_variant	0	0.4	2E-13	12.698970004336	(dimethylmalonic acid)	0.141	[0.1-0.18] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	7q22.1	7	99735325	CYP3A7	CYP3A7 - CYP3A4	ENSG00000160870	ENSG00000160868		129	21635	rs45446698-G	rs45446698	0	45446698	intergenic_variant	1	0.03	4E-12	11.397940008672	(epiandrosterone sulfate)	1.589	[1.14-2.04] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	12q24.31	12	120738280	ACADS	ACADS			ENSG00000122971	NA	NA	rs1799958-A	rs1799958	0	1799958	missense_variant	0	0.27	8E-169	168.096910013008	(ethylmalonate)	0.514	[0.48-0.55] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	6p22.2	6	25807375	SLC17A1, SLC17A3, SLC17A4	SLC17A1			ENSG00000124568	NA	NA	rs2817188-A	rs2817188	0	2817188	intron_variant	0	0.47	1E-32	32	(ferulic acid 4-sulfate)	0.534	[0.45-0.62] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	16p11.2	16	28569012	CCDC101	SGF29			ENSG00000176476	NA	NA	rs151232-T	rs151232	0	151232	intron_variant	0	0.45	3E-31	30.5228787452803	(furaneol sulfate)	0.364	[0.3-0.42] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	19p13.12	19	15868125	CYP4F2	CLEC4O - CYP4F36P	ENSG00000267453	ENSG00000273330		3221	3542	rs12611275-A	rs12611275	0	12611275	intergenic_variant	1	0.27	3E-12	11.5228787452803	(gamma-CEHC glucuronide)	0.244	[0.18-0.31] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	6p22.2	6	25828014	SLC17A1, SLC17A3, SLC17A4	SLC17A1			ENSG00000124568	NA	NA	rs765285-G	rs765285	0	765285	intron_variant	0	0.49	4E-14	13.397940008672	(gamma-CEHC sulfate)	0.498	[0.37-0.63] unit decrease	Illumina [7750367] (imputed)	N
2020-03-05	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	1,221 cases	406 cases	6p22.2	6	25818527	SLC17A1, SLC17A3, SLC17A4	SLC17A1			ENSG00000124568	NA	NA	rs9461218-A	rs9461218	0	9461218	intron_variant	0	0.23	9E-18	17.0457574905607	(3-(4-hydroxyphenyl)lactate, 4-hydroxyphenylpyruvate, indolelactate, phenyllactate(PLA), X-16071)	0.009	[0.007-0.011] unit decrease	Illumina [7750367] (imputed)	N
2020-03-05	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	1,221 cases	406 cases	6p22.2	6	25841804	SLC17A1, SLC17A3, SLC17A4	SLC17A3			ENSG00000124564	NA	NA	rs1165150-C	rs1165150	0	1165150	3_prime_UTR_variant	0	0.49	2E-11	10.698970004336	(3-hydroxysebacate, X-13874, X-18888, X-18938, X-21827)	0.006	[0.004-0.008] unit decrease	Illumina [7750367] (imputed)	N
2020-03-05	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	1,221 cases	406 cases	6p22.2	6	25870517	SLC17A1, SLC17A3, SLC17A4	SLC17A3			ENSG00000124564	NA	NA	rs556339-T	rs556339	0	556339	intron_variant	0	0.25	2E-18	17.698970004336	(adenosine 3, 5-cyclic monophosphate, biopterin)	0.008	[0.006-0.01] unit decrease	Illumina [7750367] (imputed)	N
2020-03-05	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	1,221 cases	406 cases	6p22.2	6	26328125	BTN3A1	AL021917.1			ENSG00000287050	NA	NA	rs34107459-C	rs34107459	0	34107459	intron_variant	0	0.09	9E-11	10.0457574905607	(3-(4-hydroxyphenyl)lactate, 4-hydroxyphenylpyruvate, indolelactate, phenyllactate (PLA), X-16071)	0.01	[0.0061-0.0139] unit decrease	Illumina [7750367] (imputed)	N
2020-03-05	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	1,221 cases	406 cases	7q22.1	7	99672916	CYP3A5	CYP3A5			ENSG00000106258	NA	NA	rs776746-T	rs776746	0	776746	splice_acceptor_variant	0	0.07	3E-18	17.5228787452803	(X-24327, X-24353)	0.015	[0.011-0.019] unit decrease	Illumina [7750367] (imputed)	N
2020-03-05	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	1,221 cases	406 cases	7q22.1	7	99735325	CYP3A7	CYP3A7 - CYP3A4	ENSG00000160870	ENSG00000160868		129	21635	rs45446698-G	rs45446698	0	45446698	intergenic_variant	1	0.03	1E-10	10	(glyco-beta-muricholatemtauro-beta-muricholate, X-23157)	0.017	[0.011-0.023] unit increase	Illumina [7750367] (imputed)	N
2020-03-05	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	1,221 cases	406 cases	8p22	8	18415025	NAT2	NAT2 - PSD3	ENSG00000156006	ENSG00000156011		13807	112278	rs35246381-C	rs35246381	0	35246381	regulatory_region_variant	1	0.22	2E-25	24.698970004336	(4-acetamidobutanoate, allo-threonine, N-acetylputrescine)	0.01	[0.008-0.012] unit increase	Illumina [7750367] (imputed)	N
2020-03-05	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	1,221 cases	406 cases	9p24.1	9	6667928	GLDC3	AL162411.1			ENSG00000236924	NA	NA	rs820503-A	rs820503	0	820503	intron_variant	0	0.14	6E-24	23.2218487496164	(3-hydroxy-3-methylglutarate, 3-methylglutaconate, 3-methylglutarate, 2-methylglutarate, 3-methylglutarylcarnitine)	0.012	[0.01-0.014] unit decrease	Illumina [7750367] (imputed)	N
2020-03-05	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	1,221 cases	406 cases	9q34.11	9	129128873	PPP2R4	PTPA			ENSG00000119383	NA	NA	rs7023900-C	rs7023900	0	7023900	intron_variant	0	0.28	2E-14	13.698970004336	(2-methylmalonylcarnitine(C4-DC), succinylcarnitine(C4-DC), X-24699)	0.007	[0.005-0.009] unit decrease	Illumina [7750367] (imputed)	N
2020-03-05	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	1,221 cases	406 cases	10q24.2	10	98388419	PYROXD2	PYROXD2			ENSG00000119943	NA	NA	rs2147896-G	rs2147896	0	2147896	missense_variant	0	0.36	3E-917	916.52287874528	(X-12093, X-12112, X-23776, X-24809, X-24983)	0.03	[0.028-0.032] unit decrease	Illumina [7750367] (imputed)	N
2020-03-05	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	1,221 cases	406 cases	10q26.3	10	133383915	PAOX	AL360181.3, PAOX			ENSG00000254536, ENSG00000148832	NA	NA	rs4240520-G	rs4240520	0	4240520	intron_variant	0	0.14	9E-17	16.0457574905607	(acisoga, diacetylspermidine, N1, N12-diacetylspermine, X-23656, X-23668)	0.01	[0.008-0.012] unit increase	Illumina [7750367] (imputed)	N
2020-03-05	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	1,221 cases	406 cases	11q13.2	11	67643949	ACY3	ACY3			ENSG00000132744	NA	NA	rs2514032-T	rs2514032	0	2514032	intron_variant	0	0.17	9E-12	11.0457574905607	(N-acetylkynurenine, N-acetylphenylalanine, N-acetyltryptophan, N-acetyltyrosine)	0.007	[0.005-0.009] unit decrease	Illumina [7750367] (imputed)	N
2020-03-05	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	1,221 cases	406 cases	11q14.3	11	90107954	NAALAD2	AP000648.2 - AP000648.9	ENSG00000254436	ENSG00000286665		9137	2684	rs7108196-A	rs7108196	0	7108196	intergenic_variant	1	0.15	2E-14	13.698970004336	(beta-citrylglutamate, saccharopine)	0.009	[0.007-0.011] unit decrease	Illumina [7750367] (imputed)	N
2020-03-05	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	1,221 cases	406 cases	12p12.1	12	21204819	SLCO1B1	SLCO1B1			ENSG00000134538	NA	NA	rs55695203-C	rs55695203	0	55695203	intron_variant	0	0.18	3E-16	15.5228787452803	(glycochenodeoxycholate sulfate, glycocholenate sulfate, X-14658, X-21448, X-21467)	0.009	[0.007-0.011] unit increase	Illumina [7750367] (imputed)	N
2020-03-05	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	1,221 cases	406 cases	12p12.1	12	21204819	SLCO1B1	SLCO1B1			ENSG00000134538	NA	NA	rs55695203-C	rs55695203	0	55695203	intron_variant	0	0.18	4E-22	21.397940008672	(glycochenodeoxycholate glucuronide, glycodeoxycholate sulfate, glycolithocholate sulfate, taurolithocholate 3-sulfate, X-14626, X-16654, X-22520, X-22834)	0.01	[0.008-0.012] unit increase	Illumina [7750367] (imputed)	N
2020-03-05	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	1,221 cases	406 cases	12p12.1	12	21204819	SLCO1B1	SLCO1B1			ENSG00000134538	NA	NA	rs55695203-C	rs55695203	0	55695203	intron_variant	0	0.18	1E-17	17	(taurocholenate sulfate, X-24669)	0.009	[0.007-0.011] unit increase	Illumina [7750367] (imputed)	N
2020-03-05	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	1,221 cases	406 cases	12q24.31	12	120738280	ACADS	ACADS			ENSG00000122971	NA	NA	rs1799958-A	rs1799958	0	1799958	missense_variant	0	0.27	7E-25	24.1549019599857	(5-hydroxyhexanoate, ethylmalonate, N-formylmethionine, triacetate lactone)	0.009	[0.007-0.011] unit increase	Illumina [7750367] (imputed)	N
2020-03-05	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	1,221 cases	406 cases	19p13.12	19	15871011	CYP4F2	CLEC4O - CYP4F36P	ENSG00000267453	ENSG00000273330		6107	656	rs55744319-A	rs55744319	0	55744319	intergenic_variant	1	0.27	6E-20	19.2218487496164	(alpha-CEHC glucuronide, alpha-CEHC glycine, alpha-CEHC sulfate, alpha-CEHC taurine, X-13689, X-24359)	0.009	[0.007-0.011] unit decrease	Illumina [7750367] (imputed)	N
2020-03-05	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	1,221 cases	406 cases	19q13.11	19	32865985	SLC7A9	SLC7A9			ENSG00000021488	NA	NA	rs12460876-C	rs12460876	0	12460876	intron_variant	0	0.38	2E-17	16.698970004336	(homoarginine, lysine, X-24736)	0.007	[0.005-0.009] unit increase	Illumina [7750367] (imputed)	N
2020-03-05	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	1,221 cases	406 cases	22q11.21	22	19963748	COMT	COMT			ENSG00000093010	NA	NA	rs4680-G	rs4680	0	4680	missense_variant	0	0.5	5E-54	53.301029995664	(X-12708, X-21785)	0.012	[0.01-0.014] unit increase	Illumina [7750367] (imputed)	N
2020-03-05	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	1,221 cases	406 cases	22q11.23	22	24615934	GGT1	GGT1, GGT1			ENSG00000286070, ENSG00000100031	NA	NA	rs4822523-T	rs4822523	0	4822523	non_coding_transcript_exon_variant	0	0.34	2E-11	10.698970004336	(gamma-glutamyl-epsilon-lysine, gamma-glutamylglycine, gamma-glutamylhistidine, gamma-glutamylleucine, gamma-glutamylphenylalanine, gamma-glutamylthreonine, tryptamine, tyramine, X-23593)	0.006	[0.004-0.008] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	4q13.2	4	68492323	TMPRSS11E	TMPRSS11E, TMPRSS11E			ENSG00000274058, ENSG00000087128	NA	NA	rs4694429-A	rs4694429	0	4694429	intron_variant	0	0.34	6E-24	23.2218487496164	(11-ketoetiocholanolone sulfate)	0.617	[0.5-0.74] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	19q13.33	19	47871693	SULT2A1	SULT2A1			ENSG00000105398	NA	NA	rs62129966-A	rs62129966	0	62129966	intron_variant	0	0.16	2E-11	10.698970004336	(11-ketoetiocholanolone sulfate)	0.522	[0.37-0.67] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	7q22.1	7	99533211	ZKSCAN5	ZKSCAN5			ENSG00000196652	NA	NA	rs34670419-T	rs34670419	0	34670419	3_prime_UTR_variant	0	0.03	6E-12	11.2218487496164	(16a-hydroxy DHEA 3-sulfate)	1.515	[1.08-1.95] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	11q12.3	11	63084951	SLC22A10	SLC22A24			ENSG00000197658	NA	NA	rs118186763-A	rs118186763	0	118186763	intron_variant	0	0.06	4E-53	52.397940008672	(17alpha-hydroxypregnanolone glucuronide)	1.987	[1.73-2.24] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	7q36.1	7	150845427	AOC1	AOC1			ENSG00000002726	NA	NA	rs6977081-T	rs6977081	0	6977081	intron_variant	0	0.35	1E-32	32	(1-methylhistamine)	0.381	[0.32-0.44] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	8p22	8	18414928	NAT2	NAT2 - PSD3	ENSG00000156006	ENSG00000156011		13710	112375	rs4921914-C	rs4921914	0	4921914	intergenic_variant	1	0.22	1E-11	11	(1-methylurate)	0.405	[0.29-0.52] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	8p22	8	18415371	NAT2	NAT2 - PSD3	ENSG00000156006	ENSG00000156011		14153	111932	rs1495741-G	rs1495741	0	1495741	regulatory_region_variant	1	0.22	6E-21	20.2218487496164	(1-methylxanthine)	0.589	[0.47-0.71] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	4p15.32	4	15645451	BST1	FBXL5			ENSG00000118564	NA	NA	rs7683000-G	rs7683000	0	7683000	intron_variant	0	0.17	8E-26	25.0969100130081	(2'-deoxyguanosine)	0.479	[0.39-0.57] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	2q34	2	210675783	CPS1	CPS1			ENSG00000021826	NA	NA	rs1047891-A	rs1047891	0	1047891	missense_variant	0	0.33	3E-22	21.5228787452803	(2-methylbutyrylglycine)	0.224	[0.18-0.27] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	9q34.11	9	129112362	PPP2R4	PTPA			ENSG00000119383	NA	NA	rs7849270-A	rs7849270	0	7849270	intron_variant	0	0.28	6E-30	29.2218487496164	(2-methylmalonylcarnitine (C4-DC))	0.158	[0.13-0.19] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	9q34.11	9	128922736	PHYHD1	PHYHD1			ENSG00000175287	NA	NA	rs55758160-G	rs55758160	0	55758160	intron_variant	0	0.39	1E-55	55	(2'-O-methylcytidine)	0.302	[0.26-0.34] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	9q34.11	9	128937261	PHYHD1	PHYHD1			ENSG00000175287	NA	NA	rs12555901-T	rs12555901	0	12555901	intron_variant	0	0.39	3E-37	36.5228787452803	(2'-O-methyluridine)	0.626	[0.53-0.72] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	5p13.2	5	35037010	AGXT2	AGXT2			ENSG00000113492	NA	NA	rs37369-T	rs37369	0	37369	missense_variant	0	0.08	6E-119	118.221848749616	(3-aminoisobutyrate)	2.114	[1.94-2.29] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	12p13.33	12	242301	SLC6A13	SLC6A13			ENSG00000010379	NA	NA	rs11613331-G	rs11613331	0	11613331	intron_variant	0	0.46	5E-15	14.301029995664	(3-aminoisobutyrate)	0.446	[0.33-0.56] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	16p11.2	16	28534266	NUPR1	NUPR1			ENSG00000176046	NA	NA	rs231976-G	rs231976	0	231976	3_prime_UTR_variant	0	0.45	2E-19	18.698970004336	(3-hydroxyindolin-2-one sulfate)	0.342	[0.27-0.42] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	5p15.33	5	1188170	SLC6A19	AC114291.1 - SLC6A19	ENSG00000249201	ENSG00000174358		9565	13425	rs11133665-A	rs11133665	0	11133665	intergenic_variant	1	0.27	1E-15	15	(3-hydroxykynurenine)	0.457	[0.35-0.57] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	2q34	2	210675783	CPS1	CPS1			ENSG00000021826	NA	NA	rs1047891-A	rs1047891	0	1047891	missense_variant	0	0.33	4E-14	13.397940008672	(3-methylcrotonylglycine)	0.246	[0.18-0.31] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	4p15.32	4	15698170	BST1	FAM200B			ENSG00000237765	NA	NA	rs73224656-A	rs73224656	0	73224656	intron_variant	0	0.13	4E-43	42.397940008672	(3-methylcytidine)	0.304	[0.26-0.35] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	2q34	2	210675783	CPS1	CPS1			ENSG00000021826	NA	NA	rs1047891-A	rs1047891	0	1047891	missense_variant	0	0.33	3E-25	24.5228787452803	(3-methylglutaconate)	0.226	[0.18-0.27] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	9p24.1	9	6667928	GLDC	AL162411.1			ENSG00000236924	NA	NA	rs820503-A	rs820503	0	820503	intron_variant	0	0.14	3E-22	21.5228787452803	(3-methylglutaconate)	0.292	[0.23-0.35] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	2q34	2	210675783	CPS1	CPS1			ENSG00000021826	NA	NA	rs1047891-A	rs1047891	0	1047891	missense_variant	0	0.33	5E-26	25.301029995664	(3-methylglutarate/2-methylglutarate)	0.335	[0.27-0.4] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	9p24.1	9	6667928	GLDC	AL162411.1			ENSG00000236924	NA	NA	rs820503-A	rs820503	0	820503	intron_variant	0	0.14	2E-19	18.698970004336	(3-methylglutarate/2-methylglutarate)	0.398	[0.31-0.48] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	2q34	2	210675783	CPS1	CPS1			ENSG00000021826	NA	NA	rs1047891-A	rs1047891	0	1047891	missense_variant	0	0.33	2E-21	20.698970004336	(3-methylglutarylcarnitine (2))	0.322	[0.26-0.39] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	9p24.1	9	6667928	GLDC	AL162411.1			ENSG00000236924	NA	NA	rs820503-A	rs820503	0	820503	intron_variant	0	0.14	2E-18	17.698970004336	(3-methylglutarylcarnitine (2))	0.407	[0.31-0.5] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	8p22	8	18414956	NAT2	NAT2 - PSD3	ENSG00000156006	ENSG00000156011		13738	112347	rs4921915-G	rs4921915	0	4921915	intergenic_variant	1	0.22	1E-19	19	(4-acetamidobutanoate)	0.163	[0.13-0.2] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	1p36.21	1	15549419	CASP9	DNAJC16			ENSG00000116138	NA	NA	rs3980014-C	rs3980014	0	3980014	intron_variant	0	0.43	1E-44	44	(4-guanidinobutanoate)	0.43	[0.37-0.49] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	12q24.31	12	121911152	HPD	PSMD9, AC069503.2			ENSG00000110801, ENSG00000256950	NA	NA	rs2688412-A	rs2688412	0	2688412	intron_variant	0	0.13	3E-11	10.5228787452803	(4-hydroxyphenylpyruvate)	0.533	[0.38-0.69] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	10p14	10	12091253	DHTKD1	DHTKD1			ENSG00000181192	NA	NA	rs7094385-G	rs7094385	0	7094385	intron_variant	0	0.22	4E-21	20.397940008672	(4-ureidobutyrate)	0.268	[0.21-0.32] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	8p22	8	18415025	NAT2	NAT2 - PSD3	ENSG00000156006	ENSG00000156011		13807	112278	rs35246381-C	rs35246381	0	35246381	regulatory_region_variant	1	0.22	6E-24	23.2218487496164	(5-acetylamino-6-amino-3-methyluracil)	0.534	[0.43-0.64] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	22q11.23	22	24615934	GGT1	GGT1, GGT1			ENSG00000286070, ENSG00000100031	NA	NA	rs4822523-T	rs4822523	0	4822523	non_coding_transcript_exon_variant	0	0.34	3E-16	15.5228787452803	(gamma-glutamyl-epsilon-lysine)	0.564	[0.43-0.7] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	22q11.23	22	24616973	GGT1	GGT1, GGT1			ENSG00000286070, ENSG00000100031	NA	NA	rs9612676-A	rs9612676	0	9612676	intron_variant	0	0.34	2E-12	11.698970004336	(gamma-glutamylglycine)	0.424	[0.31-0.54] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	22q11.23	22	24615934	GGT1	GGT1, GGT1			ENSG00000286070, ENSG00000100031	NA	NA	rs4822523-T	rs4822523	0	4822523	non_coding_transcript_exon_variant	0	0.34	5E-12	11.301029995664	(gamma-glutamylhistidine)	0.484	[0.35-0.62] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	22q11.23	22	24617379	GGT1	GGT1, GGT1			ENSG00000286070, ENSG00000100031	NA	NA	rs5751909-A	rs5751909	0	5751909	intron_variant	0	0.34	3E-15	14.5228787452803	(gamma-glutamylleucine)	0.527	[0.4-0.66] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	22q11.23	22	24615934	GGT1	GGT1, GGT1			ENSG00000286070, ENSG00000100031	NA	NA	rs4822523-T	rs4822523	0	4822523	non_coding_transcript_exon_variant	0	0.34	3E-14	13.5228787452803	(gamma-glutamylphenylalanine)	0.575	[0.43-0.72] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	4q23	4	99280138	ADH1A	AP002026.1, ADH1A			ENSG00000246090, ENSG00000187758	NA	NA	rs28364331-G	rs28364331	0	28364331	splice_region_variant	0	0.02	1E-21	21	(gluconate)	0.811	[0.64-0.98] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	1p33	1	46844161	CYP4B1	CYP4Z2P			ENSG00000154198	NA	NA	rs3863632-T	rs3863632	0	3863632	intron_variant	0	0.12	4E-14	13.397940008672	(glucuronide of C10H18O2 (11))	0.388	[0.29-0.49] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	1p33	1	46932824	CYP4A11	CYP4A11			ENSG00000187048	NA	NA	rs1126742-G	rs1126742	0	1126742	missense_variant	0	0.14	6E-20	19.2218487496164	(glucuronide of C10H18O2 (12))	0.345	[0.27-0.42] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	4q13.2	4	69113765	UGT2B7	UGT2B7 - AC111000.5	ENSG00000171234	ENSG00000251284		778	11509	rs7666195-C	rs7666195	0	7666195	intergenic_variant	1	0.47	2E-14	13.698970004336	(glucuronide of C12H22O4 (2))	0.31	[0.23-0.39] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	14q32.11	14	91154810	DGLUCY	DGLUCY			ENSG00000133943	NA	NA	rs10148571-G	rs10148571	0	10148571	intron_variant	0	0.33	2E-37	36.698970004336	(glutamate)	0.296	[0.25-0.34] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	22q11.23	22	24175884	CABIN1	CABIN1, CABIN1			ENSG00000281670, ENSG00000099991	NA	NA	rs75303441-A	rs75303441	0	75303441	non_coding_transcript_exon_variant	0	0.06	3E-37	36.5228787452803	(glycerophosphoserine)	0.406	[0.34-0.47] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	2q34	2	210195326	ACADL	ACADL, AC006994.1			ENSG00000115361, ENSG00000279317	NA	NA	rs2286963-G	rs2286963	0	2286963	missense_variant	0	0.36	4E-181	180.397940008672	(glycine conjugate of C9H16O2)	1.54	[1.43-1.65] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	7q22.1	7	99735325	CYP3A7	CYP3A7 - CYP3A4	ENSG00000160870	ENSG00000160868		129	21635	rs45446698-G	rs45446698	0	45446698	intergenic_variant	1	0.03	1E-13	13	(glyco-beta-muricholate)	1.623	[1.2-2.05] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	12p12.1	12	21199607	SLCO1B1	SLCO1B1			ENSG00000134538	NA	NA	rs12317268-G	rs12317268	0	12317268	intron_variant	0	0.18	2E-29	28.698970004336	(glycochenodeoxycholate glucuronide (1))	0.976	[0.81-1.15] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	12p12.1	12	21178615	SLCO1B1	SLCO1B1			ENSG00000134538	NA	NA	rs4149056-C	rs4149056	0	4149056	missense_variant	0	0.18	4E-32	31.397940008672	(glycocholenate sulfate)	0.677	[0.57-0.79] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	12p12.1	12	21204797	SLCO1B1	SLCO1B1			ENSG00000134538	NA	NA	rs56165099-T	rs56165099	0	56165099	intron_variant	0	0.21	5E-12	11.301029995664	(glycodeoxycholate sulfate)	0.649	[0.46-0.83] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	1p31.1	1	75671921	ACADM	AL137803.1			ENSG00000230863	NA	NA	rs12134854-C	rs12134854	0	12134854	intron_variant	0	0.29	3E-14	13.5228787452803	(heptanoylglutamine)	0.486	[0.36-0.61] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	6p22.2	6	25807375	SLC17A1, SLC17A3, SLC17A4	SLC17A1			ENSG00000124568	NA	NA	rs2817188-A	rs2817188	0	2817188	intron_variant	0	0.47	2E-20	19.698970004336	(heptanoylglutamine)	0.537	[0.42-0.65] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	1p31.1	1	75671921	ACADM	AL137803.1			ENSG00000230863	NA	NA	rs12134854-C	rs12134854	0	12134854	intron_variant	0	0.29	2E-20	19.698970004336	(hexanoylglutamine)	0.325	[0.26-0.39] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	6p22.2	6	25794203	SLC17A1, SLC17A3, SLC17A4	SLC17A1			ENSG00000124568	NA	NA	rs2762353-A	rs2762353	0	2762353	intron_variant	0	0.47	1E-43	43	(hexanoylglutamine)	0.432	[0.37-0.49] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	1p31.1	1	75724884	ACADM	ACADM			ENSG00000117054	NA	NA	rs1251075-G	rs1251075	0	1251075	intron_variant	0	0.32	5E-23	22.301029995664	(hexanoylglycine)	0.331	[0.26-0.4] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	2q34	2	210675783	CPS1	CPS1			ENSG00000021826	NA	NA	rs1047891-A	rs1047891	0	1047891	missense_variant	0	0.33	9E-23	22.0457574905607	(hexanoylglycine)	0.34	[0.27-0.41] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	2p13.1	2	73655945	NAT8	ALMS1P1			ENSG00000163016	NA	NA	rs13408433-A	rs13408433	0	13408433	intron_variant	0	0.21	6E-20	19.2218487496164	(homocitrulline)	0.406	[0.32-0.49] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	1p22.2	1	88907688	KYAT3	GTF2B - AL445991.1	ENSG00000137947	ENSG00000235308		15744	15682	rs10801690-C	rs10801690	0	10801690	intergenic_variant	1	0.49	6E-13	12.2218487496164	(imidazole lactate)	0.195	[0.14-0.25] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	16q21	16	58831118	GOT2	AC106793.1			ENSG00000245768	NA	NA	rs11646417-T	rs11646417	0	11646417	intron_variant	0	0.07	3E-19	18.5228787452803	(imidazole lactate)	0.478	[0.37-0.58] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	6p22.2	6	25762418	SLC17A1, SLC17A3, SLC17A4	SLC17A4			ENSG00000146039	NA	NA	rs3799340-T	rs3799340	0	3799340	intron_variant	0	0.45	8E-20	19.0969100130081	(X - 23196)	0.246	[0.19-0.3] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	4p15.2	4	22805140	GBA3	GBA3			ENSG00000249948	NA	NA	rs453881-T	rs453881	0	453881	intron_variant	0	0.15	2E-27	26.698970004336	(X - 23299)	1.087	[0.89-1.28] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	4p15.2	4	22825888	GBA3	GBA3 - AC097512.1	ENSG00000249948	ENSG00000248837		6313	163259	rs168578-T	rs168578	0	168578	intergenic_variant	1	0.15	2E-14	13.698970004336	(X - 23311)	0.593	[0.44-0.75] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	4p15.2	4	22818881	GBA3	GBA3			ENSG00000249948	NA	NA	rs358231-A	rs358231	0	358231	stop_lost	0	0.15	2E-38	37.698970004336	(X - 23314)	1.807	[1.53-2.08] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	2p13.1	2	73655945	NAT8	ALMS1P1			ENSG00000163016	NA	NA	rs13408433-A	rs13408433	0	13408433	intron_variant	0	0.21	2E-30	29.698970004336	(X - 23423)	0.326	[0.27-0.38] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	1p13.3	1	109687165	GSTM2	GSTM2			ENSG00000213366	NA	NA	rs36209093-C	rs36209093	0	36209093	intron_variant	0	0.36	7E-86	85.1549019599858	(X - 23438)	0.425	[0.38-0.47] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	6p22.2	6	25807375	SLC17A1, SLC17A3, SLC17A4	SLC17A1			ENSG00000124568	NA	NA	rs2817188-A	rs2817188	0	2817188	intron_variant	0	0.47	5E-21	20.301029995664	(X - 23518)	0.594	[0.47-0.72] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	6q27	6	166695228	RPS6KA2	RPS6KA2			ENSG00000071242	NA	NA	rs112992077-T	rs112992077	0	112992077	intron_variant	0	0.02	3E-11	10.5228787452803	(X - 23581)	1.467	[1.04-1.9] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	2p13.1	2	73622734	NAT8	ALMS1			ENSG00000116127	NA	NA	rs6546861-T	rs6546861	0	6546861	intron_variant	0	0.21	9E-48	47.0457574905607	(X - 23590)	0.289	[0.25-0.33] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	7q36.1	7	150842165	AOC1	AOC1			ENSG00000002726	NA	NA	rs6464114-A	rs6464114	0	6464114	intron_variant	0	0.46	2E-20	19.698970004336	(X - 23656)	0.33	[0.26-0.4] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	7q36.1	7	150842165	AOC1	AOC1			ENSG00000002726	NA	NA	rs6464114-A	rs6464114	0	6464114	intron_variant	0	0.46	6E-13	12.2218487496164	(X - 23668)	0.458	[0.33-0.58] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	10q24.2	10	98399379	PYROXD2	PYROXD2			ENSG00000119943	NA	NA	rs4488133-T	rs4488133	0	4488133	intron_variant	0	0.36	2E-209	208.698970004336	(X - 23776)	1.155	[1.08-1.23] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	14q24.3	14	73569909	ACOT4	AC005225.2, ACOT2			ENSG00000258603, ENSG00000119673	NA	NA	rs61987137-T	rs61987137	0	61987137	intron_variant	0	0.22	1E-52	52	(X - 24330)	0.636	[0.55-0.72] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	6p22.2	6	25799448	SLC17A1, SLC17A3, SLC17A4	SLC17A1			ENSG00000124568	NA	NA	rs1165213-G	rs1165213	0	1165213	intron_variant	0	0.47	8E-44	43.0969100130081	(X - 24339)	0.333	[0.29-0.38] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	16p13.3	16	401306	DECR2	NME4			ENSG00000103202	NA	NA	rs1698237-C	rs1698237	0	1698237	intron_variant	0	0.5	2E-12	11.698970004336	(X - 24339)	0.179	[0.13-0.23] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	6p22.2	6	25770638	SLC17A1, SLC17A3, SLC17A4	SLC17A4			ENSG00000146039	NA	NA	rs3757130-A	rs3757130	0	3757130	intron_variant	0	0.45	3E-13	12.5228787452803	(X - 24347)	0.224	[0.16-0.28] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	5p13.2	5	35980373	UGT3A1	UGT3A1			ENSG00000145626	NA	NA	rs6889699-T	rs6889699	0	6889699	intron_variant	0	0.14	1E-70	70	(X - 24348)	1.216	[1.08-1.35] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	6p22.2	6	25768764	SLC17A1, SLC17A3, SLC17A4	SLC17A4			ENSG00000146039	NA	NA	rs1892249-G	rs1892249	0	1892249	intron_variant	0	0.45	2E-11	10.698970004336	(X - 24350)	0.373	[0.26-0.48] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	7q22.1	7	99672916	CYP3A5	CYP3A5			ENSG00000106258	NA	NA	rs776746-T	rs776746	0	776746	splice_acceptor_variant	0	0.07	9E-30	29.0457574905607	(X - 24353)	0.777	[0.64-0.91] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	19p13.12	19	15868125	CYP4F2	CLEC4O - CYP4F36P	ENSG00000267453	ENSG00000273330		3221	3542	rs12611275-A	rs12611275	0	12611275	intergenic_variant	1	0.27	4E-20	19.397940008672	(X - 24359)	0.362	[0.29-0.44] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	5p13.2	5	35037010	AGXT2	AGXT2			ENSG00000113492	NA	NA	rs37369-T	rs37369	0	37369	missense_variant	0	0.08	2E-24	23.698970004336	(X - 24387)	0.476	[0.38-0.57] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	2q34	2	210675783	CPS1	CPS1			ENSG00000021826	NA	NA	rs1047891-A	rs1047891	0	1047891	missense_variant	0	0.33	1E-12	12	(X - 24402)	0.438	[0.32-0.56] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	1p21.3	1	99247284	PLPPR4	AL445433.2 - PLPPR4	ENSG00000232825	ENSG00000117600		2490	16669	rs71659190-C	rs71659190	0	71659190	intergenic_variant	1	0.04	2E-12	11.698970004336	(X - 24403)	0.771	[0.56-0.98] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	17q25.3	17	78202506	AFMID	AFMID			ENSG00000183077	NA	NA	rs72897838-G	rs72897838	0	72897838	synonymous_variant	0	0.1	2E-13	12.698970004336	(X - 24455)	0.331	[0.24-0.42] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	1p36.13	1	19308517	AKR7A2	AKR7A2			ENSG00000053371	NA	NA	rs1043657-T	rs1043657	0	1043657	missense_variant	0	0.09	2E-412	411.698970004336	(X - 24462)	1.114	[1.06-1.16] unit increase	Illumina [7750367] (imputed)	N
2020-03-05	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	1,221 cases	406 cases	1p36.13	1	19308517	AKR7A2	AKR7A2			ENSG00000053371	NA	NA	rs1043657-T	rs1043657	0	1043657	missense_variant	0	0.09	2E-26	25.698970004336	(4-hydroxyglutamate,  5-hydroxylysine,  X-24462)	0.015	[0.013-0.017] unit decrease	Illumina [7750367] (imputed)	N
2020-03-05	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	1,221 cases	406 cases	1p32.3	1	53230210	CPT2	MAGOH			ENSG00000162385	NA	NA	rs13375749-C	rs13375749	0	13375749	intron_variant	0	0.21	2E-10	9.69897000433602	(methylsuccinoylcarnitine,  X-24468,  X-24469,  X-24971)	0.006	[0.004-0.008] unit decrease	Illumina [7750367] (imputed)	N
2020-03-05	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	1,221 cases	406 cases	1p31.1	1	75677758	ACADM	AL137803.1			ENSG00000230863	NA	NA	rs7513363-G	rs7513363	0	7513363	intron_variant	0	0.32	8E-13	12.0969100130081	(heptanoylglutamine,  hexanoylglutamine,  isocaproylglutamine,  N-octanoylglutamine,  X-12636,  X-12839,  X-24347,  X-24350)	0.006	[0.004-0.008] unit decrease	Illumina [7750367] (imputed)	N
2020-03-05	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	1,221 cases	406 cases	1p31.1	1	75715193	ACADM	AL137803.1			ENSG00000230863	NA	NA	rs11161430-T	rs11161430	0	11161430	intron_variant	0	0.32	8E-26	25.0969100130081	(hexanoylglycine,  isocaproylglycine,  X-16567,  X-24402)	0.009	[0.007-0.011] unit decrease	Illumina [7750367] (imputed)	N
2020-03-05	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	1,221 cases	406 cases	1p21.3	1	99247284	PLPPR4	AL445433.2 - PLPPR4	ENSG00000232825	ENSG00000117600		2490	16669	rs71659190-C	rs71659190	0	71659190	intergenic_variant	1	0.04	3E-11	10.5228787452803	(X-11852,  X-21803,  X-24403)	0.015	[0.011-0.019] unit increase	Illumina [7750367] (imputed)	N
2020-03-05	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	1,221 cases	406 cases	2p13.2	2	73131402	RAB11FIP5	RAB11FIP5			ENSG00000135631	NA	NA	rs72841887-C	rs72841887	0	72841887	intron_variant	0	0.05	2E-10	9.69897000433602	(N-acetylarginine,  N-acetylcitrulline,  X-13698)	0.013	[0.0091-0.0169] unit increase	Illumina [7750367] (imputed)	N
2020-03-05	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	1,221 cases	406 cases	2p13.2	2	73140117	RAB11FIP5	RAB11FIP5			ENSG00000135631	NA	NA	rs1430346-C	rs1430346	0	1430346	intron_variant	0	0.28	2E-12	11.698970004336	(N2,  N6-diacetyllysine,  N-acetylasparagine,  N-acetylglutamine,  N-acetylhistidine,  N-acetylleucine)	0.006	[0.004-0.008] unit increase	Illumina [7750367] (imputed)	N
2020-03-05	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	1,221 cases	406 cases	2p13.2	2	73140117	RAB11FIP5	RAB11FIP5			ENSG00000135631	NA	NA	rs1430346-C	rs1430346	0	1430346	intron_variant	0	0.28	5E-18	17.301029995664	(N2-acetyllysine,  N-alpha-acetylornithine,  X-12124,  X-12125,  X-15666)	0.008	[0.006-0.01] unit increase	Illumina [7750367] (imputed)	N
2020-03-05	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	1,221 cases	406 cases	2p13.1	2	73503047	NAT8	ALMS1			ENSG00000116127	NA	NA	rs7607014-G	rs7607014	0	7607014	intron_variant	0	0.22	8E-25	24.0969100130081	(N-acetylkynurenine,  N-acetylphenylalanine,  N-acetyltryptophan,  N-acetyltyrosine)	0.01	[0.008-0.012] unit increase	Illumina [7750367] (imputed)	N
2020-03-05	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	1,221 cases	406 cases	2p13.1	2	73622734	NAT8	ALMS1			ENSG00000116127	NA	NA	rs6546861-T	rs6546861	0	6546861	intron_variant	0	0.21	9E-182	181.045757490561	(N-acetyl-1-methylhistidine,  N-delta-acetylornithine,  X-11357,  X-23590)	0.024	[0.022-0.026] unit increase	Illumina [7750367] (imputed)	N
2020-03-05	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	1,221 cases	406 cases	2p13.1	2	73623693	NAT8	ALMS1			ENSG00000116127	NA	NA	rs6711001-G	rs6711001	0	6711001	intron_variant	0	0.21	7E-14	13.1549019599857	(1-methylhistidine, homocitrulline, X-23587)	0.008	[0.006-0.01] unit decrease	Illumina [7750367] (imputed)	N
2020-03-05	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	1,221 cases	406 cases	2p13.1	2	73625378	NAT8	ALMS1 - NAT8	ENSG00000116127	ENSG00000144035		212	15345	rs6718843-A	rs6718843	0	6718843	regulatory_region_variant	1	0.21	5E-24	23.301029995664	(homocitrate, X-24519)	0.01	[0.008-0.012] unit decrease	Illumina [7750367] (imputed)	N
2020-03-05	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	1,221 cases	406 cases	2p13.1	2	73631838	NAT8	ALMS1 - NAT8	ENSG00000116127	ENSG00000144035		6672	8885	rs10201159-C	rs10201159	0	10201159	intergenic_variant	1	0.21	1E-363	363	(N-acetylarginine, N-acetylcitrulline, X-13698)	0.03	[0.028-0.032] unit increase	Illumina [7750367] (imputed)	N
2020-03-05	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	1,221 cases	406 cases	2p13.1	2	73640735	NAT8	NAT8			ENSG00000144035	NA	NA	rs4547554-C	rs4547554	0	4547554	3_prime_UTR_variant	0	0.21	2E-165	164.698970004336	(N2, N6-diacetyllysine, N-acetylasparagine, N-acetylglutamine, N-acetylhistidine, N-acetylleucine)	0.023	[0.021-0.025] unit increase	Illumina [7750367] (imputed)	N
2020-03-05	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	1,221 cases	406 cases	2p13.1	2	73640735	NAT8	NAT8			ENSG00000144035	NA	NA	rs4547554-C	rs4547554	0	4547554	3_prime_UTR_variant	0	0.21	5E-13	12.301029995664	(N-acetylalanine, N-acetylmethionine, N-acetylmethionine sulfoxide, sarcosine, X-12199)	0.007	[0.005-0.009] unit increase	Illumina [7750367] (imputed)	N
2020-03-05	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	1,221 cases	406 cases	2p13.1	2	73641201	NAT8	ALMS1P1, NAT8			ENSG00000163016, ENSG00000144035	NA	NA	rs13538-G	rs13538	0	13538	missense_variant	0	0.21	4E-635	634.397940008672	(N2-acetyllysine, N-alpha-acetylornithine, X-12124, X-12125, X-15666)	0.035	[0.033-0.037] unit increase	Illumina [7750367] (imputed)	N
2020-03-05	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	1,221 cases	406 cases	2q34	2	210195326	ACADL	ACADL, AC006994.1			ENSG00000115361, ENSG00000279317	NA	NA	rs2286963-G	rs2286963	0	2286963	missense_variant	0	0.36	7E-132	131.154901959986	(glycine conjugate of C9H16O2, X-12459, X-13431)	0.019	[0.017-0.021] unit increase	Illumina [7750367] (imputed)	N
2020-03-05	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	1,221 cases	406 cases	2q34	2	210675783	CPS1	CPS1			ENSG00000021826	NA	NA	rs1047891-A	rs1047891	0	1047891	missense_variant	0	0.33	2E-16	15.698970004336	(2-methylbutyrylglycine, 3-methylcrotonylglycine, indoleacetylglutamine, indoleacetylglycine, isobutyrylglycine, isovalerylglutamine, isovalerylglycine, tigloylglycine, X-17688)	0.007	[0.005-0.009] unit increase	Illumina [7750367] (imputed)	N
2020-03-05	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	1,221 cases	406 cases	2q34	2	210675783	CPS1	CPS1			ENSG00000021826	NA	NA	rs1047891-A	rs1047891	0	1047891	missense_variant	0	0.33	3E-24	23.5228787452803	(hexanoylglycine, isocaproylglycine, X-16567, X-24402)	0.009	[0.007-0.011] unit increase	Illumina [7750367] (imputed)	N
2020-03-05	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	1,221 cases	406 cases	2q34	2	210675783	CPS1	CPS1			ENSG00000021826	NA	NA	rs1047891-A	rs1047891	0	1047891	missense_variant	0	0.33	8E-30	29.0969100130081	(3-hydroxy-3-methylglutarate, 3-methylglutaconate, 3-methylglutarate, 2-methylglutarate, 3-methylglutarylcarnitine)	0.01	[0.008-0.012] unit increase	Illumina [7750367] (imputed)	N
2020-03-05	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	1,221 cases	406 cases	4p15.2	4	22805140	GBA3	GBA3			ENSG00000249948	NA	NA	rs453881-T	rs453881	0	453881	intron_variant	0	0.15	2E-30	29.698970004336	(X-13847, X-23299, X-23314, X-23502)	0.013	[0.011-0.015] unit increase	Illumina [7750367] (imputed)	N
2020-03-05	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	1,221 cases	406 cases	5p13.2	5	35037010	AGXT2	AGXT2			ENSG00000113492	NA	NA	rs37369-T	rs37369	0	37369	missense_variant	0	0.08	1E-96	96	(3-aminoisobutyrate, 5-aminovalerate, X-12096, X-12097, X-12117, X-24518)	0.028	[0.026-0.03] unit decrease	Illumina [7750367] (imputed)	N
2020-03-05	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	1,221 cases	406 cases	6p22.2	6	25758838	SLC17A1, SLC17A3, SLC17A4	SLC17A4			ENSG00000146039	NA	NA	rs12212049-T	rs12212049	0	12212049	intron_variant	0	0.44	7E-12	11.1549019599857	(X-12822, X-17682, X-19913, X-24339, X-24588)	0.006	[0.004-0.008] unit decrease	Illumina [7750367] (imputed)	N
2020-03-05	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	1,221 cases	406 cases	6p22.2	6	25768764	SLC17A1, SLC17A3, SLC17A4	SLC17A4			ENSG00000146039	NA	NA	rs1892249-G	rs1892249	0	1892249	intron_variant	0	0.45	2E-30	29.698970004336	(heptanoylglutamine, hexanoylglutamine, isocaproylglutamine, N-octanoylglutamine, X-12636, X-12839, X-24347, X-24350)	0.009	[0.007-0.011] unit decrease	Illumina [7750367] (imputed)	N
2020-03-05	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite modules (eigenmetabolites) in chronic kidney disease	1,221 cases	406 cases	6p22.2	6	25818527	SLC17A1, SLC17A3, SLC17A4	SLC17A1			ENSG00000124568	NA	NA	rs9461218-A	rs9461218	0	9461218	intron_variant	0	0.23	2E-12	11.698970004336	(X-13529, X-15497, X-18889, X-19561, X-22102)	0.007	[0.005-0.009] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	6p22.2	6	25818527	SLC17A1, SLC17A3, SLC17A4	SLC17A1			ENSG00000124568	NA	NA	rs9461218-A	rs9461218	0	9461218	intron_variant	0	0.23	1E-13	13	(X - 15497 )	0.293	[0.22-0.37] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	2p13.1	2	73641201	NAT8	ALMS1P1, NAT8			ENSG00000163016, ENSG00000144035	NA	NA	rs13538-G	rs13538	0	13538	missense_variant	0	0.21	1E-104	104	(X - 15666)	0.875	[0.8-0.95] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	10q23.33	10	95068566	CYP2C8	CYP2C8			ENSG00000138115	NA	NA	rs2071426-C	rs2071426	0	2071426	splice_donor_variant	0	0.32	2E-14	13.698970004336	(X - 16087)	0.219	[0.16-0.28] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	1p31.1	1	75724884	ACADM	ACADM			ENSG00000117054	NA	NA	rs1251075-G	rs1251075	0	1251075	intron_variant	0	0.32	2E-20	19.698970004336	(X - 16567)	0.426	[0.34-0.52] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	2q34	2	210675783	CPS1	CPS1			ENSG00000021826	NA	NA	rs1047891-A	rs1047891	0	1047891	missense_variant	0	0.33	3E-13	12.5228787452803	(X - 16567)	0.347	[0.25-0.44] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	12p12.1	12	21204819	SLCO1B1	SLCO1B1			ENSG00000134538	NA	NA	rs55695203-C	rs55695203	0	55695203	intron_variant	0	0.18	1E-12	12	(X - 16654)	0.732	[0.53-0.93] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	6q25.3	6	160143444	SLC22A1	SLC22A1			ENSG00000175003	NA	NA	rs662138-G	rs662138	0	662138	intron_variant	0	0.16	2E-13	12.698970004336	(X - 17323)	0.307	[0.22-0.39] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	6p22.2	6	25821579	SLC17A1, SLC17A3, SLC17A4	SLC17A1			ENSG00000124568	NA	NA	rs1747522-T	rs1747522	0	1747522	intron_variant	0	0.48	6E-13	12.2218487496164	(X - 18888)	0.229	[0.17-0.29] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	16q24.3	16	89631384	DPEP1	DPEP1			ENSG00000015413	NA	NA	rs2460451-A	rs2460451	0	2460451	intron_variant	0	0.45	4E-34	33.397940008672	(X - 18889 )	0.362	[0.3-0.42] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	6p22.2	6	25818538	SLC17A1, SLC17A3, SLC17A4	SLC17A1			ENSG00000124568	NA	NA	rs1165152-A	rs1165152	0	1165152	intron_variant	0	0.47	2E-11	10.698970004336	(X - 18938)	0.351	[0.25-0.45] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	4q13.2	4	68493562	TMPRSS11E	TMPRSS11E, TMPRSS11E			ENSG00000274058, ENSG00000087128	NA	NA	rs34103191-A	rs34103191	0	34103191	intron_variant	0	0.34	4E-93	92.397940008672	(X - 19141)	0.574	[0.52-0.63] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	4q13.2	4	68495042	TMPRSS11E	TMPRSS11E, TMPRSS11E			ENSG00000274058, ENSG00000087128	NA	NA	rs34594059-C	rs34594059	0	34594059	intron_variant	0	0.34	2E-27	26.698970004336	(X - 19434 )	0.764	[0.62-0.9] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	6p22.2	6	25818527	SLC17A1, SLC17A3, SLC17A4	SLC17A1			ENSG00000124568	NA	NA	rs9461218-A	rs9461218	0	9461218	intron_variant	0	0.23	3E-13	12.5228787452803	(X - 19561 )	0.259	[0.19-0.33] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	12q24.31	12	125036471	AACS	BRI3BP - AC122688.1	ENSG00000184992	ENSG00000256093		5240	19888	rs2344686-G	rs2344686	0	2344686	intergenic_variant	1	0.13	1E-21	21	(X - 19913)	0.254	[0.2-0.31] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	12p12.1	12	21204819	SLCO1B1	SLCO1B1			ENSG00000134538	NA	NA	rs55695203-C	rs55695203	0	55695203	intron_variant	0	0.18	5E-17	16.301029995664	(X - 21467)	0.526	[0.4-0.65] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	12p12.1	12	21178615	SLCO1B1	SLCO1B1			ENSG00000134538	NA	NA	rs4149056-C	rs4149056	0	4149056	missense_variant	0	0.18	2E-11	10.698970004336	(X - 21470)	0.588	[0.42-0.76] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	19q13.33	19	47962055	CABP5	SULT2A1 - BSPH1	ENSG00000105398	ENSG00000188334		75740	5991	rs2972516-T	rs2972516	0	2972516	regulatory_region_variant	1	0.17	6E-15	14.2218487496164	(X - 21470)	0.708	[0.53-0.89] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	22q11.21	22	19963748	COMT	COMT			ENSG00000093010	NA	NA	rs4680-G	rs4680	0	4680	missense_variant	0	0.5	2E-59	58.698970004336	(X - 21785)	0.221	[0.19-0.25] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	14q24.3	14	73566890	ACOT2	AC005225.2			ENSG00000258603	NA	NA	rs11626972-G	rs11626972	0	11626972	intron_variant	0	0.43	3E-145	144.52287874528	(X - 21792)	1.021	[0.94-1.1] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	1p13.3	1	109687165	GSTM2	GSTM2			ENSG00000213366	NA	NA	rs36209093-C	rs36209093	0	36209093	intron_variant	0	0.36	8E-16	15.0969100130081	(X - 21796)	0.103	[0.078-0.128] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	1p33	1	46899620	CYP4A11	CYP4Z2P			ENSG00000154198	NA	NA	rs28597732-A	rs28597732	0	28597732	intron_variant	0	0.13	5E-13	12.301029995664	(X - 21827)	0.572	[0.42-0.73] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	6p22.2	6	25818538	SLC17A1, SLC17A3, SLC17A4	SLC17A1			ENSG00000124568	NA	NA	rs1165152-A	rs1165152	0	1165152	intron_variant	0	0.47	6E-12	11.2218487496164	(X - 21829)	0.173	[0.12-0.22] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	1q24.3	1	171384725	FMO4	SRP14P4 - GM2AP2	ENSG00000268062	ENSG00000239428		39418	7504	rs1018392-T	rs1018392	0	1018392	intergenic_variant	1	0.34	1E-17	17	(X - 21842)	0.582	[0.45-0.72] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	22q13.31	22	46297163	TTC38	GTSE1			ENSG00000075218	NA	NA	rs60032274-T	rs60032274	0	60032274	intron_variant	0	0.03	6E-46	45.2218487496164	(X - 22162)	0.455	[0.39-0.52] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	11q12.3	11	63132110	SLC22A10	SLC22A24			ENSG00000197658	NA	NA	rs118072533-T	rs118072533	0	118072533	intron_variant	0	0.06	3E-43	42.5228787452803	(X - 22834)	2.583	[2.22-2.95] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	2q35	2	219385510	DNPEP	DNPEP			ENSG00000123992	NA	NA	rs115897075-C	rs115897075	0	115897075	missense_variant	0	0.02	4E-11	10.397940008672	(X - 24462)	0.532	[0.38-0.69] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	6p12.3	6	49520769	GLYATL3	GLYATL3			ENSG00000203972	NA	NA	rs12190495-A	rs12190495	0	12190495	intron_variant	0	0.29	1E-179	179	(X - 24515)	1.073	[1-1.15] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	1p22.3	1	85397700	DDAH1	DDAH1, AL078459.1			ENSG00000153904, ENSG00000223653	NA	NA	rs3949301-G	rs3949301	0	3949301	intron_variant	0	0.36	2E-32	31.698970004336	(X - 24518)	0.391	[0.33-0.46] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	5p13.2	5	35037010	AGXT2	AGXT2			ENSG00000113492	NA	NA	rs37369-T	rs37369	0	37369	missense_variant	0	0.08	9E-56	55.0457574905607	(X - 24518)	0.873	[0.76-0.98] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	2p13.1	2	73625378	NAT8	ALMS1 - NAT8	ENSG00000116127	ENSG00000144035		212	15345	rs6718843-A	rs6718843	0	6718843	regulatory_region_variant	1	0.21	3E-44	43.5228787452803	(X - 24519)	0.428	[0.37-0.49] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	12p12.1	12	21247021	SLCO1B1	SLCO1B1 - SLCO1A2	ENSG00000134538	ENSG00000084453		7225	17579	rs73069021-A	rs73069021	0	73069021	intergenic_variant	1	0.19	9E-19	18.0457574905607	(X - 24546)	0.722	[0.56-0.88] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	19q13.11	19	32865985	SLC7A9	SLC7A9			ENSG00000021488	NA	NA	rs12460876-C	rs12460876	0	12460876	intron_variant	0	0.38	9E-12	11.0457574905607	(X - 24736)	0.369	[0.26-0.47] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	5p13.2	5	35045389	AGXT2	AGXT2			ENSG00000113492	NA	NA	rs37377-G	rs37377	0	37377	intron_variant	0	0.1	1E-22	22	(X - 24796)	0.703	[0.56-0.84] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	2p13.1	2	73644538	NAT8	ALMS1P1			ENSG00000163016	NA	NA	rs13384756-T	rs13384756	0	13384756	intron_variant	0	0.21	2E-37	36.698970004336	(X - 24809)	0.86	[0.73-0.99] unit increase	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	10q24.2	10	98388419	PYROXD2	PYROXD2			ENSG00000119943	NA	NA	rs2147896-G	rs2147896	0	2147896	missense_variant	0	0.36	4E-574	573.397940008672	(X - 24809)	1.82	[1.75-1.89] unit decrease	Illumina [7750367] (imputed)	N
2020-03-03	31959995	Schlosser P	2020-01-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/31959995	Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans.	Urinary metabolite levels in chronic kidney disease	1,221 cases	406 cases	10q24.2	10	98388419	PYROXD2	PYROXD2			ENSG00000119943	NA	NA	rs2147896-G	rs2147896	0	2147896	missense_variant	0	0.36	3E-520	519.52287874528	(X - 24983)	1.103	[1.06-1.15] unit decrease	Illumina [7750367] (imputed)	N
2019-04-03	30809046	Schmitz B	2019-02-26	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/30809046	Genome-wide association study suggests impact of chromosome 10 rs139401390 on kidney function in patients with coronary artery disease.	Estimated glomerular filtration rate in coronary artery disease and impaired kidney function	499 European ancestry cases	574 European ancestry cases	2q14.2	2	120757583	GLI2	GLI2			ENSG00000074047	NA	NA	rs138730015-G	rs138730015	0	138730015	intron_variant	0	0.012	2E-6	5.69897000433602		6.13	[0.078-12.182] ml/min/1.73m2 increase	Affymetrix [> 10000000] (imputed)	N
2019-04-03	30809046	Schmitz B	2019-02-26	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/30809046	Genome-wide association study suggests impact of chromosome 10 rs139401390 on kidney function in patients with coronary artery disease.	Estimated glomerular filtration rate in coronary artery disease and impaired kidney function	499 European ancestry cases	574 European ancestry cases	10q23.31	10	88643382	RNLS, LIPL1, LIPF	RPL7P34 - LIPF	ENSG00000237205	ENSG00000182333		24448	21059	rs139401390-G	rs139401390	0	139401390	regulatory_region_variant	1	0.025	6E-8	7.22184874961636		3.72	[0.3-7.14] ml/min/1.73m2 decrease	Affymetrix [> 10000000] (imputed)	N
2018-07-13	29703844	van Zuydam NR	2018-04-27	Diabetes	www.ncbi.nlm.nih.gov/pubmed/29703844	A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.	Chronic kidney disease in type 2 diabetes	3,094 European ancestry cases, 2,906 European ancestry controls	5,406 European ancestry cases, 8,744 European ancestry controls, 2,964 Asian cases, 3,323 Asian controls, 207 Chinese ancestry cases, 273 Chinese ancestry controls, 58 Indian ancestry cases, 107 Indian ancestry controls, 103 Malay ancestry cases, 56 Malay ancestry controls controls	1p36.31	1	5975370	NR	NPHP4			ENSG00000131697	NA	NA	rs75886247-?	rs75886247	0	75886247	intron_variant	0		5E-6	5.30102999566398	(EA)	1.45	[1.29-1.63]	Affymetrix, Illumina [up to 9343778] (imputed)	N
2018-07-13	29703844	van Zuydam NR	2018-04-27	Diabetes	www.ncbi.nlm.nih.gov/pubmed/29703844	A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.	Chronic kidney disease in type 2 diabetes	3,094 European ancestry cases, 2,906 European ancestry controls	5,406 European ancestry cases, 8,744 European ancestry controls, 2,964 Asian cases, 3,323 Asian controls, 207 Chinese ancestry cases, 273 Chinese ancestry controls, 58 Indian ancestry cases, 107 Indian ancestry controls, 103 Malay ancestry cases, 56 Malay ancestry controls controls	7q22.3	7	105705501	NR	ATXN7L1			ENSG00000146776	NA	NA	rs17151401-?	rs17151401	0	17151401	intron_variant	0		3E-6	5.52287874528034	(EA)	1.31	[1.12-1.53]	Affymetrix, Illumina [up to 9343778] (imputed)	N
2018-07-13	29703844	van Zuydam NR	2018-04-27	Diabetes	www.ncbi.nlm.nih.gov/pubmed/29703844	A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.	Chronic kidney disease in type 2 diabetes	3,094 European ancestry cases, 2,906 European ancestry controls	5,406 European ancestry cases, 8,744 European ancestry controls, 2,964 Asian cases, 3,323 Asian controls, 207 Chinese ancestry cases, 273 Chinese ancestry controls, 58 Indian ancestry cases, 107 Indian ancestry controls, 103 Malay ancestry cases, 56 Malay ancestry controls controls	10q26.13	10	124549008	NR	LHPP			ENSG00000107902	NA	NA	rs12251637-?	rs12251637	0	12251637	intron_variant	0		8E-6	5.09691001300806	(EA)	1.5	[1.16-1.94]	Affymetrix, Illumina [up to 9343778] (imputed)	N
2018-07-13	29703844	van Zuydam NR	2018-04-27	Diabetes	www.ncbi.nlm.nih.gov/pubmed/29703844	A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.	Chronic kidney disease in diabetes	5,447 European ancestry cases, 4,717 European ancestry controls	5,406 European ancestry cases, 8,744 European ancestry controls, 2,964 Asian cases, 3,323 Asian controls, 207 Chinese ancestry cases, 273 Chinese ancestry controls, 58 Indian ancestry cases, 107 Indian ancestry controls, 103 Malay ancestry cases, 56 Malay ancestry controls	14q31.1	14	81151652	NR	AC007262.2			ENSG00000284959	NA	NA	rs11622435-?	rs11622435	0	11622435	intron_variant	0		2E-7	6.69897000433602	(EA)	1.48	[1.20-1.81]	Affymetrix, Illumina [up to 9343778] (imputed)	N
2018-07-13	29703844	van Zuydam NR	2018-04-27	Diabetes	www.ncbi.nlm.nih.gov/pubmed/29703844	A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.	Chronic kidney disease and diabetic kidney disease in type 2 diabetes	408 European ancestry cases, 1,890 European ancestry controls	1,408 European ancestry cases, 3,840 European ancestry controls, 268 Asian cases, 632 Asian controls, 75 Chinese ancestry cases, 119 Chinese ancestry controls	1p32.3	1	55006692	NR	BSND			ENSG00000162399	NA	NA	rs4927186-?	rs4927186	0	4927186	intron_variant	0		8E-6	5.09691001300806	(EA)	1.43	[1.30-1.57]	Affymetrix, Illumina [up to 9343778] (imputed)	N
2018-07-13	29703844	van Zuydam NR	2018-04-27	Diabetes	www.ncbi.nlm.nih.gov/pubmed/29703844	A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.	Chronic kidney disease and diabetic kidney disease in type 2 diabetes	408 European ancestry cases, 1,890 European ancestry controls	1,408 European ancestry cases, 3,840 European ancestry controls, 268 Asian cases, 632 Asian controls, 75 Chinese ancestry cases, 119 Chinese ancestry controls	4q28.3	4	137078372	NR	LINC02511			ENSG00000248869	NA	NA	rs12647735-?	rs12647735	0	12647735	intron_variant	0		2E-6	5.69897000433602	(EA)	1.45	[1.33-1.59]	Affymetrix, Illumina [up to 9343778] (imputed)	N
2018-07-13	29703844	van Zuydam NR	2018-04-27	Diabetes	www.ncbi.nlm.nih.gov/pubmed/29703844	A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.	Chronic kidney disease and diabetic kidney disease in type 2 diabetes	408 European ancestry cases, 1,890 European ancestry controls	1,408 European ancestry cases, 3,840 European ancestry controls, 268 Asian cases, 632 Asian controls, 75 Chinese ancestry cases, 119 Chinese ancestry controls	8q24.11	8	116961613	NR	SLC30A8			ENSG00000164756	NA	NA	rs6997279-?	rs6997279	0	6997279	intron_variant	0		1E-7	7		1.48	[1.19-1.84]	Affymetrix, Illumina [up to 9343778] (imputed)	N
2018-07-13	29703844	van Zuydam NR	2018-04-27	Diabetes	www.ncbi.nlm.nih.gov/pubmed/29703844	A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.	Chronic kidney disease and diabetic kidney disease in type 2 diabetes	408 European ancestry cases, 1,890 European ancestry controls	1,408 European ancestry cases, 3,840 European ancestry controls, 268 Asian cases, 632 Asian controls, 75 Chinese ancestry cases, 119 Chinese ancestry controls				NR					NA	NA	chr19:48475266:I-?	chr19:48475266:I	0			1		7E-6	5.15490195998574		1.38	[1.23-1.53]	Affymetrix, Illumina [up to 9343778] (imputed)	N
2018-07-13	29703844	van Zuydam NR	2018-04-27	Diabetes	www.ncbi.nlm.nih.gov/pubmed/29703844	A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.	Chronic kidney disease and diabetic kidney disease in diabetes	1,525 European ancestry cases, 3,908 European ancestry controls	1,408 European ancestry cases, 3,840 European ancestry controls, 268 Asian cases, 632 Asian controls, 75 Chinese ancestry cases, 119 Chinese ancestry controls				NR					NA	NA	chr6:32525987:I-?	chr6:32525987:I	0			1		5E-6	5.30102999566398		1.17	[1.08-1.26]	Affymetrix, Illumina [up to 9343778] (imputed)	N
2018-07-13	29703844	van Zuydam NR	2018-04-27	Diabetes	www.ncbi.nlm.nih.gov/pubmed/29703844	A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.	Late diabetic kidney disease in type 2 diabetes	1,339 European ancestry cases, 2,372 European ancestry controls	2,891 European ancestry cases, 6,962 European ancestry controls, 3,755 Asian cases, 10,160 Asian controls, 178 Chinese ancestry cases, 154 Chinese ancestry controls, 39 Indian ancestry cases, 64 Indian ancestry controls	3p24.3	3	17161837	NR	AC090644.1, TBC1D5			ENSG00000285731, ENSG00000131374	NA	NA	rs74796791-?	rs74796791	0	74796791	intron_variant	0		5E-6	5.30102999566398	(EA)	2.04	[1.13-3.70]	Affymetrix, Illumina [up to 9343778] (imputed)	N
2018-07-13	29703844	van Zuydam NR	2018-04-27	Diabetes	www.ncbi.nlm.nih.gov/pubmed/29703844	A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.	Late diabetic kidney disease in type 2 diabetes	1,339 European ancestry cases, 2,372 European ancestry controls	2,891 European ancestry cases, 6,962 European ancestry controls, 3,755 Asian cases, 10,160 Asian controls, 178 Chinese ancestry cases, 154 Chinese ancestry controls, 39 Indian ancestry cases, 64 Indian ancestry controls	5q11.2	5	56329506	NR	AC034245.1 - HMGN1P17	ENSG00000249697	ENSG00000250787		8109	52275	rs158342-?	rs158342	0	158342	regulatory_region_variant	1		7E-6	5.15490195998574	(EA)	1.25	[1.15-1.36]	Affymetrix, Illumina [up to 9343778] (imputed)	N
2018-07-13	29703844	van Zuydam NR	2018-04-27	Diabetes	www.ncbi.nlm.nih.gov/pubmed/29703844	A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.	Late diabetic kidney disease in type 2 diabetes	1,339 European ancestry cases, 2,372 European ancestry controls	2,891 European ancestry cases, 6,962 European ancestry controls, 3,755 Asian cases, 10,160 Asian controls, 178 Chinese ancestry cases, 154 Chinese ancestry controls, 39 Indian ancestry cases, 64 Indian ancestry controls				NR					NA	NA	chr11:81277664:D-?	chr11:81277664:D	0			1		3E-6	5.52287874528034	(EA)	1.28	[1.14-1.44]	Affymetrix, Illumina [up to 9343778] (imputed)	N
2018-07-13	29703844	van Zuydam NR	2018-04-27	Diabetes	www.ncbi.nlm.nih.gov/pubmed/29703844	A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.	Late diabetic kidney disease in type 2 diabetes	1,339 European ancestry cases, 2,372 European ancestry controls	2,891 European ancestry cases, 6,962 European ancestry controls, 3,755 Asian cases, 10,160 Asian controls, 178 Chinese ancestry cases, 154 Chinese ancestry controls, 39 Indian ancestry cases, 64 Indian ancestry controls	5q11.2	5	56329506	NR	AC034245.1 - HMGN1P17	ENSG00000249697	ENSG00000250787		8109	52275	rs158342-?	rs158342	0	158342	regulatory_region_variant	1		4E-6	5.39794000867204		1.24	[1.15-1.34]	Affymetrix, Illumina [up to 9343778] (imputed)	N
2018-07-13	29703844	van Zuydam NR	2018-04-27	Diabetes	www.ncbi.nlm.nih.gov/pubmed/29703844	A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.	Early diabetic kidney disease in type 2 diabetes	1,989 European ancestry cases, 2,238 European ancestry controls	832 European ancestry cases, 2,653 European ancestry controls, 1,518 Asian cases, 3,990 Asian controls, 286 Chinese ancestry cases, 154 Chinese ancestry controls, 114 Indian ancestry cases, 66 Indian ancestry controls, 116 Malay ancestry cases, 21 Malay ancestry controls	6q15	6	89238513	GABRR1	GABRR1 - GABRR2	ENSG00000146276	ENSG00000111886		7235	15951	rs9942471-A	rs9942471	0	9942471	intergenic_variant	1	0.64	5E-8	7.30102999566398	(EA)	1.25	[1.16-1.34]	Affymetrix, Illumina [up to 9343778] (imputed)	N
2018-07-13	29703844	van Zuydam NR	2018-04-27	Diabetes	www.ncbi.nlm.nih.gov/pubmed/29703844	A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.	Early diabetic kidney disease in diabetes	2,795 European ancestry cases, 4,831 European ancestry controls	832 European ancestry cases, 2,653 European ancestry controls, 1,518 Asian cases, 3,990 Asian controls, 286 Chinese ancestry cases, 154 Chinese ancestry controls, 114 Indian ancestry cases, 66 Indian ancestry controls, 116 Malay ancestry cases, 21 Malay ancestry controls	11q21	11	93008790	NR	MTNR1B - RPL26P31	ENSG00000134640	ENSG00000242807		23724	43605	rs768920-?	rs768920	0	768920	intergenic_variant	1		2E-6	5.69897000433602	(EA)	1.39	[1.14-1.69]	Affymetrix, Illumina [up to 9343778] (imputed)	N
2018-07-13	29703844	van Zuydam NR	2018-04-27	Diabetes	www.ncbi.nlm.nih.gov/pubmed/29703844	A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.	Early diabetic kidney disease in diabetes	2,795 European ancestry cases, 4,831 European ancestry controls	832 European ancestry cases, 2,653 European ancestry controls, 1,518 Asian cases, 3,990 Asian controls, 286 Chinese ancestry cases, 154 Chinese ancestry controls, 114 Indian ancestry cases, 66 Indian ancestry controls, 116 Malay ancestry cases, 21 Malay ancestry controls	13q34	13	110214888	NR	COL4A1			ENSG00000187498	NA	NA	rs1143914-?	rs1143914	0	1143914	intron_variant	0		3E-6	5.52287874528034	(EA)	1.15	[1.09-1.22]	Affymetrix, Illumina [up to 9343778] (imputed)	N
2018-07-13	29703844	van Zuydam NR	2018-04-27	Diabetes	www.ncbi.nlm.nih.gov/pubmed/29703844	A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.	Early diabetic kidney disease in diabetes	2,795 European ancestry cases, 4,831 European ancestry controls	832 European ancestry cases, 2,653 European ancestry controls, 1,518 Asian cases, 3,990 Asian controls, 286 Chinese ancestry cases, 154 Chinese ancestry controls, 114 Indian ancestry cases, 66 Indian ancestry controls, 116 Malay ancestry cases, 21 Malay ancestry controls	17q21.2	17	40995605	NR	KRTAP3-3 - KRTAP3-2	ENSG00000263101	ENSG00000212900		1441	3588	rs7222331-?	rs7222331	0	7222331	intergenic_variant	1		1E-7	7	(EA)	1.37	[1.18-1.59]	Affymetrix, Illumina [up to 9343778] (imputed)	N
2018-07-13	29703844	van Zuydam NR	2018-04-27	Diabetes	www.ncbi.nlm.nih.gov/pubmed/29703844	A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.	Early diabetic kidney disease in diabetes	2,795 European ancestry cases, 4,831 European ancestry controls	832 European ancestry cases, 2,653 European ancestry controls, 1,518 Asian cases, 3,990 Asian controls, 286 Chinese ancestry cases, 154 Chinese ancestry controls, 114 Indian ancestry cases, 66 Indian ancestry controls, 116 Malay ancestry cases, 21 Malay ancestry controls	11q21	11	93008790	NR	MTNR1B - RPL26P31	ENSG00000134640	ENSG00000242807		23724	43605	rs768920-?	rs768920	0	768920	intergenic_variant	1		4E-6	5.39794000867204		1.39	[1.14-1.69]	Affymetrix, Illumina [up to 9343778] (imputed)	N
2018-07-13	29703844	van Zuydam NR	2018-04-27	Diabetes	www.ncbi.nlm.nih.gov/pubmed/29703844	A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.	Early diabetic kidney disease in diabetes	2,795 European ancestry cases, 4,831 European ancestry controls	832 European ancestry cases, 2,653 European ancestry controls, 1,518 Asian cases, 3,990 Asian controls, 286 Chinese ancestry cases, 154 Chinese ancestry controls, 114 Indian ancestry cases, 66 Indian ancestry controls, 116 Malay ancestry cases, 21 Malay ancestry controls	17q21.2	17	40995605	NR	KRTAP3-3 - KRTAP3-2	ENSG00000263101	ENSG00000212900		1441	3588	rs7222331-?	rs7222331	0	7222331	intergenic_variant	1		1E-6	6		1.37	[1.18-1.59]	Affymetrix, Illumina [up to 9343778] (imputed)	N
2018-07-13	29703844	van Zuydam NR	2018-04-27	Diabetes	www.ncbi.nlm.nih.gov/pubmed/29703844	A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.	Diabetic kidney disease in type 2 diabetes	3,345 European ancestry cases, 2,372 European ancestry controls	4,579 European ancestry cases, 7,777 European ancestry controls, 7,272 Asian cases, 8,775 Asian controls, 465 Chinese ancestry cases, 154 Chinese ancestry controls, 156 Indian ancestry cases, 66 Indian ancestry controls, 202 Malay ancestry cases, 21 Malay ancestry controls				NR					NA	NA	chr4:101507002:D-?	chr4:101507002:D	0			1		1E-6	6	(EA)	1.29	[1.20-1.38]	Affymetrix, Illumina [up to 9343778] (imputed)	N
2018-07-13	29703844	van Zuydam NR	2018-04-27	Diabetes	www.ncbi.nlm.nih.gov/pubmed/29703844	A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.	Diabetic kidney disease in type 2 diabetes	3,345 European ancestry cases, 2,372 European ancestry controls	4,579 European ancestry cases, 7,777 European ancestry controls, 7,272 Asian cases, 8,775 Asian controls, 465 Chinese ancestry cases, 154 Chinese ancestry controls, 156 Indian ancestry cases, 66 Indian ancestry controls, 202 Malay ancestry cases, 21 Malay ancestry controls	6q15	6	89238513	GABRR1	GABRR1 - GABRR2	ENSG00000146276	ENSG00000111886		7235	15951	rs9942471-A	rs9942471	0	9942471	intergenic_variant	1	0.64	4E-7	6.39794000867204	(EA)	1.18	[1.11-1.25]	Affymetrix, Illumina [up to 9343778] (imputed)	N
2018-07-13	29703844	van Zuydam NR	2018-04-27	Diabetes	www.ncbi.nlm.nih.gov/pubmed/29703844	A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.	Diabetic kidney disease in type 2 diabetes	3,345 European ancestry cases, 2,372 European ancestry controls	4,579 European ancestry cases, 7,777 European ancestry controls, 7,272 Asian cases, 8,775 Asian controls, 465 Chinese ancestry cases, 154 Chinese ancestry controls, 156 Indian ancestry cases, 66 Indian ancestry controls, 202 Malay ancestry cases, 21 Malay ancestry controls	6q15	6	89233215	NR	GABRR1 - GABRR2	ENSG00000146276	ENSG00000111886		1937	21249	rs2150814-?	rs2150814	0	2150814	intergenic_variant	1		2E-6	5.69897000433602	(EA)	1.18	[1.11-1.26]	Affymetrix, Illumina [up to 9343778] (imputed)	N
2018-07-13	29703844	van Zuydam NR	2018-04-27	Diabetes	www.ncbi.nlm.nih.gov/pubmed/29703844	A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.	Diabetic kidney disease in type 2 diabetes	3,345 European ancestry cases, 2,372 European ancestry controls	4,579 European ancestry cases, 7,777 European ancestry controls, 7,272 Asian cases, 8,775 Asian controls, 465 Chinese ancestry cases, 154 Chinese ancestry controls, 156 Indian ancestry cases, 66 Indian ancestry controls, 202 Malay ancestry cases, 21 Malay ancestry controls				NR					NA	NA	chr6:6415537:D-?	chr6:6415537:D	0			1		5E-6	5.30102999566398	(EA)	1.19	[1.09-1.31]	Affymetrix, Illumina [up to 9343778] (imputed)	N
2018-07-13	29703844	van Zuydam NR	2018-04-27	Diabetes	www.ncbi.nlm.nih.gov/pubmed/29703844	A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.	Diabetic kidney disease in type 2 diabetes	3,345 European ancestry cases, 2,372 European ancestry controls	4,579 European ancestry cases, 7,777 European ancestry controls, 7,272 Asian cases, 8,775 Asian controls, 465 Chinese ancestry cases, 154 Chinese ancestry controls, 156 Indian ancestry cases, 66 Indian ancestry controls, 202 Malay ancestry cases, 21 Malay ancestry controls	10p12.1	10	25424152	NR	GPR158			ENSG00000151025	NA	NA	rs7916840-?	rs7916840	0	7916840	intron_variant	0		6E-7	6.22184874961636	(EA)	1.27	[1.19-1.37]	Affymetrix, Illumina [up to 9343778] (imputed)	N
2018-07-13	29703844	van Zuydam NR	2018-04-27	Diabetes	www.ncbi.nlm.nih.gov/pubmed/29703844	A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.	Diabetic kidney disease in type 2 diabetes	3,345 European ancestry cases, 2,372 European ancestry controls	4,579 European ancestry cases, 7,777 European ancestry controls, 7,272 Asian cases, 8,775 Asian controls, 465 Chinese ancestry cases, 154 Chinese ancestry controls, 156 Indian ancestry cases, 66 Indian ancestry controls, 202 Malay ancestry cases, 21 Malay ancestry controls	11q21	11	93008790	NR	MTNR1B - RPL26P31	ENSG00000134640	ENSG00000242807		23724	43605	rs768920-?	rs768920	0	768920	intergenic_variant	1		4E-6	5.39794000867204	(EA)	1.44	[1.14-1.80]	Affymetrix, Illumina [up to 9343778] (imputed)	N
2018-07-13	29703844	van Zuydam NR	2018-04-27	Diabetes	www.ncbi.nlm.nih.gov/pubmed/29703844	A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.	Diabetic kidney disease in type 2 diabetes	3,345 European ancestry cases, 2,372 European ancestry controls	4,579 European ancestry cases, 7,777 European ancestry controls, 7,272 Asian cases, 8,775 Asian controls, 465 Chinese ancestry cases, 154 Chinese ancestry controls, 156 Indian ancestry cases, 66 Indian ancestry controls, 202 Malay ancestry cases, 21 Malay ancestry controls				NR					NA	NA	chr15:30372504:D-?	chr15:30372504:D	0			1		2E-6	5.69897000433602	(EA)	1.79	[1.22-2.63]	Affymetrix, Illumina [up to 9343778] (imputed)	N
2018-07-13	29703844	van Zuydam NR	2018-04-27	Diabetes	www.ncbi.nlm.nih.gov/pubmed/29703844	A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.	Diabetic kidney disease in type 2 diabetes	3,345 European ancestry cases, 2,372 European ancestry controls	4,579 European ancestry cases, 7,777 European ancestry controls, 7,272 Asian cases, 8,775 Asian controls, 465 Chinese ancestry cases, 154 Chinese ancestry controls, 156 Indian ancestry cases, 66 Indian ancestry controls, 202 Malay ancestry cases, 21 Malay ancestry controls				NR					NA	NA	chr17:39098885:D-?	chr17:39098885:D	0			1		4E-6	5.39794000867204	(EA)	1.61	[1.43-1.82]	Affymetrix, Illumina [up to 9343778] (imputed)	N
2018-07-13	29703844	van Zuydam NR	2018-04-27	Diabetes	www.ncbi.nlm.nih.gov/pubmed/29703844	A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.	Diabetic kidney disease in type 2 diabetes	3,345 European ancestry cases, 2,372 European ancestry controls	4,579 European ancestry cases, 7,777 European ancestry controls, 7,272 Asian cases, 8,775 Asian controls, 465 Chinese ancestry cases, 154 Chinese ancestry controls, 156 Indian ancestry cases, 66 Indian ancestry controls, 202 Malay ancestry cases, 21 Malay ancestry controls	20q11.23	20	36992576	NR	SAMHD1 - RBL1	ENSG00000101347	ENSG00000080839		40733	3773	rs139484064-?	rs139484064	0	139484064	intergenic_variant	1		2E-6	5.69897000433602	(EA)	1.73	[1.53-1.96]	Affymetrix, Illumina [up to 9343778] (imputed)	N
2018-10-17	30181573	Jing J	2018-09-04	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/30181573	Genetics of serum urate concentrations and gout in a high-risk population, patients with chronic kidney disease.	Serum urate levels in chronic kidney disease	4,941 European ancestry cases	NA	4p16.1	4	9995266	SLC2A9	SLC2A9			ENSG00000109667	NA	NA	rs13111638-T	rs13111638	0	13111638	intron_variant	0	0.19	2E-13	12.698970004336		0.31	[0.23-0.39] mg/dl decrease	Illumina [9281895] (imputed)	N
2018-10-17	30181573	Jing J	2018-09-04	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/30181573	Genetics of serum urate concentrations and gout in a high-risk population, patients with chronic kidney disease.	Serum urate levels in chronic kidney disease	4,941 European ancestry cases	NA	4q22.1	4	88131171	ABCG2	ABCG2			ENSG00000118777	NA	NA	rs2231142-T	rs2231142	0	2231142	missense_variant	0	0.11	9E-14	13.0457574905607		0.4	[0.3-0.5] mg/dl increase	Illumina [9281895] (imputed)	N
2018-10-17	30181573	Jing J	2018-09-04	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/30181573	Genetics of serum urate concentrations and gout in a high-risk population, patients with chronic kidney disease.	Serum urate levels in chronic kidney disease	4,941 European ancestry cases	NA	6p22.2	6	26185972	HIST1H2BE	H2BC6 - H4C4	ENSG00000274290	ENSG00000277157		1317	2738	rs9379832-G	rs9379832	0	9379832	intergenic_variant	1	0.33	9E-7	6.04575749056067		0.18	[0.11-0.25] mg/dl decrease	Illumina [9281895] (imputed)	N
2018-10-17	30181573	Jing J	2018-09-04	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/30181573	Genetics of serum urate concentrations and gout in a high-risk population, patients with chronic kidney disease.	Serum urate levels in chronic kidney disease	4,941 European ancestry cases	NA	6q15	6	89918054	BACH2	GJA10			ENSG00000135355	NA	NA	rs62416056-C	rs62416056	0	62416056	intron_variant	0	0.17	1E-7	7		0.23	[0.14-0.32] mg/dl increase	Illumina [9281895] (imputed)	N
2018-10-17	30181573	Jing J	2018-09-04	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/30181573	Genetics of serum urate concentrations and gout in a high-risk population, patients with chronic kidney disease.	Serum urate levels in chronic kidney disease	4,941 European ancestry cases	NA	19p13.3	19	3456658	NFIC	NFIC			ENSG00000141905	NA	NA	rs76909566-A	rs76909566	0	76909566	intron_variant	0	0.09	5E-8	7.30102999566398		0.33	[0.21-0.45] mg/dl increase	Illumina [9281895] (imputed)	N
2018-10-17	30181573	Jing J	2018-09-04	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/30181573	Genetics of serum urate concentrations and gout in a high-risk population, patients with chronic kidney disease.	Serum urate levels in chronic kidney disease	4,941 European ancestry cases	NA	19q12	19	29914778	URI1	AC008798.1 - AC008507.3	ENSG00000267433	ENSG00000278895		12909	1084	rs4805497-A	rs4805497	0	4805497	intergenic_variant	1	0.92	5E-8	7.30102999566398		0.34	[0.22-0.46] mg/dl increase	Illumina [9281895] (imputed)	N
2018-10-17	30181573	Jing J	2018-09-04	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/30181573	Genetics of serum urate concentrations and gout in a high-risk population, patients with chronic kidney disease.	Serum urate levels in chronic kidney disease	4,941 European ancestry cases	NA	20p11.21	20	24146125	FLJ33581	LINC01721			ENSG00000230133	NA	NA	rs78260152-T	rs78260152	0	78260152	intron_variant	0	0.07	2E-7	6.69897000433602		0.34	[0.21-0.47] mg/dl increase	Illumina [9281895] (imputed)	N
2018-10-17	30181573	Jing J	2018-09-04	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/30181573	Genetics of serum urate concentrations and gout in a high-risk population, patients with chronic kidney disease.	Gout in chronic kidney disease	1,217 European ancestry cases, 3,724 European ancestry controls	NA	4p16.1	4	9959397	SLC2A9	SLC2A9			ENSG00000109667	NA	NA	rs59834205-C	rs59834205	0	59834205	intron_variant	0	0.83	1E-7	7		1.45	[1.27-1.67]	Illumina [9281895] (imputed)	N
2018-10-17	30181573	Jing J	2018-09-04	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/30181573	Genetics of serum urate concentrations and gout in a high-risk population, patients with chronic kidney disease.	Gout in chronic kidney disease	1,217 European ancestry cases, 3,724 European ancestry controls	NA	4q22.1	4	88133515	ABCG2	ABCG2			ENSG00000118777	NA	NA	rs4148155-G	rs4148155	0	4148155	intron_variant	0	0.11	5E-9	8.30102999566398		1.55	[1.34-1.79]	Illumina [9281895] (imputed)	N
2018-07-13	29703844	van Zuydam NR	2018-04-27	Diabetes	www.ncbi.nlm.nih.gov/pubmed/29703844	A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.	Diabetic kidney disease in type 2 diabetes (ESRD vs. no ESRD)	371 European ancestry cases with end-stage renal disease, 4,471 European ancestry cases without end-stage renal disease	1,640 European ancestry cases with end-stage renal disease, 7,803 European ancestry cases without end-stage renal disease, 877 Asian cases with end-stage renal disease, 4,510 Asian cases without end-stage renal disease, 20 Chinese ancestry cases with end-stage renal disease, 398 Chinese ancestry cases without end-stage renal disease	2q14.1	2	113974664	NR	LINC01191			ENSG00000234199	NA	NA	rs12472051-?	rs12472051	0	12472051	intron_variant	0		4E-6	5.39794000867204	(EA)	1.47	[1.12-1.92]	Affymetrix, Illumina [up to 9343778] (imputed)	N
2018-07-13	29703844	van Zuydam NR	2018-04-27	Diabetes	www.ncbi.nlm.nih.gov/pubmed/29703844	A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.	Diabetic kidney disease in type 2 diabetes (ESRD vs. no ESRD)	371 European ancestry cases with end-stage renal disease, 4,471 European ancestry cases without end-stage renal disease	1,640 European ancestry cases with end-stage renal disease, 7,803 European ancestry cases without end-stage renal disease, 877 Asian cases with end-stage renal disease, 4,510 Asian cases without end-stage renal disease, 20 Chinese ancestry cases with end-stage renal disease, 398 Chinese ancestry cases without end-stage renal disease	3p25.2	3	12213890	NR	SYN2 - GSTM5P1	ENSG00000157152	ENSG00000236062		21858	43911	rs73017308-?	rs73017308	0	73017308	intergenic_variant	1		7E-6	5.15490195998574	(EA)	1.58	[1.05-2.38]	Affymetrix, Illumina [up to 9343778] (imputed)	N
2018-07-13	29703844	van Zuydam NR	2018-04-27	Diabetes	www.ncbi.nlm.nih.gov/pubmed/29703844	A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.	Diabetic kidney disease in type 2 diabetes (ESRD vs. no ESRD)	371 European ancestry cases with end-stage renal disease, 4,471 European ancestry cases without end-stage renal disease	1,640 European ancestry cases with end-stage renal disease, 7,803 European ancestry cases without end-stage renal disease, 877 Asian cases with end-stage renal disease, 4,510 Asian cases without end-stage renal disease, 20 Chinese ancestry cases with end-stage renal disease, 398 Chinese ancestry cases without end-stage renal disease	6p21.1	6	41519619	NR	LINC01276, FOXP4-AS1			ENSG00000226917, ENSG00000234753	NA	NA	rs36025606-?	rs36025606	0	36025606	non_coding_transcript_exon_variant	0		4E-6	5.39794000867204	(EA)	1.48	[1.15-1.90]	Affymetrix, Illumina [up to 9343778] (imputed)	N
2018-07-13	29703844	van Zuydam NR	2018-04-27	Diabetes	www.ncbi.nlm.nih.gov/pubmed/29703844	A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.	Diabetic kidney disease in type 2 diabetes (ESRD vs. no ESRD)	371 European ancestry cases with end-stage renal disease, 4,471 European ancestry cases without end-stage renal disease	1,640 European ancestry cases with end-stage renal disease, 7,803 European ancestry cases without end-stage renal disease, 877 Asian cases with end-stage renal disease, 4,510 Asian cases without end-stage renal disease, 20 Chinese ancestry cases with end-stage renal disease, 398 Chinese ancestry cases without end-stage renal disease	6q24.1	6	139003738	NR	REPS1 - ABRACL	ENSG00000135597	ENSG00000146386		15477	25007	rs11961816-?	rs11961816	0	11961816	regulatory_region_variant	1		2E-6	5.69897000433602	(EA)	1.81	[1.10-2.97]	Affymetrix, Illumina [up to 9343778] (imputed)	N
2018-07-13	29703844	van Zuydam NR	2018-04-27	Diabetes	www.ncbi.nlm.nih.gov/pubmed/29703844	A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.	Diabetic kidney disease in type 2 diabetes (ESRD vs. no ESRD)	371 European ancestry cases with end-stage renal disease, 4,471 European ancestry cases without end-stage renal disease	1,640 European ancestry cases with end-stage renal disease, 7,803 European ancestry cases without end-stage renal disease, 877 Asian cases with end-stage renal disease, 4,510 Asian cases without end-stage renal disease, 20 Chinese ancestry cases with end-stage renal disease, 398 Chinese ancestry cases without end-stage renal disease	9p21.3	9	20184333	NR	AL591222.3 - AL512635.1	ENSG00000277711	ENSG00000237434		216339	147113	rs4977388-?	rs4977388	0	4977388	intergenic_variant	1		3E-6	5.52287874528034	(EA)	1.87	[1.18-2.94]	Affymetrix, Illumina [up to 9343778] (imputed)	N
2018-07-13	29703844	van Zuydam NR	2018-04-27	Diabetes	www.ncbi.nlm.nih.gov/pubmed/29703844	A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.	Diabetic kidney disease in type 2 diabetes (ESRD vs. no ESRD)	371 European ancestry cases with end-stage renal disease, 4,471 European ancestry cases without end-stage renal disease	1,640 European ancestry cases with end-stage renal disease, 7,803 European ancestry cases without end-stage renal disease, 877 Asian cases with end-stage renal disease, 4,510 Asian cases without end-stage renal disease, 20 Chinese ancestry cases with end-stage renal disease, 398 Chinese ancestry cases without end-stage renal disease	9q34.3	9	136140067	NR	AL138781.1 - LHX3	ENSG00000275329	ENSG00000107187		15704	56183	rs141052170-?	rs141052170	0	141052170	regulatory_region_variant	1		3E-6	5.52287874528034	(EA)	2.13	[1.07-4.23]	Affymetrix, Illumina [up to 9343778] (imputed)	N
2018-07-13	29703844	van Zuydam NR	2018-04-27	Diabetes	www.ncbi.nlm.nih.gov/pubmed/29703844	A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.	Diabetic kidney disease in type 2 diabetes (ESRD vs. no ESRD)	371 European ancestry cases with end-stage renal disease, 4,471 European ancestry cases without end-stage renal disease	1,640 European ancestry cases with end-stage renal disease, 7,803 European ancestry cases without end-stage renal disease, 877 Asian cases with end-stage renal disease, 4,510 Asian cases without end-stage renal disease, 20 Chinese ancestry cases with end-stage renal disease, 398 Chinese ancestry cases without end-stage renal disease	13q21.2	13	59495931	NR	RNU7-88P - DIAPH3	ENSG00000239003	ENSG00000139734		15799	169652	rs73206603-?	rs73206603	0	73206603	regulatory_region_variant	1		1E-7	7	(EA)	1.83	[1.17-2.87]	Affymetrix, Illumina [up to 9343778] (imputed)	N
2018-07-13	29703844	van Zuydam NR	2018-04-27	Diabetes	www.ncbi.nlm.nih.gov/pubmed/29703844	A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.	Diabetic kidney disease in type 2 diabetes (ESRD vs. no ESRD)	371 European ancestry cases with end-stage renal disease, 4,471 European ancestry cases without end-stage renal disease	1,640 European ancestry cases with end-stage renal disease, 7,803 European ancestry cases without end-stage renal disease, 877 Asian cases with end-stage renal disease, 4,510 Asian cases without end-stage renal disease, 20 Chinese ancestry cases with end-stage renal disease, 398 Chinese ancestry cases without end-stage renal disease				NR					NA	NA	chr14:95189723:D-?	chr14:95189723:D	0			1		4E-6	5.39794000867204	(EA)	1.86	[1.08-3.19]	Affymetrix, Illumina [up to 9343778] (imputed)	N
2018-07-13	29703844	van Zuydam NR	2018-04-27	Diabetes	www.ncbi.nlm.nih.gov/pubmed/29703844	A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.	Diabetic kidney disease in type 2 diabetes (ESRD vs. no ESRD)	371 European ancestry cases with end-stage renal disease, 4,471 European ancestry cases without end-stage renal disease	1,640 European ancestry cases with end-stage renal disease, 7,803 European ancestry cases without end-stage renal disease, 877 Asian cases with end-stage renal disease, 4,510 Asian cases without end-stage renal disease, 20 Chinese ancestry cases with end-stage renal disease, 398 Chinese ancestry cases without end-stage renal disease	15q24.1	15	73811619	NR	INSYN1-AS1 - AC018943.1	ENSG00000260469	ENSG00000260624		41006	59330	rs117897666-?	rs117897666	0	117897666	intergenic_variant	1		3E-7	6.52287874528034	(EA)	3.02	[0.95-9.59]	Affymetrix, Illumina [up to 9343778] (imputed)	N
2018-07-13	29703844	van Zuydam NR	2018-04-27	Diabetes	www.ncbi.nlm.nih.gov/pubmed/29703844	A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.	Diabetic kidney disease in type 2 diabetes (ESRD vs. no ESRD)	371 European ancestry cases with end-stage renal disease, 4,471 European ancestry cases without end-stage renal disease	1,640 European ancestry cases with end-stage renal disease, 7,803 European ancestry cases without end-stage renal disease, 877 Asian cases with end-stage renal disease, 4,510 Asian cases without end-stage renal disease, 20 Chinese ancestry cases with end-stage renal disease, 398 Chinese ancestry cases without end-stage renal disease	19q13.11	19	34600451	NR	SCGB2B2			ENSG00000205209	NA	NA	rs76262407-?	rs76262407	0	76262407	intron_variant	0		2E-6	5.69897000433602	(EA)	3.56	[0.81-15.69]	Affymetrix, Illumina [up to 9343778] (imputed)	N
2018-07-13	29703844	van Zuydam NR	2018-04-27	Diabetes	www.ncbi.nlm.nih.gov/pubmed/29703844	A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.	Diabetic kidney disease in type 2 diabetes (ESRD vs. no ESRD)	371 European ancestry cases with end-stage renal disease, 4,471 European ancestry cases without end-stage renal disease	1,640 European ancestry cases with end-stage renal disease, 7,803 European ancestry cases without end-stage renal disease, 877 Asian cases with end-stage renal disease, 4,510 Asian cases without end-stage renal disease, 20 Chinese ancestry cases with end-stage renal disease, 398 Chinese ancestry cases without end-stage renal disease	19q13.33	19	50657831	NR	C19orf81			ENSG00000235034	NA	NA	rs10404821-?	rs10404821	0	10404821	intron_variant	0		2E-6	5.69897000433602	(EA)	1.26	[1.08-1.48]	Affymetrix, Illumina [up to 9343778] (imputed)	N
2018-07-13	29703844	van Zuydam NR	2018-04-27	Diabetes	www.ncbi.nlm.nih.gov/pubmed/29703844	A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.	Diabetic kidney disease in type 2 diabetes (ESRD vs. no ESRD)	371 European ancestry cases with end-stage renal disease, 4,471 European ancestry cases without end-stage renal disease	1,640 European ancestry cases with end-stage renal disease, 7,803 European ancestry cases without end-stage renal disease, 877 Asian cases with end-stage renal disease, 4,510 Asian cases without end-stage renal disease, 20 Chinese ancestry cases with end-stage renal disease, 398 Chinese ancestry cases without end-stage renal disease	6p21.1	6	41519619	NR	LINC01276, FOXP4-AS1			ENSG00000226917, ENSG00000234753	NA	NA	rs36025606-?	rs36025606	0	36025606	non_coding_transcript_exon_variant	0		9E-6	5.04575749056067		1.47	[1.14-1.88]	Affymetrix, Illumina [up to 9343778] (imputed)	N
2018-07-13	29703844	van Zuydam NR	2018-04-27	Diabetes	www.ncbi.nlm.nih.gov/pubmed/29703844	A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.	Diabetic kidney disease in type 2 diabetes (ESRD vs. no ESRD)	371 European ancestry cases with end-stage renal disease, 4,471 European ancestry cases without end-stage renal disease	1,640 European ancestry cases with end-stage renal disease, 7,803 European ancestry cases without end-stage renal disease, 877 Asian cases with end-stage renal disease, 4,510 Asian cases without end-stage renal disease, 20 Chinese ancestry cases with end-stage renal disease, 398 Chinese ancestry cases without end-stage renal disease	6q24.1	6	139003738	NR	REPS1 - ABRACL	ENSG00000135597	ENSG00000146386		15477	25007	rs11961816-?	rs11961816	0	11961816	regulatory_region_variant	1		4E-6	5.39794000867204		1.72	[1.10-2.68]	Affymetrix, Illumina [up to 9343778] (imputed)	N
2018-07-13	29703844	van Zuydam NR	2018-04-27	Diabetes	www.ncbi.nlm.nih.gov/pubmed/29703844	A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.	Diabetic kidney disease in type 2 diabetes (ESRD vs. no ESRD)	371 European ancestry cases with end-stage renal disease, 4,471 European ancestry cases without end-stage renal disease	1,640 European ancestry cases with end-stage renal disease, 7,803 European ancestry cases without end-stage renal disease, 877 Asian cases with end-stage renal disease, 4,510 Asian cases without end-stage renal disease, 20 Chinese ancestry cases with end-stage renal disease, 398 Chinese ancestry cases without end-stage renal disease	19q13.33	19	50657831	NR	C19orf81			ENSG00000235034	NA	NA	rs10404821-?	rs10404821	0	10404821	intron_variant	0		9E-6	5.04575749056067		1.25	[1.07-1.46]	Affymetrix, Illumina [up to 9343778] (imputed)	N
2018-07-13	29703844	van Zuydam NR	2018-04-27	Diabetes	www.ncbi.nlm.nih.gov/pubmed/29703844	A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.	Diabetic kidney disease in diabetes (ESRD vs. no ESRD)	1,184 European ancestry cases with end-stage renal disease, 8,466 European ancestry cases without end-stage renal disease	1,640 European ancestry cases with end-stage renal disease, 7,803 European ancestry cases without end-stage renal disease, 877 Asian cases with end-stage renal disease, 4,510 Asian cases without end-stage renal disease, 20 Chinese ancestry cases with end-stage renal disease, 398 Chinese ancestry cases without end-stage renal disease	20q13.2	20	54129184	NR	BCAS1 - CYP24A1	ENSG00000064787	ENSG00000019186		58590	24262	rs117989384-?	rs117989384	0	117989384	regulatory_region_variant	1		6E-6	5.22184874961636	(EA)	2.26	[1.15-4.42]	Affymetrix, Illumina [up to 9343778] (imputed)	N
2019-06-20	29124443	Yasukochi Y	2017-11-09	Mol Genet Genomics	www.ncbi.nlm.nih.gov/pubmed/29124443	Identification of CDC42BPG as a novel susceptibility locus for hyperuricemia in a Japanese population.	Chronic kidney disease	606 Japanese ancestry cases, 1,040 Japanese ancestry controls	2,517 Japanese ancestry cases, 885 Japanese ancestry controls	2p23.3	2	27503548	GCKR	GCKR			ENSG00000084734	NA	NA	rs149847328-?	rs149847328	0	149847328	stop_gained	0	1.93199E-4	2E-16	15.698970004336		NA		Illumina [~ 244000]	N
2019-06-20	29124443	Yasukochi Y	2017-11-09	Mol Genet Genomics	www.ncbi.nlm.nih.gov/pubmed/29124443	Identification of CDC42BPG as a novel susceptibility locus for hyperuricemia in a Japanese population.	Chronic kidney disease	606 Japanese ancestry cases, 1,040 Japanese ancestry controls	2,517 Japanese ancestry cases, 885 Japanese ancestry controls	3q28	3	188874357	LPP	LPP			ENSG00000145012	NA	NA	rs9830664-?	rs9830664	0	9830664	missense_variant	0	9.65997E-5	2E-16	15.698970004336		NA		Illumina [~ 244000]	N
2019-06-20	29124443	Yasukochi Y	2017-11-09	Mol Genet Genomics	www.ncbi.nlm.nih.gov/pubmed/29124443	Identification of CDC42BPG as a novel susceptibility locus for hyperuricemia in a Japanese population.	Chronic kidney disease	606 Japanese ancestry cases, 1,040 Japanese ancestry controls	2,517 Japanese ancestry cases, 885 Japanese ancestry controls	2q31.1	2	169237232	LRP2	LRP2			ENSG00000081479	NA	NA	rs200469773-?	rs200469773	0	200469773	missense_variant	0	1.93199E-4	2E-16	15.698970004336		NA		Illumina [~ 244000]	N
2019-06-20	29124443	Yasukochi Y	2017-11-09	Mol Genet Genomics	www.ncbi.nlm.nih.gov/pubmed/29124443	Identification of CDC42BPG as a novel susceptibility locus for hyperuricemia in a Japanese population.	Chronic kidney disease	606 Japanese ancestry cases, 1,040 Japanese ancestry controls	2,517 Japanese ancestry cases, 885 Japanese ancestry controls	18q23	18	79411390	NFATC1	NFATC1			ENSG00000131196	NA	NA	rs141310123-?	rs141310123	0	141310123	missense_variant	0	9.65997E-5	2E-16	15.698970004336		NA		Illumina [~ 244000]	N
2019-06-20	29124443	Yasukochi Y	2017-11-09	Mol Genet Genomics	www.ncbi.nlm.nih.gov/pubmed/29124443	Identification of CDC42BPG as a novel susceptibility locus for hyperuricemia in a Japanese population.	Chronic kidney disease	606 Japanese ancestry cases, 1,040 Japanese ancestry controls	2,517 Japanese ancestry cases, 885 Japanese ancestry controls	6p24.3	6	7230882	RREB1	RREB1			ENSG00000124782	NA	NA	rs141635364-?	rs141635364	0	141635364	missense_variant	0	1.93199E-4	7E-15	14.1549019599857		NA		Illumina [~ 244000]	N
2019-06-20	29124443	Yasukochi Y	2017-11-09	Mol Genet Genomics	www.ncbi.nlm.nih.gov/pubmed/29124443	Identification of CDC42BPG as a novel susceptibility locus for hyperuricemia in a Japanese population.	Chronic kidney disease	606 Japanese ancestry cases, 1,040 Japanese ancestry controls	2,517 Japanese ancestry cases, 885 Japanese ancestry controls	1q43	1	243316789	SDCCAG8	SDCCAG8, SDCCAG8			ENSG00000054282, ENSG00000276111	NA	NA	rs6672843-?	rs6672843	0	6672843	missense_variant	0	1.93199E-4	2E-16	15.698970004336		NA		Illumina [~ 244000]	N
2019-06-20	29124443	Yasukochi Y	2017-11-09	Mol Genet Genomics	www.ncbi.nlm.nih.gov/pubmed/29124443	Identification of CDC42BPG as a novel susceptibility locus for hyperuricemia in a Japanese population.	Chronic kidney disease	606 Japanese ancestry cases, 1,040 Japanese ancestry controls	2,517 Japanese ancestry cases, 885 Japanese ancestry controls	3p21.1	3	52907083	SFMBT1	SFMBT1			ENSG00000163935	NA	NA	rs186459505-?	rs186459505	0	186459505	missense_variant	0	1.93237E-4	2E-16	15.698970004336		NA		Illumina [~ 244000]	N
2019-06-20	29124443	Yasukochi Y	2017-11-09	Mol Genet Genomics	www.ncbi.nlm.nih.gov/pubmed/29124443	Identification of CDC42BPG as a novel susceptibility locus for hyperuricemia in a Japanese population.	Chronic kidney disease	606 Japanese ancestry cases, 1,040 Japanese ancestry controls	2,517 Japanese ancestry cases, 885 Japanese ancestry controls	19q13.13	19	38106538	SIPA1L3	SIPA1L3			ENSG00000105738	NA	NA	rs142085340-?	rs142085340	0	142085340	splice_region_variant	0	9.65997E-5	2E-16	15.698970004336		NA		Illumina [~ 244000]	N
2019-06-20	29124443	Yasukochi Y	2017-11-09	Mol Genet Genomics	www.ncbi.nlm.nih.gov/pubmed/29124443	Identification of CDC42BPG as a novel susceptibility locus for hyperuricemia in a Japanese population.	Chronic kidney disease	606 Japanese ancestry cases, 1,040 Japanese ancestry controls	2,517 Japanese ancestry cases, 885 Japanese ancestry controls	4p16.1	4	9942000	SLC2A9	SLC2A9			ENSG00000109667	NA	NA	rs149454410-?	rs149454410	0	149454410	missense_variant	0	9.65997E-5	2E-16	15.698970004336		NA		Illumina [~ 244000]	N
2019-06-20	29124443	Yasukochi Y	2017-11-09	Mol Genet Genomics	www.ncbi.nlm.nih.gov/pubmed/29124443	Identification of CDC42BPG as a novel susceptibility locus for hyperuricemia in a Japanese population.	Chronic kidney disease	606 Japanese ancestry cases, 1,040 Japanese ancestry controls	2,517 Japanese ancestry cases, 885 Japanese ancestry controls	16p12.3	16	20341292	UMOD	UMOD			ENSG00000169344	NA	NA	rs201761378-?	rs201761378	0	201761378	missense_variant	0	8.69397E-4	2E-16	15.698970004336		NA		Illumina [~ 244000]	N
2019-06-20	29124443	Yasukochi Y	2017-11-09	Mol Genet Genomics	www.ncbi.nlm.nih.gov/pubmed/29124443	Identification of CDC42BPG as a novel susceptibility locus for hyperuricemia in a Japanese population.	Chronic kidney disease	606 Japanese ancestry cases, 1,040 Japanese ancestry controls	2,517 Japanese ancestry cases, 885 Japanese ancestry controls	15q21.3	15	53716648	WDR72	WDR72			ENSG00000166415	NA	NA	rs690346-?	rs690346	0	690346	missense_variant	0	1.93237E-4	2E-16	15.698970004336		NA		Illumina [~ 244000]	N
2019-06-20	29124443	Yasukochi Y	2017-11-09	Mol Genet Genomics	www.ncbi.nlm.nih.gov/pubmed/29124443	Identification of CDC42BPG as a novel susceptibility locus for hyperuricemia in a Japanese population.	Chronic kidney disease	606 Japanese ancestry cases, 1,040 Japanese ancestry controls	2,517 Japanese ancestry cases, 885 Japanese ancestry controls	16q24.3	16	89637333	DPEP1	DPEP1			ENSG00000015413	NA	NA	rs148240484-?	rs148240484	0	148240484	missense_variant	0	9.65997E-5	2E-16	15.698970004336		NA		Illumina [~ 244000]	N
2019-06-20	29124443	Yasukochi Y	2017-11-09	Mol Genet Genomics	www.ncbi.nlm.nih.gov/pubmed/29124443	Identification of CDC42BPG as a novel susceptibility locus for hyperuricemia in a Japanese population.	Chronic kidney disease	606 Japanese ancestry cases, 1,040 Japanese ancestry controls	2,517 Japanese ancestry cases, 885 Japanese ancestry controls	12q13.3	12	57449402	INHBC	INHBC			ENSG00000175189	NA	NA	rs145048495-?	rs145048495	0	145048495	missense_variant	0	1.93237E-4	2E-16	15.698970004336		NA		Illumina [~ 244000]	N
2019-06-20	29124443	Yasukochi Y	2017-11-09	Mol Genet Genomics	www.ncbi.nlm.nih.gov/pubmed/29124443	Identification of CDC42BPG as a novel susceptibility locus for hyperuricemia in a Japanese population.	Chronic kidney disease	606 Japanese ancestry cases, 1,040 Japanese ancestry controls	2,517 Japanese ancestry cases, 885 Japanese ancestry controls	11p15.5	11	2527999	KCNQ1	KCNQ1, KCNQ1			ENSG00000282076, ENSG00000053918	NA	NA	rs143709408-?	rs143709408	0	143709408	missense_variant	0	9.65997E-5	2E-16	15.698970004336		NA		Illumina [~ 244000]	N
2019-06-20	29124443	Yasukochi Y	2017-11-09	Mol Genet Genomics	www.ncbi.nlm.nih.gov/pubmed/29124443	Identification of CDC42BPG as a novel susceptibility locus for hyperuricemia in a Japanese population.	Chronic kidney disease	606 Japanese ancestry cases, 1,040 Japanese ancestry controls	2,517 Japanese ancestry cases, 885 Japanese ancestry controls	3p14.1	3	66386050	LRIG1	SLC25A26, SLC25A26, LRIG1			ENSG00000282739, ENSG00000144741, ENSG00000144749	NA	NA	rs147372871-?	rs147372871	0	147372871	missense_variant	0	1.93199E-4	2E-16	15.698970004336		NA		Illumina [~ 244000]	N
2019-06-20	29124443	Yasukochi Y	2017-11-09	Mol Genet Genomics	www.ncbi.nlm.nih.gov/pubmed/29124443	Identification of CDC42BPG as a novel susceptibility locus for hyperuricemia in a Japanese population.	Chronic kidney disease	606 Japanese ancestry cases, 1,040 Japanese ancestry controls	2,517 Japanese ancestry cases, 885 Japanese ancestry controls	16q22.1	16	69695279	NFAT5	NFAT5			ENSG00000102908	NA	NA	rs199749272-?	rs199749272	0	199749272	missense_variant	0	9.65997E-5	2E-16	15.698970004336		NA		Illumina [~ 244000]	N
2019-06-03	31015462	Graham SE	2019-04-23	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31015462	Sex-specific and pleiotropic effects underlying kidney function identified from GWAS meta-analysis.	Chronic kidney disease	2,044 European ancestry cases, 65,575 European ancestry controls	NA	4q22.1	4	91329657	CCSER1	CCSER1			ENSG00000184305	NA	NA	rs553908921-T	rs553908921	0	553908921	intron_variant	0	9.19726686569349E-4	2E-8	7.69897000433602		4.312875	[2.8-5.82] unit increase	Illumina [24961484] (imputed)	N
2019-06-03	31015462	Graham SE	2019-04-23	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31015462	Sex-specific and pleiotropic effects underlying kidney function identified from GWAS meta-analysis.	Chronic kidney disease	2,044 European ancestry cases, 65,575 European ancestry controls	NA	10p14	10	10650339	CELF2	CELF2-DT - AL136452.1	ENSG00000270111	ENSG00000228997		187978	125884	rs769354275-G	rs769354275	0	769354275	intergenic_variant	1	1.931706E-4	3E-8	7.52287874528034		12.229734	[7.9-16.56] unit increase	Illumina [24961484] (imputed)	N
2019-06-03	31015462	Graham SE	2019-04-23	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31015462	Sex-specific and pleiotropic effects underlying kidney function identified from GWAS meta-analysis.	Chronic kidney disease	2,044 European ancestry cases, 65,575 European ancestry controls	NA				NALCN-AS1					NA	NA	chr13:101428834-T	chr13:101428834	0			1	9.9565211865895E-5	3E-8	7.52287874528034		19.37709	[12.52-26.23] unit increase	Illumina [24961484] (imputed)	N
2019-06-21	31092297	Guan M	2019-05-15	Hum Genomics	www.ncbi.nlm.nih.gov/pubmed/31092297	Genome-wide association study identifies novel loci for type 2 diabetes-attributed end-stage kidney disease in African Americans.	Type 2 diabetes and end-stage kidney disease	3,432 African-American cases, 6,977 African-American controls	NA				NR					NA	NA	chr2:46485186-C	chr2:46485186	0			1	0.01	2E-10	9.69897000433602		3.92	[2.57-5.98]	Affymetrix, Illumina [NR] (imputed)	N
2019-06-21	31092297	Guan M	2019-05-15	Hum Genomics	www.ncbi.nlm.nih.gov/pubmed/31092297	Genome-wide association study identifies novel loci for type 2 diabetes-attributed end-stage kidney disease in African Americans.	Type 2 diabetes and end-stage kidney disease	3,432 African-American cases, 6,977 African-American controls	NA				NR					NA	NA	chr2:151713161-A	chr2:151713161	0			1	0.08	2E-9	8.69897000433602		1.52	[1.33-1.74]	Affymetrix, Illumina [NR] (imputed)	N
2019-06-21	31092297	Guan M	2019-05-15	Hum Genomics	www.ncbi.nlm.nih.gov/pubmed/31092297	Genome-wide association study identifies novel loci for type 2 diabetes-attributed end-stage kidney disease in African Americans.	Type 2 diabetes and end-stage kidney disease	3,432 African-American cases, 6,977 African-American controls	NA				NR					NA	NA	chr3:165051826-T	chr3:165051826	0			1	0.06	4E-10	9.39794000867204		1.62	[1.39-1.89]	Affymetrix, Illumina [NR] (imputed)	N
2019-06-21	31092297	Guan M	2019-05-15	Hum Genomics	www.ncbi.nlm.nih.gov/pubmed/31092297	Genome-wide association study identifies novel loci for type 2 diabetes-attributed end-stage kidney disease in African Americans.	Type 2 diabetes and end-stage kidney disease	3,432 African-American cases, 6,977 African-American controls	NA	3q28	3	188889282		LPP			ENSG00000145012	NA	NA	rs76971802-T	rs76971802	0	76971802	3_prime_UTR_variant	0	0.087	9E-6	5.04575749056067		1.35	[1.19-1.54]	Affymetrix, Illumina [NR] (imputed)	N
2019-06-21	31092297	Guan M	2019-05-15	Hum Genomics	www.ncbi.nlm.nih.gov/pubmed/31092297	Genome-wide association study identifies novel loci for type 2 diabetes-attributed end-stage kidney disease in African Americans.	Type 2 diabetes and end-stage kidney disease	3,432 African-American cases, 6,977 African-American controls	NA	4q32.2	4	161988066		FSTL5			ENSG00000168843	NA	NA	rs5863506-TA	rs5863506	0	5863506	intron_variant	0	0.33	2E-6	5.69897000433602		1.22	[1.12-1.32]	Affymetrix, Illumina [NR] (imputed)	N
2019-06-21	31092297	Guan M	2019-05-15	Hum Genomics	www.ncbi.nlm.nih.gov/pubmed/31092297	Genome-wide association study identifies novel loci for type 2 diabetes-attributed end-stage kidney disease in African Americans.	Type 2 diabetes and end-stage kidney disease	3,432 African-American cases, 6,977 African-American controls	NA				NR					NA	NA	chr5:29705905-C	chr5:29705905	0			1	0.01	1E-16	16		6.81	[4.33-10.72]	Affymetrix, Illumina [NR] (imputed)	N
2019-06-21	31092297	Guan M	2019-05-15	Hum Genomics	www.ncbi.nlm.nih.gov/pubmed/31092297	Genome-wide association study identifies novel loci for type 2 diabetes-attributed end-stage kidney disease in African Americans.	Type 2 diabetes and end-stage kidney disease	3,432 African-American cases, 6,977 African-American controls	NA				NR					NA	NA	chr5:78050391-G	chr5:78050391	0			1	0.01	1E-8	8		5.91	[3.22-10.85]	Affymetrix, Illumina [NR] (imputed)	N
2019-06-21	31092297	Guan M	2019-05-15	Hum Genomics	www.ncbi.nlm.nih.gov/pubmed/31092297	Genome-wide association study identifies novel loci for type 2 diabetes-attributed end-stage kidney disease in African Americans.	Type 2 diabetes and end-stage kidney disease	3,432 African-American cases, 6,977 African-American controls	NA				NR					NA	NA	chr6:12618492-G	chr6:12618492	0			1	0.03	3E-11	10.5228787452803		2.22	[1.76-2.81]	Affymetrix, Illumina [NR] (imputed)	N
2019-06-21	31092297	Guan M	2019-05-15	Hum Genomics	www.ncbi.nlm.nih.gov/pubmed/31092297	Genome-wide association study identifies novel loci for type 2 diabetes-attributed end-stage kidney disease in African Americans.	Type 2 diabetes and end-stage kidney disease	3,432 African-American cases, 6,977 African-American controls	NA				NR					NA	NA	chr6:42474989-T	chr6:42474989	0			1	0.01	1E-10	10		3	[2.15-4.2]	Affymetrix, Illumina [NR] (imputed)	N
2019-06-21	31092297	Guan M	2019-05-15	Hum Genomics	www.ncbi.nlm.nih.gov/pubmed/31092297	Genome-wide association study identifies novel loci for type 2 diabetes-attributed end-stage kidney disease in African Americans.	Type 2 diabetes and end-stage kidney disease	3,432 African-American cases, 6,977 African-American controls	NA				NR					NA	NA	chr8:49547701-C	chr8:49547701	0			1	0.01	1E-12	12		5.38	[3.38-8.57]	Affymetrix, Illumina [NR] (imputed)	N
2019-06-21	31092297	Guan M	2019-05-15	Hum Genomics	www.ncbi.nlm.nih.gov/pubmed/31092297	Genome-wide association study identifies novel loci for type 2 diabetes-attributed end-stage kidney disease in African Americans.	Type 2 diabetes and end-stage kidney disease	3,432 African-American cases, 6,977 African-American controls	NA				NR					NA	NA	chr8:74004192-A	chr8:74004192	0			1	0.01	4E-15	14.397940008672		6.39	[4.02-10.15]	Affymetrix, Illumina [NR] (imputed)	N
2019-06-21	31092297	Guan M	2019-05-15	Hum Genomics	www.ncbi.nlm.nih.gov/pubmed/31092297	Genome-wide association study identifies novel loci for type 2 diabetes-attributed end-stage kidney disease in African Americans.	Type 2 diabetes and end-stage kidney disease	3,432 African-American cases, 6,977 African-American controls	NA	8q11.23	8	53398379		AC022034.3			ENSG00000253369	NA	NA	rs141746998-C	rs141746998	0	141746998	intron_variant	0	0.969	9E-6	5.04575749056067		1.6129031	[1.32-2.00]	Affymetrix, Illumina [NR] (imputed)	N
2019-06-21	31092297	Guan M	2019-05-15	Hum Genomics	www.ncbi.nlm.nih.gov/pubmed/31092297	Genome-wide association study identifies novel loci for type 2 diabetes-attributed end-stage kidney disease in African Americans.	Type 2 diabetes and end-stage kidney disease	3,432 African-American cases, 6,977 African-American controls	NA	8q23.2	8	109879748		AC023245.3 - AC023245.1	ENSG00000283555	ENSG00000241385		5730	19498	rs11997465-C	rs11997465	0	11997465	intergenic_variant	1	0.28	3E-6	5.52287874528034		1.22	[1.12-1.33]	Affymetrix, Illumina [NR] (imputed)	N
2019-06-21	31092297	Guan M	2019-05-15	Hum Genomics	www.ncbi.nlm.nih.gov/pubmed/31092297	Genome-wide association study identifies novel loci for type 2 diabetes-attributed end-stage kidney disease in African Americans.	Type 2 diabetes and end-stage kidney disease	3,432 African-American cases, 6,977 African-American controls	NA				NR					NA	NA	chr10:13527266-G	chr10:13527266	0			1	0.11	1E-9	9		1.45	[1.29-1.63]	Affymetrix, Illumina [NR] (imputed)	N
2019-06-21	31092297	Guan M	2019-05-15	Hum Genomics	www.ncbi.nlm.nih.gov/pubmed/31092297	Genome-wide association study identifies novel loci for type 2 diabetes-attributed end-stage kidney disease in African Americans.	Type 2 diabetes and end-stage kidney disease	3,432 African-American cases, 6,977 African-American controls	NA				NR					NA	NA	chr10:114758349-T	chr10:114758349	0			1	0.3	2E-16	15.698970004336		1.4	[1.29-1.52]	Affymetrix, Illumina [NR] (imputed)	N
2019-06-21	31092297	Guan M	2019-05-15	Hum Genomics	www.ncbi.nlm.nih.gov/pubmed/31092297	Genome-wide association study identifies novel loci for type 2 diabetes-attributed end-stage kidney disease in African Americans.	Type 2 diabetes and end-stage kidney disease	3,432 African-American cases, 6,977 African-American controls	NA				NR					NA	NA	chr11:2149116-G	chr11:2149116	0			1	0.14	4E-8	7.39794000867204		1.36	[1.22-1.52]	Affymetrix, Illumina [NR] (imputed)	N
2019-06-21	31092297	Guan M	2019-05-15	Hum Genomics	www.ncbi.nlm.nih.gov/pubmed/31092297	Genome-wide association study identifies novel loci for type 2 diabetes-attributed end-stage kidney disease in African Americans.	Type 2 diabetes and end-stage kidney disease	3,432 African-American cases, 6,977 African-American controls	NA				NR					NA	NA	chr13:107093993-G	chr13:107093993	0			1	0.01	2E-8	7.69897000433602		2.88	[1.99-4.16]	Affymetrix, Illumina [NR] (imputed)	N
2019-06-21	31092297	Guan M	2019-05-15	Hum Genomics	www.ncbi.nlm.nih.gov/pubmed/31092297	Genome-wide association study identifies novel loci for type 2 diabetes-attributed end-stage kidney disease in African Americans.	Type 2 diabetes and end-stage kidney disease	3,432 African-American cases, 6,977 African-American controls	NA				NR					NA	NA	chr17:7289638-A	chr17:7289638	0			1	0.01	2E-9	8.69897000433602		3.86	[2.48-5.98]	Affymetrix, Illumina [NR] (imputed)	N
2019-06-21	31092297	Guan M	2019-05-15	Hum Genomics	www.ncbi.nlm.nih.gov/pubmed/31092297	Genome-wide association study identifies novel loci for type 2 diabetes-attributed end-stage kidney disease in African Americans.	Type 2 diabetes and end-stage kidney disease	3,432 African-American cases, 6,977 African-American controls	NA				NR					NA	NA	chr17:77708184-A	chr17:77708184	0			1	0.01	3E-12	11.5228787452803		4.3	[2.85-6.47]	Affymetrix, Illumina [NR] (imputed)	N
2019-06-21	31092297	Guan M	2019-05-15	Hum Genomics	www.ncbi.nlm.nih.gov/pubmed/31092297	Genome-wide association study identifies novel loci for type 2 diabetes-attributed end-stage kidney disease in African Americans.	Type 2 diabetes and end-stage kidney disease	3,432 African-American cases, 6,977 African-American controls	NA				NR					NA	NA	chr18:65489501-C	chr18:65489501	0			1	0.02	6E-9	8.22184874961636		2.52	[1.84-3.44]	Affymetrix, Illumina [NR] (imputed)	N
2019-06-21	31092297	Guan M	2019-05-15	Hum Genomics	www.ncbi.nlm.nih.gov/pubmed/31092297	Genome-wide association study identifies novel loci for type 2 diabetes-attributed end-stage kidney disease in African Americans.	Type 2 diabetes and end-stage kidney disease	3,432 African-American cases, 6,977 African-American controls	NA				NR					NA	NA	chr19:2570002-A	chr19:2570002	0			1	0.05	2E-8	7.69897000433602		1.67	[1.4-2]	Affymetrix, Illumina [NR] (imputed)	N
2019-06-21	31092297	Guan M	2019-05-15	Hum Genomics	www.ncbi.nlm.nih.gov/pubmed/31092297	Genome-wide association study identifies novel loci for type 2 diabetes-attributed end-stage kidney disease in African Americans.	Type 2 diabetes and end-stage kidney disease	3,432 African-American cases, 6,977 African-American controls	NA				NR					NA	NA	chr19:53034652-C	chr19:53034652	0			1	0.02	1E-8	8		2.53	[1.84-3.47]	Affymetrix, Illumina [NR] (imputed)	N
2019-06-21	31092297	Guan M	2019-05-15	Hum Genomics	www.ncbi.nlm.nih.gov/pubmed/31092297	Genome-wide association study identifies novel loci for type 2 diabetes-attributed end-stage kidney disease in African Americans.	Type 2 diabetes and end-stage kidney disease	3,432 African-American cases, 6,977 African-American controls	NA				NR					NA	NA	chr20:10760829-C	chr20:10760829	0			1	0.01	2E-15	14.698970004336		7.97	[4.78-13.31]	Affymetrix, Illumina [NR] (imputed)	N
2019-06-21	31092297	Guan M	2019-05-15	Hum Genomics	www.ncbi.nlm.nih.gov/pubmed/31092297	Genome-wide association study identifies novel loci for type 2 diabetes-attributed end-stage kidney disease in African Americans.	Type 2 diabetes and end-stage kidney disease	3,432 African-American cases, 6,977 African-American controls	NA				NR					NA	NA	chr21:32804223-C	chr21:32804223	0			1	0.01	8E-22	21.0969100130081		9.41	[5.95-14.87]	Affymetrix, Illumina [NR] (imputed)	N
2019-06-21	31092297	Guan M	2019-05-15	Hum Genomics	www.ncbi.nlm.nih.gov/pubmed/31092297	Genome-wide association study identifies novel loci for type 2 diabetes-attributed end-stage kidney disease in African Americans.	Type 2 diabetes and end-stage kidney disease	3,432 African-American cases, 6,977 African-American controls	NA				NR					NA	NA	chr22:36656555-G	chr22:36656555	0			1	0.55	9E-11	10.0457574905607		1.2987013	[1.19-1.39]	Affymetrix, Illumina [NR] (imputed)	N
2019-06-21	31092297	Guan M	2019-05-15	Hum Genomics	www.ncbi.nlm.nih.gov/pubmed/31092297	Genome-wide association study identifies novel loci for type 2 diabetes-attributed end-stage kidney disease in African Americans.	Type 2 diabetes and end-stage kidney disease in APOL1 risk genotype negative individuals	2,768 African-American cases, 6,059 African-American controls	NA				NR					NA	NA	chr2:151713161-A	chr2:151713161	0			1	0.08	7E-10	9.15490195998574		1.5804348	[1.366-1.829]	Affymetrix, Illumina [NR] (imputed)	N
2019-06-21	31092297	Guan M	2019-05-15	Hum Genomics	www.ncbi.nlm.nih.gov/pubmed/31092297	Genome-wide association study identifies novel loci for type 2 diabetes-attributed end-stage kidney disease in African Americans.	Type 2 diabetes and end-stage kidney disease in APOL1 risk genotype negative individuals	2,768 African-American cases, 6,059 African-American controls	NA				NR					NA	NA	chr5:29705905-C	chr5:29705905	0			1	0.01	4E-14	13.397940008672		7.0090346	[4.235-11.601]	Affymetrix, Illumina [NR] (imputed)	N
2019-06-21	31092297	Guan M	2019-05-15	Hum Genomics	www.ncbi.nlm.nih.gov/pubmed/31092297	Genome-wide association study identifies novel loci for type 2 diabetes-attributed end-stage kidney disease in African Americans.	Type 2 diabetes and end-stage kidney disease in APOL1 risk genotype negative individuals	2,768 African-American cases, 6,059 African-American controls	NA				NR					NA	NA	chr6:12617159-C	chr6:12617159	0			1	0.02	1E-9	9		2.2846208	[1.752-2.979]	Affymetrix, Illumina [NR] (imputed)	N
2019-06-21	31092297	Guan M	2019-05-15	Hum Genomics	www.ncbi.nlm.nih.gov/pubmed/31092297	Genome-wide association study identifies novel loci for type 2 diabetes-attributed end-stage kidney disease in African Americans.	Type 2 diabetes and end-stage kidney disease in APOL1 risk genotype negative individuals	2,768 African-American cases, 6,059 African-American controls	NA				NR					NA	NA	chr6:42474989-T	chr6:42474989	0			1	0.01	2E-9	8.69897000433602		3.0823739	[2.13-4.46]	Affymetrix, Illumina [NR] (imputed)	N
2019-06-21	31092297	Guan M	2019-05-15	Hum Genomics	www.ncbi.nlm.nih.gov/pubmed/31092297	Genome-wide association study identifies novel loci for type 2 diabetes-attributed end-stage kidney disease in African Americans.	Type 2 diabetes and end-stage kidney disease in APOL1 risk genotype negative individuals	2,768 African-American cases, 6,059 African-American controls	NA				NR					NA	NA	chr8:49547701-C	chr8:49547701	0			1	0.01	4E-12	11.397940008672		6.141076	[3.673-10.267]	Affymetrix, Illumina [NR] (imputed)	N
2019-06-21	31092297	Guan M	2019-05-15	Hum Genomics	www.ncbi.nlm.nih.gov/pubmed/31092297	Genome-wide association study identifies novel loci for type 2 diabetes-attributed end-stage kidney disease in African Americans.	Type 2 diabetes and end-stage kidney disease in APOL1 risk genotype negative individuals	2,768 African-American cases, 6,059 African-American controls	NA				NR					NA	NA	chr8:74005904-T	chr8:74005904	0			1	0.01	3E-12	11.5228787452803		4.9713926	[3.173-7.789]	Affymetrix, Illumina [NR] (imputed)	N
2019-06-21	31092297	Guan M	2019-05-15	Hum Genomics	www.ncbi.nlm.nih.gov/pubmed/31092297	Genome-wide association study identifies novel loci for type 2 diabetes-attributed end-stage kidney disease in African Americans.	Type 2 diabetes and end-stage kidney disease in APOL1 risk genotype negative individuals	2,768 African-American cases, 6,059 African-American controls	NA				NR					NA	NA	chr10:114758349-T	chr10:114758349	0			1	0.3	1E-15	15		1.421482	[1.304-1.55]	Affymetrix, Illumina [NR] (imputed)	N
2019-06-21	31092297	Guan M	2019-05-15	Hum Genomics	www.ncbi.nlm.nih.gov/pubmed/31092297	Genome-wide association study identifies novel loci for type 2 diabetes-attributed end-stage kidney disease in African Americans.	Type 2 diabetes and end-stage kidney disease in APOL1 risk genotype negative individuals	2,768 African-American cases, 6,059 African-American controls	NA				NR					NA	NA	chr12:87670213-G	chr12:87670213	0			1	0.91	4E-8	7.39794000867204		1.4827522	[1.29-1.71]	Affymetrix, Illumina [NR] (imputed)	N
2019-06-21	31092297	Guan M	2019-05-15	Hum Genomics	www.ncbi.nlm.nih.gov/pubmed/31092297	Genome-wide association study identifies novel loci for type 2 diabetes-attributed end-stage kidney disease in African Americans.	Type 2 diabetes and end-stage kidney disease in APOL1 risk genotype negative individuals	2,768 African-American cases, 6,059 African-American controls	NA				NR					NA	NA	chr17:77708184-A	chr17:77708184	0			1	0.01	1E-11	11		4.6562014	[2.985-7.263]	Affymetrix, Illumina [NR] (imputed)	N
2019-06-21	31092297	Guan M	2019-05-15	Hum Genomics	www.ncbi.nlm.nih.gov/pubmed/31092297	Genome-wide association study identifies novel loci for type 2 diabetes-attributed end-stage kidney disease in African Americans.	Type 2 diabetes and end-stage kidney disease in APOL1 risk genotype negative individuals	2,768 African-American cases, 6,059 African-American controls	NA				NR					NA	NA	chr20:10760829-C	chr20:10760829	0			1	0.01	3E-13	12.5228787452803		8.038158	[4.593-14.066]	Affymetrix, Illumina [NR] (imputed)	N
2019-06-21	31092297	Guan M	2019-05-15	Hum Genomics	www.ncbi.nlm.nih.gov/pubmed/31092297	Genome-wide association study identifies novel loci for type 2 diabetes-attributed end-stage kidney disease in African Americans.	Type 2 diabetes and end-stage kidney disease in APOL1 risk genotype negative individuals	2,768 African-American cases, 6,059 African-American controls	NA				NR					NA	NA	chr21:32799557-C	chr21:32799557	0			1	0.01	2E-19	18.698970004336		9.542925	[5.839-15.595]	Affymetrix, Illumina [NR] (imputed)	N
2019-06-21	31092297	Guan M	2019-05-15	Hum Genomics	www.ncbi.nlm.nih.gov/pubmed/31092297	Genome-wide association study identifies novel loci for type 2 diabetes-attributed end-stage kidney disease in African Americans.	Type 2 diabetes and end-stage kidney disease in APOL1 risk genotype negative individuals	2,768 African-American cases, 6,059 African-American controls	NA				NR					NA	NA	chr22:36618953-C	chr22:36618953	0			1	0.74	2E-10	9.69897000433602		1.3563536	[1.23-1.49]	Affymetrix, Illumina [NR] (imputed)	N
2019-06-21	31092297	Guan M	2019-05-15	Hum Genomics	www.ncbi.nlm.nih.gov/pubmed/31092297	Genome-wide association study identifies novel loci for type 2 diabetes-attributed end-stage kidney disease in African Americans.	Type 2 diabetes and end-stage kidney disease in APOL1 risk genotype negative individuals	2,768 African-American cases, 6,059 African-American controls	NA	5q23.2	5	126437641	GRAMD3	AC093535.1, GRAMD2B			ENSG00000250602, ENSG00000155324	NA	NA	rs75029938-T	rs75029938	0	75029938	intron_variant	0	0.042	2E-9	8.69897000433602	(corrected for genomic control)	1.89	[1.54-2.34]	Affymetrix, Illumina [NR] (imputed)	N
